Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
DNAAF3	"C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22"	ENSG00000167646	"Dynein axonemal assembly factor 3"		19	55158661-55166722	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	12	"fallopian tube: 29.7;testis: 60.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 16.9;HEL: 19.7;K-562: 15.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056220			Approved	"Nuclear bodies,Mitochondria"				Mitochondria	Mitochondria	"HPA056220: AB_2683071"	"unprognostic (1.71e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (1.83e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.03e-2)"	0.2	1.0	0.7	0.1	1.7	0.0	0.4	0.1	0.5	1.9	0.3	2.5	1.8	0.0	0.9	3.8	0.3	29.7	0.6	2.9	1.2	1.5	2.5	1.7	3.3	0.1	0.5	0.1	3.1	0.8	1.0	0.3	0.1	2.7	0.2	0.0	0.4	0.8	0.6	0.2	0.3	0.1	0.1	0.2	0.2	0.2	60.1	0.8	0.2	1.5	0.1	0.4	0.1	0.1	0.0	0.9	0.5	0.4	0.0	0.0	1.6	5.4	4.5	0.4	4.4	0.0	0.0	0.5	0.1	0.0	0.6	0.5	0.2	2.6	6.6	1.6	0.2	6.5	0.9	1.9	0.2	0.0	16.9	19.7	0.2	0.3	0.1	8.4	2.0	0.1	2.7	1.1	1.4	0.3	15.4	9.0	0.2	3.5	0.2	0.2	0.3	9.8	10.2	0.6	2.0	3.4	0.1	0.6	1.7	0.7	0.7	1.0	5.5	0.3	0.6	0.5	2.6	2.5	0.1	0.2	1.5	0.3	3.1	11.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.7	1.7	0.1	0.5	1.2	1.5	0.5	0.1	2.7	0.8
CCDC33	"CT61, FLJ32855"	ENSG00000140481	"Coiled-coil domain containing 33"	Q8N5R6	15	74202705-74336472	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"fallopian tube: 35.9;testis: 41.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 12.1;SCLC-21H: 6.8;SH-SY5Y: 8.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"														"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (2.16e-1)"		"unprognostic (3.16e-3)"		"unprognostic (3.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.05e-2)"		"unprognostic (4.46e-1)"	"unprognostic (4.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.37e-2)"	0.0	0.2	0.8	0.0	2.6	0.0	0.0	0.0	0.2	0.9	0.3	2.7	0.7	0.0	0.5	3.0	0.0	35.9	0.5	0.0	1.1	1.4	0.0	0.0	3.4	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.3	41.5	0.8	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.1	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	6.8	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	0.0	0.1	1.1	1.4	0.0	0.0	3.3	0.8
DAW1	"FLJ25955, ODA16, WDR69"	ENSG00000123977	"Dynein assembly factor with WD repeats 1"	Q8N136	2	227871054-227924344	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 14.9;fallopian tube: 24.4;testis: 49.9"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 14.9;U-2197: 28.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 25.4"	HPA046118	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA046118: AB_10961428"		"unprognostic (1.23e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.37e-1)"		"unprognostic (1.23e-1)"	"unprognostic (5.63e-3)"	"unprognostic (2.90e-2)"	"unprognostic (9.92e-3)"		"unprognostic (1.54e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-1)"	0.4	0.1	2.5	0.3	14.9	0.4	0.5	0.0	1.8	0.7	0.3	3.1	0.0	0.1	0.3	3.1	0.6	24.4	0.4	0.4	3.9	3.0	0.3	0.5	2.4	0.3	0.3	2.7	1.3	0.1	0.7	0.2	0.8	14.3	0.2	0.2	0.0	0.3	0.2	2.6	0.3	0.2	0.2	0.3	0.3	0.2	49.9	1.1	0.0	0.2	0.0	0.3	0.3	0.0	0.5	0.5	1.2	0.5	0.2	0.8	0.0	0.6	0.0	0.1	0.0	0.2	0.9	0.4	0.5	0.3	0.6	0.4	3.6	0.3	0.2	0.0	0.1	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.1	1.3	0.0	0.7	0.5	14.9	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.3	1.5	0.1	1.4	28.1	0.0	0.0	0.1	0.2	2.7	0.0	0.2	1.2	0.0	0.2	0.2	0.5	0.8	0.3	0.4	0.4	0.0	0.5	0.6	0.3	0.0	0.2	0.5	0.5	0.6	0.0	2.5	14.9	0.0	1.8	3.9	3.0	0.3	2.7	14.3	1.1
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 24.4;testis: 51.9"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA036700: AB_2675261, HPA036701: "	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.0	0.2	1.7	0.0	0.0	0.0	0.2	1.1	0.2	2.0	0.0	0.0	0.5	4.3	0.0	24.4	0.5	0.4	1.7	1.6	0.0	0.0	4.0	0.0	0.1	0.1	2.3	0.0	0.0	1.1	0.1	3.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	51.9	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.1	1.7	1.6	0.1	0.1	3.2	0.3
C16orf71	"DKFZp686H2240, FLJ43261"	ENSG00000166246	"Chromosome 16 open reading frame 71"	Q8IYS4	16	4734272-4749396	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"fallopian tube: 14.1;testis: 48.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 7.5;U-2197: 8.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"											HPA049468	Enhanced		Uncertain	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA049468: AB_2680779"	"unprognostic (1.24e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.39e-1)"	"prognostic favourable (7.49e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-5)"	"unprognostic (1.65e-1)"	0.3	0.5	0.7	0.3	1.9	0.0	0.3	1.0	1.0	0.9	0.3	2.4	0.6	0.2	0.6	2.5	0.4	14.1	0.8	0.3	1.1	1.0	1.0	1.1	1.7	0.1	0.7	0.5	1.2	0.4	0.8	1.7	0.1	3.6	0.5	0.1	0.4	1.3	1.1	0.4	0.2	0.3	0.4	0.5	0.2	0.3	48.9	0.7	0.2	1.1	0.0	0.4	0.3	0.5	1.4	4.1	0.0	1.1	0.0	0.7	0.4	0.6	3.2	0.7	1.9	4.3	1.9	1.4	1.8	1.5	1.4	1.9	1.5	1.3	0.1	1.8	2.6	1.5	1.7	1.7	0.3	0.7	1.1	0.4	2.4	0.1	1.3	1.4	0.6	0.5	0.4	5.7	1.5	0.8	1.1	0.9	1.5	7.5	0.4	1.2	1.0	1.6	0.5	0.8	2.2	4.0	0.7	4.9	1.8	1.8	1.5	0.6	6.6	0.4	0.6	1.2	1.3	8.2	0.9	3.2	2.5	0.8	0.7	0.4	1.3	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.7	0.1	0.9	1.4	0.4	0.5	0.0	0.0	1.1	4.1	0.0	0.4	0.7	1.9	1.0	1.0	1.1	1.0	0.7	0.5	3.6	0.7
RP1	"DCDC4A, ORP1"	ENSG00000104237	"RP1, axonemal microtubule associated"	P56715	8	54509422-54871720	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 15.4;lung: 28.7;retina: 49.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HDLM-2: 6.9;RPTEC TERT1: 14.2;U-2197: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA042257	Enhanced									"HPA042257: AB_10797385"	"unprognostic (3.19e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.16e-3)"		"unprognostic (6.24e-2)"		"unprognostic (4.56e-2)"	"unprognostic (4.13e-5)"	"unprognostic (2.48e-1)"	"unprognostic (2.16e-5)"	"unprognostic (8.92e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.96e-2)"	0.2	0.1	0.1	0.0	0.1	0.0	0.9	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.3	0.1	15.4	0.0	0.1	0.1	0.1	3.6	0.1	28.7	0.0	0.1	0.0	3.9	0.1	0.0	0.6	0.3	0.1	0.1	0.0	49.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.3	0.6	1.7	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	2.2	0.0	0.0	1.0	0.0	0.0	6.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
ZMYND10	"BLU, CILD22"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50346852	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 55.7;testis: 99.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 10.4;U-87 MG: 7.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035255			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favourable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.1	0.1	1.9	0.2	4.8	0.3	0.6	0.3	0.8	1.6	0.1	5.5	0.2	0.2	0.9	4.6	0.2	55.7	0.3	0.1	2.6	3.1	0.5	0.2	4.7	0.2	0.2	0.3	4.2	0.2	1.4	1.6	0.1	10.2	0.1	0.1	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.5	0.2	0.1	99.4	1.2	0.1	0.8	0.1	0.1	0.1	0.0	0.4	1.1	0.8	0.7	3.8	2.5	0.5	2.7	1.0	0.4	0.8	1.0	1.6	0.8	0.4	1.7	2.9	0.9	0.2	1.4	1.0	1.1	1.7	0.6	2.4	0.1	0.3	1.1	1.1	2.5	3.5	0.1	0.1	0.7	1.2	0.1	0.3	3.7	0.2	0.2	0.6	0.6	0.4	1.4	0.5	3.4	0.0	1.1	1.0	0.1	0.8	3.6	0.1	2.9	1.1	0.3	0.8	0.2	10.4	0.9	0.0	0.8	0.7	1.8	0.2	1.3	0.6	0.3	7.3	3.3	0.2	0.3	0.4	0.3	2.5	0.4	1.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.8	3.8	0.7	0.4	0.1	0.5	1.9	4.8	0.3	0.8	2.6	3.1	0.2	0.3	10.2	1.2
AC007906.2		ENSG00000277639			16	53035690-53052873	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"fallopian tube: 29.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.1;ASC TERT1: 7.8;BEWO: 12.4;HSkMC: 7.7;RPTEC TERT1: 8.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 31.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (1.97e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.46e-3)"	0.0	0.0		0.0		0.0	1.7		0.0	4.3	1.0			0.0	0.4	0.0	2.8	29.9	3.4	0.0			3.8	0.0	3.0	0.0			0.0	3.7	0.0		0.0		3.1	1.4		0.8	0.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.1		0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.6	4.4	2.2	9.1	7.8	12.4	1.2	1.0	0.1	0.0	0.3	1.8	0.2	2.2	1.8	0.7	0.0	1.7	0.5	0.2	0.1	0.0	0.1	0.6	1.8	0.0	2.0	7.7	6.7	2.5	0.8	1.8	0.1	0.1	4.0	0.1	0.1	0.0	4.9	0.6	1.1	0.0	0.0	8.0	1.7	0.2	0.0	0.3	0.0	0.1	0.9	0.1	2.1	2.9	3.0	0.1	0.0	0.0	0.0	0.0	3.6	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0										
CCDC17	FLJ33084	ENSG00000159588	"Coiled-coil domain containing 17"	Q96LX7	1	45620044-45624057	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6"	"Cell line enhanced"	"Detected in some"		"BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA028338	Enhanced									"HPA028338: AB_10669641"	"unprognostic (3.53e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.91e-1)"	"unprognostic (8.37e-7)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.91e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	3.2	0.1	0.4	0.0	0.2	0.5	24.5	0.0	31.0	0.0	0.0	0.2	0.1	0.0	0.1	23.0	0.1	0.0	0.0	9.6	0.1	0.0	1.6	0.2	1.4	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.1	1.1	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	2.3	0.1	0.4	1.0	1.3	0.3	0.0	0.1	0.0	0.3	2.3	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.3	1.8	0.1	1.0	0.0	0.1	0.0	3.0	1.1	0.0	0.2	0.4	0.0	0.0	0.2	0.9	0.0	0.0	2.0	1.2	0.7	0.0	0.0	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.3
DEUP1	"CCDC67, FLJ25393"	ENSG00000165325	"Deuterosome assembly protein 1"	Q05D60	11	93329971-93438487	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 6.0;pituitary gland: 13.0;testis: 19.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.4;Karpas-707: 1.0;NTERA-2: 4.0;SCLC-21H: 1.6;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (4.68e-1)"	"unprognostic (3.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.25e-1)"	0.0	0.7	0.2	0.0	0.8	0.0	0.4	0.0	0.2	0.1	0.1	0.8	0.8	0.0	0.2	1.5	0.2	6.0	0.1	0.0	0.3	1.0	1.0	0.0	0.6	0.0	0.3	0.0	1.6	0.9	0.1	13.0	0.0	0.7	1.1	0.1	0.1	1.6	1.8	1.3	0.2	0.1	0.1	1.0	0.0	0.1	19.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.2	4.0	0.0	0.2	0.2	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.9	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.3	1.0	0.3	0.0	0.7	0.0
FAM166B		ENSG00000215187	"Family with sequence similarity 166 member B"	A8MTA8	9	35561831-35563899	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 77.3;fallopian tube: 26.1;skeletal muscle: 102.9"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;Hep G2: 5.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 11.7;ovarian cancer: 4.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA045540	Enhanced									"HPA045540: AB_10962627"	"unprognostic (4.18e-5)"	"unprognostic (7.56e-3)"	"unprognostic (1.65e-1)"	"prognostic favourable (2.61e-5)"	"unprognostic (5.66e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (6.20e-6)"	"unprognostic (3.69e-3)"	"unprognostic (9.09e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.52e-5)"	2.8	77.3	0.9	0.7	1.2	0.0	0.7	0.1	0.5	1.3	0.6	3.1	0.3	0.0	0.5	9.4	0.8	26.1	0.9	0.1	1.3	1.5	0.4	0.1	2.7	0.1	0.1	0.2	2.5	0.1	0.0	0.2	0.1	3.8	0.1	0.0	0.7	0.6	0.6	102.9	0.2	0.3	0.3	0.4	0.2	0.0	0.5	0.6	0.1	0.3	1.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	2.5	0.7	0.6	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.2	1.4	0.5	0.9	0.0	0.3	0.0	0.0	5.6	0.0	0.4	0.4	0.0	0.5	0.0	0.5	0.4	0.0	0.6	0.0	0.1	0.0	0.4	0.5	0.6	0.0	0.2	0.0	2.0	0.3	0.8	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.7	0.4	0.8	0.0	1.3	0.8	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.2	0.1	0.5	1.3	1.5	0.1	0.2	3.8	0.6
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007299-54018186	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 64.2;lung: 16.1;ovary: 20.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 3.6;Hep G2: 14.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.1	0.1	0.0	0.0	0.6	2.1	0.4	64.2	1.1	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	20.5	0.1	0.0	1.5	0.1	0.2	0.5	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.8	4.8	0.0	0.0	0.7	0.5	2.1	0.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	3.6	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.2	0.8	14.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.3	0.0	0.1	1.0	0.0	0.8	0.1	0.0	0.3	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.2	2.1	0.4	0.3	0.4	0.2	0.3	0.5	0.3	0.4	0.1	0.7	0.4	0.5	2.1	0.4	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508800-61511018	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8"	"Group enriched"	"Detected in some"	5	"AF22: 11.9;RH-30: 12.8;SCLC-21H: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"basal ganglia: 202.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 39.3;hippocampal formation: 35.0"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	2.4	1.6	4.8	0.9	27.8	0.5	1.9	0.2	5.8	3.4	1.6	1.2	1.0	0.9	2.2	3.7	1.1	36.2	0.8	1.2	5.2	1.9	0.9	0.6	3.7	0.5	1.1	4.3	3.0	1.5	2.1	14.8	1.2	1.2	0.9	1.0	0.0	1.1	1.2	0.7	0.5	0.9	2.5	0.2	0.6	1.0	2.4	8.3	0.9	0.8	0.2	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.0	12.8	0.0	0.0	0.0	6.7	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	27.8	0.2	5.8	5.2	1.9	1.1	4.3	1.2	8.3
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414314-111427777	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 240.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.8;SK-BR-3: 8.0"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"cerebellum: 6.6"	"Low region specificity"	"Detected in many"			HPA062205	Enhanced				"Intracellular and membrane"					"HPA062205: AB_2684710"	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favourable (3.93e-5)"	0.4	0.1	0.4	0.4	0.9	0.2	0.4	1.9	1.0	0.7	0.4	0.4	0.4	0.2	9.7	7.1	0.4	240.9	0.4	0.4	0.5	0.5	0.5	1.0	0.4	0.4	0.4	0.4	32.5	0.4	1.5	0.4	0.4	0.4	0.7	0.3	0.4	0.4	0.4	0.4	1.1	0.6	0.4	0.4	0.5	0.2	1.3	0.4	0.6	0.4	0.4	0.4	0.5	0.4	0.8	0.9	0.0	0.5	0.0	1.6	0.2	0.7	0.6	1.5	0.8	3.0	3.4	2.7	0.4	2.2	0.5	1.2	0.9	0.0	1.3	2.9	0.9	0.8	0.4	0.5	0.9	3.2	7.8	0.4	1.0	3.7	1.1	1.3	3.6	3.1	4.8	0.1	1.7	0.6	0.5	2.4	0.2	0.8	1.0	1.9	0.4	2.8	1.0	0.3	1.1	2.3	5.8	1.0	0.9	0.3	8.0	1.1	0.6	1.3	1.3	0.3	0.4	4.0	1.1	3.0	0.8	0.7	0.3	2.5	0.3	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.5	0.0	0.9	0.8	1.6	1.2	0.0	0.0	0.5	0.0	0.1	0.2	0.4	0.9	1.9	1.0	0.5	0.5	0.4	0.4	0.4	0.4
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821977	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6"	"Group enriched"	"Detected in some"	6	"NB-4: 23.5;THP-1: 49.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.7	0.7	20.5	1.2	30.0	18.2	2.1	0.1	21.3	0.9	0.7	0.7	0.0	0.7	1.3	0.7	0.7	12.6	1.1	0.7	14.4	13.1	0.7	0.7	2.6	0.9	3.9	14.9	1.0	0.7	0.7	0.1	0.8	4.7	0.9	0.7	0.1	0.7	0.8	0.9	0.8	1.0	0.7	1.1	0.9	0.9	3.0	3.1	0.0	0.7	0.0	0.7	0.8	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	4.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.1	0.9	0.0	0.0	0.0	2.0	0.0	0.6	0.0	0.2	1.6	0.1	0.6	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.4	0.0	23.5	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.2	0.1	0.0	0.0	2.1	49.8	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	3.8	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	30.0	0.1	21.3	14.4	13.1	3.9	14.9	4.7	3.1
PYDC2	POP2	ENSG00000253548	"Pyrin domain containing 2"	Q56P42	3	191461163-191461456	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"fallopian tube: 1.0;testis: 1.0"	"Cell line enriched"	"Detected in single"	49	"A549: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055895	Uncertain									"HPA055895: AB_2682962"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RSPH10B		ENSG00000155026	"Radial spoke head 10 homolog B"	P0C881	7	5925550-5970683	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"fallopian tube: 9.6;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"									HPA049182	Supported									"HPA049182: AB_2680666"	"unprognostic (4.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-3)"	0.0	0.1	1.1	0.0	1.3	0.0	0.0	0.2	0.2	0.8	0.0			0.0	0.3	0.2	0.0	9.6	0.0	0.0	1.5	1.6	0.0	0.2	1.4	0.0	0.1		0.0	0.0	2.2	0.8	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	20.8			0.1		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.7	0.1	0.2	1.0	0.0	0.4	0.2	0.0	0.0	0.2	0.1	0.1	0.4	0.2	0.4	0.3	0.2	0.0	0.1	0.5	1.1	0.3	0.2	1.8	0.6	0.0	0.5	0.4	2.9	0.1	0.5	0.1	1.0	0.7	1.0	0.2	0.5	0.4	1.6	0.7	0.4	0.4	0.1	0.0	0.0	0.0	0.5	0.1	0.7	0.1	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.9	1.3	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TUBA4B	"FLJ13940, TUBA4"	ENSG00000243910	"Tubulin alpha 4b"	Q9H853	2	219253243-219272188	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"fallopian tube: 29.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.1;SCLC-21H: 3.6"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 8.4"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (3.20e-5)"	"unprognostic (1.47e-4)"	"unprognostic (1.85e-1)"	"unprognostic (3.70e-3)"	"unprognostic (9.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.78e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.08e-1)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.2	0.4	0.0	29.7	0.0	0.0			0.4	0.0	2.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		1.0	0.2	2.4	0.6	0.6	1.5	4.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.7	0.0	0.7	0.0	0.7	0.0	0.4	0.2	0.2	0.6	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.1	0.0	0.1	3.6	0.1	0.9	0.3	0.0	0.2	0.4	0.0	0.0	0.5	0.3	0.1	0.4	0.0	0.6	0.8	0.5	0.0	0.7	0.4	1.4	0.7	0.4	0.8	1.0	1.5	1.2	0.2	0.8	1.2	1.4	2.4	0.6	0.6	0.1	1.3	4.0										
C1orf141		ENSG00000203963	"Chromosome 1 open reading frame 141"	Q5JVX7	1	67092165-67231853	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 14.9;fallopian tube: 12.8;testis: 18.7"	"Cell line enriched"	"Detected in single"	37	"HEL: 17.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 14.9"	"Group enriched"	"Detected in some"	5	"basophil: 2.5;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.5"					"Low region specificity"	"Detected in all"			HPA035316			Uncertain	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA035316: AB_10600886"					"unprognostic (1.48e-1)"			"unprognostic (8.09e-2)"		"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"			"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"			0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.1	1.3	0.3	0.1	1.9	0.0	0.0	0.1	1.1	0.0	12.8	0.2	0.0	2.6	1.8	0.1	0.1	2.0	0.1	0.3	0.7	1.8	0.0	0.0	1.0	0.0	14.9	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.2	18.7	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	2.5	0.1	0.4	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	17.7	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.4	0.0	0.1	0.0	0.5	1.1	2.6	0.1	1.3	2.6	1.8	0.3	0.7	14.9	0.9
C22orf15	"FLJ36561, N27C7-3"	ENSG00000169314	"Chromosome 22 open reading frame 15"	Q8WYQ4	22	23763021-23765861	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"fallopian tube: 22.3"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;BJ: 2.5;BJ hTERT+: 5.4;HSkMC: 2.3;MOLT-4: 3.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.7"					"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.9"	"Low lineage specificity"	"Detected in many"																"Secreted in female reproductive system"						"unprognostic (2.37e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.28e-1)"	"prognostic favourable (8.53e-5)"	"unprognostic (1.86e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.08e-3)"	0.0	0.1	1.0	0.0	1.7	0.4	0.1	0.0	0.0	0.8	0.1			0.0	0.2	0.0	0.0	22.3	0.2	0.0	1.4	1.9	0.0	0.0	2.7	0.2	0.0		0.5	0.0	0.0	1.5	0.2		0.1	0.0		0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	3.6			0.0		0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	1.8	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	2.5	5.4	0.0	0.5	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.6	1.0	0.8	0.4	0.5	1.8	0.5	0.0	0.0	0.0	2.9	0.0	0.2										
CCDC187	MGC50722	ENSG00000260220	"Coiled-coil domain containing 187"	A0A096LP49	9	136249971-136306901	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 10.2;testis: 35.9"	"Group enriched"	"Detected in some"	7	"RPMI-8226: 14.5;SCLC-21H: 4.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"					"Cell type enriched"	"Detected in single"	5	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"																				"unprognostic (1.11e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.31e-2)"		"unprognostic (6.18e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.93e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	10.2	0.0	0.0	0.0		0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	35.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	14.5	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CDC20B	FLJ37927	ENSG00000164287	"Cell division cycle 20B"	Q86Y33	5	55112995-55173175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.4;T-47d: 3.3;U-87 MG: 1.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 0.4"					HPA053900	Uncertain									"HPA053900: AB_2682299"	"unprognostic (7.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.15e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.29e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.8	0.1	0.1	5.5	0.1	0.1	0.1	0.1	2.9	0.1	4.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.1	0.4	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.3	3.3	0.0	0.4	0.0	0.2	0.7	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148458-86832604	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 29.5;epididymis: 9.3;fallopian tube: 8.0"	"Cell line enriched"	"Detected in some"	7	"HAP1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.9	0.9	7.9	0.6	29.5	0.6	0.6	0.2	17.8	1.0	0.8	0.3	0.0	1.2	1.2	9.3	0.7	8.0	0.6	0.6	13.5	10.8	2.4	0.6	0.9	0.6	3.4	10.4	1.4	1.1	0.7	1.3	0.6	11.8	1.5	0.7	1.6	0.7	0.8	0.6	0.7	1.3	0.8	0.7	0.6	1.4	0.7	1.7	0.0	0.7	0.0	0.6	1.4	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	29.5	0.2	16.8	13.5	10.8	3.4	10.4	11.8	1.7
FGF14	"FHF4, SCA27"	ENSG00000102466	"Fibroblast growth factor 14"	Q92915	13	101710804-102402457	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 46.4;cervix, uterine: 23.2;fallopian tube: 15.7"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 20.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Region enhanced"	"Detected in all"		"cerebellum: 46.4"	"Group enriched"	"Detected in some"	11	"memory CD4 T-cell: 1.0;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049828			Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA049828: AB_2680901"	"unprognostic (2.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.80e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.86e-2)"	"unprognostic (8.48e-2)"	1.6	4.4	6.0	0.8	12.1	0.4	0.8	46.4	13.6	23.2	0.9	1.0	0.1	1.2	0.8	1.5	2.4	15.7	1.1	3.5	4.5	10.4	1.3	2.1	3.0	0.6	2.3	4.5	0.5	1.5	0.5	4.6	0.6	6.5	0.7	1.1	0.0	1.2	1.4	0.7	1.2	0.8	0.8	1.8	0.6	3.2	3.5	3.6	0.0	0.7	0.0	0.5	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	4.8	20.5	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.3	0.3	0.0	0.3	0.0	0.0	4.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	6.0	12.1	46.4	11.4	4.5	10.4	2.3	4.5	6.5	3.6
GJB7	"bA136M9.1, CX25"	ENSG00000164411	"Gap junction protein beta 7"	Q6PEY0	6	87282978-87329278	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.7;HDLM-2: 10.8;MCF7: 5.9;RT4: 5.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"														"unprognostic (8.30e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-3)"		"unprognostic (2.61e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.10e-2)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0			0.0	0.1	0.0	0.0	12.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	10.0	4.5		0.0	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3			0.0		0.1	0.5	0.0	0.7	0.1	1.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	10.8	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	5.9	0.0	0.1	1.9	0.0	0.2	0.0	0.0	0.0	5.3	0.1	0.0	1.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.6	1.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0										
MEGF11	"DKFZp434L121, KIAA1781"	ENSG00000157890	"Multiple EGF like domains 11"	A6BM72	15	65895079-66253747	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 34.7;fallopian tube: 16.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;HEK 293: 3.6;RPTEC TERT1: 12.4;SCLC-21H: 9.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in many"	4	"cerebellum: 39.2"	"Region enriched"	"Detected in all"	7	"cerebellum: 62.2"												"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.84e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.81e-3)"	"unprognostic (5.71e-5)"	"unprognostic (7.94e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.89e-2)"	0.6	0.8	8.7	0.9	5.4	1.3	0.6	34.7	17.1	0.6	0.7	5.3	0.0	0.6	0.8	2.3	0.7	16.3	0.7	0.6	11.6	5.7	4.6	0.6	1.6	0.9	6.5	2.5	0.7	1.0	0.5	1.5	0.6	9.2	0.7	0.6	3.4	0.6	0.8	0.6	3.2	0.7	0.6	9.2	0.9	1.0	2.6	5.5	0.0	0.7	0.0	0.7	0.6	0.2	0.3	0.1	0.5	0.2	0.0	1.5	0.0	0.0	0.1	0.5	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.7	0.0	0.1	0.3	0.0	0.1	0.2	3.6	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.1	12.4	0.3	9.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.0	0.0	0.1	0.4	1.5	0.5	0.0	0.0	0.1	0.1	0.0	8.7	5.4	34.7	4.7	11.6	5.7	6.5	2.5	9.2	5.5
MS4A8	"CD20L5, MS4A4, MS4A8B"	ENSG00000166959	"Membrane spanning 4-domains A8"	Q9BY19	11	60699574-60715811	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"fallopian tube: 36.8;intestine: 123.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CAPAN-2: 1.7;HDLM-2: 1.6;NB-4: 2.5;RPMI-8226: 4.4;SCLC-21H: 3.2;SH-SY5Y: 1.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA007318, HPA007319"	Enhanced									"HPA007318: AB_1854139, HPA007319: AB_1854138"	"unprognostic (7.28e-3)"	"unprognostic (2.11e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.52e-2)"			"unprognostic (9.41e-2)"	"unprognostic (4.89e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-2)"		"unprognostic (1.59e-3)"	0.1	0.2	1.4	2.0	0.2	0.0	0.1	0.2	0.6	7.1	43.9	0.4	0.6	46.6	2.5	5.9	0.3	36.8	8.9	0.3	0.6	0.3	0.2	0.1	8.6	0.1	0.1	0.5	4.2	1.2	0.0	4.7	0.1	1.0	2.3	4.0	0.2	0.4	10.9	0.8	0.1	123.9	0.1	0.1	0.1	12.7	0.7	0.1	0.2	0.1	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	4.4	0.0	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.2	0.6	0.6	0.3	0.1	0.5	1.0	0.1
OBP2A	"hOBPIIa, LCN13, OBP"	ENSG00000122136	"Odorant binding protein 2A"	Q9NY56	9	135546139-135549969	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 23.7;testis: 13.3"	"Group enriched"	"Detected in some"	11	"U-266/70: 2.7;U-266/84: 10.3"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055955	Uncertain				"Secreted in other tissues"					"HPA055955: AB_2682985"	"unprognostic (2.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.20e-1)"		"unprognostic (2.75e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.83e-11)"	"unprognostic (5.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.84e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	23.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.0	1.2	0.4	0.1	0.4	0.0	0.1	0.1	0.1	0.1	2.9	0.1	0.1	0.1	0.2	0.0	13.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
RSPH10B2		ENSG00000169402	"Radial spoke head 10 homolog B2"	B2RC85	7	6754109-6799365	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 10.7;testis: 19.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;SH-SY5Y: 1.4;U-266/84: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049182	Supported									"HPA049182: AB_2680666"	"unprognostic (7.74e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.28e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.05e-3)"		"unprognostic (2.58e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.02e-2)"	0.0	0.0	0.4	0.0	0.9	0.2	0.0	0.1	0.0	0.3	0.0			0.0	0.1	0.3	0.0	10.7	0.0	0.0	0.9	1.0	0.0	0.0	1.3	0.0	0.0		0.0	0.0	2.4	0.5	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.3			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.1	0.4	0.8	0.0	0.1	2.0	0.1	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.7	0.1	1.0	0.1	0.0	0.2	0.0	0.8	0.0	0.3	0.2	0.4	0.0	0.4	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.2	0.0	0.3	3.3	0.0	0.4	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SNTN	"FLJ44379, S100AL"	ENSG00000188817	"Sentan, cilia apical structure protein"	A6NMZ2	3	63652668-63679020	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;RH-30: 2.6;SH-SY5Y: 3.6"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 1.2"	"HPA043322, HPA058399"	Enhanced									"HPA043322: AB_10793945, HPA058399: AB_2683705"	"unprognostic (9.70e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-3)"				"unprognostic (4.34e-3)"		"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.73e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"		"unprognostic (8.43e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.1	26.6	0.0	73.9	0.0	0.0	0.6	0.3	0.0	0.0	29.5	0.0	0.0	0.0	18.5	0.1	0.0	1.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	5.8	0.0	0.1	0.0	0.0	0.9	0.4	1.6	0.2	0.4	0.5	0.1	0.3	0.2	0.6	0.8	0.1	1.5	0.5	0.0	0.0	0.0	0.3	0.2	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.4	2.6	0.2	0.2	0.4	0.3	3.6	0.1	0.4	0.0	0.1	0.3	0.0	0.7	0.6	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.6	1.6	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.0	0.9	0.5	0.4	1.1	0.4	0.2	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0
SPAG8	"BS-84, CT142, HSD-1, hSMP-1, SPAG3"	ENSG00000137098	"Sperm associated antigen 8"	Q99932	9	35808045-35812272	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.7;epididymis: 9.7;fallopian tube: 30.0;testis: 23.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"basal ganglia: 8.6;pons and medulla: 32.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA068012	Enhanced									"HPA068012: AB_2685941"	"unprognostic (1.01e-4)"	"unprognostic (3.52e-3)"	"unprognostic (6.36e-3)"	"prognostic favourable (2.15e-4)"	"unprognostic (2.62e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-3)"	1.0	1.4	2.4	0.9	8.6	1.1	1.1	1.1	3.5	3.7	1.3	9.1	2.7	1.4	1.6	9.7	1.2	30.0	1.6	2.6	4.1	3.2	1.2	0.8	2.9	1.2	1.6	2.8	2.5	1.2	2.2	3.9	1.0	32.7	1.4	0.8	2.5	1.3	3.5	1.3	1.1	1.0	1.0	2.2	1.2	1.2	23.6	4.4	0.9	2.9	0.4	0.9	1.7	0.7	1.3	3.0	4.2	1.8	2.3	2.7	1.0	0.1	0.2	0.0	0.4	4.2	1.4	0.0	0.5	0.2	1.4	0.5	0.8	0.2	0.0	0.0	0.2	1.0	0.4	1.9	0.2	0.9	0.3	1.3	0.2	0.1	0.3	0.0	0.4	1.1	0.8	1.6	0.8	1.2	0.1	1.5	1.5	0.8	0.3	0.1	0.4	0.8	0.4	0.5	1.3	1.5	0.0	1.5	0.9	0.1	0.1	0.4	0.9	1.5	1.2	0.3	0.6	0.7	0.1	0.5	0.6	0.1	2.1	1.2	0.9	4.2	1.8	0.0	1.6	1.2	0.5	0.2	1.3	1.8	3.0	1.3	0.9	2.5	0.0	2.3	0.1	0.1	2.7	1.0	2.4	8.6	1.1	3.5	4.1	3.2	1.6	2.8	32.7	4.4
TCTE1	"D6S46, DRC5, FAP155, MGC33600"	ENSG00000146221	"T-complex-associated-testis-expressed 1"	Q5JU00	6	44278743-44297688	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 17.3;testis: 48.6"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.6;Karpas-707: 3.8;SCLC-21H: 3.1;U-266/70: 1.7;U-266/84: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031739			Uncertain	Vesicles				Vesicles	Vesicles	"HPA031739: AB_10601269"	"unprognostic (3.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.23e-5)"	"unprognostic (7.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.68e-1)"	0.2	0.2	2.2	0.2	2.2	1.1	0.2	5.8	1.8	0.7	0.2	1.1	0.0	0.2	0.6	3.0	0.2	17.3	0.3	0.2	2.8	2.0	0.2	0.2	2.1	0.2	0.8	1.0	2.2	0.3	0.2	0.2	0.2	3.2	0.4	0.2	0.0	0.4	0.4	0.2	0.6	0.3	0.3	0.6	0.3	0.2	48.6	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.9	0.0	0.1	0.0	0.2	0.1	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.1	0.2	0.1	0.6	0.3	0.0	0.0	2.6	0.0	0.1	3.8	0.0	0.3	0.2	0.5	0.2	0.0	0.9	0.4	0.0	0.0	0.1	3.1	1.0	0.0	0.2	1.2	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.7	3.2	0.3	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.1	0.2	0.0	2.2	2.2	5.8	1.8	2.8	2.0	0.8	1.0	3.2	0.3
TEKT2	TEKTB1	ENSG00000092850	"Tektin 2"	Q9UIF3	1	36084075-36088275	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 41.4;testis: 33.3"	"Cell line enriched"	"Detected in some"	7	"NB-4: 28.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	45	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027248, HPA027461"	Approved		Uncertain	Microtubules				Microtubules	Microtubules	"HPA027248: , HPA027461: AB_10600912"	"unprognostic (1.02e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-3)"	"unprognostic (5.28e-4)"	"unprognostic (6.11e-2)"	"prognostic favourable (1.98e-4)"	"unprognostic (9.78e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.68e-2)"	0.2	0.5	1.9	0.2	3.8	0.9	0.8	0.8	1.1	2.3	0.2	3.1	0.5	0.2	1.1	6.1	0.2	41.4	0.2	0.2	2.3	2.5	1.0	0.1	4.0	0.2	0.5	0.8	3.3	1.1	1.2	2.0	0.2	6.4	0.3	0.1	0.1	0.4	1.1	0.1	0.1	0.1	0.4	0.7	0.1	0.3	33.3	1.2	0.3	1.9	0.3	0.2	0.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	28.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	1.9	3.8	0.8	1.1	2.3	2.5	0.5	0.8	6.4	1.2
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.2;SH-SY5Y: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"				Cytosol	Cytosol	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.0	0.9	2.0	0.1	4.2	3.8	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.7	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2
BMP15	GDF9B	ENSG00000130385	"Bone morphogenetic protein 15"	O95972	X	50910784-50916607	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 2.2;testis: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"																							0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.1	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C1orf158	MGC35194	ENSG00000157330	"Chromosome 1 open reading frame 158"	Q8N1D5	1	12746215-12763699	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 23.5;testis: 74.6"	"Low cell line specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.5"	HPA028396			Uncertain	Cytosol				Cytosol	Cytosol	"HPA028396: AB_10603451"	"unprognostic (1.11e-2)"			"unprognostic (4.94e-3)"	"unprognostic (4.62e-1)"			"unprognostic (8.00e-2)"		"unprognostic (4.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.45e-1)"		"unprognostic (3.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"		0.0	0.0	0.7	0.0	2.4	0.3	0.0	0.0	0.2	0.9	0.0	6.2	0.0	0.0	0.4	4.2	0.1	23.5	0.1	0.0	1.0	1.4	0.0	0.0	2.8	0.1	0.2	0.1	4.8	0.1	0.0	0.4	0.1	9.3	0.0	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.2	0.1	0.1	74.6	0.9	0.0	0.5	0.0	0.1	0.0	0.0	0.9	0.6	2.3	0.6	1.1	0.8	0.1	0.5	1.3	1.1	0.7	0.6	0.0	1.0	0.1	0.3	0.2	0.2	1.3	0.7	1.1	0.3	0.3	0.4	0.1	0.1	0.2	0.2	0.7	1.1	1.9	0.5	0.0	0.9	1.0	0.1	0.7	0.2	0.1	0.0	0.9	1.4	0.3	0.5	0.2	0.7	1.5	0.5	0.6	0.3	0.9	0.1	0.5	1.8	0.8	0.5	0.6	0.3	0.7	0.2	0.5	0.5	0.8	0.4	0.8	0.6	0.5	1.2	1.0	1.1	0.5	1.6	0.6	0.5	0.7	0.5	0.6	0.5	0.5	0.5	0.1	0.9	0.8	0.7	2.3	1.1	0.6	0.6	0.4	0.1	0.7	2.4	0.0	0.2	1.0	1.4	0.2	0.1	9.3	0.9
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 36.5;fallopian tube: 60.2;testis: 77.6"	"Cell line enhanced"	"Detected in some"		"AF22: 4.4;RPTEC TERT1: 1.0;SCLC-21H: 6.1;U-87 MG: 1.7"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 36.5"	"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA031144: AB_10602109, HPA049684: AB_2680849"	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.3	0.4	1.5	0.3	6.8	0.3	0.4	0.3	2.6	1.8	0.3	12.3	0.0	0.4	1.0	11.1	0.4	60.2	0.3	0.3	3.0	1.6	0.3	0.3	7.5	0.4	0.5	1.8	10.3	0.7	0.4	2.7	0.3	36.5	0.4	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.7	0.3	0.5	77.6	2.3	0.0	0.5	0.0	0.3	0.5	0.2	0.2	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.1	0.3	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	6.8	0.3	2.6	3.0	1.6	0.5	1.8	36.5	2.3
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397832	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 47.6;fallopian tube: 76.2;testis: 23.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced									"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favourable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.5	1.2	12.7	1.0	20.0	0.8	1.0	1.5	10.8	3.3	1.6	12.2	0.0	2.1	1.3	7.2	1.1	76.2	1.0	4.8	11.2	11.0	1.9	1.0	10.3	0.9	5.3	6.4	6.2	1.5	0.8	3.1	0.9	47.6	1.5	1.3	0.0	2.0	1.1	1.6	1.2	4.3	1.2	2.0	0.9	1.4	23.7	3.0	0.0	1.2	0.1	1.0	0.9	0.0	0.6	0.4	0.1	0.1	0.9	3.6	0.5	0.8	0.0	1.5	0.6	0.3	0.0	1.3	0.6	0.6	0.3	1.3	1.3	0.0	0.3	0.5	0.0	1.2	0.5	0.2	0.0	2.3	1.2	0.0	1.6	4.0	0.0	0.1	2.0	0.3	0.2	0.4	0.0	0.6	0.0	0.6	0.2	0.0	1.3	0.8	0.6	0.8	0.6	0.1	0.1	0.5	0.1	1.6	0.6	0.0	0.4	0.1	1.0	0.0	0.0	1.2	1.0	0.5	0.8	2.4	1.3	0.4	1.3	0.2	2.4	0.0	0.0	0.0	1.1	0.1	0.0	0.6	1.3	0.4	0.4	0.0	3.6	1.1	0.1	0.9	0.0	0.0	1.7	0.5	12.7	20.0	1.5	10.8	11.2	11.0	5.3	6.4	47.6	3.0
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877789-138124624	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 20.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA044347	Uncertain									"HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.5	6.2	5.7	0.7	8.7	0.5	0.5	18.7	18.9	1.2	0.8	0.2	0.0	0.6	0.6	1.7	0.4	6.6	1.4	1.0	4.5	7.3	0.4	1.2	0.5	0.5	2.9	9.1	0.5	1.2	0.4	4.8	0.4	3.6	1.6	0.8	0.4	0.4	1.3	0.4	0.9	0.7	0.8	4.5	0.6	0.6	8.1	1.4	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	20.7	3.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	8.7	18.7	10.9	4.5	7.3	2.9	9.1	3.6	1.4
CFAP126	"C1orf192, Flattop, Fltp"	ENSG00000188931	"Cilia and flagella associated protein 126"	Q5VTH2	1	161364731-161367874	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 53.4;fallopian tube: 85.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;RPTEC TERT1: 2.5;SCLC-21H: 2.4;T-47d: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	7	"pons and medulla: 53.4"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045904	Enhanced									"HPA045904: AB_10960411"																		0.7	0.7	5.8	0.7	7.5	0.7	1.1	1.2	2.7	3.0	0.7	23.3	0.0	0.7	2.7	14.8	0.7	85.7	0.8	0.7	7.0	8.0	1.8	0.8	8.1	0.7	4.1	3.9	11.2	0.8	0.7	3.3	0.7	53.4	0.8	0.7	0.0	0.7	1.2	2.8	0.7	0.7	0.7	3.3	0.7	0.7	15.3	4.3	0.0	2.7	0.1	0.8	0.7	0.0	0.0	0.1	0.6	0.5	0.0	1.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.8	7.5	1.2	2.7	7.0	8.0	4.1	3.9	53.4	4.3
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706989-127716002	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5"	"Cell line enhanced"	"Detected in many"		"A549: 9.1;HeLa: 7.4;MCF7: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 19.8;pons and medulla: 30.2"	"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favourable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7.0	1.6	0.2	1.0	24.0	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0.0	0.0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0.0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0.0	0.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	9.1	0.9	1.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.9	1.3	1.4	1.4	0.0	4.5	0.0	0.0	0.0	3.4	1.0	0.9	7.4	2.2	0.0	0.7	2.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	6.5	1.3	0.5	0.8	4.9	2.0	0.9	1.5	0.0	0.4	6.3	1.1	1.9	3.6	0.7	3.2	0.3	1.7	1.9	1.5	4.9	0.8	1.0	2.5	1.1	0.7	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	19.8	0.1	0.3	4.6	5.8	0.0	0.0	30.2	3.5
CFAP206	"C6orf165, dJ382I10.1, FLJ25974"	ENSG00000272514	"Cilia and flagella associated protein 206"	Q8IYR0	6	87407983-87464465	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 17.7;testis: 60.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.4;RPTEC TERT1: 5.3;T-47d: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"									"HPA044891, HPA072261"	Approved		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Nucleoplasm	"HPA044891: AB_10960832, HPA072261: AB_2686501"	"unprognostic (4.31e-1)"	"unprognostic (8.75e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.51e-2)"		"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.99e-3)"	"unprognostic (9.08e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	0.2	0.5	1.3	0.3	3.0	0.2	0.5	0.3	2.2	0.9	0.3	3.0	0.2	0.3	0.7	3.4	0.2	17.7	0.4	0.3	2.1	2.0	1.5	0.3	2.4	0.2	0.7	1.4	2.7	0.3	0.8	2.6	0.4	8.1	0.5	0.2	0.3	0.3	0.5	0.2	0.3	0.2	0.3	0.5	0.2	0.2	60.5	0.6	0.0	1.4	0.0	0.2	0.4	0.1	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.9	0.5	2.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.2	1.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.9	0.0	0.2	0.0	0.1	0.8	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	1.2	1.1	0.6	0.4	0.5	0.3	9.0	0.2	0.0	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.3	3.0	0.3	2.2	2.1	2.0	0.7	1.4	8.1	0.6
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643459	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 29.5;fallopian tube: 46.9;testis: 26.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.2;HeLa: 2.8;MCF7: 5.2;REH: 3.5;T-47d: 3.1"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023247	Enhanced									"HPA023247: AB_1858797"	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.4	0.6	3.7	0.4	8.4	0.4	0.4	0.3	2.5	2.6	0.4	8.5	0.1	0.9	1.3	6.4	0.4	46.9	0.5	0.4	5.9	6.0	0.5	0.4	3.9	0.3	0.5	0.5	4.8	0.3	0.7	5.4	0.5	29.5	0.5	0.3	0.7	1.3	0.5	0.3	0.5	0.9	0.3	1.1	0.4	0.4	26.8	3.5	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	1.7	2.1	0.0	0.7	1.4	1.0	1.0	0.0	0.1	0.0	0.0	0.1	4.2	0.0	0.5	0.0	2.3	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.4	0.1	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	5.2	0.0	0.8	0.4	0.2	3.5	0.0	0.1	0.4	1.0	0.9	0.0	0.7	1.4	0.0	3.1	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	8.4	0.3	2.5	5.9	6.0	0.5	0.5	29.5	3.5
DNAH3	"DKFZp434N074, DLP3, Dnahc3b, Hsadhc3"	ENSG00000158486	"Dynein axonemal heavy chain 3"	Q8TD57	16	20933111-21159441	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 10.4;testis: 6.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.1;hTEC/SVTERT24-B: 1.3;U-698: 1.2"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062493			Approved	"Nuclear membrane,Intermediate filaments"				"Nuclear membrane"	"Nuclear membrane"	"HPA062493: "	"unprognostic (1.68e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.57e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.2			0.0	0.2	0.0	0.0	10.4	0.0	0.0	0.5	0.7	0.0	0.0	1.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.3		0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	6.2			0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	1.0	1.1	0.1	0.4	0.0	0.4	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.3	1.3	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.7	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DNAI1	"CILD1, DIC1, PCD"	ENSG00000122735	"Dynein axonemal intermediate chain 1"	Q9UI46	9	34457414-34520989	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.6;fallopian tube: 32.2;pituitary gland: 36.4;testis: 47.0"	"Cell line enhanced"	"Detected in some"		"AF22: 1.8;BEWO: 5.6;HDLM-2: 4.0;RPTEC TERT1: 2.1;SK-BR-3: 2.9;T-47d: 1.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA021649, HPA021843"	Enhanced									"HPA021649: AB_1847913, HPA021843: AB_1847914"	"unprognostic (9.61e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	0.4	0.4	2.3	0.4	8.0	0.4	0.9	0.3	3.1	2.2	0.4	3.6	0.0	0.4	1.3	6.8	0.4	32.2	0.5	0.4	2.7	3.3	0.9	0.5	4.3	0.4	1.0	0.2	3.5	1.2	1.9	36.4	0.4	14.6	0.5	0.4	1.3	0.4	0.5	0.4	0.4	0.4	0.4	0.6	0.4	0.6	47.0	1.5	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	1.8	0.7	0.2	0.0	5.6	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	2.1	0.0	0.4	0.3	0.0	2.9	0.8	1.9	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	8.0	0.3	3.1	2.7	3.3	1.0	0.2	14.6	1.5
DNAI2	"CILD9, DIC2"	ENSG00000171595	"Dynein axonemal intermediate chain 2"	Q9GZS0	17	74274247-74314884	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 28.1;testis: 47.2"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 6.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 7.9"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 7.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB006245, HPA050565"	Enhanced									"CAB006245: AB_426059, HPA050565: AB_2681177"	"unprognostic (6.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.62e-3)"	0.1	0.0	0.8	0.2	1.3	0.1	0.0	0.0	0.1	2.5	0.0	3.1	0.0	0.0	0.9	2.9	0.0	28.1	0.0	0.0	1.6	1.7	0.0	0.0	3.8	0.1	0.0	0.0	3.7	0.0	0.0	1.9	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	47.2	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.9	0.7	0.0	0.0	0.1	0.1	0.0	7.9	0.0	0.0	0.6	0.1	0.8	1.3	0.0	0.1	1.6	1.7	0.0	0.0	3.6	0.3
KCNE1B		ENSG00000276289	"Potassium voltage-gated channel subfamily E regulatory subunit 1B"	A0A087WTH5	21	7816675-7829926	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 4.0;fallopian tube: 8.2;heart muscle: 8.3;kidney: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.9;SK-MEL-30: 2.5;U-266/70: 1.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.0;eosinophil: 4.0"	"Group enriched"	"Detected in many"	17	"granulocytes: 4.0;monocytes: 1.6"																				"unprognostic (5.41e-4)"	"unprognostic (8.78e-2)"		"unprognostic (7.14e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.34e-2)"		"unprognostic (1.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.24e-1)"		"unprognostic (1.73e-3)"	"unprognostic (6.59e-2)"	"unprognostic (1.49e-1)"			0.0	0.0		0.0		0.0	1.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	8.2	0.0	8.3			3.8	0.4	1.2	0.0			0.0	0.0	0.8		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.9		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	4.0	1.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.7	0.5	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	3.0	1.6	4.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.1	0.2										
KLHL32	"BKLHD5, KIAA1900"	ENSG00000186231	"Kelch like family member 32"	Q96NJ5	6	96924620-97140754	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"brain: 47.1;fallopian tube: 12.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.0;HDLM-2: 8.1;RPMI-8226: 3.7;SCLC-21H: 3.5;U-266/70: 4.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.2;T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039150	Enhanced									"HPA039150: AB_2676367"	"unprognostic (1.75e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.22e-2)"	"unprognostic (5.00e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-5)"	"unprognostic (5.82e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.49e-4)"	1.0	2.6	14.2	1.5	47.1	1.1	1.5	8.8	36.9	1.5	2.0	19.4	0.0	2.3	1.3	1.8	1.0	12.8	1.5	2.1	16.2	11.1	4.3	2.0	2.2	1.6	31.0	14.7	2.7	3.2	2.6	3.0	1.0	22.0	1.2	2.5	0.1	1.8	1.3	2.9	1.1	2.9	1.2	30.6	1.4	1.7	3.7	32.2	0.0	2.3	0.0	1.6	1.1	0.5	2.2	0.1	0.1	0.0	0.7	5.5	1.5	0.0	0.0	0.7	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.5	6.0	0.2	0.0	0.2	0.6	0.2	0.0	8.1	1.3	0.4	0.1	0.2	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.9	3.0	0.0	0.0	1.5	0.4	0.4	0.3	0.2	0.0	3.7	0.0	0.0	3.5	1.2	0.0	0.0	0.8	0.2	0.2	0.4	0.0	0.1	0.0	0.0	4.3	0.7	2.4	0.2	0.3	0.4	0.0	0.0	0.0	0.9	0.0	2.1	2.2	3.6	1.3	0.1	1.5	4.2	5.5	0.1	0.7	0.0	0.0	2.5	1.5	14.2	47.1	8.8	36.9	16.2	11.1	31.0	14.7	22.0	32.2
LRRC46	MGC16309	ENSG00000141294	"Leucine rich repeat containing 46"	Q96FV0	17	47831627-47837713	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 51.2;testis: 94.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 7.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.4"	"Region enriched"	"Detected in many"	4	"pons and medulla: 14.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021882, HPA074893"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA021882: AB_1853320, HPA074893: AB_2732271"	"unprognostic (1.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (9.24e-2)"	"prognostic favourable (2.11e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-1)"	0.3	0.4	1.8	0.3	3.3	0.6	0.5	0.4	0.5	2.3	0.3	5.2	1.6	0.4	1.5	13.8	0.4	51.2	0.5	0.5	2.0	2.4	0.7	0.4	11.8	0.5	0.3	0.1	8.8	0.5	0.3	4.2	0.4	14.0	0.5	0.3	1.8	0.4	1.3	0.3	0.3	0.3	0.3	0.6	0.5	0.3	94.4	1.1	1.2	1.4	0.0	0.4	0.3	0.1	0.6	2.5	4.4	1.6	2.4	1.0	0.5	1.4	6.3	0.8	3.2	0.5	1.4	1.8	0.2	1.7	1.7	3.3	3.0	1.4	0.6	4.0	0.8	1.4	0.8	1.1	2.6	2.8	2.7	1.2	1.7	1.0	0.3	0.1	1.5	0.0	1.0	3.5	1.3	0.3	1.2	0.8	2.2	2.3	2.1	0.3	0.2	1.3	2.0	0.2	1.3	2.7	1.1	2.6	1.9	0.7	0.0	0.9	7.5	0.2	0.5	3.4	1.3	0.6	0.4	1.4	1.2	1.3	2.3	0.5	0.3	4.4	1.3	2.0	0.2	1.6	0.0	0.6	0.1	1.0	2.5	0.4	0.7	0.0	1.6	2.4	1.5	1.3	0.2	0.5	1.8	3.3	0.4	0.5	2.0	2.4	0.3	0.1	14.0	1.1
MORN5	"C9orf113, C9orf18, FLJ46909"	ENSG00000185681	"MORN repeat containing 5"	Q5VZ52	9	122159908-122200088	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 56.9;testis: 52.1"	"Cell line enhanced"	"Detected in some"		"HHSteC: 3.2;NB-4: 5.0;RPTEC TERT1: 1.3;U-87 MG: 3.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.24e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.12e-1)"	"prognostic favourable (4.86e-4)"	"unprognostic (1.12e-1)"			"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-1)"	0.2	0.2	2.8	0.5	4.1	0.1	0.3	0.3	2.1	1.8	10.7	4.5	2.1	0.6	2.9	5.3	1.3	56.9	2.2	0.2	3.1	3.4	0.8	0.1	5.4	0.2	1.1	2.7	4.1	0.4	1.8	3.8	0.2	9.2	0.6	3.1	0.7	0.9	2.2	0.1	0.1	1.2	8.8	0.9	0.1	2.1	52.1	1.3	0.0	0.2	0.0	0.2	2.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	4.1	0.3	2.1	3.1	3.4	1.1	2.7	9.2	1.3
NMBR	"BB1, BB1R"	ENSG00000135577	"Neuromedin B receptor"	P28336	6	142058330-142088799	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 2.5;fallopian tube: 3.3;testis: 5.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;RPTEC TERT1: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026665			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA026665: "	"unprognostic (6.24e-2)"	"unprognostic (3.05e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.88e-2)"			"unprognostic (3.54e-2)"		"unprognostic (8.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.94e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.45e-2)"	0.1	0.0	0.6	0.0	2.5	0.0	0.4	0.0	0.8	0.5	0.0			0.0	0.2	0.3	0.6	3.3	0.0	0.0	0.5	1.6	0.2	0.0	0.2	0.0	0.6		0.3	0.0	0.0	0.0	0.1		0.0	0.0		0.2	0.6	0.0	0.0	0.0	0.2	0.8	0.1	0.2	5.1			0.4		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.9	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.5	0.0	0.4	0.0	0.2	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPACA9	"C9orf9, Mast"	ENSG00000165698	"Sperm acrosome associated 9"	Q96E40	9	132878027-132890201	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"epididymis: 55.8;fallopian tube: 29.1;testis: 53.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022243, HPA051600"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA022243: AB_1845844, HPA051600: AB_2681546"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-3)"	"unprognostic (8.00e-3)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.51e-2)"	"prognostic favourable (8.31e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	2.7	6.0	7.8	1.6	8.4	1.7	3.9	4.3	9.3	5.1	4.8	8.5	7.9	1.7	5.3	55.8	5.3	29.1	4.5	7.0	7.0	8.9	7.0	1.8	4.6	2.1	7.2	7.3	9.2	2.8	2.7	5.8	3.0	6.9	4.1	2.1	5.7	7.7	6.2	1.5	8.0	1.7	4.3	7.7	2.3	3.1	53.8	5.1	6.2	10.2	3.6	3.0	2.9	3.8	6.0	3.0	5.6	3.3	7.8	3.5	1.6	2.7	3.0	4.6	3.7	6.4	8.3	5.5	1.7	3.3	2.5	2.7	0.8	8.6	0.7	4.1	8.0	3.9	1.9	5.0	2.3	3.2	3.6	0.7	2.1	0.9	9.4	2.0	0.3	9.4	10.8	6.1	6.7	2.8	0.8	2.3	6.7	5.9	6.8	7.8	1.0	2.8	3.3	1.0	1.9	10.0	1.1	1.2	4.5	7.4	1.3	5.9	9.8	0.7	2.7	5.4	3.6	5.1	0.7	0.9	1.5	2.4	9.9	0.8	2.6	5.6	2.2	3.6	2.2	2.0	2.5	6.0	2.4	1.3	3.0	4.7	2.9	2.6	3.1	7.8	3.3	1.0	3.5	1.6	7.8	8.4	4.3	9.3	7.0	8.9	7.2	7.3	6.9	5.1
TTC16	FLJ32780	ENSG00000167094	"Tetratricopeptide repeat domain 16"	Q8NEE8	9	127716066-127731600	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 10.4;testis: 30.8"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.1;REH: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"gdTCR: 3.9;MAIT T-cell: 2.4;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 3.6"	"Lineage enriched"	"Detected in single"	40	"T-cells: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (3.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-4)"	"unprognostic (4.08e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.87e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.35e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.54e-3)"	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.6	0.4	0.0	0.4	0.0	0.0	0.2	1.3	0.0	10.4	0.1	0.0	0.3	0.3	0.2	0.0	2.1	0.4	0.0	0.2	1.3	0.0	0.2	1.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.9	0.0	2.4	0.0	1.3	2.8	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.5	0.0	0.6	0.3	0.3	0.0	0.2	0.6	0.1
ZCCHC12	"FLJ16123, PNMA7A, SIZN, SIZN1"	ENSG00000174460	"Zinc finger CCHC-type containing 12"	Q6PEW1	X	118823790-118826968	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 51.3;endometrium 1: 53.4;fallopian tube: 60.7;smooth muscle: 72.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.4;HEK 293: 13.9;NTERA-2: 4.4;SH-SY5Y: 3.5"	"Cancer enriched"	"Detected in many"	76	"thyroid cancer: 256.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"naive CD8 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"									"HPA031016, HPA034940"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA031016: AB_2673698, HPA034940: AB_10671098"	"unprognostic (1.29e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.34e-4)"	"unprognostic (9.18e-13)"	"unprognostic (4.14e-3)"	"unprognostic (1.63e-1)"	"prognostic favourable (3.42e-5)"	"unprognostic (1.18e-1)"	0.9	4.8	30.5	1.2	20.2	0.8	1.0	20.3	17.3	9.7	1.1	1.6	0.9	1.0	53.4	11.6	0.8	60.7	1.0	0.8	28.7	51.3	0.8	0.8	0.9	1.1	4.4	11.6	6.7	0.8	0.8	7.9	0.8	14.7	1.0	1.0	1.1	0.8	1.1	0.8	0.8	1.1	72.5	4.5	0.9	0.8	1.0	0.8	0.0	2.9	0.0	1.1	0.8	1.7	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	0.0	5.4	0.0	0.2	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	4.4	0.0	0.1	0.0	0.0	0.0	0.0	1.9	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.2	30.5	20.2	20.3	17.3	28.7	51.3	4.4	11.6	14.7	0.8
AC117457.1		ENSG00000275163			3	178419123-178843300	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"brain: 11.1;epididymis: 11.8;fallopian tube: 12.2;kidney: 5.2;pituitary gland: 19.9"	"Cell line enriched"	"Detected in single"	14	"HSkMC: 5.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.0	11.8	0.0	12.2	0.3	0.2	0.3		5.2	0.2	1.5	0.0	0.0	0.0	2.6	2.9	0.0	19.9	0.0	11.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
AP000812.5		ENSG00000284922	"Leucine-rich repeat-containing protein 51 "		11	72080777-72110782	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	4	"fallopian tube: 26.0;testis: 24.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 5.9;HBEC3-KT: 5.8;MCF7: 6.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039949	Approved		Uncertain	Microtubules				Microtubules	Microtubules	"HPA039949: AB_10960708"																		0.7	0.6	2.7	0.6	5.0	0.8	1.1	0.1	3.3	0.6	0.7	5.7	0.9	0.6	1.9	3.1	0.6	26.0	0.6	0.7	2.4		2.1	0.9	1.7	0.6	1.7	3.3	3.3	0.6	2.5	3.7	0.6	4.6	1.0	0.9	2.1	0.6	1.0	0.9	0.6	0.9	1.0	0.8	0.9	0.6	24.2	2.6	0.7	3.7	0.0	0.8	1.1	0.0	0.1	0.0	0.6	0.0	0.0	0.9	0.0	0.5	0.2	0.0	0.4	1.3	0.8	0.4	1.1	1.1	0.8	2.4	0.0	0.5	0.1	0.2	5.9	1.3	0.8	5.8	1.0	2.4	1.1	0.8	0.4	0.2	0.2	0.0	0.0	1.7	0.0	2.7	0.9	0.2	0.1	0.0	0.9	6.5	0.1	0.0	0.3	0.0	1.4	1.2	0.6	2.1	1.0	0.7	0.0	0.9	0.8	0.1	2.3	0.3	0.0	0.3	0.3	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0										
C1orf189		ENSG00000163263	"Chromosome 1 open reading frame 189"	Q5VU69	1	154199372-154206333	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 11.9;fallopian tube: 41.8;testis: 21.0"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA045779	Uncertain									"HPA045779: AB_2679448"	"unprognostic (8.23e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.01e-3)"	"unprognostic (2.50e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.36e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.05e-2)"	0.1	0.0	0.4	0.1	0.6	0.5	0.1	0.1	0.2	2.2	0.1	0.8	0.1	0.0	0.7	11.9	0.1	41.8	0.1	0.1	0.8	1.1	0.1	0.3	5.6	0.1	0.1	0.1	4.2	0.1	0.0	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	21.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.3	3.2	1.0	0.0	1.6	0.3	0.1	0.0	1.8	0.0	1.4	0.0	0.9	0.6	0.8	2.1	0.0	3.3	0.9	1.2	0.4	0.0	0.5	1.4	2.2	0.0	1.3	2.1	0.8	2.7	2.3	2.1	0.6	0.8	2.6	1.8	0.8	0.0	0.0	1.1	0.4	1.0	3.7	0.8	0.3	3.2	3.7	0.4	1.5	0.9	0.0	0.0	0.9	0.0	0.0	0.0	2.7	2.5	0.0	1.8	0.0	1.9	1.3	1.2	2.3	2.2	0.5	0.4	0.5	0.0	0.0	0.1	1.5	0.2	1.0	0.0	0.2	0.1	0.4	0.3	0.8	0.2	1.6	3.2	0.0	0.5	0.0	0.4	0.3	0.4	0.6	0.1	0.2	0.8	1.1	0.1	0.1	0.9	0.3
C1QTNF8	"CTRP8, UNQ5829"	ENSG00000184471	"C1q and TNF related 8"	P60827	16	1090005-1096244	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.6;brain: 2.1;fallopian tube: 4.5;pituitary gland: 4.1"	"Cell line enhanced"	"Detected in single"		"A549: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA056438	Uncertain				"Secreted - unknown location"					"HPA056438: AB_2683134"			"unprognostic (8.65e-2)"		"unprognostic (2.56e-2)"									"unprognostic (5.46e-2)"				0.0	2.6	0.7	0.0	1.7	0.0	0.0	0.0	0.5	0.1	0.0			0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.8	2.1	0.1	0.0	0.3	0.0	0.4		0.0	0.0	0.0	4.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C5orf49	LOC134121	ENSG00000215217	"Chromosome 5 open reading frame 49"	A4QMS7	5	7830378-7851490	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.9;fallopian tube: 65.6;testis: 28.9"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;CAPAN-2: 2.0;RPTEC TERT1: 2.2;SCLC-21H: 1.4;T-47d: 2.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043759	Enhanced									"HPA043759: AB_2678655"	"unprognostic (1.55e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.93e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.20e-2)"	1.0	1.3	9.7	1.0	16.9	0.8	1.6	0.5	7.4	3.0	0.9	12.2	1.2	1.0	2.1	9.9	0.9	65.6	1.3	0.9	10.4	12.4	3.5	1.3	10.1	0.9	5.7	6.3	6.9	2.4	2.7	5.9	0.9	35.9	2.3	0.9	0.7	0.9	2.0	0.9	1.1	0.9	1.1	2.7	0.9	1.4	28.9	4.0	0.0	1.6	0.0	0.9	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	3.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	1.1	0.0	0.0	0.2	0.0	2.2	0.1	1.4	0.8	0.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	16.9	0.5	7.4	10.4	12.4	5.7	6.3	35.9	4.0
CCDC103	"CILD17, FLJ13094, FLJ34211, PR46b"	ENSG00000167131	"Coiled-coil domain containing 103"	Q8IW40	17	44899142-44905390	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 19.6;testis: 35.5"	"Cell line enhanced"	"Detected in many"		"A549: 12.6;RPTEC TERT1: 9.9;U-87 MG: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA043131			Approved	Cytosol				Cytosol	Cytosol	"HPA043131: "	"unprognostic (9.40e-3)"	"unprognostic (1.75e-1)"			"unprognostic (5.60e-2)"	"unprognostic (1.99e-2)"		"unprognostic (4.50e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-2)"		"unprognostic (4.69e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.60e-1)"	0.6	2.3	2.6	0.9	6.3	0.6	1.2	0.5	4.7	1.4	0.9	2.9	1.6	0.5	1.7	2.8	0.4	19.6	2.8	0.4	2.5	3.0	2.7	0.7	1.9	0.3	1.5	3.9	3.5	0.8	1.9	2.1	0.5	4.3	0.9	0.7	1.6	1.2	1.5	0.3	0.7	0.4	1.2	1.0	0.4	0.9	35.5	1.0	0.2	3.5	0.1	0.5	0.7	0.4	0.8	2.5	3.0	3.7	0.7	0.4	2.4	2.2	12.6	1.9	2.4	2.7	2.3	1.6	1.0	3.8	1.7	1.3	2.4	4.1	0.3	2.1	0.8	3.8	0.8	1.8	1.0	7.8	1.4	0.6	2.6	0.0	1.8	1.6	0.3	1.5	3.0	1.9	0.7	1.3	1.6	0.3	0.1	2.3	0.0	0.7	0.4	1.9	0.3	0.7	0.5	9.9	1.2	5.0	1.0	0.5	0.4	2.2	3.4	1.6	1.0	0.8	2.0	1.0	1.9	0.4	0.5	0.4	11.1	0.8	0.3	1.2	3.7	3.0	0.3	1.9	0.4	0.0	0.0	0.4	2.5	0.8	0.4	0.3	0.5	0.7	1.7	0.8	0.1	2.4	2.6	6.3	0.5	4.7	2.5	3.0	1.5	3.9	4.3	1.0
CCDC157		ENSG00000187860	"Coiled-coil domain containing 157"	Q569K6	22	30356635-30378658	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 11.5;testis: 43.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042943	Uncertain									"HPA042943: AB_10794767"	"unprognostic (3.69e-3)"	"unprognostic (1.72e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.74e-3)"	"unprognostic (8.72e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.89e-4)"	"unprognostic (2.33e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.45e-2)"	0.9	1.8	4.3	1.5	5.9	2.5	2.0	3.3	4.0	1.6	1.4	2.5	2.2	1.5	1.6	3.0	1.4	11.5	2.0	1.1	4.4	5.8	3.3	1.0	3.5	2.0	2.3	1.9	2.1	3.0	1.7	4.5	0.9	5.9	1.6	0.9	2.1	2.4	1.7	0.9	1.8	1.1	0.9	1.2	1.8	1.4	43.7	1.8	1.3	4.4	1.2	1.2	1.1	0.8	1.6	2.3	6.7	1.6	1.9	2.3	1.2	2.8	3.2	3.0	5.6	1.7	1.1	3.7	1.4	1.8	2.9	2.8	4.1	2.1	2.5	1.8	1.5	2.8	1.6	1.9	1.5	1.7	6.9	1.4	3.0	2.4	2.0	2.6	2.4	1.0	1.4	5.2	0.9	1.7	2.2	2.3	2.3	2.7	3.3	2.8	3.8	1.7	2.9	1.7	2.2	6.9	2.9	10.1	6.6	4.5	1.7	1.8	5.4	1.1	3.0	2.7	3.6	1.8	1.1	1.9	0.9	2.0	4.4	1.6	2.2	2.0	1.6	2.0	2.1	1.1	2.3	0.9	1.8	2.1	0.9	1.6	1.1	1.8	6.7	1.9	1.4	2.3	1.4	1.2	4.3	5.9	3.3	4.0	4.4	5.8	2.3	1.9	5.9	1.8
CCDC78	"C16orf25, FLJ34512"	ENSG00000162004	"Coiled-coil domain containing 78"	A2IDD5	16	722582-726954	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.1;epididymis: 21.3;fallopian tube: 47.9;lung: 13.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.6;RPMI-8226: 10.1;SCLC-21H: 12.1;U-266/70: 10.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.2"	"Low lineage specificity"	"Detected in many"																						"unprognostic (1.10e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.62e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.82e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-3)"	0.3	1.1	3.6	1.1	11.3	1.2	0.5	2.0	1.2	2.5	0.4	6.4	1.3	0.3	1.1	21.3	0.3	47.9	0.6	0.4	4.3	4.7	0.4	0.4	13.3	1.1	1.9	0.1	5.7	0.3	0.7	2.3	0.6	20.1	0.6	0.5	0.3	0.7	1.0	0.4	0.4	0.6	0.4	2.6	0.9	0.9	1.1	1.7	0.2	0.5	0.1	1.6	1.0	0.1	0.4	1.2	1.3	0.0	1.2	3.2	0.1	0.5	1.0	1.2	2.8	1.3	1.1	1.3	1.0	2.4	0.6	0.4	0.4	4.7	1.0	1.0	0.6	0.8	2.7	1.5	0.1	8.6	0.0	2.4	1.4	0.0	1.5	0.8	1.5	3.7	0.8	0.3	4.3	0.4	0.3	3.3	0.8	6.0	0.0	2.0	1.8	0.3	2.1	0.9	10.1	4.1	1.8	12.1	1.2	1.1	7.1	0.6	4.6	1.6	1.0	0.9	0.4	0.0	0.1	10.0	0.2	2.6	0.9	1.1	2.8	0.0	0.0	1.3	0.2	0.0	3.2	0.4	0.1	1.9	0.0	0.1	0.0	0.0	0.0	1.2	0.0	1.2	0.1	0.1	3.6	11.3	2.0	1.2	4.3	4.7	1.9	0.1	20.1	1.7
CLDN22	CLDN21	ENSG00000177300	"Claudin 22"	Q8N7P3	4	183318194-183320774	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"fallopian tube: 4.2;salivary gland: 7.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.0;RT4: 1.2;SCLC-21H: 1.4;THP-1: 1.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"																																							0.0	0.4	0.2	0.0	0.4	0.2	0.0	0.3	0.5	0.1	0.1			0.0	1.0	0.0	0.9	4.2	0.0	0.0	0.5	0.2	1.1	1.3	0.1	0.0	0.1		0.0	0.2	0.1	0.4	0.0		0.4	0.0		7.2	0.1	0.5	0.4	0.0	0.1	0.2	0.2	0.0	0.1			0.5		0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
DNAJB13	"RSPH16A, TSARG6"	ENSG00000187726	"DnaJ heat shock protein family (Hsp40) member B13"	P59910	11	73950319-73970366	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 30.4;testis: 10.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 8.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA052465, HPA061330"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA052465: AB_2681842, HPA061330: AB_2732659"	"unprognostic (1.07e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.72e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (2.10e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.40e-2)"	0.0	0.0	1.2	0.4	1.4	2.1	0.0	0.0	0.1	4.7	0.0			0.1	1.0	3.2	0.0	30.4	1.1	0.0	1.6	1.5	0.6	0.0	1.9	1.0	0.0		0.0	0.3	0.0	0.5	0.1		0.3	0.0		0.4	1.6	0.0	0.2	1.4	0.0	0.2	0.5	0.0	10.8			0.1		0.0	0.0	0.0	1.6	3.4	3.1	0.8	0.6	1.7	0.4	0.4	0.9	1.3	1.7	0.1	0.4	0.8	0.3	0.0	0.4	0.1	1.7	0.7	1.8	3.9	0.7	1.3	0.3	0.0	0.1	5.0	0.8	2.0	1.9	0.7	0.0	1.1	1.5	0.0	0.8	0.4	0.0	0.0	0.7	5.1	1.0	0.8	1.2	1.8	0.6	2.9	0.8	2.7	1.8	8.1	1.6	0.7	2.0	1.0	4.2	0.4	0.7	1.4	0.3	0.6	1.3	1.8	0.7	4.3	3.4	3.4	0.6	0.5	0.5	3.1	0.8	1.1	1.2	0.2	0.4	1.6	1.2	0.7	0.7	1.5	1.0	1.7	1.4	0.6	0.3	3.4	1.1	0.4										
DRC7	"C16orf50, CCDC135, CFAP50, DKFZp434I099, FAP50"	ENSG00000159625	"Dynein regulatory complex subunit 7"	Q8IY82	16	57694793-57731805	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 16.0;testis: 60.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;Hep G2: 6.8;HMC-1: 3.1;NB-4: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 8.9;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 8.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 7.9;hippocampal formation: 7.4;hypothalamus: 3.9;pons and medulla: 7.0;thalamus: 6.2"	"Low region specificity"	"Detected in many"														"unprognostic (4.04e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.11e-2)"	"prognostic favourable (3.61e-4)"	"unprognostic (9.96e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.34e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.53e-2)"	0.0	0.0	1.0	0.2	3.5	0.7	0.0	0.2	1.3	1.1	0.0	2.4	0.2	0.0	0.4	2.3	0.0	16.0	0.5	0.0	1.4	1.6	0.7	0.2	1.5	0.1	0.3	1.1	1.6	0.9	1.6	0.8	0.1	2.5	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.1	0.1	0.4	0.1	0.2	60.2	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.3	8.9	0.3	0.0	0.0	0.3	0.0	1.7	0.7	0.4	0.0	0.1	3.1	0.0	0.0	0.0	0.0	1.0	2.5	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.8	0.9	0.7	3.1	1.5	0.0	0.4	0.0	0.4	1.7	0.0	0.0	0.0	0.8	3.2	0.2	0.0	1.9	0.0	0.0	1.3	0.0	1.6	1.9	0.0	0.0	0.1	0.2	1.9	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.1	0.6	8.9	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.3	1.0	3.5	0.2	1.3	1.4	1.6	0.3	1.1	2.5	0.8
DYNLRB2	"DNCL2B, DNLC2B, ROBLD2"	ENSG00000168589	"Dynein light chain roadblock-type 2"	Q8TF09	16	80540734-80550760	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 34.2;testis: 76.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.6;MCF7: 9.5;RPTEC TERT1: 6.4;SCLC-21H: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (3.91e-5)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.15e-4)"	"unprognostic (1.55e-4)"	0.4	1.0	3.4	0.3	4.1	0.1	2.0	1.5	1.8	1.1	0.2	4.4	2.2	0.3	0.8	9.6	0.5	34.2	1.1	0.3	4.1	3.9	2.9	0.5	3.4	0.2	1.6	2.1	2.6	0.9	2.1	2.8	0.6	12.8	1.0	0.2	0.9	0.4	1.6	0.1	1.0	0.2	0.6	1.8	0.1	0.3	76.1	2.6	0.2	1.9	0.0	0.4	0.4	0.2	0.8	3.7	4.7	0.5	1.4	4.0	0.7	0.1	0.0	0.6	0.0	1.6	0.9	0.2	0.0	0.3	0.8	0.0	0.0	3.6	0.0	0.2	0.0	2.6	0.0	0.0	0.0	2.9	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.8	9.5	0.0	0.0	0.2	2.0	0.2	0.0	0.0	6.4	1.3	3.2	0.7	1.3	2.6	0.0	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.2	1.4	0.5	0.9	0.8	1.3	1.0	0.2	0.3	1.7	4.0	4.7	1.4	0.3	3.7	3.8	0.7	3.4	4.1	1.5	1.8	4.1	3.9	1.6	2.1	12.8	2.6
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795926-138904070	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;SCLC-21H: 2.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 8.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain									"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.5	0.3	0.7	0.2	1.1	0.5	0.4	0.8	0.7	1.1	0.3	4.2	0.0	0.2	0.6	7.7	1.0	18.5	1.7	2.7	1.1	1.1	0.1	0.2	12.2	0.2	0.3	0.0	9.4	0.1	0.3	1.8	0.2	8.1	0.3	0.1	0.8	0.6	0.2	0.5	0.7	0.6	1.6	0.3	0.3	0.3	1.2	0.8	0.0	0.4	0.0	0.1	0.8	0.3	0.6	0.3	1.7	0.6	0.7	0.8	0.0	0.2	0.1	0.2	0.8	0.0	0.4	1.2	0.0	0.0	0.1	0.1	0.8	0.8	0.8	0.3	0.0	0.3	0.0	0.0	0.8	0.2	0.5	2.7	0.2	0.0	0.1	0.9	0.4	1.3	0.9	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.6	1.0	0.6	0.6	0.5	0.3	0.2	0.0	0.6	2.8	0.6	0.2	0.7	0.4	0.3	1.1	0.0	0.6	0.3	0.8	0.3	0.4	0.2	0.3	0.4	0.7	0.2	1.7	0.3	0.6	0.3	0.3	0.4	0.3	0.2	0.7	0.1	0.6	0.7	0.8	0.6	0.7	0.6	0.3	0.2	0.0	0.7	1.1	0.8	0.7	1.1	1.1	0.3	0.0	8.1	0.8
FAM81B	FLJ25333	ENSG00000153347	"Family with sequence similarity 81 member B"	Q96LP2	5	95391344-95450454	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 27.3;testis: 33.8"	"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 5.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 1.5;basal ganglia: 1.9;hippocampal formation: 2.2;hypothalamus: 2.6"	"Cell type enriched"	"Detected in single"	37	"basophil: 7.6"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 7.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA072554	Approved									"HPA072554: AB_2686533"	"unprognostic (2.22e-3)"	"unprognostic (8.86e-3)"		"unprognostic (2.61e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-1)"		"unprognostic (2.63e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.28e-2)"	0.4	0.0	1.5	0.4	1.9	0.1	0.4	0.4	0.4	1.1	0.4	0.4	0.4	0.0	0.4	2.0	0.4	27.3	0.4	2.9	2.2	2.6	0.4	0.4	2.3	0.4	0.4	0.4	0.4	0.4	2.5	1.5	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.5	0.4	0.0	33.8	0.4	0.4	0.8	0.4	0.4	0.4	0.4	0.0	0.2	7.6	0.0	0.0	0.1	0.8	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.5	1.9	0.4	0.4	2.2	2.6	0.4	0.4	0.4	0.4
FRMPD2	"MGC35285, PDZD5C, PDZK5C"	ENSG00000170324	"FERM and PDZ domain containing 2"	Q68DX3	10	48153088-48274870	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.2;epididymis: 7.9;fallopian tube: 11.1;heart muscle: 6.3;retina: 11.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.6;HBEC3-KT: 2.8;Hep G2: 1.5;SCLC-21H: 2.8;SK-BR-3: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 7.6"												"unprognostic (1.53e-1)"	"unprognostic (3.08e-1)"		"unprognostic (7.88e-4)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.54e-3)"		"unprognostic (1.85e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.25e-12)"	"unprognostic (3.48e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.43e-5)"	0.4	0.4	5.6	0.4	12.0	0.4	2.1	7.3	4.1	1.4	0.6	12.7	0.0	0.4	0.9	7.9	0.4	11.1	0.4	6.3	6.4	4.0	1.1	0.4	1.5	0.4	3.1	1.3	0.8	0.7	0.4	0.5	0.7	14.2	1.8	1.0	11.4	0.5	0.6	0.4	0.4	0.5	0.4	2.4	0.4	0.4	1.5	6.5	0.0	2.3	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	2.8	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	12.0	7.3	1.7	6.4	4.0	3.1	1.3	14.2	6.5
KIF6	"C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317"	ENSG00000164627	"Kinesin family member 6"	Q6ZMV9	6	39329990-39725405	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 18.8;fallopian tube: 9.9;pituitary gland: 5.6;testis: 12.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 10.4;SCLC-21H: 14.6;SK-MEL-30: 5.9;U-2197: 3.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA038811, HPA058624"	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA038811: AB_10795140, HPA058624: AB_2683781"	"unprognostic (4.94e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.25e-4)"	"unprognostic (3.12e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.12e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	1.3	1.4	5.1	0.7	9.1	0.9	1.9	2.2	11.4	1.4	1.0	18.8	0.1	1.7	1.0	2.6	1.3	9.9	1.6	1.3	7.3	7.1	1.4	1.3	2.4	1.2	11.8	3.2	1.8	1.6	1.2	5.6	1.2	8.6	1.1	0.9	1.7	1.0	0.9	1.6	1.2	1.1	0.8	10.6	0.9	0.9	12.6	7.8	0.0	2.0	0.0	0.9	0.7	0.4	1.2	2.7	2.5	0.6	1.3	0.7	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.1	1.2	0.3	0.7	0.1	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.3	0.0	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	10.4	0.3	0.1	14.6	0.2	0.0	0.1	5.9	0.1	0.1	0.2	0.1	0.2	3.4	0.8	0.2	0.0	0.0	0.8	0.1	1.8	1.9	0.6	0.4	0.5	0.3	0.5	0.7	0.5	0.4	0.2	1.2	0.6	0.7	2.5	1.3	0.4	2.7	0.3	0.1	5.1	9.1	2.2	5.4	7.3	7.1	11.8	3.2	8.6	7.8
LRRC23	"B7, LRPB7"	ENSG00000010626	"Leucine rich repeat containing 23"	Q53EV4	12	6873569-6914243	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"fallopian tube: 94.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037766, HPA057533"	Enhanced		Supported	Nucleoli				Nucleoli	Nucleoli	"HPA037766: AB_10672609, HPA057533: AB_2683459"	"prognostic favourable (6.02e-4)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.25e-2)"	3.6	4.2	11.4	2.4	12.8	3.4	4.8	10.5	10.9	5.8	3.1	10.8	6.9	2.2	6.0	13.1	2.9	94.2	4.2	4.7	12.2	12.9	6.9	3.7	9.4	2.9	7.3	9.6	5.9	2.5	9.3	9.0	3.4	9.9	4.8	3.3	9.4	4.0	5.0	5.5	3.5	2.1	4.8	7.0	3.5	4.5	21.1	8.4	2.2	7.1	2.4	3.7	3.1	3.1	7.8	5.9	9.0	4.4	5.3	4.7	2.2	5.5	10.8	1.8	4.0	8.2	6.2	6.4	2.2	7.7	3.8	7.1	2.2	11.4	4.9	2.5	5.9	1.4	3.3	4.7	8.0	3.8	1.6	3.5	4.2	4.4	6.6	1.9	3.3	4.3	8.8	7.1	6.5	5.0	2.0	2.8	4.3	6.2	4.2	1.3	1.2	3.2	4.0	9.0	5.6	7.6	1.6	3.0	7.0	3.6	4.8	6.8	2.4	4.4	2.2	3.7	9.9	4.2	2.5	2.6	1.8	4.0	9.1	2.5	5.3	1.3	4.4	9.0	3.7	4.2	4.7	7.8	3.6	3.1	4.0	4.8	4.1	4.0	0.7	5.3	3.8	5.9	0.2	2.2	11.4	12.8	10.5	10.9	12.2	12.9	7.3	9.6	9.9	8.4
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3"	"Cell line enhanced"	"Detected in some"		"A-431: 15.5;CAPAN-2: 5.5;HaCaT: 5.3;HeLa: 26.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"					"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.3	0.0			0.0	2.4	0.0	0.2	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.0		6.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.4	2.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952394	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.5;MCF7: 15.8;SK-BR-3: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	18000	18000	"Plasma membrane"	"Plasma membrane"	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	1.4	2.9	8.4	1.8	11.9	2.1	2.0	13.4	26.0	2.4	1.4	4.2	0.0	1.0	2.0	2.2	1.7	10.8	1.9	1.6	5.9	3.2	1.5	0.9	1.4	1.8	2.7	8.3	2.9	2.9	24.7	6.9	0.8	11.4	4.0	0.8	1.8	2.0	2.9	1.5	2.5	1.2	1.7	2.3	1.5	1.5	3.9	3.2	1.2	3.4	0.0	2.0	2.1	1.8	1.8	1.5	0.9	0.6	1.7	3.8	1.0	0.2	0.7	2.5	3.3	12.5	1.7	0.8	1.2	2.4	1.4	3.3	0.2	2.4	1.3	0.3	2.9	0.2	0.9	3.1	0.6	6.7	1.4	0.5	1.3	0.0	1.2	0.3	1.2	3.2	0.2	1.2	0.5	0.6	0.7	3.3	1.8	15.8	3.0	0.2	6.1	1.5	1.8	0.3	1.3	0.7	0.2	4.8	3.2	1.2	23.8	0.4	6.4	0.2	0.6	0.3	3.4	0.6	0.9	4.3	4.4	0.4	7.9	0.2	0.9	0.9	0.6	0.5	3.3	0.3	3.7	1.6	3.4	3.3	0.2	1.8	3.8	3.5	0.8	1.7	0.4	1.5	0.6	1.0	8.4	11.9	13.4	26.0	5.9	3.2	2.7	8.3	11.4	3.2
PTPRT	"KIAA0283, RPTPrho"	ENSG00000196090	"Protein tyrosine phosphatase, receptor type T"	O14522	20	42072752-43189970	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 23.5;fallopian tube: 17.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;RPMI-8226: 1.2;SCLC-21H: 2.9;U-266/70: 1.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017336, CAB069423"	Approved									"CAB069423: AB_1622602, HPA017336: AB_1855943"	"unprognostic (7.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	0.6	0.8	5.0	0.6	11.1	0.5	4.6	1.6	23.5	1.6	0.7	0.9	0.0	1.2	0.5	1.8	0.5	17.0	0.7	0.8	4.7	6.5	0.6	0.9	2.1	1.0	2.2	12.6	0.5	0.9	0.5	4.1	4.6	5.1	0.8	0.6	0.5	2.0	4.6	0.5	0.8	1.0	0.5	1.4	0.7	1.8	2.8	0.9	4.9	0.5	0.0	1.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	11.1	1.6	22.6	4.7	6.5	2.2	12.6	5.1	0.9
RIBC1	FLJ32783	ENSG00000158423	"RIB43A domain with coiled-coils 1"	Q8N443	X	53422690-53431120	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 12.7;fallopian tube: 24.5;testis: 37.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 8.4;T-47d: 11.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001150			Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA001150: AB_2666211"	"unprognostic (1.08e-2)"	"prognostic favourable (1.90e-5)"	"unprognostic (1.25e-1)"	"prognostic favourable (9.66e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.39e-3)"	"unprognostic (9.88e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	0.6	2.9	2.0	1.3	3.7	0.4	1.3	0.5	1.4	1.8	0.7	5.3	0.8	0.7	2.1	5.4	1.1	24.5	1.4	1.1	2.5	3.0	2.3	0.3	2.9	0.6	1.3	1.4	5.5	1.6	1.9	5.0	0.5	12.7	1.1	0.4	2.4	1.9	1.5	0.5	1.0	0.7	0.5	1.4	0.6	0.7	37.6	1.2	0.3	3.1	0.2	0.5	0.8	0.5	1.5	1.0	2.9	1.5	3.7	2.3	1.1	1.9	5.2	2.0	1.4	0.7	1.3	1.2	0.5	0.3	1.1	1.0	2.0	3.2	1.9	3.6	0.2	3.6	0.5	1.1	1.5	1.1	3.3	1.1	8.4	0.9	0.3	1.1	2.0	0.4	0.4	3.1	0.7	0.9	0.8	2.3	0.7	1.3	2.2	1.0	2.5	1.4	1.6	1.4	1.5	3.1	1.0	4.5	0.8	5.1	1.9	1.2	11.6	0.5	0.6	0.6	2.6	1.5	0.7	2.4	1.6	1.1	2.1	0.4	0.9	0.0	0.7	0.0	0.3	1.2	2.3	0.2	0.9	1.9	1.0	1.5	0.4	0.4	2.9	3.7	1.5	0.8	1.9	1.1	2.0	3.7	0.5	1.4	2.5	3.0	1.3	1.4	12.7	1.2
SCGB1D4	IIS	ENSG00000197745	"Secretoglobin family 1D member 4"	Q6XE38	11	62296277-62299064	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 27.5;ductus deferens: 9.9;endometrium 1: 9.5;epididymis: 27.9;fallopian tube: 36.8"	"Group enriched"	"Detected in some"	20	"HL-60: 3.1;Karpas-707: 1.0;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in some"	57	"endometrial cancer: 100.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in female reproductive system"									"unprognostic (2.26e-3)"						"unprognostic (3.20e-1)"								0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	27.5	0.1	0.1	9.9	0.0	9.5	27.9	0.1	36.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051331-52097292	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 41.7;testis: 65.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 19.7;BEWO: 14.8;BJ hTERT+: 9.5;HSkMC: 18.2;hTCEpi: 17.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.5"	"Cell type enriched"	"Detected in single"	23	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favourable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	4.2	2.6	1.2	3.3	0.0	3.7	0.1	1.1	6.8	2.3	3.6	5.3	1.2	2.5	9.9	4.9	41.7	11.5	1.5	3.1	2.8	3.7	4.4	12.0	0.3	0.6	0.6	7.6	1.6	4.2	6.1	1.8	12.5	3.5	3.5	1.4	13.2	6.0	1.1	4.3	2.8	1.8	0.8	0.5	2.9	65.7	0.8	1.3	1.6	4.1	3.1	2.3	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.1	0.0	7.9	19.7	14.8	5.5	9.5	0.3	0.4	0.0	0.9	0.0	0.0	7.2	0.1	0.0	4.2	0.2	0.0	0.6	0.0	0.0	4.6	7.0	0.0	0.0	18.2	17.5	0.6	2.7	4.1	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	1.1	1.2	0.6	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.3	0.1	1.1	3.1	2.8	0.6	0.6	12.5	0.8
SPATS1	"FLJ25442, SPATA8, SRSP1"	ENSG00000249481	"Spermatogenesis associated serine rich 1"	Q496A3	6	44342660-44377167	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 9.0;testis: 33.5"	"Cell line enriched"	"Detected in single"	67	"SK-MEL-30: 12.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030897, HPA049722"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA030897: AB_2673647, HPA049722: AB_2680861"				"unprognostic (2.30e-3)"														0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.4	0.3	0.0	1.5	0.0	0.0	0.1	4.8	0.1	9.0	0.0	0.0	0.7	0.7	0.0	0.0	1.5	0.0	0.4	0.0	1.6	0.0	0.2	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	1.0	0.0	0.4	0.7	0.7	0.4	0.0	3.5	0.1
TCTEX1D4		ENSG00000188396	"Tctex1 domain containing 4"	Q5JR98	1	44805913-44806675	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 7.9;epididymis: 3.1;fallopian tube: 12.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;EFO-21: 2.4;HDLM-2: 2.7;TIME: 3.4"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 7.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062652	Enhanced									"HPA062652: AB_2684818"	"unprognostic (3.12e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.81e-1)"	"prognostic favourable (1.58e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.83e-3)"	0.0	1.1	0.2	0.4	0.2	0.8	0.2	0.0	0.1	1.0	0.2			0.5	0.8	3.1	0.2	12.4	0.7	0.2	0.3	0.4	0.3	0.5	1.8	0.0	0.0		0.0	0.7	0.0	0.3	0.0		0.1	0.0		0.6	0.3	0.1	0.2	0.5	0.0	0.1	0.0	1.2	0.1			0.5		0.0	0.2	0.0	0.0	0.0	7.9	0.6	0.0	0.2	0.3	1.4	1.1	0.3	0.0	0.0	0.0	3.3	1.5	0.0	0.0	0.2	0.0	1.2	0.0	2.4	0.0	1.8	0.0	0.0	0.0	2.7	0.0	0.3	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.5	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.0	0.0	3.4	0.2	1.9	0.2	0.7	1.4	1.2	0.0	0.2	0.4	0.6	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.3										
TTC25	DKFZP434H0115	ENSG00000204815	"Tetratricopeptide repeat domain 25"	Q96NG3	17	41930635-41965651	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 7.7;fallopian tube: 24.6;pituitary gland: 10.6;testis: 29.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.9;U-87 MG: 8.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023908	Enhanced									"HPA023908: AB_2241243"	"unprognostic (3.08e-3)"	"unprognostic (4.51e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.76e-1)"	"unprognostic (2.71e-1)"	0.3	0.8	2.0	0.1	5.3	2.3	0.7	0.5	4.0	1.5	0.3	3.8	1.5	0.3	2.1	4.1	0.3	24.6	0.7	0.5	2.0		1.5	0.3	2.8	0.6	0.6	2.5	2.9	0.8	4.0	10.6	2.2	7.7	0.7	0.3	2.8	0.3	0.8	0.9	0.3	0.2	0.9	0.6	0.2	0.5	29.6	1.7	0.0	1.8	0.0	0.2	0.4	0.0	0.5	1.8	0.0	0.5	0.0	1.0	0.3	0.1	2.7	3.5	4.6	0.7	0.8	0.5	0.1	1.9	0.8	1.5	0.4	3.2	0.3	1.6	0.7	0.6	0.6	0.4	0.8	0.7	0.6	1.3	0.8	0.1	0.9	0.0	2.0	0.6	0.6	2.5	0.2	0.1	0.1	2.6	0.5	1.8	1.8	0.5	0.8	0.3	0.0	0.1	1.7	4.5	0.3	6.9	5.4	0.0	0.9	3.5	1.9	0.7	0.0	0.2	2.0	1.6	0.9	2.6	2.6	0.2	8.3	0.1	1.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	1.0	0.0	1.1	0.5	1.0	0.2	0.0	0.0	0.0	1.8	0.0	0.3										
WDR38		ENSG00000136918	"WD repeat domain 38"	Q5JTN6	9	124853417-124857890	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"fallopian tube: 51.4"	"Cell line enhanced"	"Detected in some"		"A549: 1.3;CAPAN-2: 2.5;HDLM-2: 2.9;HeLa: 1.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 12.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA056607	Uncertain									"HPA056607: AB_2683188"	"unprognostic (5.66e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.51e-2)"	"prognostic favourable (3.97e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-5)"	"unprognostic (1.01e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.42e-2)"	0.2	0.2	2.0	0.2	3.1	0.2	0.2	0.2	0.5	2.9	0.2	10.6	0.0	0.2	0.7	11.9	0.2	51.4	0.2	0.3	2.8	3.3	0.2	0.2	10.8	0.2	0.3	0.4	6.0	0.2	0.2	1.0	0.2	8.8	0.2	0.2	0.0	0.2	0.3	0.3	0.3	0.2	0.3	0.7	0.2	0.2	7.0	1.3	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.3	0.5	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.1	0.4	2.5	0.1	0.1	0.2	0.1	0.2	0.0	0.0	2.9	0.3	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.7	0.1	0.6	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.4	0.5	0.2	0.4	0.5	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.1	0.2	0.5	2.8	3.3	0.3	0.4	8.8	1.3
AC013470.2		ENSG00000226690			7	12469621-12542222	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 7.7;epididymis: 6.3;fallopian tube: 10.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;hTCEpi: 2.9;Karpas-707: 2.0;U-266/70: 2.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"																						"unprognostic (3.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.53e-4)"		"unprognostic (1.14e-3)"	"unprognostic (3.62e-3)"	"unprognostic (7.82e-3)"	"unprognostic (3.61e-1)"	"unprognostic (8.04e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.88e-2)"		"unprognostic (2.67e-1)"	0.1	0.1	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.7	6.3	0.0	10.6	0.0	0.0	0.0		0.1	0.0	2.5	0.0	0.0	0.0	2.8	0.4	0.0	1.1	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.3	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.7	2.3	0.5	0.8	0.4	0.0	0.1	0.2	1.0	0.4	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.1	1.1	0.1	0.2	0.1	0.2	4.7	0.0	0.0	0.1	0.1	0.0	0.8	0.5	0.0	1.1	0.2	0.1	2.9	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.0	0.2	1.6	0.0	0.3	0.1	0.4	0.0	0.5	1.2	0.1	0.0	0.3	0.2	0.2	0.3	0.0	0.5	0.6	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	2.3	0.5	0.3	0.3	0.2	0.4	0.8	0.3	0.3	0.2	0.9	0.4	0.3	1.8	0.8	0.4	0.7	0.3	0.0										
ADCYAP1R1	"PAC1, PAC1R, PACAPR"	ENSG00000078549	"ADCYAP receptor type I"	P41586	7	31052461-31111479	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.2;fallopian tube: 25.1"	"Group enriched"	"Detected in some"	6	"AF22: 5.4;NTERA-2: 7.2;SCLC-21H: 6.1;SH-SY5Y: 10.9"	"Cancer enriched"	"Detected in some"	11	"glioma: 45.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030739, HPA049877"	Enhanced		Enhanced	Vesicles				Vesicles	Vesicles	"HPA030739: AB_2732461, HPA049877: AB_2680928"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-2)"	"prognostic favourable (5.78e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.67e-3)"	"unprognostic (6.43e-4)"	"unprognostic (1.09e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-4)"	5.4	10.6	23.6	2.7	24.2	0.9	2.9	13.7	71.2	12.8	2.7	13.4	0.0	1.6	5.4	2.3	3.3	25.1	2.0	2.8	22.1	21.6	1.0	1.1	1.6	1.0	19.0	20.2	1.9	2.2	2.9	4.4	1.0	18.7	2.1	2.0	0.0	2.6	3.7	1.9	1.8	2.0	3.9	6.5	1.3	1.6	2.2	13.3	0.0	2.3	0.9	1.6	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	10.9	0.0	0.0	0.0	0.0	0.0	0.3	0.9	1.3	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.6	24.2	13.7	17.3	22.1	21.6	19.0	20.2	18.7	13.3
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859405-16881987	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 40.5;intestine: 99.1"	"Cell line enriched"	"Detected in some"	41	"T-47d: 86.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	31000	31000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.0	0.6	7.5	0.7	0.0	13.1	0.7	0.6	4.4	45.8	0.6	0.6	29.2	1.2	5.4	0.9	40.5	11.8	0.6	0.6	0.3	1.5	0.6	26.3	0.6	0.6	0.6	5.1	1.9	0.0	12.9	2.8	1.9	1.1	38.9	0.6	9.4	0.6	0.6	0.3	99.1	1.2	0.8	0.6	17.1	1.0	0.6	0.6	1.4	1.9	3.9	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.3	0.1	0.0	0.1	0.0	86.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.6	0.6	0.3	0.6	0.6	1.9	0.6
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866480-127877743	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 84.5;skeletal muscle: 279.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		32000000	32000000	Cytosol	Cytosol	"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	7.7	9.2	19.6	3.7	18.8	6.5	3.9	9.8	17.3	10.5	8.6	18.1	12.2	5.2	3.4	17.3	9.0	84.5	12.0	60.4	17.6	18.5	6.3	10.7	18.7	2.2	16.4	15.3	12.3	4.6	5.6	7.1	2.9	17.5	5.2	10.8	7.0	13.4	15.7	279.0	3.4	2.6	6.3	11.5	5.6	5.8	9.8	11.1	0.0	10.5	61.5	4.0	4.4	4.4	1.2	3.4	2.8	0.4	1.4	1.5	1.2	15.2	6.6	8.4	11.5	20.5	41.8	7.7	10.6	10.7	18.9	11.5	4.8	9.7	0.4	11.6	21.8	22.0	0.0	11.8	7.6	2.4	7.3	2.2	18.9	8.4	11.5	0.0	0.3	31.7	23.0	14.0	10.2	25.2	8.9	0.6	21.4	14.5	0.0	0.3	3.0	20.4	0.4	8.5	3.3	12.6	1.1	13.7	8.5	28.0	16.1	8.1	12.9	9.1	20.8	13.2	5.4	46.5	10.1	1.0	0.1	0.0	16.6	0.0	9.2	0.9	0.4	0.4	1.5	0.3	1.1	0.3	0.6	1.1	0.1	1.2	0.3	1.1	2.8	1.4	0.4	3.4	0.3	1.2	19.6	18.8	9.8	17.3	17.6	18.5	16.4	15.3	17.5	11.1
AK7	FLJ32864	ENSG00000140057	"Adenylate kinase 7"	Q96M32	14	96392111-96489427	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.4;CAPAN-2: 9.0;MCF7: 28.7;REH: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.6"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 10.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003543	Enhanced									"HPA003543: AB_1078117"	"unprognostic (4.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.40e-3)"	"prognostic favourable (3.18e-4)"	"unprognostic (4.98e-5)"	"unprognostic (8.41e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.14e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.25e-3)"	1.5	3.4	4.0	0.9	12.6	2.0	2.1	0.7	3.1	2.7	2.8	8.4	5.1	2.5	2.8	13.1	2.4	29.0	5.0	1.2	6.7	9.2	7.6	3.0	9.2	1.4	2.3	2.6	4.9	2.9	11.7	17.5	0.9	16.7	1.4	2.2	1.5	1.6	2.9	0.5	7.5	3.1	1.6	2.7	4.3	3.5	17.6	4.2	1.1	4.8	1.3	0.8	1.1	1.5	0.4	0.1	10.6	0.3	0.3	0.4	0.2	0.1	2.9	1.2	1.0	0.5	1.7	10.4	0.1	0.3	0.2	0.1	0.3	9.0	0.2	0.2	0.1	1.1	2.8	0.1	0.1	1.3	0.2	0.2	1.3	0.1	0.5	0.1	0.1	0.1	0.4	1.5	0.0	0.1	0.1	0.2	0.2	28.7	0.2	0.2	0.5	0.6	20.4	0.3	0.3	4.5	0.2	2.0	4.1	1.1	0.4	0.0	2.5	0.1	0.0	0.3	0.1	0.3	0.1	0.4	1.3	0.1	0.1	0.0	0.4	10.6	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.4	0.2	0.2	0.6	0.3	0.3	0.1	0.1	0.2	4.0	12.6	0.7	3.1	6.7	9.2	2.3	2.6	16.7	4.2
AK8	"C9orf98, FLJ32704"	ENSG00000165695	"Adenylate kinase 8"	Q96MA6	9	132725578-132878777	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 12.8;fallopian tube: 17.7;testis: 15.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;MCF7: 5.2;RPTEC TERT1: 6.0;T-47d: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 3.9"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021443, HPA023894"	Enhanced									"HPA021443: AB_1845852, HPA023894: AB_1845854"	"unprognostic (4.14e-2)"	"unprognostic (1.20e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.43e-1)"	0.5	0.7	1.3	0.5	2.2	0.0	0.5	1.6	1.3	1.6	0.5	0.5	0.5	0.0	1.1	12.8	0.5	17.7	0.7	0.5	1.3	2.0	1.4	0.5	1.1	0.5	1.2	0.5	0.9	0.5	2.5	1.7	1.5	2.3	0.5	0.0	0.9	1.0	1.8	0.5	1.1	0.5	0.5	1.7	0.5	0.3	15.6	0.5	0.5	3.1	0.5	0.5	0.5	0.5	0.1	0.0	0.0	0.0	3.9	0.5	0.0	2.0	1.0	0.6	3.1	0.4	0.8	0.6	0.3	0.2	0.2	0.0	0.4	2.1	0.0	0.7	0.3	0.5	0.2	0.0	0.1	0.1	0.7	0.0	0.2	0.0	1.3	0.0	0.0	1.8	0.9	0.3	0.6	0.2	0.1	0.0	0.5	5.2	1.5	0.4	0.2	0.6	0.0	0.0	0.0	6.0	0.0	1.1	1.2	2.6	0.0	0.4	4.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.3	2.2	1.6	1.0	1.3	2.0	1.2	0.5	2.3	0.5
AKAP14	AKAP28	ENSG00000186471	"A-kinase anchoring protein 14"	Q86UN6	X	119895837-119920716	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.1;fallopian tube: 31.0;testis: 33.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;LHCN-M2: 2.0;REH: 1.6;SCLC-21H: 7.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.5"	"Region enriched"	"Detected in many"	7	"pons and medulla: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060999	Enhanced									"HPA060999: AB_2684407"	"unprognostic (1.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.68e-2)"		"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.80e-1)"	0.0	0.0	2.6	0.1	1.5	0.2	0.1	0.2	0.6	1.0	0.1	2.4	0.0	0.3	0.6	9.0	0.0	31.0	0.0	0.0	1.3	2.9	0.1	0.1	7.5	0.1	0.6	0.2	4.2	0.0	0.0	0.3	0.1	21.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.1	0.2	0.1	0.0	33.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.4	2.0	0.3	0.0	0.6	0.2	0.0	1.6	0.0	0.0	0.0	0.7	7.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	1.5	0.2	0.6	1.3	2.9	0.6	0.2	21.1	0.5
ALPPL2		ENSG00000163286	"Alkaline phosphatase, placental like 2"	P10696	2	232406843-232410714	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.2;lung: 9.4"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 24.5;HaCaT: 18.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB020698, HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"CAB020698: , HPA038764: AB_2676194, HPA038765: , HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.5	24.5	0.0	0.0	0.0	18.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKDD1B		ENSG00000189045	"Ankyrin repeat and death domain containing 1B"	A6NHY2	5	75611459-75671846	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 5.6;intestine: 4.5"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 6.5;RPTEC TERT1: 2.7;SH-SY5Y: 1.9"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	7	"NK-cell: 3.2;T-reg: 1.8"	"Group enriched"	"Detected in many"	11	"NK-cells: 3.2;T-cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059722	Uncertain									"HPA059722: AB_2684112"	"unprognostic (5.11e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (2.30e-7)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	0.2	0.6	0.4	0.6	0.8	0.0	0.5	0.0	0.1	0.9	3.3			0.5	0.4	1.1	0.1	5.6	0.5	0.0	0.8	0.8	3.8	0.1	1.2	0.0	0.1		0.1	0.8	2.6	0.7	0.4		0.9	4.5		0.1	0.0	0.0	1.0	0.7	0.5	0.2	0.3	2.5	0.8			0.5		0.3	0.8	0.6	0.0	0.2	0.2	0.1	3.2	1.8	0.7	0.3	0.3	0.0	0.5	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.3	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	6.5	2.7	0.1	0.8	1.9	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.2	3.2	0.1	0.0	1.8	0.7										
ANKFN1	FLJ38335	ENSG00000153930	"Ankyrin repeat and fibronectin type III domain containing 1"	Q8N957	17	55882301-56511659	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.9;MOLT-4: 16.4;T-47d: 5.7;U-2197: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA021566, HPA022538, HPA048953"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: "	"unprognostic (6.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.38e-5)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.44e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-2)"	3.9	1.0	5.5	0.5	10.2	0.5	1.2	2.6	4.7	19.9	0.7	11.4	0.5	0.7	0.8	3.4	0.7	10.9	0.9	0.5	6.8	4.6	0.7	0.6	2.0	0.6	6.3	3.7	0.5	0.5	0.5	1.0	2.1	11.8	0.9	0.8	0.0	0.7	0.8	0.6	5.2	0.8	0.5	7.5	0.6	1.1	3.6	10.0	0.0	0.6	0.0	0.5	3.2	5.3	0.2	0.5	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.3	0.2	0.3	0.0	2.8	0.2	0.3	0.0	0.1	0.3	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.1	0.1	0.4	16.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	1.5	0.0	1.7	0.0	0.3	5.7	0.0	0.0	0.0	0.4	5.5	0.1	1.5	0.3	0.0	0.8	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.3	0.1	0.5	0.0	0.0	5.5	10.2	2.6	4.7	6.8	4.6	6.3	3.7	11.8	10.0
ANKRD65		ENSG00000235098	"Ankyrin repeat domain 65"	E5RJM6	1	1418420-1421769	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;fallopian tube: 33.6"	"Group enriched"	"Detected in some"	7	"Hep G2: 19.9;RT4: 19.5;SCLC-21H: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"myeloid DC: 4.8;plasmacytoid DC: 10.4"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065720	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065720: AB_2685545"	"unprognostic (2.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.08e-5)"	"unprognostic (1.64e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.76e-2)"	4.6	1.1	12.4	2.8	20.8	0.4	4.2	8.0	13.3	6.7	4.8	21.0	3.7	2.2	4.0	5.6	6.7	33.6	2.7	2.2	12.0	8.6	1.9	0.9	9.9	7.1	37.8	8.2	6.9	13.3	1.1	0.6	6.3	13.7	8.9	1.8	2.1	14.0	21.2	2.8	4.8	2.1	3.8	16.7	1.4	4.3	3.1	28.0	4.2	1.8	1.0	6.3	13.2	3.3	0.5	10.4	0.3	0.3	0.0	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.5	2.6	0.2	2.5	0.0	0.3	0.2	0.0	0.0	19.9	0.5	0.0	0.0	0.2	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	2.6	0.0	0.0	19.5	27.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	4.8	0.5	0.1	0.4	0.0	0.0	0.0	10.4	0.0	0.2	12.4	20.8	8.0	13.3	12.0	8.6	37.8	8.2	13.7	28.0
ANKRD66		ENSG00000230062	"Ankyrin repeat domain 66"	B4E2M5	6	46746917-46759506	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	6	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																	"unprognostic (1.67e-3)"	"unprognostic (2.52e-1)"			"unprognostic (2.44e-2)"		"unprognostic (2.03e-2)"		"unprognostic (9.36e-2)"		"unprognostic (4.30e-3)"	"unprognostic (2.19e-1)"			0.1	0.2	2.0	0.2	4.3	0.1	0.2	0.0	0.6	1.7	0.1	5.9	0.0	0.1	0.9	12.1	0.1	36.0	0.1	0.1	3.0	3.0	0.1	0.1	7.1	0.2	0.0	0.0	11.1	0.1	0.1	0.5	0.2	15.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.9	1.9	0.0	0.2	0.1	0.2	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.3	0.0	0.6	3.0	3.0	0.0	0.0	15.0	1.9
ANKUB1	C3orf16	ENSG00000206199	"Ankyrin repeat and ubiquitin domain containing 1"	A6NFN9	3	149761100-149968385	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.2;lung: 11.9;ovary: 10.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.2"	"Cell type enriched"	"Detected in single"	8	"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.8"					"Low region specificity"	"Detected in many"			HPA053749	Uncertain									"HPA053749: AB_2682248"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-9)"	"unprognostic (3.06e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.07e-4)"	0.0	0.0	0.8	0.2	1.2	0.6	0.0	0.0	0.3	2.1	0.0	1.8	0.0	0.2	0.9	0.1	0.0	12.2	0.1	0.0	1.5	1.7	0.0	0.0	11.9	0.1	0.0	0.0	10.4	0.1	0.0	1.1	0.1	5.2	0.1	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.3	0.2	0.3	2.2	0.8	0.0	0.0	0.6	0.1	0.1	0.0	0.4	0.3	4.8	0.4	0.2	0.3	0.0	0.6	0.8	0.8	0.3	0.0	0.1	0.6	0.3	0.0	0.1	0.0	1.2	1.2	1.1	0.2	0.0	1.8	0.5	0.6	0.2	0.6	0.4	1.1	2.5	0.5	0.0	0.5	0.9	0.2	0.0	0.0	0.1	0.0	0.6	1.0	0.0	0.4	0.7	1.1	0.5	0.6	1.1	0.8	0.7	0.0	1.1	0.7	0.1	0.5	0.6	0.0	1.0	0.3	0.0	0.7	0.6	0.3	0.4	0.7	0.5	1.0	0.5	1.0	0.2	0.5	0.4	0.5	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.4	0.1	0.3	4.8	0.2	0.1	0.3	0.1	0.0	0.8	1.2	0.0	0.3	1.5	1.7	0.0	0.0	5.2	0.8
APOBEC4	"C1orf169, FLJ25691, MGC26594, RP1-127C7.4"	ENSG00000173627	"Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4"	Q8WW27	1	183646404-183653316	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 15.9;testis: 23.6"	"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015636, HPA015637"	Approved									"HPA015636: AB_1844942, HPA015637: AB_1844941"			"unprognostic (2.27e-1)"	"prognostic favourable (2.65e-4)"				"unprognostic (2.61e-1)"		"unprognostic (3.84e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.73e-1)"		"unprognostic (7.10e-2)"	"unprognostic (4.00e-2)"			0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.1	0.2	5.4	0.0	15.9	0.0	0.0	0.1	0.1	0.0	0.0	4.1	0.0	0.0	0.0	5.6	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	23.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.1
ARMC3	"CT81, FLJ32827"	ENSG00000165309	"Armadillo repeat containing 3"	Q5W041	10	22928024-23038523	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 40.2;fallopian tube: 38.6;testis: 25.7"	"Cell line enriched"	"Detected in some"	9	"CAPAN-2: 11.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 40.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037823, HPA037824"	Enhanced									"HPA037823: AB_2675689, HPA037824: AB_10671634"	"unprognostic (8.11e-3)"	"unprognostic (5.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"		"unprognostic (5.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.37e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.21e-3)"	"unprognostic (9.53e-4)"	"unprognostic (1.40e-2)"	0.3	0.4	3.5	0.3	10.1	0.3	0.4	0.0	1.0	1.9	0.3	11.3	0.0	0.3	1.7	9.0	0.5	38.6	0.3	0.4	4.7	4.1	0.7	0.3	4.1	0.3	1.9	2.2	4.5	0.6	0.3	4.1	0.3	40.2	0.3	0.3	0.0	0.3	0.5	0.3	0.3	0.3	0.4	1.0	0.3	0.3	25.7	6.3	0.0	0.6	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.9	2.3	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.8	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	3.5	10.1	0.0	1.0	4.7	4.1	1.9	2.2	40.2	6.3
ARMC4	"CILD23, DKFZP434P1735, FLJ10376, FLJ10817"	ENSG00000169126	"Armadillo repeat containing 4"	Q5T2S8	10	27812164-27999048	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 18.5;testis: 22.0"	"Cell line enhanced"	"Detected in some"		"AF22: 6.4;BJ: 6.4;fHDF/TERT166: 7.5;HEK 293: 5.4;NTERA-2: 5.6;RH-30: 16.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA037829	Enhanced									"HPA037829: AB_10670960"	"unprognostic (1.03e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-3)"	"unprognostic (7.72e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.24e-2)"	0.3	0.9	0.9	0.8	2.2	0.3	0.3	0.1	1.0	2.1	1.2	3.4	0.6	0.1	1.1	3.0	0.4	19.6	1.0	0.4	1.6	1.6	0.3	0.4	2.3	0.2	0.3	1.3	4.3	0.1	0.1	18.5	0.2	5.5	4.9	0.3	0.8	0.1	3.1	0.1	0.1	0.2	2.7	0.9	0.2	0.5	22.0	0.8	0.6	0.5	0.0	0.1	1.0	0.4	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	6.4	0.0	0.0	0.0	0.2	6.4	2.4	3.6	2.9	0.0	0.3	0.0	0.0	7.5	0.0	1.0	0.0	4.3	0.0	5.4	0.0	3.2	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.8	0.0	2.6	0.2	5.6	1.8	0.1	16.1	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.0	2.3	0.1	3.0	0.0	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	2.2	0.1	1.0	1.6	1.6	0.3	1.3	5.5	0.8
C10orf67	"bA215C7.4, C10orf115, LINC01552, MGC46732"	ENSG00000179133	"Chromosome 10 open reading frame 67"	Q8IYJ2	10	23201916-23344845	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2;SiHa: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.2"	"Low lineage specificity"	"Detected in many"											"HPA038130, HPA038131"	Approved		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles"				Nucleoplasm	Nucleoplasm	"HPA038130: AB_2675847, HPA038131: AB_10670658"	"unprognostic (4.76e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.91e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.58e-2)"	0.1	0.1	1.3	1.7	2.6	0.2	0.0	0.1	1.9	0.3	0.5	0.4	1.3	0.5	0.2	4.6	0.1	7.3	0.2	3.2	1.6	1.4	5.0	0.5	4.0	0.3	0.9	0.5	1.8	0.3	0.4	9.0	0.1	1.2	0.1	0.0	0.2	0.1	0.1	0.6	1.9	0.4	0.0	0.7	0.2	0.1	13.8	0.6	0.0	0.6	0.7	0.1	0.1	0.1	1.1	1.1	1.0	0.5	1.1	4.2	0.0	1.5	0.1	1.9	0.2	0.0	0.5	0.4	0.2	0.1	2.0	1.6	0.1	2.4	0.2	0.2	1.5	5.2	0.2	0.7	1.6	0.5	0.4	0.1	0.7	0.3	1.0	0.1	0.0	0.6	1.7	0.6	1.0	0.0	0.2	0.7	0.0	0.3	0.1	0.5	0.9	0.1	0.1	0.2	0.4	1.7	0.3	0.9	0.4	8.4	0.3	0.1	0.3	0.3	0.2	0.4	1.5	0.4	0.1	1.0	0.2	0.1	2.5	0.2	0.1	1.0	0.5	0.6	0.7	0.3	0.6	1.1	1.5	0.8	0.1	1.0	1.1	1.0	0.8	1.1	0.3	1.1	4.2	0.0	1.3	2.6	0.1	1.9	1.6	1.4	0.9	0.5	1.2	0.6
C11orf16		ENSG00000176029	"Chromosome 11 open reading frame 16"	Q9NQ32	11	8920076-8933006	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 19.1;lymphoid tissue: 10.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;CACO-2: 1.5;EFO-21: 1.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.0;T-reg: 1.6"	"Group enriched"	"Detected in many"	9	"monocytes: 1.0;T-cells: 1.6"	"Low region specificity"	"Detected in some"																		"unprognostic (5.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.09e-3)"	"prognostic favourable (3.32e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.94e-5)"	"unprognostic (6.40e-4)"	"unprognostic (1.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.13e-3)"	0.0	0.2	0.5	0.0	0.8	0.0	0.2	0.0	0.3	2.3	0.0	0.7	0.0	0.1	0.6	3.1	0.0	19.1	0.0	0.0	0.8	1.3	0.4	0.0	5.2	0.0	0.0	0.0	2.8	0.0	0.0	1.6	0.0	2.9	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.7	0.0	10.8	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.0	0.1	1.6	0.0	0.9	1.3	1.2	0.5	0.0	0.0	1.5	0.4	0.0	0.0	0.0	1.5	0.2	0.1	1.5	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.0	0.7	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.6	0.9	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.4	0.0	0.7	1.0	0.5	0.3	0.2	0.0	0.3	0.0	0.2	0.6	1.1	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.5	0.8	0.0	0.3	0.8	1.3	0.0	0.0	2.9	0.0
C11orf70	MGC13040	ENSG00000137691	"Chromosome 11 open reading frame 70"	Q9BRQ4	11	102047443-102084560	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.5;testis: 54.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.0"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038585	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA038585: AB_10795357"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-6)"	"unprognostic (1.76e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.94e-2)"	"unprognostic (6.73e-3)"	2.5	3.7	2.9	1.1	4.2	0.1	3.1	0.7	1.4	5.9	1.6	5.4	11.6	0.8	5.3	11.9	2.3	25.5	4.9	1.7	3.9	4.5	3.0	0.3	7.2	1.2	1.7	1.3	7.5	0.8	3.7	13.7	4.0	16.0	5.6	0.8	4.2	1.1	7.0	0.5	1.6	0.8	5.5	1.9	0.2	1.6	54.7	2.2	0.0	3.3	1.1	0.8	3.8	2.5	0.6	0.3	2.3	0.6	0.3	0.4	0.2	0.0	6.6	6.7	0.0	6.1	14.7	0.2	2.6	6.7	3.6	5.2	0.5	8.6	0.0	1.6	5.1	1.6	1.6	0.8	2.6	0.0	1.0	0.0	1.1	0.0	4.3	0.0	0.0	6.2	8.4	9.4	6.3	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	9.9	1.8	7.4	0.0	8.5	0.1	0.0	7.5	0.0	1.0	0.9	2.8	8.8	2.1	0.1	0.0	0.0	3.0	0.0	0.4	1.6	0.6	0.4	0.3	0.2	0.2	0.5	0.3	0.3	0.1	0.6	0.4	0.3	2.3	0.3	0.2	0.3	0.2	0.2	2.9	4.2	0.7	1.4	3.9	4.5	1.7	1.3	16.0	2.2
C11orf88	FLJ46266	ENSG00000183644	"Chromosome 11 open reading frame 88"	Q6PI97	11	111514785-111537031	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 48.8;fallopian tube: 53.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.7;CAPAN-2: 2.2;Karpas-707: 5.0;U-266/70: 2.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Region enriched"	"Detected in many"	4	"pons and medulla: 48.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (2.25e-1)"	"unprognostic (3.07e-5)"	"unprognostic (3.85e-4)"	"unprognostic (4.16e-2)"	"unprognostic (4.44e-5)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.86e-1)"	"unprognostic (9.96e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.80e-3)"	"unprognostic (7.57e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	0.2	0.2	5.7	0.3	10.9	0.3	0.2	0.2	1.0	5.8	0.2	5.7	0.0	0.4	2.2	13.1	0.2	53.7	0.4	0.2	7.3	7.6	0.2	0.2	13.9	0.3	0.6	0.2	8.3	0.2	0.2	0.5	0.4	48.8	0.3	0.2	0.0	0.3	0.3	0.2	0.3	0.3	0.2	1.1	0.3	0.3	13.5	1.5	0.1	0.7	0.0	0.2	0.2	0.0	0.7	0.6	2.6	0.5	0.6	0.4	0.0	0.3	1.0	0.1	0.1	0.0	0.0	0.6	1.6	0.0	0.1	0.0	4.7	2.2	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.2	0.5	0.4	0.0	0.5	0.0	0.0	0.1	5.0	0.0	0.5	0.3	0.2	0.2	0.5	0.0	0.8	0.0	0.1	0.2	0.2	0.5	0.3	0.1	0.0	0.9	0.0	0.0	0.7	0.6	0.7	1.0	2.9	0.4	0.2	0.4	0.4	1.0	1.7	0.5	1.2	0.3	0.2	0.4	0.5	0.2	0.1	0.4	0.7	0.3	0.3	2.6	0.6	0.5	0.6	0.4	0.0	5.7	10.9	0.2	1.0	7.3	7.6	0.6	0.2	48.8	1.5
C11orf97	LINC01171	ENSG00000257057	"Chromosome 11 open reading frame 97"	A0A1B0GVM6	11	94512432-94532123	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 19.2;fallopian tube: 22.9;testis: 17.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.0;RPTEC TERT1: 3.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"					"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																	"unprognostic (3.62e-3)"	"unprognostic (1.29e-1)"		"unprognostic (1.22e-1)"	"unprognostic (4.18e-1)"		"unprognostic (4.70e-1)"	"unprognostic (9.64e-3)"		"unprognostic (9.44e-3)"	"unprognostic (3.86e-3)"				0.1	0.1	3.4	0.1	19.2	0.4	0.1	0.0	3.4	1.1	0.1	1.5	0.0	0.1	0.8	7.0	0.1	22.9	0.3	0.1	8.2		1.1	1.7	5.5	0.1	0.0	1.9	1.8	0.8	0.1	0.0	0.1	14.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	17.9	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.4	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C1orf228	"MGC33556, NCRNA00082, p40"	ENSG00000198520	"Chromosome 1 open reading frame 228"	Q6PIY5	1	44674692-44725591	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.0;testis: 17.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.4;MOLT-4: 6.9;NB-4: 9.8;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034769	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA034769: AB_10670979"	"unprognostic (2.01e-5)"	"unprognostic (4.28e-3)"	"unprognostic (7.27e-2)"	"prognostic favourable (8.64e-4)"	"unprognostic (9.23e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.22e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-10)"	"unprognostic (1.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-3)"	0.9	2.2	6.3	0.7	11.2	4.3	1.5	3.2	6.8	1.7	1.0	5.6	3.9	0.7	3.1	6.8	1.3	14.0	1.5	0.6	6.5	2.4	1.4	7.0	2.0	1.5	1.4	7.5	4.5	1.4	3.0	5.4	0.8	7.7	1.8	0.9	3.3	1.6	1.4	0.5	1.7	0.8	0.9	2.4	0.8	1.4	17.9	5.4	0.2	1.3	0.0	1.0	0.8	0.8	1.4	6.2	10.4	2.7	0.5	2.3	1.8	0.2	0.3	2.0	0.1	0.7	2.5	0.5	0.0	0.3	0.5	0.3	0.4	4.2	0.3	0.3	0.9	0.5	0.0	0.0	0.0	1.1	0.2	1.0	2.5	0.6	0.2	8.4	5.0	2.0	0.3	0.8	0.0	0.2	0.1	0.7	0.2	0.1	6.9	9.8	0.1	0.1	3.6	0.1	2.4	0.8	0.0	1.4	0.9	0.0	1.4	1.1	0.4	4.4	0.0	0.3	0.3	0.3	0.0	0.3	0.3	0.2	0.3	13.4	0.4	10.4	2.7	7.5	0.3	0.8	0.1	0.7	1.5	1.0	1.3	1.4	2.2	2.3	1.2	0.5	0.1	6.2	0.1	1.8	6.3	11.2	3.2	6.8	6.5	2.4	1.4	7.5	7.7	5.4
C1orf232		ENSG00000282872	"Chromosome 1 open reading frame 230"	A0A0U1RR37	1	26164161-26168581	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 1.4;testis: 2.2;thyroid gland: 1.6"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 8.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.8"																																	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.4	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.8	0.0	0.0	0.0		0.0	0.0	2.2			1.6		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C1orf87	"CREF, MGC34837"	ENSG00000162598	"Chromosome 1 open reading frame 87"	Q8N0U7	1	59987269-60073770	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.1;fallopian tube: 33.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.2;HSkMC: 3.2;SCLC-21H: 1.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 19.1;pons and medulla: 17.7"	"Cell type enriched"	"Detected in single"	19	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA031366, HPA031368"	Enhanced									"HPA031366: AB_2673847, HPA031368: AB_10600795"				"unprognostic (1.16e-2)"	"unprognostic (9.87e-2)"			"unprognostic (3.83e-2)"		"unprognostic (1.92e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.11e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"			0.3	0.3	3.2	0.3	19.1	0.3	0.3	0.0	0.9	1.7	0.3	3.4	0.0	0.3	0.9	4.8	0.3	33.4	0.3	0.3	3.8	4.5	0.5	0.3	6.8	0.3	1.3	0.7	5.1	0.4	0.7	0.8	0.3	17.7	0.4	0.3	2.5	3.4	0.6	0.3	0.3	0.3	0.3	0.9	0.3	0.3	1.2	3.6	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.2	19.1	0.0	0.9	3.8	4.5	1.3	0.7	17.7	3.6
C20orf85	"bA196N14.1, LLC1"	ENSG00000124237	"Chromosome 20 open reading frame 85"	Q9H1P6	20	58150904-58161150	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 113.6;testis: 62.8"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 3.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 57.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.5"	"Low region specificity"	"Detected in many"			"HPA058271, HPA065540"	Enhanced									"HPA058271: AB_2683661, HPA065540: AB_2685510"				"unprognostic (4.50e-3)"				"unprognostic (1.87e-1)"		"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.46e-2)"		"unprognostic (3.62e-1)"	"unprognostic (2.79e-2)"			0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	7.4	0.0	0.5	0.2	0.0	1.4	26.9	0.0	113.6	0.0	0.0	0.1	0.8	0.0	0.0	29.4	0.3	0.0	0.0	29.0	0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	62.8	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.1	0.8	0.0	0.0	1.5	0.1
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1"	"Cell line enhanced"	"Detected in many"		"REH: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.2"	"Low lineage specificity"	"Detected in many"											"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favourable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.3	1.8	2.2	4.3	5.0	11.1	5.2	3.6	3.1	3.2	3.5	4.6	3.3	4.7	2.2	9.7	3.1	27.2	3.2	2.6	2.9	2.9	1.3	1.3	9.1	5.9	2.9	1.8	8.0	3.2	1.4	25.1	2.1	5.8	2.3	2.7	1.9	2.5	1.7	1.6	5.3	4.3	1.5	1.8	2.8	3.7	5.7	2.2	22.7	1.8	2.1	4.6	1.7	2.1	2.1	1.8	8.2	0.5	0.7	1.8	0.9	12.2	5.6	14.9	9.3	1.5	2.0	8.3	7.6	2.8	5.3	5.2	2.6	9.0	8.9	1.9	2.1	9.9	4.0	3.2	1.6	9.2	8.7	14.3	14.7	1.4	0.3	4.0	8.2	0.9	0.7	3.8	0.9	3.3	8.1	23.7	4.3	5.0	19.9	5.5	6.4	2.8	29.6	6.7	7.9	1.6	2.3	12.3	7.7	5.7	4.1	1.8	10.0	8.1	2.3	3.3	9.4	3.2	4.5	9.6	4.2	4.2	5.8	17.7	8.5	8.2	0.5	1.1	0.9	0.3	0.5	0.2	1.1	1.2	0.1	2.1	1.8	1.4	0.7	0.7	0.2	1.8	1.3	0.9	2.2	5.0	3.6	3.1	2.9	2.9	2.9	1.8	5.8	2.2
C2orf50	FLJ25143	ENSG00000150873	"Chromosome 2 open reading frame 50"	Q96LR7	2	11133053-11146790	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.3;fallopian tube: 21.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.1;T-47d: 3.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"pons and medulla: 17.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA062894	Enhanced									"HPA062894: AB_2684897"	"unprognostic (6.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.92e-3)"	"unprognostic (3.35e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.97e-4)"	"unprognostic (7.03e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.25e-3)"	"unprognostic (7.36e-2)"	0.4	0.5	2.1	0.5	2.7	0.7	0.6	0.5	4.0	1.2	0.3	2.2	0.0	0.6	0.7	5.5	0.2	21.1	0.4	0.2	4.1	3.2	0.6	0.3	4.0	0.6	1.0	1.7	5.0	0.5	0.3	3.8	0.4	17.3	0.5	0.3	0.0	1.1	0.3	0.4	0.6	0.4	0.4	0.6	0.6	0.4	0.6	0.5	0.0	0.5	0.0	0.5	0.2	0.0	1.1	0.8	2.0	0.7	1.3	2.4	0.4	0.3	1.7	0.8	0.4	0.1	0.2	0.9	0.2	0.4	0.6	0.5	0.8	4.1	0.3	0.6	0.3	0.8	2.6	0.2	0.5	1.7	0.5	0.3	0.2	0.5	0.0	0.2	0.8	0.1	0.3	0.1	0.3	0.0	0.2	1.4	0.0	3.0	0.7	0.4	0.7	0.5	1.8	0.0	0.3	0.5	0.6	1.2	0.7	0.2	0.8	0.6	3.6	0.7	1.3	0.4	0.6	0.2	0.4	1.2	0.4	0.2	0.6	0.2	0.6	1.8	0.6	0.5	0.5	0.3	0.4	0.9	0.8	0.7	0.8	1.1	2.4	0.7	2.0	1.3	0.7	0.5	0.8	0.4	2.1	2.7	0.5	4.0	4.1	3.2	1.0	1.7	17.3	0.5
C2orf70	LOC339778	ENSG00000173557	"Chromosome 2 open reading frame 70"	A6NJV1	2	26562582-26579532	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 11.5;testis: 44.9"	"Cell line enhanced"	"Detected in some"		"A-431: 7.3;CAPAN-2: 5.6;EFO-21: 3.6;RPTEC TERT1: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062453	Enhanced		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"	"Nuclear membrane, Vesicles"	"HPA062453: AB_2684769"	"unprognostic (5.44e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.40e-6)"		"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (6.49e-4)"	"unprognostic (4.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.08e-3)"	0.1	0.3	1.1	0.3	2.2	0.0	0.3	0.1	0.8	0.5	1.0	3.1	2.3	0.3	0.4	5.2	0.2	11.5	0.6	1.4	1.1	2.7	0.7	0.1	1.0	0.1	0.8	0.7	2.7	4.5	0.0	1.2	0.1	4.4	0.4	0.6	0.0	3.1	1.7	0.2	0.1	0.2	0.1	0.7	0.1	7.6	44.9	0.5	0.0	3.1	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.0	3.6	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	1.7	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	0.1	0.8	1.1	2.7	0.8	0.7	4.4	0.5
C2orf81	"hCG40743, LOC388963"	ENSG00000284308	"Chromosome 2 open reading frame 81"		2	74414176-74421591	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.9;testis: 20.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 11.9;RPMI-8226: 11.3;SCLC-21H: 14.8;SH-SY5Y: 16.2"									"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.2"	"Low lineage specificity"	"Detected in many"											"HPA049564, HPA054835"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA049564: , HPA054835: AB_2682620"																		0.4	0.9	2.2	1.2	5.5	0.5	0.9	1.2	3.4	1.3	0.8	2.6	8.2	0.9	2.2	4.9	1.6	17.9	2.0	0.7	2.1		1.9	0.0	2.5	3.0	0.0	2.8	3.2	1.6	4.9	13.7	1.0	1.9	1.8	0.2	3.2	1.3	3.5	0.8	0.3	1.1	0.7	0.0	2.1	1.7	20.0	0.8	5.3	2.1	0.7	1.9	1.9	0.0	6.5	13.2	0.2	1.8	3.1	3.4	1.3	3.5	6.5	2.0	7.2	2.2	1.9	0.7	0.6	2.1	0.6	0.7	0.4	4.0	8.4	1.6	1.0	1.3	0.1	1.7	0.7	4.7	0.5	0.9	0.5	0.1	1.1	1.7	1.9	1.1	4.3	0.8	0.8	0.0	0.3	1.3	1.1	11.9	2.2	4.4	3.9	1.4	1.1	0.7	11.3	2.6	1.5	14.8	16.2	2.0	3.2	0.9	3.0	1.6	0.1	0.7	3.2	2.2	1.8	3.1	5.5	2.7	4.5	1.7	1.5	0.1	1.8	0.0	0.6	1.8	0.3	5.7	0.7	0.8	6.2	6.5	3.4	1.5	0.2	3.1	1.4	13.2	0.6	1.3										
C4orf22		ENSG00000197826	"Chromosome 4 open reading frame 22"	Q6V702	4	80335720-80963756	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;fallopian tube: 19.8;testis: 34.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;ASC TERT1: 2.1;BJ: 4.5;LHCN-M2: 2.7;SCLC-21H: 3.0;U-251 MG: 2.9;U-87 MG: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.4;pons and medulla: 22.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Low region specificity"	"Detected in many"							HPA043383	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.1	1.4	0.1	8.4	0.1	0.3	0.6	0.2	0.9	0.1	5.1	0.1	0.3	0.4	7.8	0.2	19.8	0.3	0.1	2.8	2.5	0.4	0.1	5.9	0.3	0.1	0.1	3.5	0.1	0.1	1.2	0.1	22.0	0.2	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.1	0.1	34.8	2.4	2.9	0.7	0.0	0.2	0.1	0.0	2.1	0.5	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.3	2.1	0.0	4.5	0.8	0.1	0.2	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.9	0.0	0.0	1.2	2.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.4	8.4	0.6	0.2	2.8	2.5	0.1	0.1	22.0	2.4
C4orf47	LOC441054	ENSG00000205129	"Chromosome 4 open reading frame 47"	A7E2U8	4	185426249-185449826	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.8;fallopian tube: 20.3;testis: 20.6"	"Cell line enhanced"	"Detected in some"		"A-431: 4.1;ASC TERT1: 4.3;U-87 MG: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043662, HPA063485"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA043662: AB_10964715, HPA063485: "	"unprognostic (3.38e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.82e-5)"	"unprognostic (3.72e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.50e-1)"	0.9	0.5	4.4	0.7	13.3	0.8	3.7	1.7	4.0	1.8	0.7	3.6	0.8	0.6	2.2	12.3	0.7	20.3	1.8	1.2	3.8	3.8	2.4	1.0	3.3	0.5	2.4	2.9	3.0	1.3	1.0	7.1	0.7	20.8	1.2	0.7	2.1	1.0	1.4	0.6	1.9	0.7	1.0	4.7	0.8	0.5	20.6	5.5	0.0	7.3	0.0	0.6	1.0	0.6	0.1	0.7	4.1	0.6	0.9	0.6	0.2	4.1	0.0	0.4	2.2	0.8	4.3	1.3	0.1	0.3	0.4	0.5	0.6	2.5	0.1	0.8	0.2	0.3	0.5	0.6	1.0	0.8	0.7	0.0	0.1	0.6	1.0	0.0	0.3	0.9	1.0	1.0	0.5	0.0	0.6	0.3	3.2	0.5	0.0	0.0	0.5	1.6	0.1	0.1	0.3	1.2	0.1	2.3	1.0	0.7	0.1	2.6	0.2	0.7	1.3	0.7	0.3	0.0	0.1	1.8	0.0	0.0	10.7	0.0	0.3	0.0	0.6	0.6	0.2	0.1	0.4	0.0	0.6	0.6	0.2	0.1	0.1	0.2	4.1	0.9	0.2	0.7	0.0	0.2	4.4	13.3	1.7	4.0	3.8	3.8	2.4	2.9	20.8	5.5
C6orf118	"bA85G2.1, MGC23884"	ENSG00000112539	"Chromosome 6 open reading frame 118"	Q5T5N4	6	165279664-165309607	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6"	"Group enriched"	"Detected in some"	5	"AF22: 7.2;SCLC-21H: 4.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA029787, HPA029789"	Approved		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA029787: AB_10599999, HPA029789: AB_10601002"	"unprognostic (2.84e-1)"	"unprognostic (3.09e-4)"		"unprognostic (2.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.34e-2)"		"unprognostic (1.41e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.18e-9)"	"unprognostic (3.22e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.55e-3)"	"unprognostic (4.50e-1)"	0.3	0.3	4.4	0.3	11.4	0.3	0.3	0.1	0.8	1.5	0.3	7.5	0.1	0.3	1.0	7.2	0.3	23.9	0.3	0.3	4.3	2.7	0.3	0.3	4.7	0.3	0.3	1.0	3.4	0.3	0.3	10.4	0.3	14.5	0.3	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.3	0.8	0.3	0.3	9.6	3.9	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.2	0.0	0.2	0.0	4.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.4	0.1	0.8	4.3	2.7	0.3	1.0	14.5	3.9
C7orf57		ENSG00000164746	"Chromosome 7 open reading frame 57"	Q8NEG2	7	48035511-48061304	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;fallopian tube: 20.9;testis: 11.4"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.1;U-266/70: 5.9;U-698: 3.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 20.0"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021286	Enhanced									"HPA021286: AB_1845760"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-5)"	"unprognostic (5.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.20e-1)"	0.2	0.2	2.3	0.2	5.0	0.5	0.3	0.1	1.0	0.8	0.2	3.5	0.0	0.3	0.9	7.1	1.4	20.9	0.2	0.3	3.7	4.0	0.3	0.2	4.3	0.3	0.1	0.4	1.6	0.1	0.7	0.4	0.2	20.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.7	0.2	0.2	11.4	2.1	0.0	0.5	1.8	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.6	2.3	0.1	0.8	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.3	0.4	0.0	2.4	0.0	0.2	0.2	0.3	0.0	1.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.6	0.9	0.5	0.6	5.9	0.8	3.4	1.4	0.0	1.0	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.6	0.6	0.1	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1	2.3	5.0	0.1	1.0	3.7	4.0	0.1	0.4	20.0	2.1
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330722-68819022	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;parathyroid gland: 19.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.4;HEK 293: 5.7;LHCN-M2: 4.9;RH-30: 5.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA044420: AB_10963791, HPA053065: AB_2682030"	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	4.2	0.9	7.4	0.8	10.6	1.1	1.5	9.6	8.4	4.0	0.7	9.6	0.2	0.7	1.5	2.5	2.1	15.3	3.2	1.6	8.9	7.0	1.0	0.7	8.3	0.8	3.7	5.0	1.4	2.1	19.9	2.7	0.9	10.4	3.9	0.9	3.5	1.4	2.2	0.9	1.8	0.8	1.7	3.2	0.8	1.7	1.4	6.7	0.0	1.0	1.1	0.7	1.2	1.1	1.8	2.0	2.9	0.7	1.3	1.8	0.5	0.3	0.0	0.8	0.4	1.2	2.2	0.2	1.4	4.4	0.7	0.6	0.3	0.4	0.2	0.9	1.2	0.3	0.3	0.8	0.2	0.1	5.7	0.7	1.0	0.4	0.2	0.1	0.5	0.1	0.6	0.8	1.5	0.1	0.3	1.0	4.9	0.6	0.1	0.5	2.5	0.1	0.2	5.3	0.1	0.6	0.4	1.1	0.1	0.3	0.3	0.0	2.5	0.2	0.1	1.0	0.6	3.3	0.2	0.8	0.0	0.1	0.4	0.3	0.8	2.1	0.7	1.2	1.4	0.3	1.1	1.0	1.2	1.1	0.3	1.8	1.5	1.8	2.9	1.3	0.5	2.0	0.8	0.5	7.4	10.6	9.6	8.4	8.9	7.0	3.7	5.0	10.4	6.7
C9orf116	"MGC29761, PIERCE1, RbEST47"	ENSG00000160345	"Chromosome 9 open reading frame 116"	Q5BN46	9	135495181-135501734	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 63.3;testis: 47.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 22.2;T-47d: 23.0;U-2197: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021439, HPA065287"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA021439: AB_1845799, HPA065287: AB_2732732"	"unprognostic (9.02e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.93e-1)"	"prognostic favourable (3.53e-5)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	1.5	7.2	8.0	1.0	9.2	1.0	2.2	1.5	6.2	4.1	1.1	6.2	8.2	1.1	3.3	22.1	1.0	63.3	2.7	1.5	9.6	9.3	7.8	1.5	9.8	0.9	4.9	4.9	9.3	4.5	3.3	7.6	1.5	19.9	2.0	1.3	1.7	2.0	5.0	1.4	1.2	1.0	1.3	2.6	1.0	1.8	47.8	2.6	0.1	6.7	0.2	1.2	2.2	0.3	1.7	0.9	0.1	2.6	1.8	4.2	1.1	5.8	10.1	4.5	6.9	1.9	4.2	0.9	4.0	2.8	4.8	3.3	3.8	5.9	1.0	5.3	2.6	4.0	4.9	2.2	4.1	0.3	4.5	0.0	11.2	11.6	5.4	0.8	2.8	2.9	1.7	2.4	0.7	2.3	5.4	0.8	2.3	22.2	3.0	1.0	9.4	11.9	4.6	2.2	3.6	11.4	4.2	4.3	4.6	5.5	2.4	0.6	23.0	0.9	1.1	2.7	3.7	23.7	1.5	2.6	6.4	0.9	8.2	0.3	0.8	0.1	2.6	0.0	1.9	1.6	4.2	0.7	1.3	1.4	0.9	1.7	2.4	1.8	0.0	1.8	0.4	0.4	1.6	1.1	8.0	9.2	1.5	6.2	9.6	9.3	4.9	4.9	19.9	2.6
C9orf135		ENSG00000204711	"Chromosome 9 open reading frame 135"	Q5VTT2	9	69820793-69906232	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.6;fallopian tube: 31.8;pituitary gland: 35.4;testis: 18.4"	"Group enriched"	"Detected in some"	7	"HAP1: 9.3;NTERA-2: 24.7"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 7.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 3.3;naive CD8 T-cell: 4.0;T-reg: 3.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021261, HPA021325"	Uncertain									"HPA021261: AB_1845811, HPA021325: AB_1845812"	"unprognostic (1.05e-2)"			"unprognostic (4.39e-1)"	"unprognostic (1.97e-1)"			"unprognostic (1.39e-1)"		"unprognostic (1.90e-1)"	"unprognostic (5.22e-3)"	"unprognostic (5.72e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.60e-2)"		0.1	0.5	3.2	0.1	2.4	0.1	0.1	0.0	0.1	0.8	0.1	3.1	0.0	0.1	0.6	9.8	0.1	31.8	1.3	0.1	2.2	2.2	1.3	0.3	7.0	0.1	0.3	0.0	3.2	0.7	3.1	35.4	0.1	17.6	0.1	0.1	0.4	0.2	0.4	0.5	0.1	0.1	0.1	0.4	0.1	0.2	18.4	0.4	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.1	0.0	0.0	3.3	4.0	0.0	0.0	0.0	0.0	3.6	0.1	3.2	2.4	0.0	0.1	2.2	2.2	0.3	0.0	17.6	0.4
CABCOCO1	"bA63A2.1, C10orf107, Em:AC022398.2, MGC44593"	ENSG00000183346	"Ciliary associated calcium binding coiled-coil 1"	Q8IVU9	10	61662961-61766766	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 33.1;testis: 18.6"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	Centrosome	"HPA041398: AB_10794374"	"unprognostic (1.89e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (1.79e-4)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.52e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.33e-2)"	1.5	1.2	6.3	0.7	5.7	0.5	2.1	0.4	6.8	6.1	1.6	9.5	3.0	1.0	5.2	7.6	0.9	33.1	3.8	0.7	8.1	7.3	2.6	0.9	10.3	0.9	8.1	5.8	4.1	1.6	10.0	5.2	1.4	13.7	5.9	1.3	1.5	1.7	3.7	0.6	0.8	0.9	3.0	14.8	1.9	0.9	18.6	5.6	0.0	1.9	0.0	0.6	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.4	0.0	0.4	1.6	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	5.7	0.4	6.8	8.1	7.3	8.1	5.8	13.7	5.6
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine		19	5911707-5915877	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 71.4;fallopian tube: 116.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.0;U-266/70: 10.0"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 71.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favourable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favourable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	2.6	4.1	8.0	4.3	14.7	4.3	2.8	1.4	3.3	12.4	3.3	34.4	15.6	3.1	9.1	49.4	2.8	116.0	13.6	2.0	13.4	6.6	8.9	5.0	25.4	4.4	8.0	7.8	26.7	6.5	2.5	7.5	17.7	71.4	9.4	2.0	3.3	7.7	12.7	2.0	5.7	5.0	2.9	7.5	7.6	9.4	2.1	17.9	0.4	7.8	0.9	2.5	8.8	11.3	4.9	4.0	5.2	2.2	5.3	4.8	2.4	1.0	1.1	0.7	3.4	1.3	1.8	2.1	0.5	0.4	0.2	0.3	0.8	7.4	0.8	2.2	0.9	1.3	0.3	0.3	0.1	2.4	1.0	0.6	2.2	2.0	1.2	0.6	1.8	2.2	2.1	0.2	0.5	0.5	0.5	2.9	0.4	2.1	1.4	2.0	0.6	5.6	1.7	0.3	2.3	1.0	3.1	0.7	2.5	0.5	36.0	3.6	2.2	2.3	1.0	0.6	0.4	2.6	9.5	10.0	3.4	0.6	4.2	1.0	1.4	3.3	2.2	1.6	4.8	1.8	2.6	3.1	3.0	3.6	2.1	4.9	2.4	2.0	5.2	5.3	1.6	4.0	3.2	2.4	8.0	14.7	1.4	3.3	13.4	6.6	8.0	7.8	71.4	17.9
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.7"	"Cell line enhanced"	"Detected in many"		"A549: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040004	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome				Centrosome	Centrosome	"HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	2.6	4.2	8.0	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5.0	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2.0	4.4	5.5	3.6	3.8	2.6	1.9	2.0	8.7	2.6	3.2	8.0	9.5	1.4	9.3	2.2	1.4	2.6	2.0	0.1	0.6	0.0	0.7	1.1	1.8	0.1	1.8	5.0	1.4	0.4	2.5	1.9	0.2	1.0	0.2	2.7	2.9	0.0	2.3	0.5	4.4	0.7	1.1	0.0	2.2	1.9	1.7	0.8	2.1	0.8	0.0	0.0	0.3	0.0	0.8	1.3	2.3	0.5	0.3	0.4	0.8	3.5	0.1	2.4	2.0	0.7	0.7	0.0	0.0	0.2	3.5	0.0	2.9	1.4	0.2	0.1	1.6	1.7	0.7	1.1	2.5	1.1	0.6	0.4	0.2	0.0	0.0	2.2	0.0	2.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	0.0	0.0	0.1	0.6	0.9	0.0	1.1	0.7	0.6	1.8	0.1	8.0	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904295-35938779	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 34.9;epididymis: 18.3;fallopian tube: 59.4"	"Group enriched"	"Detected in some"	4	"BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.8;REH: 7.6;U-698: 18.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 14.1;ovarian cancer: 3.4"	"Region enriched"	"Detected in many"	7	"pons and medulla: 34.9"	"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules				"Nucleoplasm, Microtubules"	"Nucleoplasm, Microtubules"	"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.1	0.2	3.6	0.1	4.4	0.2	0.2	0.0	0.5	2.4	0.1	4.3	0.4	0.1	1.3	18.3	0.2	59.4	0.2	0.2	5.2	5.3	0.7	0.1	11.8	0.1	0.3	0.0	6.7	0.4	0.1	17.0	0.2	34.9	0.2	0.1	0.0	0.4	0.4	0.2	0.2	0.1	0.2	0.8	0.1	0.2	5.4	0.5	0.5	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.3	6.2	0.0	0.0	2.1	0.0	0.9	0.0	0.1	0.0	4.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	1.3	0.0	0.0	1.2	2.2	0.0	0.5	0.0	0.0	18.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	4.4	0.0	0.3	5.2	5.3	0.3	0.0	34.9	0.5
CASC1	"FLJ10921, LAS1, PPP1R54"	ENSG00000118307	"Cancer susceptibility 1"	Q6TDU7	12	25108420-25195162	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.1;pituitary gland: 21.5;testis: 25.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Group enriched"	"Detected in many"	5	"B-cells: 2.6;granulocytes: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039662	Enhanced									"HPA039662: AB_10795468"	"unprognostic (6.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.62e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.21e-4)"	"unprognostic (2.54e-2)"	"prognostic favourable (3.13e-4)"	"unprognostic (2.01e-1)"	"unprognostic (8.74e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.19e-1)"	0.6	1.0	3.1	0.5	7.6	0.8	2.0	0.7	4.6	2.7	0.6	3.7	1.9	0.2	2.2	12.4	0.9	17.1	1.0	0.9	3.5	4.0	3.6	0.3	4.8	0.7	1.5	4.1	5.4	1.3	5.5	21.5	0.4	12.2	1.4	0.3	1.1	1.0	3.4	0.4	1.4	0.4	0.7	2.4	0.5	1.0	25.3	2.5	0.0	5.2	0.0	0.4	0.6	0.6	2.6	0.7	4.2	0.4	0.2	0.6	0.3	0.6	1.1	1.2	0.9	0.0	0.7	0.7	0.0	0.9	0.8	0.8	0.1	3.3	3.4	1.1	0.0	0.6	0.1	0.6	0.7	1.0	0.2	0.0	0.1	0.0	0.0	0.5	1.4	0.0	0.5	0.6	0.0	0.0	1.7	1.2	0.0	0.0	0.5	1.3	0.4	0.0	1.1	0.5	0.0	3.2	0.3	2.1	0.8	0.5	0.0	0.6	3.2	0.2	0.0	0.2	2.6	1.6	0.3	1.4	0.6	2.7	0.9	0.6	0.6	0.4	0.3	0.8	0.3	0.3	0.3	1.6	0.1	0.6	0.1	2.6	0.4	0.5	4.2	0.2	0.4	0.7	0.0	0.3	3.1	7.6	0.7	4.6	3.5	4.0	1.5	4.1	12.2	2.5
CATIP	"C2orf62, MGC50811"	ENSG00000158428	"Ciliogenesis associated TTC17 interacting protein"	Q7Z7H3	2	218356856-218368099	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 12.0;fallopian tube: 24.5"	"Cell line enriched"	"Detected in single"	11	"BEWO: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.4;neutrophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044818	Supported									"HPA044818: AB_10959301"	"unprognostic (7.11e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.19e-1)"	0.2	0.2	1.5	0.2	3.3	0.2	0.1	0.1	0.6	2.1	0.1	5.7	4.9	0.1	0.7	12.0	0.2	24.5	1.2	0.1	2.1	2.7	3.6	0.1	2.7	0.2	0.4	1.9	3.6	5.5	2.6	1.7	2.0	9.3	1.3	0.1	0.3	0.1	1.6	0.1	0.1	0.1	0.2	0.4	0.3	0.2	9.5	1.8	0.0	5.7	0.0	0.2	0.7	0.0	0.0	0.5	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	1.5	3.3	0.1	0.6	2.1	2.7	0.4	1.9	9.3	1.8
CCDC113	"DKFZp434N1418, HSPC065"	ENSG00000103021	"Coiled-coil domain containing 113"	Q9H0I3	16	58231157-58283836	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 39.1"	"Cell line enhanced"	"Detected in many"		"SiHa: 23.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 7.9"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 7.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040759, HPA040869"	Uncertain									"HPA040759: AB_2677121, HPA040869: AB_2677180"	"unprognostic (8.50e-2)"	"unprognostic (3.39e-2)"	"prognostic favourable (8.65e-4)"	"prognostic favourable (7.01e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.87e-4)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.59e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.61e-2)"	3.2	4.3	9.2	2.0	13.5	1.1	3.8	3.5	16.4	4.0	2.4	10.3	3.8	1.3	3.3	6.7	2.9	39.1	2.8	5.0	9.9	9.0	3.1	2.8	5.3	1.6	6.3	10.4	4.7	2.5	13.6	5.5	3.4	9.7	3.8	2.8	3.6	2.1	3.5	4.1	3.7	1.5	2.7	4.9	1.2	2.8	21.0	4.5	0.0	4.1	1.8	1.4	3.0	1.4	0.4	0.4	7.9	0.3	0.2	0.3	0.1	4.6	3.9	1.7	7.2	4.0	4.3	5.8	2.8	1.8	2.3	0.5	0.5	6.0	0.1	3.7	0.9	0.7	0.6	2.6	2.2	0.5	1.4	0.1	3.0	0.5	4.0	2.3	0.5	2.2	4.6	0.6	6.4	0.4	4.1	0.0	0.5	3.4	0.1	0.7	2.7	5.9	1.4	0.0	0.9	4.1	1.3	1.9	3.0	23.6	2.0	1.0	6.8	2.4	0.2	2.4	2.5	1.5	0.8	1.8	1.2	1.2	5.7	1.5	1.7	7.9	0.2	0.2	0.2	0.3	0.2	0.4	0.3	0.1	0.4	0.4	0.2	0.2	1.5	0.2	0.1	0.2	0.1	0.1	9.2	13.5	3.5	16.4	9.9	9.0	6.3	10.4	9.7	4.5
CCDC114	"CILD20, FLJ32926"	ENSG00000105479	"Coiled-coil domain containing 114"	Q96M63	19	48296457-48321894	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 9.9;testis: 6.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;Karpas-707: 2.6;U-266/70: 4.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.4"					"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042524	Approved									"HPA042524: AB_10795706"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.70e-5)"	"unprognostic (1.54e-2)"	"unprognostic (5.09e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.50e-3)"	"unprognostic (4.35e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.15e-2)"	0.0	0.0	0.8	0.0	1.9	0.8	0.1	0.0	0.2	1.1	0.0			0.0	0.4	0.3	0.0	9.9	0.0	0.0	1.6	2.3	0.0	0.0	1.5	0.2	0.0		0.4	0.0	0.2	0.4	0.1		0.1	0.0		0.2	0.5	0.0	1.3	0.0	0.0	0.2	0.2	0.2	6.3			0.4		0.0	0.0	0.0	0.5	0.3	1.0	0.4	0.3	0.4	0.0	0.2	0.6	0.2	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.5	0.4	0.9	0.0	0.4	0.1	0.0	0.0	1.1	0.2	1.5	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.4	0.0	0.5	2.6	0.0	0.2	0.4	1.6	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.5	0.1	0.5	0.6	0.4	1.6	0.2	0.0	0.3	0.3	0.0	0.3	4.7	1.5	0.0	0.3	0.2	0.0	0.9	0.2	0.4	0.3	0.0	0.4	0.5	0.3	0.3	0.0	0.2	0.2	0.3	1.0	0.3	0.4	0.3	0.0	0.0										
CCDC13	FLJ25467	ENSG00000244607	"Coiled-coil domain containing 13"	Q8IYE1	3	42692663-42773253	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.2;fallopian tube: 13.6;testis: 15.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;Daudi: 1.2;HDLM-2: 2.9;NTERA-2: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA047429	Approved		Supported	Centrosome				Centrosome	Centrosome	"HPA047429: AB_2680043"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.83e-7)"	"unprognostic (6.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (2.04e-2)"	0.7	1.0	3.0	0.7	12.2	0.6	0.7	0.8	4.0	1.3	0.9	6.3	2.3	1.1	2.1	7.0	0.7	13.6	1.5	1.7	3.7	2.7	1.1	1.7	2.5	0.7	1.9	4.6	1.5	2.0	1.0	3.7	0.7	8.1	0.7	1.4	1.5	1.6	1.1	2.0	0.6	1.1	0.9	3.4	0.8	0.8	15.0	2.5	0.0	1.9	0.3	0.6	0.7	0.5	0.0	0.0	0.1	0.2	0.5	1.2	0.2	0.0	0.0	0.0	1.1	2.3	0.9	0.7	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.1	2.9	0.8	0.0	0.3	0.0	0.0	0.0	0.4	0.6	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	3.0	12.2	0.8	4.0	3.7	2.7	1.9	4.6	8.1	2.5
CCDC146	KIAA1505	ENSG00000135205	"Coiled-coil domain containing 146"	Q8IYE0	7	77122434-77329533	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;fallopian tube: 27.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"pons and medulla: 32.7"	"Cell type enhanced"	"Detected in many"		"eosinophil: 12.5;neutrophil: 14.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 14.0;NK-cells: 5.0;T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020082, HPA020105"	Uncertain		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA020082: AB_1852410, HPA020105: AB_2072056"	"unprognostic (3.07e-3)"	"unprognostic (9.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.85e-1)"	"prognostic favourable (7.37e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.02e-3)"	"unprognostic (4.05e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.70e-3)"	"unprognostic (5.58e-3)"	1.8	0.8	6.5	1.9	7.2	1.3	1.9	1.8	8.3	4.3	3.2	4.5	2.7	1.9	3.7	9.1	3.5	27.9	2.6	1.4	7.4	3.4	4.2	1.3	4.9	2.2	1.6	4.2	6.4	1.8	2.9	10.9	1.5	32.7	3.4	2.2	4.4	3.9	1.8	1.6	7.4	2.2	2.4	2.8	2.8	2.5	22.2	2.9	0.5	6.3	0.9	2.0	3.1	3.4	1.0	1.8	14.0	0.7	5.0	4.4	0.6	1.0	1.5	4.4	2.4	2.9	3.0	0.5	1.1	1.0	1.1	1.9	0.0	7.5	2.5	0.2	0.3	1.5	0.6	1.4	1.9	3.0	0.5	2.9	2.0	1.3	0.9	3.2	2.4	1.7	2.2	2.0	0.3	1.0	0.0	2.8	0.3	0.3	2.6	4.7	0.5	1.1	6.9	0.7	0.3	4.6	0.8	3.4	2.2	1.6	1.5	0.9	1.4	1.1	1.4	1.7	0.6	2.4	0.7	4.4	6.8	2.1	3.9	4.9	4.0	0.6	0.5	12.5	4.4	0.7	3.1	1.0	1.9	3.0	0.8	0.2	1.2	1.9	14.0	5.0	0.3	1.8	1.4	0.6	6.5	7.2	1.8	8.3	7.4	3.4	1.6	4.2	32.7	2.9
CCDC151	MGC20983	ENSG00000198003	"Coiled-coil domain containing 151"	A5D8V7	19	11420604-11435782	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.7;fallopian tube: 18.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 4.0;T-47d: 9.2;U-87 MG: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.3;memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044184, HPA054626"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA044184: , HPA054626: AB_2682547"	"unprognostic (1.50e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.41e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.76e-4)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.05e-1)"	0.8	3.1	5.7	0.6	9.9	0.6	0.6	4.4	7.7	1.6	0.6	4.0	1.4	0.6	1.0	2.8	0.6	18.2	0.6	1.2	7.7	4.3	2.0	0.8	2.7	0.6	2.3	4.6	2.5	0.6	9.8	10.4	1.4	12.7	0.8	0.6	0.7	4.0	1.8	0.5	0.5	0.6	0.6	1.7	1.9	0.9	8.5	5.4	0.0	2.1	0.0	0.7	0.6	0.4	1.5	0.7	0.1	2.3	0.0	0.0	0.1	0.5	0.1	1.2	0.1	0.1	0.4	1.0	0.5	0.1	0.6	0.7	0.1	0.0	0.3	0.5	0.2	0.2	0.9	0.4	0.0	1.0	1.0	0.4	0.6	0.0	0.5	0.0	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.9	0.2	0.8	0.0	0.1	0.4	2.1	0.4	0.1	1.4	0.7	0.0	4.0	2.7	1.2	0.2	0.1	9.2	0.4	0.0	1.4	0.3	3.4	0.1	3.4	2.7	0.2	3.6	0.6	0.1	0.0	0.6	0.0	0.0	2.3	0.0	1.5	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	5.7	9.9	4.4	7.7	7.7	4.3	2.3	4.6	12.7	5.4
CCDC153	LOC283152	ENSG00000248712	"Coiled-coil domain containing 153"	Q494R4	11	119189638-119196769	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0"	"Cell line enhanced"	"Detected in many"		"T-47d: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041497	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA041497: AB_10794378"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.98e-3)"	1.4	1.1	2.2	0.6	4.8	3.8	0.8	0.5	0.9	1.4	0.6	2.0	0.5	0.5	1.1	5.3	1.5	15.8	3.1	2.0	2.6	3.9	1.5	0.6	5.2	0.5	0.5	0.5	1.7	0.5	3.3	20.0	1.3	9.8	0.5	0.6	0.5	0.7	1.6	0.5	1.4	0.8	0.7	1.2	0.8	1.6	2.8	2.4	0.5	1.1	0.5	0.9	0.7	0.5	0.4	1.6	15.1	2.4	0.3	0.6	0.7	2.2	2.9	1.8	1.8	0.3	0.3	4.3	1.2	1.4	0.6	0.7	4.8	7.5	1.5	6.2	0.3	1.6	0.4	1.4	0.1	2.9	2.5	7.0	2.2	3.2	1.0	2.3	0.9	0.7	1.0	1.6	0.4	1.5	2.1	2.8	0.1	8.7	1.5	2.2	0.9	5.1	1.9	2.5	1.4	0.5	2.1	2.3	1.2	2.9	1.4	1.7	12.8	2.7	2.9	3.3	2.6	1.9	2.6	1.1	1.7	1.2	1.4	1.3	3.9	0.4	2.4	3.8	0.3	1.5	0.2	0.4	0.2	0.4	1.6	0.4	0.6	0.5	15.1	0.3	1.5	1.6	0.4	0.7	2.2	4.8	0.5	0.9	2.6	3.9	0.5	0.5	9.8	2.4
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494030-151621193	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.4;fallopian tube: 33.0"	"Group enriched"	"Detected in some"	5	"MCF7: 13.8;T-47d: 8.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.1"	"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"				"Golgi apparatus"	"Golgi apparatus"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	6.2	2.1	1.4	6.7	0.3	4.0	0.4	2.4	3.9	0.9	6.5	0.3	2.6	5.2	19.4	0.6	33.0	1.5	3.3	3.7	3.6	1.6	1.5	9.7	3.6	1.3	1.4	14.4	0.5	0.3	1.5	1.6	16.1	1.2	0.7	3.9	0.5	0.6	0.8	0.6	1.2	1.5	1.2	2.9	1.8	5.9	1.5	0.7	5.7	0.6	0.8	1.7	1.2	0.1	1.8	8.6	4.1	0.1	0.1	0.9	0.0	0.2	0.5	0.0	0.5	0.4	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	8.1	0.1	0.8	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	3.1	8.6	0.1	4.1	0.1	0.1	0.0	0.0	1.8	0.1	0.1	0.1	2.9	0.1	3.7	0.1	0.1	0.9	2.1	6.7	0.4	2.4	3.7	3.6	1.3	1.4	16.1	1.5
CCDC40	"CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640"	ENSG00000141519	"Coiled-coil domain containing 40"	Q4G0X9	17	80036632-80100613	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 24.3;testis: 29.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 13.8;SH-SY5Y: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022974	Enhanced		Approved	Microtubules				Microtubules	Microtubules	"HPA022974: AB_1848791"	"unprognostic (5.89e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.76e-3)"	"prognostic favourable (2.95e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.04e-5)"	"unprognostic (7.38e-2)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.26e-2)"	3.4	3.6	3.0	3.0	10.4	1.0	3.6	2.5	5.1	3.2	2.4	10.2	2.3	1.3	4.5	10.1	1.5	24.3	3.8	3.8	6.2	4.8	5.5	2.3	5.5	1.5	3.3	3.1	4.5	3.2	3.6	10.2	1.4	19.4	4.4	1.3	4.8	2.5	4.1	2.6	2.2	2.6	2.8	3.5	2.3	3.2	29.5	5.0	0.0	6.0	1.2	1.2	2.0	1.4	0.9	0.5	2.5	0.4	0.7	1.1	0.1	2.3	7.8	7.0	7.8	0.9	1.1	1.9	2.2	1.6	2.0	2.1	0.8	3.3	0.3	1.1	1.6	0.7	1.8	1.7	0.5	0.1	1.4	0.1	3.8	3.8	1.7	0.2	2.5	1.8	2.4	2.4	0.2	1.1	0.9	0.0	1.6	2.7	0.1	0.5	3.3	2.6	2.0	3.9	0.0	4.0	1.6	13.8	10.0	3.4	1.7	1.6	3.2	0.2	1.3	4.4	2.7	2.8	0.5	2.3	0.7	0.3	1.0	0.2	2.1	1.7	0.4	0.4	0.5	0.2	1.1	0.5	0.3	0.2	0.0	0.9	0.5	0.4	2.5	0.7	0.2	0.5	0.1	0.1	3.0	10.4	2.5	5.1	6.2	4.8	3.3	3.1	19.4	5.0
CCDC60	MGC39827	ENSG00000183273	"Coiled-coil domain containing 60"	Q8IWA6	12	119334712-119541047	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0;fallopian tube: 21.1;smooth muscle: 17.5;testis: 25.7"	"Cell line enhanced"	"Detected in some"		"AF22: 1.0;BEWO: 1.8;HBEC3-KT: 2.4;HeLa: 1.7;RT4: 2.6;U-2 OS: 1.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-3)"		"unprognostic (1.00e-1)"		"unprognostic (2.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.92e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.54e-1)"	0.1	0.0	1.8	0.6	3.3	0.0	0.0	0.0	0.1	6.9	2.1	5.2	3.6	0.2	1.4	4.9	2.8	21.1	0.2	0.1	2.4	2.6	0.1	0.1	3.2	0.1	0.1	0.0	5.3	0.1	0.0	0.1	0.6	22.0	5.4	5.7	8.9	3.5	2.1	0.2	0.2	0.2	17.5	0.4	0.1	0.4	25.7	0.3	0.0	0.1	0.4	2.6	10.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.3	0.0	0.1	2.4	2.6	0.1	0.0	22.0	0.3
CCDC65	"CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28"	ENSG00000139537	"Coiled-coil domain containing 65"	Q8IXS2	12	48904110-48931840	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.5;testis: 53.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 13.7"	"Group enriched"	"Detected in many"	11	"gdTCR: 8.9;MAIT T-cell: 9.5;memory CD4 T-cell: 7.6;memory CD8 T-cell: 7.1;naive CD4 T-cell: 4.7;naive CD8 T-cell: 6.3;T-reg: 4.1"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038520, HPA057573"	Uncertain		Approved	"Vesicles,Centriolar satellite"				Vesicles	Vesicles	"HPA038520: AB_10672714, HPA057573: AB_2683473"	"unprognostic (3.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.23e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.03e-4)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.16e-2)"	0.3	0.4	2.2	0.6	5.1	1.1	0.5	0.6	2.2	1.6	0.3	4.5	0.5	0.4	1.3	5.1	0.3	22.5	1.1	0.3	2.9	3.2	2.0	0.2	5.0	0.8	0.6	2.0	2.7	0.7	1.1	3.9	0.2	13.7	0.3	0.1	2.1	0.4	0.5	0.3	1.3	0.5	0.2	0.7	1.0	0.3	53.2	1.0	0.0	2.2	0.0	0.3	0.3	0.2	0.3	0.0	0.1	0.0	0.6	9.5	2.2	1.2	4.8	2.2	4.2	0.1	0.0	2.1	1.1	0.1	0.6	2.0	5.8	2.9	1.6	1.6	0.0	1.4	0.0	0.1	0.9	2.6	2.3	2.6	7.3	2.1	0.3	2.1	2.4	0.0	0.1	1.2	0.0	0.0	1.1	0.6	0.1	2.7	0.6	2.8	4.7	1.2	1.5	1.0	1.8	3.5	3.1	1.2	2.0	1.3	1.7	1.6	4.5	1.8	1.9	1.6	1.6	1.8	0.9	2.1	2.1	1.5	1.7	1.7	0.4	0.0	0.0	0.0	8.9	0.0	9.5	0.3	7.6	7.1	0.0	0.3	4.7	6.3	0.1	0.6	0.0	0.0	4.1	2.2	2.2	5.1	0.6	2.2	2.9	3.2	0.6	2.0	13.7	1.0
CCDC74A	FLJ40345	ENSG00000163040	"Coiled-coil domain containing 74A"	Q96AQ1	2	131527675-131533666	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.1;testis: 41.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.0;SCLC-21H: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 3.3"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 3.3"									HPA060727			Uncertain	Vesicles				Vesicles	Vesicles	"HPA060727: "	"prognostic favourable (5.11e-4)"	"unprognostic (2.89e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (1.70e-7)"	"unprognostic (7.28e-3)"	"prognostic favourable (4.92e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.53e-2)"	1.3	12.8	5.8	2.7	6.5	0.2	6.8	1.1	4.4	5.6	1.9	3.2	4.7	0.9	7.1	7.1	1.9	26.1	5.1	2.2	5.1	6.8	3.0	0.5	3.0	0.9	2.2	4.1	7.1	1.5	13.3	14.1	0.9	13.6	5.2	1.3	2.4	1.8	5.1	0.9	3.5	0.8	5.9	3.0	1.0	1.0	41.2	1.9	2.2	2.6	0.9	1.2	4.5	2.7	0.0	3.3	0.0	0.1	0.0	0.8	0.2	0.0	3.9	4.0	0.2	5.7	13.9	0.3	3.3	5.6	3.1	2.3	0.1	5.9	1.5	2.1	5.1	3.0	1.7	1.0	1.2	3.9	7.4	0.0	3.7	0.1	0.7	0.1	0.3	4.5	0.4	3.0	0.0	1.2	2.1	4.3	2.7	2.4	8.4	2.3	19.0	2.5	4.0	0.0	1.7	7.8	0.0	15.6	11.4	0.4	0.5	0.5	5.4	0.8	1.2	0.9	2.9	12.0	2.5	0.9	0.7	0.5	12.9	0.3	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	3.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	5.8	6.5	1.1	4.4	5.1	6.8	2.2	4.1	13.6	1.9
CCDC74B	DKFZp434E2321	ENSG00000152076	"Coiled-coil domain containing 74B"	Q96LY2	2	130139287-130145134	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 12.4;testis: 22.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.4;SH-SY5Y: 14.8"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060727			Uncertain	Vesicles				Vesicles	Vesicles	"HPA060727: "	"prognostic favourable (4.46e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.43e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-4)"	"unprognostic (8.31e-3)"	"unprognostic (9.94e-3)"	0.0	1.4	2.8	0.1	2.4	0.0	0.4	0.0	2.2	8.3	0.1			0.0	3.5	0.6	0.1	12.4	1.1	0.1	3.0	4.0	1.0	0.0	1.0	0.1	0.9		2.1	0.2	7.5	7.7	0.0		2.7	0.0		0.2	2.5	0.0	0.1	0.0	1.0	1.4	0.0	0.0	22.7			3.7		0.0	0.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.8	2.8	0.1	2.6	5.7	0.6	2.2	1.1	0.3	0.5	0.8	0.7	0.0	3.6	2.0	1.0	0.2	0.3	0.4	1.9	5.4	0.0	6.7	0.1	0.3	0.1	0.2	1.2	0.0	0.9	0.0	0.1	0.1	1.7	0.8	2.0	0.0	0.0	5.8	5.8	4.4	0.0	3.1	1.7	0.0	10.4	14.8	1.6	0.1	0.2	5.9	0.6	0.4	1.1	4.9	5.9	0.5	0.1	0.2	0.0	6.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5										
CCDC81	"FLJ16339, FLJ23514"	ENSG00000149201	"Coiled-coil domain containing 81"	Q6ZN84	11	86374736-86423109	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.2;fallopian tube: 28.9"	"Cell line enhanced"	"Detected in some"		"BJ: 7.6;BJ hTERT+: 4.2;HBF TERT88: 4.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.5"	"Region enriched"	"Detected in many"	8	"pons and medulla: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (1.02e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.00e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.14e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	0.5	0.3	0.9	0.3	1.6	0.3	0.3	0.4	0.7	1.6	0.3	7.4	0.8	0.0	2.0	4.5	0.3	28.9	0.5	0.3	1.5	1.8	0.2	0.1	1.5	1.1	0.5	0.6	4.3	0.1	0.3	5.5	3.1	15.2	0.6	0.3	0.8	0.1	0.9	0.7	0.2	0.2	1.1	0.7	0.3	0.2	5.6	1.7	0.0	0.5	0.4	0.4	0.6	0.3	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.3	2.4	0.0	0.8	0.3	0.9	7.6	4.2	1.3	0.9	0.8	0.7	0.4	3.0	1.1	0.5	1.3	0.2	4.4	0.5	0.4	0.8	0.2	0.7	0.4	0.4	0.5	0.2	1.4	2.2	0.6	1.4	0.4	0.1	1.0	1.2	1.0	2.2	0.2	0.0	0.4	0.2	0.7	0.6	0.0	0.4	0.4	0.3	0.6	0.0	0.4	0.9	0.4	1.9	1.0	1.7	0.2	0.1	0.6	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.6	0.4	0.7	1.5	1.8	0.5	0.6	15.2	1.7
CD164L2		ENSG00000174950	"CD164 molecule like 2"	Q6UWJ8	1	27379176-27383380	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.5;HaCaT: 3.5;HBEC3-KT: 3.9;hTCEpi: 5.3;SK-BR-3: 4.8;T-47d: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062915	Enhanced		Approved	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA062915: AB_2684903"	"unprognostic (8.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (1.64e-5)"		"unprognostic (7.81e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.91e-6)"	"unprognostic (1.33e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.71e-2)"	0.1	0.1	0.2	0.1	0.5	0.0	2.3	0.1	0.4	3.2	0.4	0.7	1.2	0.0	0.4	12.6	13.4	26.8	0.1	0.1	0.4	0.4	0.4	0.3	7.4	0.1	0.1	0.6	3.3	0.3	0.4	5.8	0.1	1.1	2.4	0.2	1.0	12.9	0.3	0.1	8.1	0.1	0.1	0.1	0.1	0.2	1.0	0.4	0.1	0.9	5.9	6.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	3.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.3	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.1	1.0	0.0	0.9	0.0	0.0	4.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.4	0.4	0.4	0.1	0.6	1.1	0.4
CDHR3	"CDH28, FLJ23834, FLJ44366"	ENSG00000128536	"Cadherin related family member 3"	Q6ZTQ4	7	105876796-106033773	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 51.9;lung: 28.9;ovary: 22.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;Daudi: 9.9;WM-115: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 15.9"	"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 6.9;granulocytes: 1.8"	"Low region specificity"	"Detected in many"							HPA011218	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA011218: AB_1078886"	"unprognostic (4.38e-4)"	"unprognostic (9.18e-2)"	"unprognostic (8.16e-3)"	"unprognostic (8.08e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.51e-3)"	0.4	0.6	2.2	0.6	3.3	0.5	2.5	4.4	1.4	2.4	7.6	4.9	1.1	1.1	2.4	14.9	5.9	51.9	0.2	3.3	3.1	2.1	0.7	0.6	28.9	0.4	1.1	0.3	22.3	0.3	0.1	1.4	0.1	15.9	0.3	0.9	0.1	0.3	0.6	0.5	0.4	12.0	1.7	0.6	0.2	4.6	2.2	1.2	0.1	1.4	0.4	0.7	0.3	0.1	6.9	0.2	1.8	0.2	0.3	0.7	0.1	0.1	0.4	7.7	1.4	2.7	2.6	0.2	0.7	0.6	0.3	0.2	0.0	0.1	9.9	0.0	0.5	0.1	1.8	0.0	0.3	0.8	1.2	0.0	0.2	0.7	0.0	0.1	0.4	0.9	0.3	0.5	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.1	1.7	0.6	0.0	0.0	0.4	0.1	0.1	0.6	2.8	0.0	0.7	0.5	0.0	0.0	0.4	1.4	0.5	1.5	0.0	0.0	0.0	3.2	0.2	0.3	6.7	0.1	0.1	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	6.9	0.3	0.1	1.8	0.3	0.2	0.2	0.7	0.1	2.2	3.3	4.4	1.4	3.1	2.1	1.1	0.3	15.9	1.2
CDHR4	"CDH29, VLLR9392"	ENSG00000187492	"Cadherin related family member 4"	A6H8M9	3	49790732-49799835	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 37.8;fallopian tube: 42.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.6;HeLa: 4.4"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 6.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 5.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 17.7"	"Low region specificity"	"Detected in many"			HPA076277	Enhanced				"Intracellular and membrane"					"HPA076277: AB_2732306"	"unprognostic (1.50e-4)"	"unprognostic (4.87e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.35e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-11)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.37e-1)"	0.2	0.1	0.4	0.1	1.6	0.3	0.1	0.0	0.0	4.9	0.2	1.9	0.0	0.1	1.3	37.8	0.1	42.7	0.1	0.1	0.7	0.9	0.1	0.1	11.4	0.1	0.0	0.0	8.0	0.0	0.0	0.8	0.6	5.7	0.1	0.1	0.0	0.1	0.2	0.1	0.9	0.1	0.3	0.2	0.0	0.1	3.9	0.0	0.0	0.0	0.5	0.2	0.2	0.1	1.1	1.5	3.0	4.1	1.3	0.4	5.8	0.5	1.7	0.5	0.3	0.5	4.6	0.3	0.4	0.1	0.9	1.0	0.0	2.6	0.0	0.2	1.1	0.5	0.1	0.0	0.3	0.3	0.3	0.8	4.4	1.0	0.0	0.3	0.5	0.7	1.5	0.8	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.8	0.3	0.2	0.8	0.2	0.0	0.0	0.3	0.1	0.1	1.5	1.1	0.0	0.2	0.1	0.0	0.6	0.2	0.7	0.1	0.6	2.3	0.1	2.1	1.2	0.0	3.0	4.1	0.4	0.4	1.6	0.3	0.4	0.3	0.3	1.5	1.1	0.3	0.4	2.5	1.3	0.2	0.5	0.2	5.8	0.4	1.6	0.0	0.0	0.7	0.9	0.0	0.0	5.7	0.0
CES4A	"CES8, FLJ37464"	ENSG00000172824	"Carboxylesterase 4A"	Q5XG92	16	66988589-67009758	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 32.3"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA035701	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol	Cytosol	"HPA035701: AB_10696357"	"unprognostic (6.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (2.35e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-3)"	3.2	3.6	12.9	2.4	11.8	2.2	3.6	8.7	13.8	2.6	1.7	8.5	3.5	2.3	1.6	13.0	2.2	32.3	2.0	3.2	9.1	2.6	3.9	11.7	3.1	1.4	5.8	13.7	2.1	3.0	3.3	10.0	2.2	7.2	2.1	1.7	2.1	4.2	3.5	5.8	13.9	2.3	1.4	2.4	1.5	2.3	2.0	9.9	0.0	5.0	1.0	2.0	2.4	1.6	0.9	1.6	0.0	5.0	0.0	1.6	1.3	0.3	1.2	0.1	0.0	0.9	0.9	0.0	0.1	0.4	0.1	0.0	0.0	1.5	0.0	0.1	1.5	0.7	0.0	0.2	0.0	19.4	0.0	0.0	0.9	0.0	0.1	0.0	4.6	1.6	3.3	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.2	0.0	1.2	0.0	0.2	0.9	0.9	4.2	2.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.5	1.3	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.7	3.3	0.9	0.9	1.6	1.1	1.6	0.0	1.2	0.2	0.0	0.0	5.0	1.5	0.4	1.3	12.9	11.8	8.7	13.8	9.1	2.6	5.8	13.7	7.2	9.9
CETN2	"CALT, CEN2"	ENSG00000147400	"Centrin 2"	P41208	X	152826973-152830777	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 97.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028956	Approved									"HPA028956: AB_10601798"	"unprognostic (3.32e-1)"	"prognostic favourable (7.54e-6)"	"unprognostic (7.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.73e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (9.97e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.20e-1)"	11.7	17.1	26.6	7.8	26.4	9.1	16.7	7.5	25.3	27.3	16.7	11.4	23.8	6.3	27.5	48.3	16.6	97.3	13.0	13.5	30.0	30.8	29.4	12.6	15.9	6.7	21.2	24.0	24.2	8.6	14.8	26.7	11.1	54.2	21.1	10.9	9.9	10.4	33.0	10.2	7.3	7.0	22.1	19.8	8.0	10.5	11.2	10.3	9.9	34.6	11.7	8.6	17.9	12.4	9.1	15.4	26.2	10.1	8.8	11.5	8.7	40.0	18.3	22.8	17.1	30.3	33.0	9.1	17.5	21.1	23.2	17.8	8.2	21.6	14.4	46.1	23.4	15.7	15.8	21.7	27.6	6.4	11.4	3.2	9.9	24.0	11.4	13.4	3.6	19.8	28.7	21.4	11.4	18.2	8.4	6.0	22.4	18.7	9.9	14.6	7.9	23.6	8.8	16.6	14.7	42.0	9.9	11.2	14.5	11.6	12.2	10.2	13.0	10.3	16.9	16.4	13.2	32.3	19.4	6.1	8.0	22.6	34.6	8.1	8.0	12.9	8.8	26.2	9.6	10.1	11.5	9.1	9.4	10.5	10.3	7.8	10.2	10.3	8.4	8.8	10.0	15.4	8.0	8.7	26.6	26.4	7.5	25.3	30.0	30.8	21.2	24.0	54.2	10.3
CFAP100	"CCDC37, FLJ40083, MIA1"	ENSG00000163885	"Cilia and flagella associated protein 100"	Q494V2	3	126394939-126436556	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 38.7;fallopian tube: 29.2;testis: 21.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BEWO: 1.4;HaCaT: 1.2;Hep G2: 1.1;NTERA-2: 1.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 14.7;pons and medulla: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA046354	Enhanced									"HPA046354: AB_2679634"	"unprognostic (1.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (7.17e-5)"	"unprognostic (1.61e-3)"	"unprognostic (6.75e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-5)"	"unprognostic (3.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.58e-4)"	0.3	0.3	1.6	0.3	14.7	0.3	0.3	0.0	0.8	3.2	0.3	10.9	0.0	0.3	1.5	12.0	0.3	29.2	0.3	0.3	4.5	3.0	0.4	0.3	8.2	0.4	0.1	1.1	3.4	0.3	0.3	1.9	0.3	38.7	0.3	0.3	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	21.9	4.5	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	14.7	0.0	0.8	4.5	3.0	0.1	1.1	38.7	4.5
CFAP161	"C15orf26, FLJ38615"	ENSG00000156206	"Cilia and flagella associated protein 161"	Q6P656	15	81007033-81149175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0;fallopian tube: 22.4;retina: 14.9;testis: 18.2"	"Group enriched"	"Detected in some"	5	"HEL: 41.4;K-562: 13.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076975	Supported									"HPA076975: "	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.07e-2)"	"prognostic favourable (3.05e-4)"	"unprognostic (1.57e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.22e-2)"	0.8	0.4	2.3	0.4	5.2	0.9	0.6	0.4	1.1	1.5	0.4	6.8	0.2	0.2	1.1	5.4	0.4	22.4	0.5	1.1	3.3	3.3	0.5	0.5	4.0	0.3	0.6	1.1	4.2	2.7	0.2	9.9	2.1	18.0	0.4	0.3	14.9	0.5	0.5	0.5	0.9	0.4	0.6	0.8	0.9	0.5	18.2	1.5	0.0	1.0	0.0	0.6	0.5	0.2	0.0	0.3	2.3	0.4	0.0	0.7	7.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	41.4	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.1	0.5	0.8	13.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.5	0.4	0.0	0.2	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.1	2.3	0.0	0.1	0.1	0.0	7.3	2.3	5.2	0.4	1.1	3.3	3.3	0.6	1.1	18.0	1.5
CFAP221	"FAP221, PCDP1"	ENSG00000163075	"Cilia and flagella associated protein 221"	Q4G0U5	2	119544432-119662251	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.4;testis: 26.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.6;RPTEC TERT1: 10.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.98e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.62e-3)"	"unprognostic (6.26e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.71e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.90e-3)"	"unprognostic (2.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.19e-1)"	0.8	2.2	4.1	0.8	8.2	1.4	0.6	1.0	9.5	2.2	0.6	4.5	0.1	9.6	1.7	6.3	0.7	28.4	2.6	1.1	8.7	4.6	9.8	1.7	8.4	0.8	2.5	6.9	3.7	10.6	1.9	7.7	1.1	11.9	1.0	0.7	3.1	0.6	1.1	0.7	1.6	1.5	0.6	2.0	0.9	2.8	26.3	2.0	0.0	3.1	0.0	0.8	0.9	0.6	1.9	1.3	3.8	1.0	1.7	1.4	0.3	0.3	0.6	2.3	0.4	0.5	0.2	0.6	0.0	0.0	0.2	0.0	3.5	0.5	0.6	2.2	0.1	0.4	0.1	0.3	0.3	0.5	1.9	0.4	3.6	0.8	0.6	0.4	0.8	0.3	0.1	0.1	0.0	0.2	0.4	1.4	0.1	0.6	0.8	1.7	0.6	0.3	1.0	0.1	0.3	10.4	1.1	1.2	1.5	0.3	0.4	0.2	2.8	0.9	0.6	0.4	1.1	0.5	0.4	0.3	0.4	0.8	0.3	0.5	0.3	1.8	1.0	0.9	1.1	0.7	0.8	0.9	1.0	0.7	0.4	1.9	1.4	1.1	3.8	1.7	0.9	1.3	0.7	0.3	4.1	8.2	1.0	9.5	8.7	4.6	2.5	6.9	11.9	2.0
CFAP43	"bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96"	ENSG00000197748	"Cilia and flagella associated protein 43"	Q8NDM7	10	104129888-104232362	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5;epididymis: 21.6;fallopian tube: 37.7;testis: 40.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.0;U-266/70: 6.4;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"																		"unprognostic (1.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.46e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.11e-4)"	"unprognostic (6.67e-2)"	0.5	0.9	5.3	0.6	15.3	0.5	2.4	0.9	4.4	4.6	0.6	7.1	3.2	0.7	2.7	21.6	0.5	37.7	1.1	0.5	6.0	7.5	2.5	0.8	9.1	0.6	1.1	1.9	5.2	1.3	4.3	10.9	0.7	25.5	1.3	0.6	1.8	1.2	1.5	0.5	1.1	0.8	0.6	1.7	0.6	0.9	40.3	2.9	0.0	4.1	0.1	0.6	0.7	0.3	0.0	0.0	0.5	0.4	0.0	1.1	0.0	3.1	1.2	1.1	2.0	0.0	0.6	0.2	0.0	0.9	0.7	0.5	0.2	8.0	0.0	0.1	0.0	1.1	0.2	1.2	1.5	0.4	1.3	0.0	0.5	0.4	0.2	0.0	0.3	0.7	1.1	0.9	0.6	0.3	2.2	0.2	0.0	2.0	0.2	0.4	0.3	0.5	0.2	0.0	0.0	2.8	0.0	1.8	1.8	0.8	0.1	1.6	1.1	0.0	0.1	0.3	0.7	1.0	0.4	6.4	5.2	0.7	0.4	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	1.1	0.0	5.3	15.3	0.9	4.4	6.0	7.5	1.1	1.9	25.5	2.9
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900163	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 35.5;testis: 29.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.0;HEL: 14.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 6.0;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.3	0.3	2.0	0.4	7.5	0.6	0.5	0.0	0.2	2.5	0.2	11.9	0.0	0.4	1.3	10.5	0.4	35.5	0.2	0.5	3.1	2.8	0.3	0.2	6.1	0.3	0.1	0.1	7.3	0.1	0.1	0.2	3.3	12.5	0.2	0.2	0.0	0.2	0.5	0.2	0.3	0.2	0.4	0.5	0.5	0.6	29.7	3.4	0.0	0.7	0.0	0.3	0.4	0.1	0.7	0.3	6.0	0.3	0.2	0.5	0.2	2.5	0.6	0.0	0.0	0.1	0.2	11.0	1.3	1.6	2.4	1.0	1.8	3.2	1.0	0.5	0.6	1.5	0.3	0.3	1.4	0.6	0.3	14.2	0.6	0.1	0.7	1.2	0.5	1.0	0.7	2.6	0.9	1.6	1.5	0.5	0.4	3.4	0.2	1.1	0.6	1.2	0.0	1.1	0.4	0.3	0.6	1.0	0.2	1.3	3.8	0.4	3.8	0.2	2.1	1.0	2.9	1.9	2.3	1.1	0.0	0.4	5.3	0.5	0.8	0.0	0.3	6.0	0.0	0.3	0.0	0.5	0.3	0.5	0.3	0.7	0.0	0.5	4.9	0.2	0.0	0.3	0.0	0.2	2.0	7.5	0.0	0.1	3.1	2.8	0.1	0.1	12.5	3.4
CFAP47	"CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1"	ENSG00000165164	"Cilia and flagella associated protein 47"	Q6ZTR5	X	35919734-36385319	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.4;fallopian tube: 12.8;pituitary gland: 24.5"	"Group enriched"	"Detected in some"	7	"Karpas-707: 4.1;U-266/70: 7.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044633, HPA054859"	Uncertain									"HPA044633: AB_10960684, HPA054859: AB_2682627"	"unprognostic (1.88e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.50e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.19e-3)"	0.3	0.3	2.0	0.2	5.9	0.2	0.3	0.3	1.2	0.9	0.3	6.2	1.2	0.2	0.7	7.0	0.3	12.8	0.2	0.3	3.7	1.3	0.4	0.5	3.7	0.2	1.2	1.5	5.3	0.3	2.3	24.5	0.3	12.4	0.3	0.2	2.0	0.3	0.3	0.3	0.3	0.3	0.2	1.1	0.3	0.3	2.1	2.7	0.0	1.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.9	0.3	1.2	3.7	1.3	1.2	1.5	12.4	2.7
CFAP53	"CCDC11, FLJ32743"	ENSG00000172361	"Cilia and flagella associated protein 53"	Q96M91	18	50227193-50266522	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.1;fallopian tube: 19.7;testis: 44.9"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 17.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA041069, HPA066142"	Enhanced		Approved	Midbody				Midbody	Midbody	"HPA041069: AB_10805835, HPA066142: AB_2732739"	"unprognostic (1.73e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (5.85e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.61e-3)"	0.4	1.0	2.1	0.4	4.8	0.6	1.0	2.9	1.0	1.6	0.3	4.9	1.7	0.4	1.0	9.3	0.3	19.7	0.7	0.4	2.7	3.3	2.2	0.4	4.5	0.4	1.0	1.1	4.8	1.6	2.7	12.3	0.4	17.1	1.1	0.3	1.2	0.8	2.5	1.4	0.9	0.4	0.5	1.4	0.4	0.5	44.9	2.2	0.2	4.3	0.0	0.4	0.5	0.4	2.1	1.0	2.2	1.0	1.4	1.2	0.4	2.4	1.6	1.0	2.0	1.4	2.7	1.8	0.5	0.3	0.3	0.4	0.2	2.1	1.4	1.4	0.5	1.0	0.8	1.0	0.5	1.1	1.5	0.5	0.8	0.2	0.8	1.0	0.9	0.8	4.1	1.1	9.5	0.7	2.7	0.7	0.6	2.3	2.3	0.5	0.5	1.0	0.3	0.5	2.0	2.8	0.0	1.7	1.3	0.3	0.1	0.8	1.3	0.2	0.1	1.4	1.0	0.9	0.8	4.3	1.5	0.3	1.6	1.1	0.3	2.2	0.4	0.0	0.9	1.0	0.5	0.5	0.4	0.9	0.4	2.1	1.2	0.8	0.1	1.4	0.4	1.0	1.0	0.4	2.1	4.8	2.9	1.0	2.7	3.3	1.0	1.1	17.1	2.2
CFAP57	"FLJ32000, WDR65"	ENSG00000243710	"Cilia and flagella associated protein 57"	Q96MR6	1	43172149-43254358	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.6;testis: 29.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 6.8;HDLM-2: 4.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002736, HPA028623"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA002736: AB_2272982, HPA028623: AB_10603234"	"unprognostic (1.15e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.16e-1)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.50e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.78e-2)"	0.4	0.4	1.6	0.3	6.7	0.2	0.6	0.1	1.8	1.6	0.3	4.2	0.0	0.3	1.0	9.1	0.4	25.6	0.5	0.4	3.6	2.7	1.5	2.7	4.7	0.2	0.3	1.4	7.1	0.9	0.4	5.9	0.5	12.7	0.7	0.3	0.3	0.5	0.5	0.4	0.9	0.3	0.3	0.4	0.2	0.4	29.2	0.4	0.0	1.9	0.0	0.3	0.5	0.2	3.2	2.4	0.7	4.8	1.2	1.5	1.4	2.9	1.0	0.7	0.6	0.2	0.1	0.9	1.1	1.8	1.4	1.4	0.8	1.2	0.3	1.3	2.4	6.8	0.4	0.9	2.6	4.4	0.2	0.3	0.6	0.6	0.5	0.0	0.3	0.2	1.1	1.1	0.4	2.0	0.2	0.1	0.2	0.1	0.3	0.3	1.4	0.1	0.4	1.0	0.2	2.9	0.5	1.1	0.5	1.3	0.2	1.1	1.6	0.5	3.8	0.2	1.4	0.7	0.8	0.4	0.6	0.3	0.3	0.8	0.8	0.5	1.1	0.7	1.4	2.0	1.4	2.2	1.4	1.2	2.4	3.2	1.3	1.3	0.0	1.2	4.8	1.9	1.5	1.4	1.6	6.7	0.1	1.8	3.6	2.7	0.3	1.4	12.7	0.4
CFAP58	"bA554P13.1, C10orf80, CCDC147, FLJ35908"	ENSG00000120051	"Cilia and flagella associated protein 58"	Q5T655	10	104353764-104455090	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 10.9;testis: 17.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 5.1;U-2 OS: 10.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	55	"granulocytes: 5.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036555, HPA071938"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	Vesicles	"HPA036555: AB_10673622, HPA071938: "	"unprognostic (5.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.57e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.62e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.59e-1)"	0.3	0.5	0.8	0.6	2.0	0.4	0.3	0.7	1.0	3.0	0.3	2.9	0.3	0.1	2.3	0.3	0.3	10.9	0.3	3.0	1.4	1.5	0.3	0.3	2.1	0.3	0.3	0.3	2.0	0.3	1.5	1.9	0.4	6.8	0.4	0.0	0.6	0.3	0.4	1.4	0.2	0.3	0.8	0.3	0.3	0.1	17.5	0.7	0.3	0.8	0.3	0.4	0.3	0.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.2	0.6	0.2	1.7	5.1	1.0	2.8	0.0	0.0	3.9	0.4	0.6	0.3	0.0	0.3	3.1	0.4	0.2	0.9	1.2	0.0	0.6	0.5	0.7	0.6	2.2	0.8	2.7	1.6	1.0	1.2	1.3	0.0	0.0	1.1	0.3	0.0	0.4	0.3	0.5	0.6	0.0	0.6	0.4	0.0	0.2	0.9	0.3	0.6	3.3	1.1	10.7	0.6	3.0	0.3	0.1	0.2	1.2	1.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	2.0	0.7	1.0	1.4	1.5	0.3	0.3	6.8	0.7
CFAP61	"C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156"	ENSG00000089101	"Cilia and flagella associated protein 61"	Q8NHU2	20	20052514-20360702	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.1;heart muscle: 14.8;pituitary gland: 15.0;skeletal muscle: 23.9;testis: 25.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.2;HMC-1: 4.1;SCLC-21H: 9.5;SK-MEL-30: 3.7;U-87 MG: 7.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.3;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009079	Approved									"HPA009079: AB_1078344"	"unprognostic (5.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (3.67e-3)"	"unprognostic (8.58e-4)"	"unprognostic (8.24e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.76e-4)"	"unprognostic (2.77e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.06e-1)"	0.2	1.2	1.0	0.2	9.5	0.1	0.5	0.6	2.6	0.9	0.2	5.3	0.8	0.1	1.1	4.5	0.2	15.1	0.3	14.8	4.0	1.9	1.1	0.2	3.5	0.2	0.9	2.0	3.3	0.5	1.0	15.0	0.2	11.4	0.5	0.2	0.1	0.3	0.4	23.9	0.5	0.3	0.3	0.7	0.2	0.3	25.5	1.1	0.0	1.1	0.0	0.2	0.2	0.2	0.0	1.5	0.0	0.0	0.6	2.3	0.0	0.4	1.3	0.2	0.5	0.0	0.0	0.5	0.1	0.4	0.0	0.4	0.0	0.7	4.2	0.1	0.0	0.1	0.2	0.0	0.1	1.1	1.5	0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.3	0.0	0.3	2.1	0.7	0.0	9.5	0.2	0.2	0.4	3.7	0.7	0.0	0.7	0.0	0.4	0.6	0.3	1.4	0.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.5	0.0	0.0	1.0	9.5	0.6	2.6	4.0	1.9	0.9	2.0	11.4	1.1
CFAP65	"CCDC108, DKFZp434O0527, MGC35338"	ENSG00000181378	"Cilia and flagella associated protein 65"	Q6ZU64	2	219002846-219041527	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.3;fallopian tube: 29.2;testis: 20.4"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.6;SH-SY5Y: 4.1;U-87 MG: 2.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.1"	"Region enhanced"	"Detected in many"		"pons and medulla: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 13.1"	HPA055156	Uncertain				"Intracellular and membrane"					"HPA055156: AB_2682720"	"unprognostic (3.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.88e-3)"	"prognostic favourable (6.08e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.60e-2)"	0.2	0.4	1.8	0.3	6.4	0.3	0.3	0.0	2.1	2.2	0.4	5.4	0.3	0.3	0.9	6.0	0.2	29.2	0.6	0.2	2.9	3.2	0.5	0.2	3.6	0.3	0.4	1.2	4.2	0.6	0.3	6.1	0.2	16.3	0.3	0.5	2.8	0.4	0.4	0.2	0.2	0.7	0.2	0.6	0.3	0.6	20.4	2.5	0.0	1.3	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.5	0.5	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.3	1.0	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	1.6	4.1	0.0	0.1	0.7	1.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.8	6.4	0.0	2.1	2.9	3.2	0.4	1.2	16.3	2.5
CFAP73	"CCDC42B, MIA2"	ENSG00000186710	"Cilia and flagella associated protein 73"	A6NFT4	12	113149858-113159276	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;epididymis: 17.8;fallopian tube: 35.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.3;REH: 3.2;T-47d: 3.8;U-698: 12.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Region enhanced"	"Detected in many"		"pons and medulla: 27.2"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.0;naive CD4 T-cell: 1.3"	"Group enriched"	"Detected in many"	9	"B-cells: 1.0;T-cells: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA048539	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA048539: AB_2680434"	"unprognostic (2.42e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (1.90e-3)"	"prognostic favourable (5.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.03e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.55e-2)"	0.2	0.3	4.3	0.5	16.9	2.0	0.3	0.5	0.9	3.1	0.3	15.3	1.0	0.5	1.0	17.8	0.6	35.5	0.4	0.2	5.8	6.1	0.6	0.2	5.7	0.9	0.2	0.9	6.8	0.3	0.7	0.9	0.2	27.2	0.3	0.3	0.0	2.2	0.9	0.5	4.5	0.6	0.2	1.1	0.5	3.9	1.5	4.7	0.0	0.5	0.5	1.3	0.4	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.2	0.3	0.1	0.4	0.4	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	3.0	6.3	0.2	0.0	1.0	0.0	0.0	0.0	0.2	0.5	0.3	2.1	0.2	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.3	1.1	0.4	0.2	3.2	0.0	0.5	0.8	0.7	0.6	0.1	0.0	0.9	0.0	3.8	0.0	0.1	0.1	1.0	0.3	0.2	0.6	0.2	12.7	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.3	16.9	0.5	0.9	5.8	6.1	0.2	0.9	27.2	4.7
CFAP74	"C1orf222, FLJ45476, KIAA1751"	ENSG00000142609	"Cilia and flagella associated protein 74"	Q9C0B2	1	1921951-2003837	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;fallopian tube: 12.1;testis: 26.4"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028521, HPA029274, HPA030240"	Enhanced									"HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_2732455"	"unprognostic (5.41e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	0.4	2.3	1.3	0.5	4.8	1.6	0.3	11.8	3.8	1.7	0.4	3.9	0.4	0.4	1.0	6.6	1.6	12.1	1.2	0.3	1.9	1.8	0.2	1.7	3.1	1.0	0.8	1.5	2.5	0.1	0.3	2.4	0.5	5.4	0.2	0.4	0.0	0.5	0.7	1.2	5.5	0.3	0.2	0.4	0.4	0.3	26.4	1.0	0.0	1.9	0.0	0.2	0.9	0.1	1.4	1.2	1.5	1.4	1.9	1.1	0.1	1.5	0.0	2.4	1.5	0.0	3.5	2.1	0.3	0.0	0.0	1.2	3.4	0.3	2.0	3.1	0.6	0.5	0.0	0.6	0.5	1.8	2.8	4.2	5.1	2.3	0.6	3.2	1.4	2.3	2.1	0.0	0.0	0.0	5.8	1.6	1.2	0.6	1.6	1.1	1.9	2.6	1.7	0.7	1.0	0.0	3.3	3.1	1.1	0.6	0.3	0.1	0.7	0.9	3.6	2.0	2.0	0.8	2.3	2.2	0.8	2.2	0.2	3.2	1.0	0.3	1.4	1.1	0.8	0.6	0.3	1.0	0.6	0.5	0.5	1.4	0.8	1.1	1.5	1.9	0.9	1.2	0.6	0.1	1.3	4.8	11.8	3.8	1.9	1.8	0.8	1.5	5.4	1.0
CFAP77	"C9orf171, FLJ46082"	ENSG00000188523	"Cilia and flagella associated protein 77"	Q6ZQR2	9	132410043-132573317	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 30.9;testis: 22.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.7;SH-SY5Y: 6.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021329, HPA024647, HPA061069"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657"	"unprognostic (7.28e-4)"	"unprognostic (5.68e-2)"	"unprognostic (5.25e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.74e-1)"		"unprognostic (3.01e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	0.2	0.2	1.6	0.2	4.5	0.2	0.2	1.6	0.3	1.6	0.2	8.4	0.0	0.2	0.7	8.8	0.2	30.9	0.2	4.2	2.5	2.5	0.2	0.2	5.5	0.2	0.1	0.0	9.7	0.3	0.2	1.7	0.2	8.9	0.2	0.2	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	22.0	1.6	0.0	0.3	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.3	0.4	0.4	0.1	0.0	0.0	0.2	1.7	6.5	0.0	0.0	0.0	0.3	0.0	0.6	0.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.5	1.6	0.1	2.5	2.5	0.1	0.0	8.9	1.6
CFAP97D2		ENSG00000283361	"CFAP97 domain containing 2"		13	114154691-114223084	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 7.7;brain: 8.4;fallopian tube: 22.4;pancreas: 7.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;NTERA-2: 1.0"									"Cell type enriched"	"Detected in single"	12	"naive CD8 T-cell: 7.7"	"Lineage enriched"	"Detected in single"	78	"T-cells: 7.7"																																					0.0	0.0	0.5	0.0	7.0	0.8	0.0	0.0	1.4	0.3	0.0	8.4	0.0	0.0	0.0	2.1	0.0	22.4	0.0	0.0	1.9		0.0	0.0	2.6	0.3	0.0	2.0	3.6	7.8	0.0	0.1	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	2.4	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.7										
CFAP99		ENSG00000206113	"Cilia and flagella associated protein 99"	D6REC4	4	2418974-2462942	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;fallopian tube: 8.8;testis: 37.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.3;SCLC-21H: 1.5;T-47d: 1.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (7.54e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.93e-5)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.49e-1)"	0.0	1.7	0.8	0.1	5.5	0.0	0.1	0.0	0.6	0.4	0.1	3.5	0.0	0.1	0.5	4.5	0.0	8.8	0.2	0.0	2.4		0.6	0.3	2.9	0.0	0.0	0.0	0.8	0.8	0.0	2.9	0.0	9.9	0.1	0.1	1.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	37.2	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.0	0.2	0.5	0.0	0.6	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.6	3.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.6	1.2	1.3	0.2	0.1	0.0	0.6	1.1	0.0	1.5	0.7	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.7	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5										
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335329-40355217	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7"	"Cell line enriched"	"Detected in some"	8	"U-87 MG: 18.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Low region specificity"	"Detected in many"														"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.2	4.6	0.7	2.6	0.0	0.0	0.0	2.7	0.0	0.0	2.7	0.0	0.0	3.3	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.4	0.7	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.1	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.5	0.0	0.3	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	1.4	0.2	0.6	0.0	0.0	2.6	0.0
CNGA4	"CNCA2, CNG5, CNGB2, OCNC2, OCNCb"	ENSG00000132259	"Cyclic nucleotide gated channel alpha 4"	Q8IV77	11	6234765-6244429	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 8.0;fallopian tube: 22.5;ovary: 9.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.5;CAPAN-2: 2.6;HaCaT: 2.2;HMC-1: 3.3"	"Cancer enriched"	"Detected in single"	6	"endometrial cancer: 2.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (1.11e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.69e-3)"	"prognostic favourable (1.48e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.55e-3)"	0.2	0.3	1.5	0.3	2.0	0.6	0.2	0.6	1.1	1.0	0.4	1.9	0.1	0.5	1.2	8.0	0.4	22.5	0.3	0.1	1.7	1.4	0.3	0.2	6.6	0.4	1.0	0.1	9.1	0.3	0.3	2.3	0.2	3.3	0.3	0.2	0.3	0.2	0.8	0.1	0.4	0.3	0.3	1.3	0.3	0.3	7.4	1.4	0.1	0.3	0.1	0.3	0.2	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.7	2.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.7	0.3	0.0	2.2	0.1	0.5	0.0	1.6	0.3	0.0	0.4	0.1	0.1	0.2	3.3	1.6	1.2	0.2	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.3	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.2	0.6	0.0	1.1	0.6	0.0	0.7	0.3	1.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.0	0.6	1.1	1.7	1.4	1.0	0.1	3.3	1.4
CNTN3	"BIG-1, PANG"	ENSG00000113805	"Contactin 3"	Q9P232	3	74262568-74521140	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.9;fallopian tube: 8.7"	"Group enriched"	"Detected in some"	5	"BJ: 7.3;fHDF/TERT166: 19.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003341	Approved				"Intracellular and membrane"	54000000	54000000			"HPA003341: AB_1078556"	"unprognostic (1.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.94e-5)"	"unprognostic (4.25e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.30e-7)"	"unprognostic (4.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	2.2	3.3	5.3	0.0	3.0	0.0	1.2	1.2	8.9	2.6	3.3			0.1	0.7	1.7	0.1	8.7	2.1	1.7	4.4	3.9	4.1	3.2	0.6	0.0	1.4		0.9	1.6	0.0	3.7	0.0		6.9	3.0		0.3	5.1	0.0	0.3	0.2	0.1	0.5	1.7	1.0	0.4			1.5		0.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	7.3	0.0	1.2	0.4	0.0	0.0	0.0	0.0	19.9	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.5	0.0	1.5	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578969-68727806	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.5;fallopian tube: 27.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;ASC TERT1: 27.4;HSkMC: 19.7;hTEC/SVTERT24-B: 16.0;U-87 MG: 27.3"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.2;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	21	"B-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"	"Plasma membrane, Focal adhesion sites"	"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	4.4	15.7	3.2	30.1	1.9	4.8	33.7	53.5	6.5	3.4	27.3	0.8	2.4	7.5	3.9	2.7	27.4	6.3	7.2	23.0	15.1	5.5	2.0	5.8	3.5	20.9	18.8	18.4	2.9	1.6	1.5	4.7	23.6	3.2	2.9	11.8	3.4	6.9	3.8	5.6	3.3	8.4	35.0	3.6	2.0	2.2	17.5	0.0	4.6	0.6	1.9	3.0	1.6	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	12.1	1.0	12.7	27.4	0.0	6.1	6.8	1.0	1.5	0.1	1.3	1.4	0.7	1.0	0.0	0.4	0.1	4.4	0.0	0.5	0.0	0.0	0.6	4.6	0.0	0.1	19.7	0.1	16.0	0.9	0.4	0.0	0.0	11.2	0.0	0.0	0.0	2.9	0.0	0.9	0.0	0.5	1.7	0.0	7.0	0.1	0.1	0.0	3.6	0.0	1.4	0.1	3.6	4.1	0.7	8.1	0.0	0.0	1.4	27.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	30.1	33.7	29.3	23.0	15.1	20.9	18.8	23.6	17.5
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727384-49744437	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3"	"Group enriched"	"Detected in some"	65	"HEL: 14.2;RT4: 4.8;SK-BR-3: 10.8;T-47d: 5.3"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"neutrophil: 6.0;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	45	"granulocytes: 6.0;monocytes: 2.9"					"Low region specificity"	"Detected in many"			HPA054392	Supported				"Secreted in other tissues"	390000000	390000000			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.2	0.2	0.2	0.0	0.2	33.5	0.2	0.2	0.2	11.1	0.2	0.0	156.3	0.0	0.7	0.0	45.3	117.6	2.0	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.2	0.0	15.9	1.7	0.0	0.2	0.0	0.0	3.0	0.0	0.0	233.3	17.7	0.2	0.6	0.2	0.0	0.2	0.4	0.2	0.2	0.0	0.0	0.2	56.7	14.8	1.2	14.4	0.0	0.0	6.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	10.8	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	2.9	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CROCC2		ENSG00000226321	"Ciliary rootlet coiled-coil, rootletin family member 2"	H7BZ55	2	240906330-240993311	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 9.5;epididymis: 19.4;fallopian tube: 14.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.2;Hep G2: 1.2;HSkMC: 2.8;RPMI-8226: 7.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.5"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;hippocampal formation: 4.2;pons and medulla: 9.5"	"Group enriched"	"Detected in some"	18	"intermediate monocyte: 1.1;non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	26	"monocytes: 3.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA048678	Enhanced									"HPA048678: AB_2680491"	"unprognostic (4.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.68e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.75e-4)"	"unprognostic (2.84e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-2)"	"unprognostic (9.90e-3)"	"unprognostic (7.19e-2)"	0.2	0.1	0.6	0.3	5.0	0.2	0.0	0.0	0.1	2.4	0.1	3.8	0.0	0.5	0.4	19.4	0.0	14.9	0.1	0.0	4.2	1.4	0.1	0.5	2.3	1.4	0.0	0.0	3.2	0.1	0.0	2.1	0.1	9.5	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.8	0.1	0.0	4.7	0.3	0.4	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.6	5.0	0.0	0.1	4.2	1.4	0.0	0.0	9.5	0.5
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 34.0;lung: 42.1;retina: 31.6;seminal vesicle: 31.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.5;HUVEC TERT2: 8.7;SCLC-21H: 5.8;SK-MEL-30: 9.6;TIME: 11.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008175	Enhanced				"Secreted to extracellular matrix"	360000000	360000000			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favourable (1.51e-4)"	4.5	1.4	6.2	1.6	7.2	0.8	2.0	7.2	27.3	3.9	6.0	3.8	4.5	1.2	1.2	4.8	7.9	34.0	1.1	6.2	5.5	7.0	3.1	1.1	42.1	1.1	9.2	5.8	2.2	1.8	1.4	3.2	0.8	27.5	3.3	1.1	31.6	3.4	31.1	1.4	2.9	1.2	3.6	6.8	0.8	1.0	4.0	2.7	0.0	4.4	0.7	1.0	25.5	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	3.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.2	5.8	1.3	0.7	0.0	9.6	0.1	0.0	11.7	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.2	7.2	18.7	5.5	7.0	9.2	5.8	27.5	2.7
CTXND2		ENSG00000283324	"Cortexin domain containing 2"		1	150887136-150913292	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in single"		"fallopian tube: 3.2"	"Cell line enriched"	"Detected in some"	4	"BEWO: 5.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	3.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.8		0.0	0.0		0.0	0.0	0.6	0.1	0.0	0.0		0.0	0.0	0.8			0.0		0.0	0.0		0.2	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
DCDC2B		ENSG00000222046	"Doublecortin domain containing 2B"	A2VCK2	1	32209094-32216196	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 11.1;fallopian tube: 26.6;lung: 10.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;TIME: 3.8;U-266/70: 1.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045832	Uncertain									"HPA045832: AB_10962048"	"unprognostic (6.45e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.66e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.71e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.18e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.39e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	11.1	0.0	26.6	0.2	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	5.5	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.0	0.6	0.1	0.2	0.3	0.0	0.1	0.9	1.6	0.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	1.0	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.1	0.0	1.3	0.4	0.0	0.0	0.6	0.2	0.8	0.1	3.8	0.1	0.8	1.1	0.7	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0
DEFB124	DEFB-24	ENSG00000180383	"Defensin beta 124"	Q8NES8	20	31465506-31476757	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 9.1;testis: 7.7"	"Cell line enhanced"	"Detected in some"		"HEL: 4.8;HMC-1: 2.8;U-2 OS: 2.1;WM-115: 10.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 1.6;thalamus: 3.4"						"Secreted in other tissues"						"unprognostic (1.24e-2)"	"unprognostic (9.76e-3)"		"unprognostic (1.27e-1)"	"unprognostic (3.23e-3)"	"unprognostic (6.92e-3)"		"unprognostic (3.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.07e-2)"	"unprognostic (4.43e-1)"	"unprognostic (3.32e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.28e-1)"	3.5	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.7	1.9			0.0	5.3	4.6	0.4	9.1	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.6	0.0		0.4	0.0	1.3	0.9	0.0		1.0	0.9		0.5	5.0	0.9	0.2	0.9	0.6	0.0	0.6	0.9	7.7			0.8		0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DENND6B	"AFI1B, FAM116B, MGC33692"	ENSG00000205593	"DENN domain containing 6B"	Q8NEG7	22	50309030-50327060	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 24.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 8.2;RPMI-8226: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018934, HPA021653, HPA029570"	Uncertain		Uncertain	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131"	"unprognostic (2.50e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavourable (1.41e-4)"	"prognostic favourable (5.93e-5)"	"unprognostic (9.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	2.7	5.5	11.6	4.3	17.0	2.0	3.2	21.1	22.8	5.7	2.8	7.5	5.5	2.5	5.2	5.3	3.4	24.7	6.2	2.3	8.4	10.2	5.7	1.3	7.3	5.2	4.9	14.4	4.3	6.4	6.8	15.1	2.3	10.4	4.7	2.3	4.1	5.9	7.4	1.1	5.0	3.0	3.6	3.2	4.4	4.2	9.0	4.5	0.0	6.0	1.0	3.5	4.4	2.7	0.7	1.8	0.5	3.9	1.0	0.7	0.9	0.6	2.3	4.9	5.4	1.2	4.8	0.0	1.0	2.4	0.6	0.4	0.1	3.5	8.2	2.1	2.3	4.2	0.1	0.1	0.2	2.0	1.2	1.4	3.9	0.2	1.1	0.2	3.7	4.1	5.2	0.1	0.7	1.0	1.7	1.5	1.2	3.6	0.0	0.8	0.3	0.2	1.1	0.0	11.9	6.2	2.0	2.1	4.0	2.6	3.4	0.4	5.4	1.2	1.1	0.9	0.8	0.8	0.1	1.3	0.3	1.1	2.2	0.9	1.0	0.5	2.6	0.1	0.4	3.2	0.6	0.6	0.6	0.7	1.8	0.7	0.6	0.7	0.5	1.0	3.9	1.4	0.6	0.9	11.6	17.0	21.1	22.8	8.4	10.2	4.9	14.4	10.4	4.5
DLEC1	"CFAP81, DLC1"	ENSG00000008226	"Deleted in lung and esophageal cancer 1"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 23.2;testis: 28.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA019077	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	0.8	0.3	1.3	0.7	8.3	1.1	0.5	0.0	0.6	3.3	0.6	6.1	3.5	0.7	1.1	21.1	0.3	23.2	1.3	0.3	1.7	2.5	0.3	0.3	10.0	1.7	0.5	0.2	6.3	0.2	0.6	14.2	0.3	9.8	0.8	0.6	0.8	0.6	1.8	0.2	0.7	0.7	0.3	0.6	0.7	0.6	28.9	1.7	0.0	0.8	0.0	0.6	0.4	0.1	0.2	0.1	0.9	0.4	0.1	1.1	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.1	3.4	0.0	0.0	0.0	0.2	0.1	2.8	0.5	0.2	0.3	1.7	0.5	0.1	0.3	0.0	0.0	0.4	0.3	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.8	0.2	0.4	0.2	1.1	0.0	0.1	0.1	0.2	0.0	0.9	0.1	0.1	0.1	0.2	0.1	1.3	8.3	0.0	0.6	1.7	2.5	0.5	0.2	9.8	1.7
DNAAF1	"CILD13, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.3;testis: 49.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.4;Karpas-707: 8.6;PC-3: 2.6;SK-BR-3: 2.4;U-266/70: 7.2;U-266/84: 4.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.1"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA041166: AB_10794190, HPA074239: AB_2732250"	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favourable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.8	1.2	3.5	0.6	9.4	1.5	0.5	0.1	1.5	2.1	0.6	5.3	1.5	0.4	1.0	13.3	0.9	21.3	0.5	0.4	4.6	6.5	0.7	2.0	3.7	0.9	0.5	1.5	4.2	0.4	0.7	6.1	1.5	11.1	0.4	0.4	0.9	0.5	0.6	0.6	0.5	0.6	0.4	1.0	7.2	0.5	49.6	1.2	0.0	1.2	0.0	0.4	0.8	0.0	0.5	1.0	5.5	0.8	0.9	2.1	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.1	1.3	0.2	0.0	0.0	2.4	0.1	0.9	0.0	0.0	0.4	0.0	0.0	0.0	7.2	4.7	0.7	0.2	0.4	0.0	3.6	0.8	0.4	0.4	0.6	0.1	0.0	0.2	0.1	0.4	0.5	0.8	0.8	5.5	0.9	0.4	1.0	2.1	0.9	3.5	9.4	0.1	1.5	4.6	6.5	0.5	1.5	11.1	1.2
DNAH10	FLJ43808	ENSG00000197653	"Dynein axonemal heavy chain 10"	Q8IVF4	12	123762188-123936206	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.0;epididymis: 10.1;fallopian tube: 9.5;lung: 11.8;testis: 16.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;ASC diff: 4.0;ASC TERT1: 1.7;U-87 MG: 1.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.8;pons and medulla: 10.0"	"Cell type enhanced"	"Detected in some"		"gdTCR: 1.6;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"									HPA039066	Enhanced									"HPA039066: AB_10673237"	"unprognostic (1.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.08e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.28e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.11e-3)"	0.4	0.2	0.7	0.2	4.8	3.1	0.3	1.2	0.6	1.9	0.7	3.9	0.5	0.5	0.6	10.1	0.2	9.5	0.2	0.2	1.4	1.7	0.4	0.2	11.8	0.2	0.5	0.0	6.2	0.2	0.1	0.2	0.4	10.0	1.1	0.2	0.0	0.2	0.2	0.1	0.2	1.1	0.2	1.5	0.3	0.2	16.4	0.3	0.0	0.5	0.0	0.2	0.4	0.9	0.1	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.0	0.1	2.3	4.0	1.7	0.6	1.0	0.3	0.0	0.2	0.0	0.5	0.1	0.2	1.2	0.5	0.0	0.0	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	1.1	1.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.8	0.0	0.2	0.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	4.8	1.2	0.5	1.4	1.7	0.5	0.0	10.0	0.3
DNAH12	"DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19"	ENSG00000174844	"Dynein axonemal heavy chain 12"	Q6ZR08	3	57293699-57544344	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.1;LHCN-M2: 2.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enriched"	"Detected in many"	8	"pons and medulla: 23.0"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA037493, HPA058203, HPA061365"	Enhanced									"HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493"	"unprognostic (4.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.43e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.47e-2)"	0.2	0.3	0.6	0.1	3.0	0.1	0.4	0.2	0.5	1.3	0.2	5.3	0.0	0.1	1.4	11.6	0.2	16.7	0.5	0.1	2.9	0.8	0.2	0.3	17.5	0.2	0.4	0.0	7.6	3.1	0.1	8.9	0.1	23.0	0.2	0.2	0.0	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.2	0.2	17.6	1.0	0.0	0.3	0.0	0.1	0.2	0.2	0.5	0.5	0.0	0.0	1.2	0.9	0.1	0.3	0.7	0.0	0.0	0.9	0.3	0.1	0.0	0.2	0.3	0.0	3.1	0.3	0.1	0.0	0.4	0.4	0.0	0.3	0.2	0.7	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.1	0.4	0.2	0.2	0.1	2.1	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.9	0.1	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.5	0.2	0.0	0.0	1.2	0.0	0.5	0.0	0.1	0.6	3.0	0.2	0.3	2.9	0.8	0.4	0.0	23.0	1.0
DNAH2	"DNHD3, FLJ46675, KIAA1503"	ENSG00000183914	"Dynein axonemal heavy chain 2"	Q9P225	17	7717354-7833744	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 14.3;parathyroid gland: 20.0;testis: 21.0"	"Cell line enhanced"	"Detected in some"		"A-431: 4.8;CACO-2: 7.5;CAPAN-2: 4.7;SCLC-21H: 4.5;SiHa: 4.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA067103	Enhanced		Approved	Microtubules				Microtubules	Microtubules	"HPA067103: AB_2685778"	"unprognostic (2.03e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.50e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.60e-2)"	0.2	0.1	1.5	0.2	4.8	0.5	0.5	1.8	0.9	1.3	0.2	7.9	1.1	0.2	0.7	5.7	0.2	14.3	0.4	0.2	2.1	1.9	0.2	0.3	5.5	0.2	0.2	0.6	3.0	0.5	20.0	1.2	1.8	7.0	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	21.0	0.7	0.2	0.3	0.2	0.2	0.2	0.2	1.2	0.6	3.2	0.7	0.6	0.7	0.1	4.8	0.2	0.2	0.3	0.1	0.0	0.8	0.2	0.1	0.0	0.1	7.5	4.7	0.2	2.3	0.1	0.4	0.0	1.1	0.1	0.1	0.2	0.1	0.5	0.1	1.2	0.3	0.2	0.4	0.0	0.7	0.1	0.0	0.2	0.3	0.0	0.9	0.1	0.4	0.4	1.6	0.2	0.5	0.1	0.0	1.4	4.5	0.3	4.5	0.1	2.3	0.4	0.3	0.2	0.4	0.8	0.1	0.0	0.4	0.1	0.2	0.1	0.1	0.8	0.7	0.7	0.4	0.7	0.3	0.5	0.5	0.4	0.6	0.2	1.2	0.5	0.7	3.2	0.6	0.3	0.6	0.3	0.1	1.5	4.8	1.8	0.9	2.1	1.9	0.2	0.6	7.0	0.7
DNAH5	"CILD3, Dnahc5, HL1, KTGNR, PCD"	ENSG00000039139	"Dynein axonemal heavy chain 5"	Q8TE73	5	13690331-13944543	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.1;LHCN-M2: 2.7;PC-3: 6.6;RPTEC TERT1: 3.6;TIME: 2.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 3.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037469, HPA037470"	Enhanced									"HPA037469: AB_10672791, HPA037470: AB_10672348"	"unprognostic (3.85e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.94e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-3)"	"unprognostic (8.87e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	0.0	0.1	0.5	0.0	1.1	0.0	3.7	0.0	0.4	0.7	0.0			0.0	0.3	0.2	0.0	8.9	0.2	0.0	0.8	1.1	1.9	1.6	3.8	0.0	0.2		0.0	1.7	0.0	3.3	0.0		1.6	0.0		0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7			2.4		0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.2	0.1	0.0	0.2	0.1	0.9	4.1	0.2	0.3	0.0	1.4	0.0	1.4	0.6	0.3	0.0	0.9	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.7	0.0	0.0	2.7	0.2	0.0	0.0	0.0	6.6	0.0	0.0	0.0	3.6	1.0	0.7	0.0	0.1	0.2	0.0	0.1	0.0	2.5	0.2	0.5	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DNAH6	"Dnahc6, DNHL1, FLJ37357, HL-2"	ENSG00000115423	"Dynein axonemal heavy chain 6"	Q9C0G6	2	84516455-84819589	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;fallopian tube: 15.3;pituitary gland: 17.4"	"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 1.5;SK-MEL-30: 2.9;U-266/70: 1.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"naive CD4 T-cell: 3.8;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.8"	"Low region specificity"	"Detected in many"							HPA036391	Enhanced									"HPA036391: AB_10672220"	"unprognostic (4.87e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-8)"	"unprognostic (2.04e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.97e-2)"	1.4	1.2	7.7	0.8	17.7	0.7	1.7	0.6	10.0	1.8	1.0	3.2	0.7	0.7	2.0	11.0	0.6	15.3	0.8	0.6	7.9	3.5	1.9	3.6	4.8	1.0	0.9	7.2	5.1	1.2	6.2	17.4	0.7	23.7	1.1	1.1	0.5	0.6	1.3	0.5	0.7	0.8	0.8	1.6	0.8	2.0	7.2	3.0	0.0	3.9	0.0	0.8	0.7	0.6	0.0	0.2	0.1	0.0	0.0	3.8	0.4	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.9	0.0	2.9	0.0	0.5	0.0	0.5	0.5	0.4	0.2	1.6	0.1	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	3.8	1.2	0.0	0.0	0.0	0.2	0.0	0.4	7.7	17.7	0.6	10.0	7.9	3.5	0.9	7.2	23.7	3.0
DNAH7	KIAA0944	ENSG00000118997	"Dynein axonemal heavy chain 7"	Q8WXX0	2	195737703-196068812	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7;fallopian tube: 19.4;pituitary gland: 25.2"	"Cell line enhanced"	"Detected in some"		"PC-3: 10.5;RPTEC TERT1: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"neutrophil: 2.0;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;granulocytes: 2.0"					"Low region specificity"	"Detected in many"			"HPA034724, HPA044070"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA034724: AB_10670977, HPA044070: AB_2678798"	"unprognostic (1.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.98e-2)"	1.0	2.6	6.8	1.4	9.9	0.7	1.9	0.6	6.4	3.3	1.9	4.6	4.3	0.9	2.2	12.9	1.1	19.4	1.9	1.4	7.1	5.8	4.5	1.2	9.5	0.9	3.4	3.5	3.9	4.2	3.6	25.2	0.9	21.7	1.9	1.6	1.8	1.8	2.5	0.6	0.9	1.9	1.2	2.1	0.8	1.5	18.3	2.3	0.0	5.9	0.0	1.0	1.3	0.5	0.3	2.0	2.0	0.0	0.1	0.2	0.2	0.6	2.4	0.5	0.2	1.3	0.9	0.1	0.2	1.4	0.5	0.5	0.5	1.7	0.0	0.7	0.5	0.1	0.0	0.3	0.4	0.0	1.4	0.0	2.9	0.7	0.2	0.1	0.2	0.3	0.4	2.1	0.4	0.0	0.6	3.3	0.9	2.4	0.0	0.1	0.5	10.5	0.1	0.6	0.8	4.9	0.3	1.1	1.9	0.6	0.4	0.2	0.9	0.2	0.0	1.3	0.4	2.0	0.6	2.6	2.3	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.1	2.0	0.1	0.0	2.0	0.0	0.2	6.8	9.9	0.6	6.4	7.1	5.8	3.4	3.5	21.7	2.3
DNAH9	"DNAH17L, Dnahc9, DNAL1, DYH9, HL-20, HL20, KIAA0357"	ENSG00000007174	"Dynein axonemal heavy chain 9"	Q9NYC9	17	11598431-11969748	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.8;fallopian tube: 41.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.2;Karpas-707: 1.6;NTERA-2: 2.3;SH-SY5Y: 1.9;WM-115: 4.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA052641	Enhanced									"HPA052641: AB_2681895"	"unprognostic (4.16e-3)"	"unprognostic (3.67e-2)"	"unprognostic (9.31e-2)"	"prognostic favourable (6.79e-5)"	"unprognostic (8.37e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-3)"	"unprognostic (5.31e-2)"	2.8	1.4	8.1	0.9	8.3	0.6	1.1	0.8	5.2	2.0	0.7	13.1	2.1	0.6	2.3	9.6	0.8	41.2	1.0	0.6	11.4	10.4	1.7	0.7	5.5	0.6	8.4	2.2	8.2	2.7	2.8	3.0	1.0	18.8	1.5	0.7	0.8	0.6	3.1	0.9	1.0	0.6	1.2	8.5	0.7	0.7	7.1	3.6	0.0	1.5	0.0	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.3	0.8	5.2	11.4	10.4	8.4	2.2	18.8	3.6
DNALI1	"dJ423B22.5, hp28, P28"	ENSG00000163879	"Dynein axonemal light intermediate chain 1"	O14645	1	37556919-37566857	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 50.5;testis: 59.5"	"Cell line enhanced"	"Detected in some"		"AF22: 10.3;ASC TERT1: 9.1;HHSteC: 6.9;hTEC/SVTERT24-B: 6.7;RPTEC TERT1: 12.3;SH-SY5Y: 8.5;T-47d: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028305	Approved									"HPA028305: AB_10601807"	"unprognostic (1.21e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"prognostic favourable (6.02e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.52e-2)"	2.4	6.3	9.7	1.3	10.8	0.6	7.7	2.6	7.2	9.2	3.9	17.2	10.5	1.7	8.4	20.6	3.2	50.5	8.8	2.9	10.1	13.2	11.9	11.3	9.9	1.3	8.5	6.2	13.9	8.7	8.5	19.2	2.1	23.9	6.9	2.8	7.5	4.1	8.7	1.5	0.9	1.9	5.2	9.1	1.5	6.0	59.5	8.1	0.0	12.1	1.1	1.2	3.3	1.8	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.3	0.9	2.2	9.1	0.1	1.3	2.8	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	6.9	0.0	0.0	4.1	0.0	6.7	0.0	1.1	0.7	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	12.3	0.0	1.2	8.5	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.8	2.6	7.2	10.1	13.2	8.5	6.2	23.9	8.1
DRC1	"C2orf39, CCDC164, CILD21, FLJ32660, MGC16372"	ENSG00000157856	"Dynein regulatory complex subunit 1"	Q96MC2	2	26401916-26456711	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.5;fallopian tube: 36.8;testis: 29.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.6;SCLC-21H: 1.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.3"	"Region enriched"	"Detected in many"	4	"pons and medulla: 20.5"	"Cell type enriched"	"Detected in single"	64	"neutrophil: 11.2"	"Lineage enriched"	"Detected in single"	64	"granulocytes: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (2.28e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.41e-3)"	"unprognostic (8.56e-3)"	"unprognostic (7.02e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.06e-3)"	"unprognostic (8.19e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-2)"	0.3	0.4	2.4	0.3	3.6	1.0	0.3	0.1	2.1	2.0	0.3	7.7	0.0	0.3	1.3	11.3	0.3	36.8	0.3	0.3	3.6	4.8	0.4	0.3	6.0	0.3	1.3	1.8	5.2	0.3	0.3	4.8	0.3	20.5	0.4	0.3	0.0	0.3	0.7	0.3	0.3	0.3	0.3	1.0	0.3	0.4	29.6	2.9	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	11.2	0.1	0.0	0.0	0.0	0.2	0.6	0.6	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.8	4.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	2.4	3.6	0.1	2.1	3.6	4.8	1.3	1.8	20.5	2.9
DRC3	"CFAP134, DKFZP586M1120, LRRC48"	ENSG00000171962	"Dynein regulatory complex subunit 3"	Q9H069	17	17972813-18016889	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 46.9"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.1;U-87 MG: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036040, HPA036041"	Approved									"HPA036040: AB_10602349, HPA036041: AB_2674915"	"prognostic favourable (1.51e-4)"	"unprognostic (5.86e-3)"	"unprognostic (9.48e-2)"	"prognostic favourable (4.05e-5)"	"unprognostic (1.06e-1)"	"unprognostic (7.64e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.33e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-2)"	0.7	1.1	3.3	0.4	5.9	0.3	2.2	1.2	3.1	5.0	0.7	8.2	7.2	0.9	5.3	15.9	0.7	46.9	2.3	1.1	5.1	5.1	3.7	1.1	6.5	0.7	0.8	2.3	8.2	3.3	6.8	18.5	0.6	13.4	2.2	0.7	6.1	1.6	2.1	1.3	1.2	0.5	1.9	1.2	0.9	0.8	15.4	2.6	0.0	7.0	0.3	0.5	0.6	1.0	0.4	0.4	3.1	0.7	0.0	1.0	0.2	1.0	3.9	0.6	2.3	0.4	1.5	0.3	1.0	0.5	1.9	2.0	0.6	4.2	0.0	3.3	0.6	3.3	1.2	0.5	1.1	0.2	2.7	0.1	0.3	0.0	1.4	0.6	0.2	1.3	1.1	3.0	0.4	0.5	0.0	0.3	2.2	1.2	0.2	0.1	0.7	0.8	0.2	1.1	0.0	7.1	1.4	1.2	3.4	1.4	0.1	3.6	3.8	0.0	1.0	1.1	0.9	0.2	0.5	0.5	0.2	0.1	5.7	0.0	3.3	0.0	0.7	2.0	0.3	0.2	0.2	0.4	0.1	1.0	0.4	0.3	0.3	0.6	3.1	0.0	0.2	0.2	0.0	0.2	3.3	5.9	1.2	3.1	5.1	5.1	0.8	2.3	13.4	2.6
DTHD1	FLJ16686	ENSG00000197057	"Death domain containing 1"	Q6ZMT9	4	36281622-36345756	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.6;fallopian tube: 20.6;lung: 18.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 6.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (9.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.45e-5)"	"unprognostic (5.12e-3)"	"unprognostic (9.11e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.05e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.12e-3)"	0.7	0.5	1.9	5.8	14.8	0.9	0.4	0.3	0.3	2.1	1.1	2.8	1.4	0.7	1.1	11.9	0.7	20.6	3.5	0.4	3.1	2.9	0.4	0.7	18.5	5.4	0.4	0.0	8.1	0.3	0.2	0.8	0.2	16.6	0.5	0.7	0.1	0.6	0.3	0.2	0.2	1.3	0.4	0.7	8.0	0.8	2.2	4.5	0.0	0.6	1.2	4.0	3.1	0.5	0.0	0.0	0.1	0.0	1.1	6.8	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.1	6.8	0.0	1.2	0.0	0.6	2.1	0.0	0.0	0.0	2.6	0.0	1.1	0.0	0.0	0.0	0.7	1.9	14.8	0.3	0.2	3.1	2.9	0.4	0.0	16.6	4.5
DYDC2	"bA36D19.6, MGC16186"	ENSG00000133665	"DPY30 domain containing 2"	Q96IM9	10	80344745-80368073	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.3;fallopian tube: 56.4"	"Cell line enhanced"	"Detected in some"		"AF22: 4.3;NTERA-2: 6.8;SCLC-21H: 5.9;SH-SY5Y: 4.0;U-2197: 4.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Group enriched"	"Detected in many"	5	"amygdala: 6.3;basal ganglia: 9.1;hippocampal formation: 7.7;hypothalamus: 6.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA038006, HPA038007"	Enhanced									"HPA038006: AB_10672734, HPA038007: AB_2675783"	"unprognostic (1.60e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.55e-1)"	"prognostic favourable (3.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.40e-2)"	0.2	0.2	6.3	0.2	9.1	0.6	0.4	0.1	1.7	1.6	0.3	3.0	0.1	0.3	1.3	10.0	0.5	56.4	0.4	0.2	7.7	6.8	0.3	0.3	3.6	0.2	0.2	0.4	4.3	0.6	0.2	0.1	0.4	16.3	0.3	0.2	0.1	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2	0.4	5.2	0.7	0.1	0.3	0.1	0.2	0.2	0.1	0.6	0.6	2.4	0.3	1.2	0.4	0.0	0.2	0.1	4.3	0.1	0.5	0.0	0.1	0.0	0.6	0.4	0.1	0.4	0.7	0.1	0.9	0.1	0.2	0.3	0.1	0.1	0.2	0.6	0.3	0.2	1.5	0.0	0.0	0.4	0.2	1.0	0.0	0.1	0.0	0.2	0.3	0.2	0.3	0.7	0.0	6.8	0.0	1.8	0.5	1.5	0.0	0.1	5.9	4.0	0.2	0.0	0.6	0.0	2.7	0.1	0.1	0.3	4.3	0.0	0.1	0.1	0.3	0.3	0.0	0.0	2.4	0.3	0.1	0.3	0.1	0.4	0.3	0.3	0.2	0.0	0.6	0.3	0.4	0.5	1.2	0.2	0.6	0.0	0.0	6.3	9.1	0.1	1.6	7.7	6.8	0.2	0.4	16.3	0.7
EFCAB1	FLJ11767	ENSG00000034239	"EF-hand calcium binding domain 1"	Q9HAE3	8	48710789-48735311	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 61.9"	"Cell line enhanced"	"Detected in some"		"A-431: 8.9;ASC diff: 3.9;ASC TERT1: 9.1;CAPAN-2: 4.4;hTEC/SVTERT24-B: 3.7;SCLC-21H: 7.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023527, HPA069955"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA023527: AB_2231065, HPA069955: AB_2686220"	"unprognostic (5.29e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.94e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.47e-3)"	0.6	1.5	5.4	0.5	9.5	0.9	2.5	0.2	4.1	8.1	0.8	14.0	10.3	0.9	8.6	19.0	0.9	61.9	0.9	0.6	9.1	8.4	0.6	0.9	16.5	0.5	2.7	3.9	13.7	1.8	0.4	2.0	0.8	23.9	4.2	0.7	1.9	1.8	4.6	0.5	3.5	1.1	2.7	1.4	0.6	0.8	19.7	3.0	0.0	0.5	0.3	0.6	1.4	2.1	1.0	0.0	4.1	0.0	1.1	1.1	0.3	8.9	0.0	1.1	0.0	3.9	9.1	0.0	0.1	0.9	0.0	0.3	0.0	4.4	0.0	0.0	0.2	2.4	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.1	3.2	0.3	3.7	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	0.3	0.1	0.0	0.0	0.0	2.1	7.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.5	0.0	1.1	1.0	0.7	0.8	0.0	0.8	0.5	0.3	4.1	1.1	0.0	0.0	0.7	0.3	5.4	9.5	0.2	4.1	9.1	8.4	2.7	3.9	23.9	3.0
EFCAB10		ENSG00000185055	"EF-hand calcium binding domain 10"	A6NFE3	7	105565120-105600875	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.0;testis: 34.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA019751	Uncertain									"HPA019751: AB_1848011"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.96e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.67e-2)"	0.4	0.8	2.0	0.9	9.6	2.2	0.3	0.7	3.7	1.5	0.7	4.2	0.0	0.7	1.3	6.2	0.9	29.0	0.5	0.5	2.9	3.5	0.7	0.7	6.4	1.0	0.7	3.5	6.9	1.6	0.2	2.0	0.4	11.8	0.7	0.5	0.0	1.0	0.2	1.3	1.4	0.8	0.2	1.1	0.9	0.8	34.9	2.3	0.0	0.7	0.0	0.3	0.8	0.4	2.9	1.7	3.7	1.2	1.4	3.0	0.6	2.0	5.9	3.2	2.1	0.6	0.2	1.3	2.9	0.0	0.0	0.1	1.1	1.3	2.9	2.6	0.1	0.8	0.1	0.0	0.0	1.1	5.3	1.5	4.0	3.2	0.4	1.8	1.9	0.2	0.0	0.2	0.0	0.0	4.3	2.4	0.1	4.4	2.1	4.0	5.3	2.2	1.4	3.3	6.2	0.3	1.3	3.1	4.1	1.7	6.1	1.0	1.2	2.2	1.5	3.0	2.1	6.4	1.9	3.4	4.0	2.6	1.8	2.9	1.5	3.7	1.2	1.0	1.9	0.9	1.7	1.6	1.9	1.6	0.7	2.9	3.0	2.2	1.4	1.4	0.9	1.7	1.2	0.6	2.0	9.6	0.7	3.7	2.9	3.5	0.7	3.5	11.8	2.3
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 24.4;fallopian tube: 29.9;testis: 24.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.6;RPTEC TERT1: 3.7;SCLC-21H: 2.9"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"basal ganglia: 14.9;pons and medulla: 24.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Region enhanced"	"Detected in many"		"midbrain: 14.2"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"				Nucleoplasm	Nucleoplasm	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.7	0.6	2.2	0.7	14.9	1.5	0.9	1.7	3.0	2.0	0.6	7.8	0.0	0.5	1.8	10.1	0.6	29.9	1.5	0.7	4.2	4.3	1.2	2.1	3.6	0.8	0.5	3.5	6.1	1.0	3.1	15.2	0.7	24.4	4.1	0.6	1.5	0.6	0.9	0.5	0.5	0.5	0.6	1.0	0.7	1.0	24.8	1.6	0.0	2.4	0.0	0.9	0.5	0.1	1.4	0.0	1.3	0.4	0.3	0.6	0.0	0.4	2.2	0.7	2.2	0.4	0.1	0.4	0.0	0.2	0.3	0.1	0.8	1.2	0.4	0.4	0.0	0.3	0.0	0.4	0.3	0.6	0.5	0.5	0.6	4.6	0.3	0.3	0.9	0.5	0.0	0.5	0.0	0.0	1.3	0.9	0.0	0.3	0.1	1.6	0.3	0.1	0.8	0.0	0.5	3.7	0.0	2.9	0.1	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.5	1.0	0.2	1.4	1.8	2.1	0.5	0.7	0.2	0.0	0.4	0.8	0.1	0.0	0.3	0.3	0.0	0.6	0.0	1.4	0.3	0.2	1.3	0.3	0.0	0.0	0.2	0.0	2.2	14.9	1.7	3.0	4.2	4.3	0.5	3.5	24.4	1.6
EFHB	"CFAP21, FLJ25200"	ENSG00000163576	"EF-hand domain family member B"	Q8N7U6	3	19879472-19947025	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.3;testis: 19.2"	"Cell line enriched"	"Detected in single"	33	"RPTEC TERT1: 21.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078067			Approved	Nucleoli				Nucleoli	Nucleoli	"HPA078067: AB_2732370"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.51e-5)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	1.1	1.5	3.9	0.7	6.0	0.7	1.8	0.7	4.3	2.0	0.7	6.5	0.0	0.6	2.0	7.8	1.0	23.3	1.3	0.8	6.3	4.7	1.8	0.7	3.9	0.7	4.4	2.2	5.5	0.5	0.5	1.6	1.0	9.5	1.0	1.0	2.3	0.6	1.3	0.7	1.1	0.6	1.6	3.1	1.2	0.6	19.2	6.0	0.0	1.2	0.0	0.8	0.7	0.6	1.3	0.6	1.1	0.8	0.4	2.2	0.4	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	21.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	2.2	0.1	0.1	0.8	0.3	0.4	0.0	1.3	0.5	0.3	1.1	0.4	0.3	0.6	0.0	0.4	3.9	6.0	0.7	3.8	6.3	4.7	4.4	2.2	9.5	6.0
EFHC1	"EJM, EJM1, FLJ10466"	ENSG00000096093	"EF-hand domain containing 1"	Q5JVL4	6	52362123-52529886	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 49.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035307	Approved									"HPA035307: AB_2674561"	"unprognostic (2.11e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.60e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (2.33e-4)"	"unprognostic (3.04e-1)"	"prognostic unfavourable (3.29e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.27e-1)"	4.1	5.2	12.5	4.1	25.5	5.2	8.7	12.6	18.3	10.1	10.2	29.4	12.5	4.0	10.6	10.9	4.1	49.3	6.1	4.3	16.7	9.7	6.8	2.9	8.5	4.1	37.8	13.4	10.9	6.0	8.1	18.8	6.1	23.0	6.5	5.9	3.5	5.5	22.4	3.7	8.9	14.9	6.2	21.3	4.9	5.9	23.1	29.3	2.9	13.3	0.8	3.7	5.2	6.0	5.6	8.6	2.8	0.8	1.9	1.2	0.6	2.9	3.3	8.1	5.6	7.9	13.7	1.5	3.4	9.0	4.7	7.6	2.1	3.4	1.2	8.1	5.7	3.0	2.3	6.4	6.2	0.6	2.8	1.1	8.3	2.6	5.5	1.1	1.5	6.4	3.7	6.8	6.2	9.9	2.6	2.1	7.1	2.4	1.2	1.9	2.4	1.4	1.8	4.3	1.5	6.5	1.1	16.6	4.6	0.9	1.5	7.0	5.8	1.4	3.2	3.4	4.7	1.3	2.6	1.7	2.4	2.1	9.5	0.4	6.1	0.8	0.8	2.0	1.2	0.3	0.6	5.2	0.5	1.0	1.9	5.6	0.6	1.0	2.8	1.9	0.5	8.6	0.4	0.6	12.5	25.5	12.6	18.3	16.7	9.7	37.8	13.4	23.0	29.3
EFHC2	"FLJ22843, MRX74"	ENSG00000183690	"EF-hand domain containing 2"	Q5JST6	X	44147882-44343672	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6;fallopian tube: 20.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;HEL: 5.3;HMC-1: 17.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 20.6"	"Group enriched"	"Detected in some"	5	"basophil: 14.1;NK-cell: 6.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 14.1;NK-cells: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034492, HPA057359"	Approved	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA034492: AB_10671227, HPA057359: "	"unprognostic (1.93e-1)"	"unprognostic (7.80e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.07e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.13e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.97e-2)"	0.7	0.6	4.0	0.8	6.2	1.9	1.2	1.6	3.1	4.6	1.6	6.5	3.7	0.6	5.4	12.6	2.9	20.8	3.0	6.0	4.8	3.9	2.0	0.1	4.5	0.5	1.5	2.0	5.2	0.3	0.9	6.9	1.3	20.6	2.9	0.6	0.6	9.6	5.8	0.1	4.7	0.8	2.6	1.4	0.6	1.6	10.1	3.1	0.4	3.7	1.4	0.9	1.7	1.4	0.1	0.4	14.1	0.0	6.6	2.1	1.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	5.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	17.6	0.3	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.3	0.6	0.1	0.3	0.0	0.0	1.4	0.0	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	14.1	0.0	0.0	2.1	0.0	0.8	0.1	0.8	0.1	0.4	0.1	0.7	1.0	1.9	6.6	0.0	0.0	0.0	1.4	4.0	6.2	1.6	3.1	4.8	3.9	1.5	2.0	20.6	3.1
ENKUR	"C10orf63, CFAP106, enkurin, MGC26778"	ENSG00000151023	"Enkurin, TRPC channel interacting protein"	Q8TC29	10	24981979-25062279	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7;fallopian tube: 46.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;CAPAN-2: 7.0"	"Cancer enhanced"	"Detected in some"		"glioma: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037593, HPA037594, HPA061503"	Enhanced									"HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543"	"unprognostic (2.33e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.69e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.20e-6)"	"unprognostic (3.94e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-3)"	"unprognostic (8.43e-3)"	0.7	1.1	8.4	1.2	13.4	1.0	0.7	1.1	10.6	2.2	0.9	6.2	0.0	2.0	2.5	7.0	0.7	46.2	1.0	0.8	8.8	10.8	1.2	2.4	6.7	0.7	9.2	3.5	6.5	0.6	0.8	10.4	1.4	18.7	0.7	0.8	0.0	0.8	0.7	0.9	0.8	4.6	0.9	6.5	1.0	0.9	8.4	8.6	0.0	1.2	0.0	0.8	0.7	0.0	0.0	0.4	4.1	0.3	0.0	0.0	9.9	0.4	1.2	1.2	4.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.7	7.0	0.7	1.0	0.2	0.5	0.0	0.7	0.1	0.4	0.4	0.8	0.9	0.4	0.1	0.0	0.2	0.0	0.0	0.4	0.6	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.3	1.0	2.3	0.4	0.2	0.2	0.6	0.0	0.2	0.4	1.2	0.6	1.0	0.0	0.1	0.0	2.1	0.2	0.1	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.1	0.0	0.1	0.4	0.0	9.9	8.4	13.4	1.1	5.2	8.8	10.8	9.2	3.5	18.7	8.6
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase family member 4"	A6NNW6	10	116849512-116911788	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1;epididymis: 12.6;fallopian tube: 13.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;MCF7: 8.2;T-47d: 5.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA037937: , HPA037938: AB_2675746"	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.7	2.1	4.3	0.6	4.3	0.2	2.2	2.6	3.6	1.7	1.0	8.0	0.9	0.3	4.3	12.6	1.4	13.6	1.3	0.5	6.4	4.7	2.3	2.7	3.9	1.2	4.1	4.8	4.2	3.2	3.7	3.4	0.5	12.1	2.1	0.8	3.0	1.6	1.2	0.2	1.1	0.5	0.9	4.4	0.5	0.8	8.8	1.9	0.2	4.2	0.0	0.6	1.8	0.5	1.8	1.0	0.0	0.6	0.0	1.2	0.1	1.4	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.3	1.1	0.0	0.9	2.0	2.6	0.0	0.7	0.8	0.0	1.5	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.1	0.1	0.0	0.7	8.2	0.0	0.0	1.4	0.2	0.0	0.0	0.0	1.1	0.6	0.9	0.0	2.1	0.1	0.0	5.1	0.0	0.5	0.0	0.7	0.4	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	1.6	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.0	0.2	1.0	1.2	0.1	4.3	4.3	2.6	3.6	6.4	4.7	4.1	4.8	12.1	1.9
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.4;EFO-21: 7.0;HEK 293: 5.2;RPTEC TERT1: 7.7;SCLC-21H: 4.3;T-47d: 6.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					140000	140000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	1.6	1.9	15.1	1.2	15.0	1.0	13.4	18.6	14.1	7.8	1.1	7.6	8.8	1.1	1.5	1.2	1.3	24.5	1.2	7.0	14.3	6.5	11.9	1.1	2.9	1.2	7.8	10.7	1.3	2.4	10.8	5.1	1.3	8.8	1.7	1.1	2.0	9.7	18.1	3.8	1.8	1.2	1.1	7.3	1.2	1.5	7.6	12.0	0.0	4.5	1.1	1.2	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	7.0	1.0	0.4	0.2	0.0	0.0	0.1	5.2	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.7	0.4	4.3	0.2	0.0	0.1	0.1	6.9	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	15.0	18.6	14.1	14.3	6.5	7.8	10.7	8.8	12.0
ERICH3	"C1orf173, DKFZp547I048, RP11-653A5.1"	ENSG00000178965	"Glutamate rich 3"	Q5RHP9	1	74568111-74673738	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.5;fallopian tube: 21.1;testis: 26.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.2;SCLC-21H: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA028655, HPA072916"	Approved									"HPA028655: AB_10961002, HPA072916: "	"unprognostic (4.49e-4)"	"unprognostic (1.02e-2)"		"prognostic favourable (1.56e-5)"	"unprognostic (1.71e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-4)"	"unprognostic (9.21e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	0.4	3.5	12.7	0.5	10.7	0.4	1.4	7.0	14.5	7.6	0.5	0.5	0.0	0.5	1.7	3.0	0.4	21.1	0.5	0.5	12.0	4.2	0.5	0.6	3.7	0.7	1.0	10.3	1.2	0.4	0.4	6.3	0.5	2.4	0.5	0.6	0.0	0.7	0.5	0.4	0.5	0.5	0.5	0.7	0.6	0.6	26.4	1.6	0.0	0.5	0.0	0.7	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	3.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	10.7	7.0	12.0	12.0	4.2	1.0	10.3	2.4	1.6
FAM183A	"hCG23177, LOC440585"	ENSG00000186973	"Family with sequence similarity 183 member A"	A6NL82	1	43145153-43156396	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 25.5;fallopian tube: 55.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.6;hTCEpi: 4.9;MCF7: 3.3;NTERA-2: 6.0;SCLC-21H: 5.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 19.3"	"Region enhanced"	"Detected in many"		"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA043382, HPA049120"	Approved									"HPA043382: AB_2678456, HPA049120: AB_2680640"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.42e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.73e-2)"	0.1	0.1	3.6	0.1	9.8	0.1	0.8	0.0	0.5	2.6	0.3	6.5	0.0	0.2	1.3	16.5	0.5	55.8	0.2	0.1	4.6	4.7	0.3	0.2	14.5	0.2	0.1	0.2	10.1	0.3	1.0	5.5	0.5	25.5	1.4	0.3	0.0	0.9	0.3	0.1	5.5	0.1	0.3	0.6	0.2	0.2	6.7	1.7	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.6	0.6	0.7	1.2	6.6	0.0	0.8	0.5	0.8	0.0	0.4	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.5	0.0	0.1	0.0	0.0	3.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	2.6	1.2	5.1	0.0	0.0	0.3	0.0	1.5	0.0	1.0	0.0	0.7	0.2	0.1	2.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	9.8	0.0	0.5	4.6	4.7	0.1	0.2	25.5	1.7
FAM187A		ENSG00000214447	"Family with sequence similarity 187 member A"	A6NFU0	17	44899712-44905390	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.2;testis: 37.0"	"Cell line enhanced"	"Detected in many"		"A549: 8.7;RPTEC TERT1: 12.3;U-87 MG: 13.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.9"	"Low lineage specificity"	"Detected in many"											"HPA022794, HPA043131"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA022794: AB_1848384, HPA043131: "																		0.7	1.3	5.8	0.6	8.9	0.7	1.4	1.0	5.0	2.5	0.9	3.1	1.7	0.3	1.9	2.7	0.5	21.2	3.0	0.6	5.4	6.7	3.7	0.5	2.0	0.7	5.3	4.1	3.7	1.6	2.2	2.2	0.3	4.5	1.1	1.0	1.7	1.3	1.9	0.4	0.6	0.6	1.1	4.2	0.4	0.6	37.0	1.1	0.3	4.5	0.2	0.6	0.9	0.3	0.8	1.8	1.9	2.9	0.2	0.8	2.0	1.7	8.7	2.2	1.7	2.7	3.0	1.4	0.5	4.2	2.4	3.0	2.6	4.6	0.2	1.4	1.6	5.2	0.5	2.2	1.1	5.2	2.1	0.7	3.6	0.7	1.1	1.0	0.7	0.4	3.0	4.7	1.0	1.1	1.6	0.1	0.9	1.1	0.1	1.3	0.7	1.2	0.8	0.2	0.4	12.3	0.8	5.8	1.3	0.5	0.1	0.7	6.2	1.0	0.6	1.0	2.2	1.2	1.0	0.1	0.2	0.4	13.9	0.8	1.1	0.0	2.9	1.9	0.2	0.8	0.0	0.0	0.0	0.8	1.8	0.8	0.0	0.1	0.0	0.2	0.3	0.0	0.6	2.0	5.8	8.9	1.0	5.0	5.4	6.7	5.3	4.1	4.5	1.1
FAM216B	"C13orf30, FLJ40919"	ENSG00000179813	"Family with sequence similarity 216 member B"	Q8N7L0	13	42781550-42791549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3"	"Cell line enriched"	"Detected in single"	12	"U-87 MG: 6.3"	"Group enriched"	"Detected in some"	10	"endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.5;pons and medulla: 21.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040118	Uncertain									"HPA040118: AB_10674429"	"unprognostic (1.03e-2)"		"unprognostic (2.24e-1)"	"prognostic favourable (9.77e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.27e-1)"		"unprognostic (8.14e-3)"	"unprognostic (1.37e-1)"		"unprognostic (1.30e-2)"	0.3	0.2	1.7	0.9	9.5	0.2	0.2	0.1	0.6	3.0	0.3	8.0	0.0	0.3	1.3	18.2	0.2	51.3	0.4	10.0	3.1	3.2	0.2	0.2	28.5	2.2	0.1	0.0	18.3	0.3	0.2	2.0	0.2	21.0	0.2	0.5	0.0	0.7	0.2	0.2	0.2	1.5	0.2	0.5	0.3	0.3	1.0	1.7	0.0	0.2	0.0	3.9	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	9.5	0.1	0.6	3.1	3.2	0.1	0.0	21.0	1.7
FAM86B2		ENSG00000145002	"Family with sequence similarity 86 member B2"	P0C5J1	8	12425614-12436343	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 4.6"	"Group enriched"	"Detected in some"	7	"hTERT-HME1: 6.2;RPMI-8226: 18.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA041610, HPA055718"	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA041610: AB_2677581, HPA055718: AB_2682895"	"unprognostic (3.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.04e-4)"	"unprognostic (9.37e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.13e-2)"	0.4	0.9	0.2	0.4	0.7	0.0	0.8	0.2	0.3	0.8	0.8			0.4	1.0	0.0	3.9	4.6	0.7	0.1	0.2	0.5	1.1	0.5	0.6	0.1	0.2		1.3	1.1	0.6	2.2	0.1		0.6	0.6		0.5	1.8	0.3	1.2	0.0	0.6	0.0	0.0	0.4	0.1			3.4		0.1	1.0	0.6	0.4	1.3	0.0	0.9	0.6	2.1	0.3	0.2	1.3	0.2	0.0	0.3	1.4	1.4	0.2	0.7	0.5	1.3	0.5	1.3	0.8	0.0	1.4	0.2	1.0	1.7	0.0	0.0	0.0	0.2	1.7	0.0	1.2	0.0	0.0	0.4	1.5	1.4	6.2	0.0	1.2	0.2	0.1	0.4	0.0	0.4	1.2	0.4	0.2	0.7	18.1	0.0	1.2	1.8	0.0	0.5	1.4	0.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.5	0.4	0.9	1.1	1.3	0.4	0.4	0.3	0.0	0.6	0.9	0.0	2.1	0.3										
FAM92B	FLJ44299	ENSG00000153789	"Family with sequence similarity 92 member B"	Q6ZTR7	16	85098358-85112508	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.2;fallopian tube: 50.7;lung: 13.8"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 7.4;TIME: 2.2"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 5.4;lung cancer: 1.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA041022	Enhanced									"HPA041022: AB_10795500"	"unprognostic (1.77e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.10e-13)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	0.1	0.9	2.0	0.7	8.3	0.3	0.3	0.7	0.6	2.0	0.5	6.3	0.0	0.9	0.9	10.8	0.1	50.7	0.2	0.1	2.7	5.0	0.1	0.1	13.8	0.3	0.0	0.0	8.8	0.1	0.1	13.5	0.1	14.2	0.2	0.4	0.0	0.3	0.2	0.1	0.3	0.5	0.1	0.4	0.6	0.3	0.7	1.8	0.0	0.1	0.0	1.2	1.3	0.0	1.2	0.2	0.9	0.3	2.5	0.4	0.2	0.4	0.0	0.5	0.3	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.4	0.3	0.6	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.1	0.5	0.2	0.1	0.5	0.2	0.3	0.4	7.4	0.9	0.0	0.1	0.2	0.7	0.7	2.2	0.6	0.5	0.1	0.2	0.2	0.2	0.4	0.4	0.2	1.6	0.1	0.2	0.1	0.4	0.3	0.2	1.2	0.2	0.1	0.2	0.3	0.2	0.2	0.9	2.5	0.1	0.2	0.0	0.2	2.0	8.3	0.7	0.6	2.7	5.0	0.0	0.0	14.2	1.8
FANK1		ENSG00000203780	"Fibronectin type III and ankyrin repeat domains 1"	Q8TC84	10	125896539-126009592	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.3;fallopian tube: 24.7;testis: 44.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.2;HaCaT: 8.4;hTCEpi: 8.9;RPTEC TERT1: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	14	"T-reg: 28.3"	"Lineage enriched"	"Detected in single"	284	"T-cells: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038413			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA038413: AB_10697249"	"unprognostic (4.25e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (3.83e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.02e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.44e-1)"	0.5	2.4	4.1	1.3	8.3	0.7	3.4	0.8	1.8	2.5	2.2	4.0	3.8	1.6	2.3	18.5	2.2	24.7	4.9	0.5	4.9	6.4	4.5	0.1	4.0	0.8	2.7	1.3	5.6	3.1	2.3	7.8	2.0	14.1	1.5	3.3	2.0	1.5	2.9	0.2	3.9	1.9	1.3	2.1	0.3	3.5	44.7	2.4	0.4	5.8	1.1	1.7	1.7	1.4	0.0	0.0	0.0	0.0	0.0	28.3	0.1	6.2	2.1	0.5	3.6	2.8	2.8	4.0	2.4	1.7	0.6	0.6	0.1	17.2	0.0	0.4	1.8	8.4	0.0	3.0	0.5	0.2	0.1	0.0	0.7	0.0	1.1	0.3	0.6	0.8	8.9	2.4	0.8	0.9	0.3	0.0	1.0	5.2	0.0	1.2	0.4	0.2	0.0	0.2	0.5	12.3	1.7	0.4	1.8	1.9	4.0	0.5	0.6	0.3	0.8	1.2	2.0	1.7	0.1	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.1	4.1	8.3	0.8	1.8	4.9	6.4	2.7	1.3	14.1	2.4
FBXO21	"FBX21, KIAA0875"	ENSG00000135108	"F-box protein 21"	O94952	12	117141988-117190531	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 78.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062411, HPA071452"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA062411: AB_2684755, HPA071452: AB_2686398"	"unprognostic (6.38e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.44e-2)"	"prognostic favourable (2.05e-8)"	"unprognostic (1.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.29e-2)"	8.1	29.4	17.8	8.8	21.6	5.2	11.4	27.0	28.0	12.6	10.5	18.8	25.5	10.6	16.1	70.1	10.2	78.4	14.2	18.9	17.9	18.4	33.3	17.0	11.2	8.2	13.5	21.4	38.8	19.0	17.3	18.8	12.3	17.5	17.4	9.8	14.0	10.7	19.8	16.3	11.8	9.5	12.8	17.0	11.6	11.8	27.8	14.2	9.9	19.1	6.9	9.3	12.7	10.2	12.8	8.5	3.7	10.5	9.2	13.0	7.1	9.4	22.4	14.2	7.8	11.7	12.2	16.2	12.6	13.7	11.9	9.7	14.4	6.7	12.4	12.5	12.9	12.9	16.6	12.6	14.3	6.9	14.9	0.6	12.4	11.6	10.6	4.0	4.4	12.0	12.2	9.5	15.2	16.5	4.9	4.1	10.1	15.4	11.4	2.9	21.1	14.7	13.6	20.6	13.0	11.9	22.6	28.1	17.0	31.6	8.4	6.8	19.5	1.6	12.7	7.9	10.3	9.2	8.1	7.3	7.5	16.3	11.5	6.3	11.0	1.1	5.8	3.7	10.7	10.5	11.2	9.8	11.3	11.1	8.5	12.8	13.0	11.7	0.5	9.2	10.1	5.8	11.4	7.1	17.8	21.6	27.0	28.0	17.9	18.4	13.5	21.4	17.5	14.2
FHAD1	KIAA1937	ENSG00000142621	"Forkhead associated phosphopeptide binding domain 1"	B1AJZ9	1	15247272-15400283	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.8;epididymis: 16.0;fallopian tube: 17.9;testis: 28.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.5;HMC-1: 38.9;K-562: 8.3;U-87 MG: 20.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"pons and medulla: 13.8"	"Cell type enhanced"	"Detected in many"		"gdTCR: 3.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054284	Enhanced									"HPA054284: AB_2682436"	"unprognostic (3.18e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.36e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-3)"	0.4	0.4	1.4	0.8	2.0	0.0	1.1	0.2	0.9	2.6	0.4	6.7	0.8	1.0	1.0	16.0	0.2	17.9	0.6	0.2	3.0	2.6	0.6	0.3	7.6	0.2	0.5	0.2	8.2	0.9	1.8	1.1	0.5	13.8	1.0	0.3	0.5	0.6	1.3	0.1	0.3	1.1	0.3	0.6	0.2	2.5	28.5	2.8	0.0	1.4	0.1	0.3	0.9	0.3	0.8	0.4	0.0	1.6	1.2	3.6	0.8	0.9	0.2	0.8	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.6	0.3	0.1	0.2	0.1	0.0	0.1	13.5	0.1	0.0	0.0	0.0	0.2	1.1	38.9	0.4	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.2	0.0	3.4	0.1	4.0	0.0	0.0	4.4	0.0	20.9	0.0	0.1	0.0	1.6	0.0	3.6	0.6	0.1	0.8	0.4	1.2	0.4	0.0	0.0	1.5	0.0	1.2	1.2	0.0	0.0	0.8	1.4	2.0	0.2	0.9	3.0	2.6	0.5	0.2	13.8	2.8
FOXD4L3	FOXD6	ENSG00000187559	"Forkhead box D4 like 3"	Q6VB84	9	68302867-68304905	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.6;fallopian tube: 2.4;lymphoid tissue: 2.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.7;NB-4: 1.2;THP-1: 1.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.0"									HPA012836	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012836: "		"unprognostic (7.93e-4)"			"unprognostic (8.71e-2)"					"unprognostic (7.04e-2)"				"unprognostic (4.75e-2)"				0.0	0.1	0.7	1.4	1.3	0.0	0.0	2.1	2.3	0.3	0.1			0.0	0.0	0.0	0.0	2.4	0.4	0.0	2.6	0.7	0.0	0.0	0.0	1.6	0.5		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.3	0.0	0.0	0.4	0.0	0.0	0.1	2.0	0.0	0.9			0.0		0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.3	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.2	0.5	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.6	0.1	0.8	0.5	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOXJ1	"FKHL13, HFH-4, HFH4"	ENSG00000129654	"Forkhead box J1"	Q92949	17	76136333-76141299	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.9;epididymis: 20.4;fallopian tube: 45.9"	"Group enriched"	"Detected in some"	9	"BEWO: 22.4;CAPAN-2: 18.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 55.6"	HPA005714	Enhanced									"HPA005714: AB_1078902"	"prognostic favourable (9.39e-4)"	"unprognostic (4.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.71e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (2.03e-5)"	"unprognostic (7.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-1)"	0.4	0.4	4.1	0.5	8.9	0.6	0.4	0.1	2.2	5.1	0.9	19.9	0.4	0.6	2.4	20.4	0.4	45.9	0.4	0.4	6.5	6.6	1.5	0.4	17.0	0.4	2.0	1.2	14.7	1.2	0.4	1.2	0.4	19.6	0.6	0.6	0.1	0.4	2.8	0.4	0.8	0.6	0.5	1.8	0.4	0.9	15.2	3.4	0.0	2.9	0.0	0.4	1.1	0.2	0.0	0.0	0.0	0.0	0.2	2.6	0.1	0.0	0.4	1.3	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	2.3	18.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.6	2.6	0.0	0.2	0.0	0.0	0.0	0.1	4.1	8.9	0.1	2.2	6.5	6.6	2.0	1.2	19.6	3.4
FYB2	"ARAP, C1orf168, FLJ43208, RP4-758N20.2"	ENSG00000187889	"FYN binding protein 2"	Q5VWT5	1	56718804-56819696	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.5;liver: 22.6;retina: 16.7"	"Cell line enriched"	"Detected in single"	18	"T-47d: 10.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 1.6;pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in many"														"unprognostic (6.12e-5)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.19e-3)"	"unprognostic (4.77e-3)"		"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-3)"	0.2	0.2	0.2	0.0	0.2	0.0	0.7	0.7	0.7	4.1	0.9	2.0	7.5	0.3	3.7	7.7	0.6	15.5	0.0	3.7	1.6	0.2	10.0	22.6	3.2	0.0	0.2	0.8	4.3	1.2	0.0	12.4	0.2	5.7	2.1	0.5	16.7	3.0	2.1	2.8	0.2	3.0	0.1	0.2	0.2	0.5	2.1	0.0	2.5	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.3	1.6	0.2	0.2	0.8	5.7	0.0
GAS2L2	GAR17	ENSG00000270765	"Growth arrest specific 2 like 2"	Q8NHY3	17	35744511-35752878	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 8.4;fallopian tube: 20.1"	"Cell line enriched"	"Detected in some"	5	"HaCaT: 5.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA044370	Enhanced									"HPA044370: AB_2678915"	"unprognostic (3.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.54e-3)"	"prognostic favourable (7.00e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-1)"		"unprognostic (6.67e-2)"		"unprognostic (4.42e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.92e-2)"	0.6	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.2	0.1	0.1	4.0	3.4	0.0	1.2	8.4	0.1	20.1	0.0	0.0	0.5		0.0	0.0	6.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.0	0.0	1.5	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0										
GMNC	GEMC1	ENSG00000205835	"Geminin coiled-coil domain containing"	A6NCL1	3	190852877-190892429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.7;kidney: 26.9;liver: 8.5"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 4.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043663	Uncertain									"HPA043663: AB_10959313"				"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.73e-2)"		"unprognostic (2.55e-3)"		0.1	0.1	3.5	0.1	2.9	0.1	0.1	0.2	0.7	0.8	0.1	5.0	0.0	0.1	2.0	4.4	0.1	12.7	0.1	0.9	4.6	1.4	26.9	8.5	0.1	0.1	0.6	0.9	0.5	1.1	0.1	0.2	0.3	4.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.4	2.0	0.1	0.1	2.3	3.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.9	0.2	0.7	4.6	1.4	0.6	0.9	4.2	3.0
GRIN3B	GluN3B	ENSG00000116032	"Glutamate ionotropic receptor NMDA type subunit 3B"	O60391	19	1000419-1009732	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.7"	"Cell line enhanced"	"Detected in some"		"U-266/70: 8.2"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.6"	"Not detected"	"Not detected"														"unprognostic (7.86e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.78e-3)"	"unprognostic (9.35e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.34e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-1)"	0.3	0.5	0.1	0.4	0.4	0.2	0.1	0.6	0.1	2.0	0.0			0.7	0.3	0.0	0.1	8.7	0.0	0.0	0.3	0.4	1.0	0.0	2.2	1.1	0.0		0.2	0.6	0.0	0.7	0.2		0.2	0.0		0.5	0.0	0.4	1.6	0.4	0.0	0.2	3.0	0.4	0.7			0.6		0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.0	0.7	0.3	0.3	1.5	2.5	1.2	0.2	0.0	0.0	0.1	0.2	1.2	1.7	0.0	0.8	0.0	0.2	0.0	0.5	2.5	0.5	0.6	0.3	0.1	0.2	1.8	0.1	0.1	0.0	0.0	0.1	0.5	1.2	0.0	0.7	0.4	0.3	0.4	0.1	2.6	0.3	1.0	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.4	0.9	1.1	0.3	0.7	0.8	0.1	8.2	1.9	0.2	0.1	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909685	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;BJ hTERT+: 1.1;CACO-2: 1.5;HAP1: 2.8;HEK 293: 1.5;SK-BR-3: 2.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: "	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.2	36.5	0.2	0.2	0.6	0.0	0.7	0.3	0.2	0.9	0.2	1.0	0.2	0.0	0.3	6.6	0.2	32.4	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	0.2	0.2	3.8	0.2	1.1	0.2	51.9	2.1	0.2	0.0	0.5	0.6	0.2	0.2	12.5	0.2	0.2	0.2	0.2	1.0	6.4	0.3	0.2	0.2	0.9	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.2	0.2	0.2	0.2	0.2	2.1	0.3
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.4"	"Group enriched"	"Detected in some"	9	"AN3-CA: 28.6;HEK 293: 39.0"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 5.9;NK-cell: 2.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.9;NK-cells: 2.0"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.5"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	Nucleoplasm	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favourable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.2	2.9	0.0	1.2	0.0	0.0	2.3	0.0	0.0	1.6	5.4			0.0	6.7	4.6	0.1	10.4	0.0	0.0	0.0	0.0	5.9	0.0	2.3	0.8	0.0		0.0	0.0	0.5	0.0	0.0		2.5	1.5		0.0	2.2	1.0	3.2	4.2	1.4	1.0	0.0	1.2	0.0			0.0		0.0	4.3	1.3	0.1	0.5	5.9	0.1	2.0	0.2	0.0	0.5	0.9	0.0	28.6	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.6	3.3	0.6	1.0	0.2	1.3	0.7	0.0	0.0	0.8	39.0	0.4	0.5	0.3	0.0	0.6	1.0	2.3	0.0	0.0	0.3	1.3	0.2	0.0	0.3	0.3	0.0	0.1	0.0	1.0	3.7	0.0	0.0	2.8	1.8	3.0	0.0	1.3	0.1	0.6	0.3	0.3	0.0	0.0	0.4	1.5	1.0	0.0	0.0	0.6	0.0	2.8	2.8	5.9	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0										
IL5RA	"CD125, CDw125, IL5R"	ENSG00000091181	"Interleukin 5 receptor subunit alpha"	Q01344	3	3066326-3126613	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 70.1;fallopian tube: 18.6"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 41.0"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	196	"basophil: 31.4;eosinophil: 70.1"	"Lineage enriched"	"Detected in single"	308	"granulocytes: 70.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	92000	92000				"unprognostic (1.38e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-4)"	"unprognostic (4.32e-3)"	"unprognostic (3.08e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.93e-2)"	0.5	0.2	6.7	0.6	6.2	0.7	1.3	0.2	0.3	1.8	0.9	1.8	0.0	2.2	0.6	8.2	0.6	18.6	2.0	2.4	2.3	2.1	0.6	1.3	7.9	1.2	0.1	0.0	3.8	0.5	0.1	7.5	0.1	11.8	2.6	1.4	0.5	2.2	0.1	0.3	0.4	2.1	0.6	0.6	4.6	1.3	1.6	0.7	1.1	0.4	1.1	1.9	4.2	0.4	0.1	0.0	70.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.4	0.0	70.1	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	6.7	6.2	0.2	0.3	2.3	2.1	0.1	0.0	11.8	0.7
IQCD	"CFAP84, DRC10"	ENSG00000166578	"IQ motif containing D"	Q96DY2	12	113195441-113221094	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.4;testis: 33.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.3;CAPAN-2: 8.6;RPTEC TERT1: 11.0;U-698: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.6;classical monocyte: 2.8;myeloid DC: 2.1;plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 3.6;monocytes: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046810, HPA048782"	Supported		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046810: AB_2679818, HPA048782: AB_2680519"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.26e-5)"	"unprognostic (2.23e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.04e-1)"	"prognostic favourable (3.90e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.20e-2)"	1.2	1.2	2.8	1.3	6.4	0.6	1.8	2.0	3.8	2.6	1.1	6.8	1.7	0.6	2.3	6.3	1.8	22.4	1.4	1.6	3.8	3.2	3.4	0.6	3.0	1.3	4.8	1.5	2.5	1.4	5.4	8.7	1.2	11.4	1.1	1.2	1.6	1.2	1.7	0.7	0.9	0.7	1.4	2.5	0.6	1.0	33.8	6.4	0.0	4.0	1.1	3.3	1.6	1.0	0.6	3.7	3.6	2.8	0.0	0.1	0.5	2.7	3.2	1.1	0.8	1.2	1.3	0.7	0.4	22.3	1.1	1.5	0.5	8.6	3.0	2.4	0.6	0.5	0.5	0.9	1.8	0.2	0.9	1.0	1.1	0.5	0.7	0.3	0.7	0.5	0.6	3.5	1.1	0.7	0.2	0.2	0.2	3.1	0.2	5.8	0.2	0.8	0.2	0.5	0.8	11.0	3.4	2.5	1.0	0.7	1.1	3.5	4.0	1.7	0.3	0.5	1.7	1.1	0.6	0.9	0.7	12.0	1.6	0.1	1.9	3.6	2.8	0.0	0.1	0.2	0.0	0.6	0.0	0.0	2.1	0.2	0.0	0.1	0.1	0.0	0.0	3.7	0.0	0.5	2.8	6.4	2.0	3.8	3.8	3.2	4.8	1.5	11.4	6.4
IQCG	"CFAP122, DKFZp434B227, DRC9"	ENSG00000114473	"IQ motif containing G"	Q9H095	3	197889075-197960142	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 44.9;testis: 34.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042787, HPA051981"	Enhanced		Approved	"Actin filaments,Cytosol"				"Actin filaments"	"Actin filaments"	"HPA042787: , HPA051981: AB_2732572"	"unprognostic (1.50e-2)"	"unprognostic (6.20e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.75e-2)"	6.2	5.0	10.9	3.0	14.6	3.0	5.4	3.6	7.6	5.7	3.0	12.3	4.1	2.5	4.5	11.6	3.9	44.9	4.4	4.2	12.6	12.9	5.9	3.6	8.0	3.9	9.0	5.7	5.0	2.1	4.5	12.0	3.4	20.8	3.9	3.7	5.3	2.5	4.6	2.0	2.8	2.6	4.1	9.2	3.1	3.4	34.2	11.2	1.4	7.4	1.0	3.9	4.5	2.2	8.9	7.3	8.9	8.4	6.6	9.1	5.0	3.8	4.2	5.5	5.3	11.9	12.2	2.2	4.7	5.2	5.5	5.8	0.8	3.7	1.3	5.3	3.8	3.6	3.9	3.6	9.1	2.9	2.7	2.3	2.2	2.0	2.7	3.1	3.7	6.2	4.6	6.0	2.0	2.6	2.4	5.2	4.2	8.8	1.7	1.5	3.3	5.6	4.9	3.6	1.9	5.4	1.6	4.8	5.8	7.9	3.2	3.2	23.9	2.1	2.7	3.6	2.4	10.8	4.3	4.6	12.9	2.3	13.3	4.4	5.8	4.6	8.4	8.9	8.2	6.4	5.3	8.9	6.9	5.4	7.3	4.2	6.2	9.1	5.8	6.6	5.7	6.5	6.8	5.0	10.9	14.6	3.6	7.6	12.6	12.9	9.0	5.7	20.8	11.2
KCNE1	"ISK, JLNS2, LQT5, minK"	ENSG00000180509	"Potassium voltage-gated channel subfamily E regulatory subunit 1"	P15382	21	34446688-34512275	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 3.0;CACO-2: 9.0;HBF TERT88: 2.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 10.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 6.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.8"																				"unprognostic (8.24e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.30e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	9.3	0.4	0.7	1.3	0.9	1.6	4.8	0.1	0.5	1.8	3.2	2.7	0.0	0.4	0.8	4.0	0.7	17.6	0.4	9.2	1.3	0.8	3.4	4.3	12.0	10.6	1.7	0.0	2.9	0.2	1.0	1.3	3.5	10.6	1.0	0.4	0.5	0.8	0.3	0.2	0.4	0.6	0.7	0.5	7.3	0.5	4.8	0.3	0.2	0.7	0.1	0.3	1.6	14.8	0.0	0.5	6.8	1.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.5	1.1	3.0	1.0	9.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.2	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.1	0.1	1.3	6.8	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.0	0.0	1.5	0.0	0.0	0.4	0.7	0.9	0.1	0.5	1.3	0.8	1.7	0.0	10.6	0.3
KCNRG		ENSG00000198553	"Potassium channel regulator"	Q8N5I3	13	50015254-50020922	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 27.7;ovary: 17.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001027			Uncertain	Vesicles				Vesicles	Vesicles	"HPA001027: "	"unprognostic (1.85e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-2)"	"prognostic favourable (2.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.16e-2)"	0.4	0.2	0.3	0.3	0.3	1.1	0.6	0.9	0.3	1.8	0.3	0.5	0.3	0.3	1.0	4.8	0.6	27.7	0.3	1.0	0.3	0.5	0.6	0.3	9.1	0.3	0.3	0.3	17.1	0.3	0.4	0.4	0.3	0.5	0.5	0.8	0.3	0.3	1.7	0.4	0.8	0.4	0.4	0.3	0.4	0.3	1.7	0.3	0.3	0.4	0.3	0.6	0.3	0.3	2.7	1.2	4.4	1.1	1.3	1.4	0.4	1.0	0.9	3.1	1.0	1.0	1.5	0.5	0.2	2.4	2.0	0.1	3.6	1.0	2.0	0.6	2.9	1.2	2.3	0.8	1.5	1.4	1.5	4.0	1.5	1.6	2.9	3.3	1.1	2.0	2.2	1.5	3.7	3.9	1.6	0.4	2.5	1.2	3.6	3.2	2.1	1.4	2.6	0.0	0.0	1.8	2.6	2.6	5.6	1.1	1.9	1.8	1.5	1.1	1.3	1.8	0.8	1.1	0.8	0.2	0.5	2.1	0.6	1.3	0.4	3.2	1.1	0.7	0.5	1.1	0.7	1.5	0.7	1.0	0.9	2.7	0.8	0.9	4.4	1.3	0.8	1.2	1.4	0.4	0.3	0.3	0.9	0.3	0.3	0.5	0.3	0.3	0.5	0.3
KIAA2012		ENSG00000182329	KIAA2012	Q0VF49	2	202073289-202205203	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.0;fallopian tube: 19.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;BJ hTERT+: 1.2;CAPAN-2: 1.8;SCLC-21H: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077834	Enhanced									"HPA077834: "	"unprognostic (1.91e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.94e-5)"	"unprognostic (1.60e-1)"	"unprognostic (9.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (9.95e-3)"	0.3	0.5	6.2	0.4	10.0	0.3	0.4	0.6	8.4	1.2	0.4	5.1	0.0	0.5	0.5	2.5	0.4	19.2	0.4	0.4	6.7	3.5	0.4	2.5	2.0	0.4	0.2	4.4	3.8	0.4	0.3	2.8	0.4	6.5	0.4	0.5	0.0	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.4	2.6	1.0	0.0	0.4	0.0	0.3	0.4	0.1	0.6	0.5	0.9	0.6	0.5	0.8	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.7	1.2	0.1	0.0	0.4	1.8	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.1	0.9	0.3	0.6	0.2	0.2	0.5	0.5	0.2	0.6	0.8	0.4	0.3	0.5	0.5	0.5	0.0	0.0	6.2	10.0	0.6	8.4	6.7	3.5	0.2	4.4	6.5	1.0
KIF19	"FLJ37300, KIF19A"	ENSG00000196169	"Kinesin family member 19"	Q2TAC6	17	74326210-74355820	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;fallopian tube: 25.2"	"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 5.5"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043638, HPA073303"	Enhanced		Approved	"Plasma membrane,Actin filaments,Centrosome"				"Plasma membrane"	"Plasma membrane"	"HPA043638: , HPA073303: AB_2686593"	"unprognostic (1.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-9)"	"unprognostic (5.16e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.53e-1)"	1.6	0.9	9.3	1.6	29.5	1.1	1.1	25.8	14.1	2.1	3.1	17.4	0.0	6.6	1.1	1.1	1.1	25.2	1.6	1.1	11.9	6.6	0.9	1.6	3.1	1.0	25.0	4.2	1.1	3.0	0.9	0.3	0.8	6.5	0.9	2.1	0.8	2.5	1.3	1.0	0.8	5.2	1.6	6.2	11.6	2.2	1.2	29.9	0.0	2.3	0.0	1.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	9.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.9	1.6	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	9.3	29.5	25.8	14.1	11.9	6.6	25.0	4.2	6.5	29.9
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439770-71586310	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 15.8;SH-SY5Y: 46.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.1"	"Region enriched"	"Detected in some"	8	"olfactory region: 41.8"	"Low region specificity"	"Detected in many"			HPA012530	Approved									"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favourable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	2.3	2.2	3.5	0.8	18.1	0.4	2.1	0.9	9.5	2.2	4.2	24.5	0.0	6.1	4.9	1.7	0.6	19.9	0.8	0.8	5.0	3.4	0.9	1.4	1.4	0.4	32.3	5.1	1.5	0.6	1.0	2.0	21.6	10.8	1.8	4.6	0.9	3.1	9.0	26.6	4.0	6.5	0.7	15.0	0.6	2.9	0.7	25.7	0.0	0.9	0.9	2.1	0.7	1.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.4	15.8	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	1.0	0.0	0.0	0.0	6.3	0.1	46.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	18.1	0.9	9.5	5.0	3.4	32.3	5.1	10.8	25.7
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.4;RT4: 6.6;SH-SY5Y: 6.7;U-2197: 23.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA038640: AB_2676127"				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.3	4.3	0.7	6.7	0.4	1.1	3.3	1.6	1.4	3.9	7.1	0.0	1.5	0.8	6.0	0.3	19.0	0.9	0.5	8.5	2.8	0.8	0.2	4.1	0.4	1.1	3.0	4.0	0.7	0.1	21.3	0.3	13.4	0.4	3.8	1.3	0.2	0.3	0.2	0.6	0.6	1.2	4.1	0.6	0.6	15.0	6.5	0.0	1.1	0.0	0.2	0.4	0.3	2.6	2.2	2.7	0.9	0.7	1.6	0.6	0.3	0.3	0.1	0.2	0.2	1.5	2.3	3.1	5.4	1.2	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.9	0.1	0.9	0.8	1.9	0.3	0.1	0.1	0.5	0.2	1.6	0.4	0.1	1.9	0.3	0.0	0.4	0.0	0.3	1.6	0.5	0.4	0.2	0.2	0.2	6.6	0.1	6.7	0.2	0.4	3.8	0.3	1.5	0.3	0.2	0.9	23.5	0.2	0.8	1.3	1.6	0.3	1.5	2.5	1.9	0.9	0.6	1.4	0.3	0.5	2.1	1.0	1.3	0.4	2.6	1.4	1.6	2.7	0.7	0.4	2.2	0.5	0.6	4.3	6.7	3.3	1.6	8.5	2.8	1.1	3.0	13.4	6.5
LPAR3	"Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3"	ENSG00000171517	"Lysophosphatidic acid receptor 3"	Q9UBY5	1	84811602-84893213	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 32.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 13.0;HBEC3-KT: 16.0;hTCEpi: 17.2;NTERA-2: 14.5;PC-3: 16.2;SK-MEL-30: 15.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 24.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"olfactory region: 3.5"	"Low region specificity"	"Detected in many"			HPA013421			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA013421: AB_1847990"	"unprognostic (2.85e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (4.31e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.13e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	0.0	1.2	2.4	0.5	1.9	0.3	0.7	0.2	3.5	8.8	0.4	2.2	2.9	0.1	2.4	11.8	7.2	32.0	0.5	12.4	3.7	0.9	0.0	0.1	4.2	0.1	0.1	2.6	5.1	8.6	0.3	0.4	1.1	6.8	11.5	0.5	0.7	5.0	4.7	0.3	4.0	0.5	0.5	0.3	0.1	0.2	14.7	0.2	0.7	0.2	3.3	4.3	4.8	6.9	0.6	0.4	1.1	0.1	1.8	0.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.2	1.2	1.1	0.8	0.0	0.0	0.0	0.2	0.0	0.2	13.0	16.0	1.0	0.1	2.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	17.2	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	16.2	0.0	0.0	0.0	0.0	3.7	0.9	0.7	0.0	0.3	15.3	0.0	1.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.2	0.3	0.0	0.2	0.4	0.5	0.5	0.3	0.6	0.4	0.3	1.1	1.8	0.1	0.4	0.1	0.1	2.4	1.9	0.2	3.5	3.7	0.9	0.1	2.6	6.8	0.2
LRRC18	"MGC34773, UNQ933, UNQ9338, VKGE9338"	ENSG00000165383	"Leucine rich repeat containing 18"	Q8N456	10	48909483-48914232	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 9.1;testis: 15.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.4;HDLM-2: 1.5;HL-60: 2.2;NB-4: 3.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"					"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.4;naive B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039256	Enhanced									"HPA039256: AB_10671873"	"unprognostic (1.31e-2)"		"unprognostic (3.66e-2)"	"unprognostic (9.83e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.98e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.16e-2)"		"unprognostic (8.57e-3)"	"unprognostic (4.08e-1)"		"unprognostic (1.13e-1)"	0.0	0.0	0.3	0.2	0.7	0.2	0.2	0.0	0.0	0.6	0.2			0.1	0.0	0.0	0.2	9.1	0.1	0.2	0.8	0.9	0.0	0.0	3.1	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.6		0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.0	0.0	15.5			0.0		0.0	0.3	0.0	1.4	0.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.5	0.1	1.4	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.0	0.4	0.2	0.0	0.0	2.2	0.6	0.5	0.5	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.1	3.8	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.2	0.1	0.4	0.0	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	1.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0										
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793428-169812986	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 13.7;testis: 23.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.5;HEL: 9.4;HL-60: 9.9;NTERA-2: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	7	"B-cells: 2.2;dendritic cells: 4.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules"				"Cell Junctions, Microtubules"	"Cell Junctions, Microtubules"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	2.8	1.1	4.8	1.2	9.6	2.7	2.3	1.1	4.0	2.3	0.9	4.2	1.4	1.0	1.9	3.9	1.0	13.7	1.1	2.0	4.1	3.8	2.1	0.9	3.4	1.9	3.5	5.6	2.2	0.5	1.0	7.9	0.9	11.8	2.0	0.7	2.6	1.3	2.4	0.9	1.0	1.1	2.0	3.6	1.8	1.1	23.8	4.8	1.7	2.7	0.5	1.2	1.0	0.9	2.2	4.6	0.1	0.3	0.0	0.5	0.4	2.7	0.4	0.8	0.0	1.1	4.1	0.0	1.2	2.4	2.8	2.7	0.1	0.0	1.6	0.0	0.7	0.0	2.5	0.0	1.0	0.4	7.5	9.4	0.1	0.0	0.7	9.9	2.5	1.4	0.5	1.1	0.0	1.8	0.2	0.0	1.1	0.0	0.9	2.0	10.0	3.1	4.9	0.0	0.5	2.3	0.2	4.9	3.8	0.8	0.1	0.0	0.0	4.8	0.4	0.6	0.0	0.3	0.0	0.0	0.0	2.3	4.5	0.1	2.7	0.0	0.2	0.0	0.0	0.3	0.2	2.2	0.0	0.0	1.4	1.5	0.0	0.0	0.1	0.0	0.0	4.6	0.5	0.4	4.8	9.6	1.1	4.0	4.1	3.8	3.5	5.6	11.8	4.8
LRRC43	MGC35140	ENSG00000158113	"Leucine rich repeat containing 43"	Q8N309	12	122167738-122203471	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 2.8;HSkMC: 3.2;HUVEC TERT2: 6.4;SCLC-21H: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA039425			Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA039425: AB_2676501"	"unprognostic (6.42e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.03e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.21e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.49e-1)"	0.9	0.9	3.0	0.3	5.0	0.8	0.7	1.2	4.6	1.5	0.7	4.1	1.3	1.0	1.4	6.6	0.4	26.6	1.6	1.5	4.5	3.0	3.1	0.5	2.5	0.4	3.1	1.5	3.3	1.2	3.5	3.4	0.5	6.4	1.3	0.5	2.9	1.8	2.2	0.4	0.8	0.5	0.6	1.0	0.8	0.7	10.8	1.8	0.0	2.5	0.0	0.4	0.7	0.3	0.0	0.9	0.0	0.6	2.9	1.9	0.8	0.0	0.0	0.3	0.0	0.3	0.7	0.4	0.0	1.8	0.5	0.5	0.6	0.1	0.0	1.3	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	2.8	0.1	0.6	3.2	0.0	1.0	0.0	6.4	0.0	0.0	1.2	0.0	0.0	1.3	0.0	0.3	0.1	0.0	0.1	0.0	0.3	5.2	1.1	0.0	0.2	0.3	0.8	1.6	0.5	0.0	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.8	0.0	0.0	1.9	0.0	2.9	0.6	0.9	0.0	0.8	3.0	5.0	1.2	4.6	4.5	3.0	3.1	1.5	6.4	1.8
LRRC6	"CILD19, LRTP, TSLRP"	ENSG00000129295	"Leucine rich repeat containing 6"	Q86X45	8	132571953-132675617	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.9;testis: 27.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 7.7;CAPAN-2: 8.4;RPTEC TERT1: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028058	Approved									"HPA028058: AB_1853337"	"unprognostic (1.53e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.42e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (5.98e-4)"	"unprognostic (4.17e-2)"	3.1	4.2	7.8	2.4	18.2	4.2	3.6	2.0	10.6	6.5	2.7	4.5	2.4	1.5	4.2	8.2	1.6	22.9	4.6	2.1	6.5	7.3	14.0	1.8	4.2	1.3	3.7	8.1	4.6	2.9	7.8	10.6	2.4	17.6	2.0	2.2	5.4	1.9	3.2	0.8	1.9	3.3	3.3	3.8	3.6	1.4	27.6	4.1	0.4	8.0	0.0	1.1	3.9	2.1	0.2	0.7	6.3	0.5	0.0	0.6	0.7	0.4	2.4	3.5	0.0	3.1	5.0	7.7	0.3	0.5	1.7	1.6	0.4	8.4	0.0	2.5	3.2	0.0	0.6	1.1	1.7	0.3	0.0	0.0	0.6	0.1	1.3	0.0	3.8	4.3	2.1	3.8	0.1	0.8	0.3	0.0	2.2	2.7	0.0	0.1	5.6	2.1	0.0	0.1	1.1	15.9	0.0	1.8	2.7	0.3	0.0	0.4	0.9	0.5	0.0	2.0	7.4	6.3	0.7	0.0	0.9	0.1	5.4	0.4	0.2	1.3	0.5	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.7	0.0	0.7	7.8	18.2	2.0	10.6	6.5	7.3	3.7	8.1	17.6	4.1
LRRC71	"C1orf92, FLJ32884"	ENSG00000160838	"Leucine rich repeat containing 71"	Q8N4P6	1	156920650-156933094	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.5;fallopian tube: 16.9;testis: 26.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.2;PC-3: 3.7;TIME: 3.3;U-2 OS: 1.6"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (8.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-3)"	"unprognostic (5.43e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.18e-1)"	"unprognostic (1.68e-7)"	"unprognostic (2.29e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	0.3	0.8	1.1	0.1	4.0	0.1	0.1	0.0	0.3	1.1	0.1	5.6	0.0	0.1	0.5	5.6	0.1	16.9	0.1	0.1	1.7	1.8	0.1	0.1	3.0	0.1	0.2	0.4	3.6	0.1	0.1	0.0	0.3	9.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	26.4	1.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	4.0	0.0	0.3	1.7	1.8	0.2	0.4	9.5	1.2
LRRC74B		ENSG00000187905	"Leucine rich repeat containing 74B"	Q6ZQY2	22	21045960-21064168	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 17.1;epididymis: 5.6;fallopian tube: 11.4"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.6;U-87 MG: 3.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049947	Uncertain									"HPA049947: AB_2680966"	"unprognostic (3.43e-2)"	"unprognostic (1.76e-1)"		"unprognostic (3.28e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.44e-3)"		"unprognostic (2.23e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.57e-9)"	"unprognostic (4.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.92e-2)"	0.2	0.2	2.1	0.2	2.3	0.2	0.2	0.4	1.6	1.5	0.2	3.7	0.0	0.4	0.3	5.6	0.2	11.4	0.2	0.2	1.5	1.2	0.2	0.2	1.9	0.2	0.1	0.7	1.9	0.2	0.2	0.9	0.2	17.1	0.2	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.3	0.4	1.6	1.5	1.2	0.1	0.7	17.1	0.3
LRTOMT	"CFAP111, COMT2, DFNB63, LRRC51"	ENSG00000184154	"Leucine rich transmembrane and O-methyltransferase domain containing"	"Q8WZ04, Q96E66"	11	72080331-72110782	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 49.8;testis: 47.8"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA039949	Approved		Uncertain	Microtubules				Microtubules	Microtubules	"HPA039949: AB_10960708"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.85e-2)"	"prognostic favourable (7.70e-4)"	"unprognostic (8.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.22e-2)"	"prognostic favourable (5.36e-4)"	"unprognostic (6.12e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	3.5	3.7	10.6	2.0	11.1	2.1	7.1	3.7	8.9	7.1	4.2	14.0	6.1	3.2	6.0	13.6	3.5	49.8	5.3	2.6	8.8	7.6	9.0	6.2	6.2	2.6	7.7	8.5	8.5	7.0	7.1	8.9	4.4	10.6	7.5	6.2	7.3	4.3	4.7	5.2	4.5	2.5	4.8	7.7	3.2	3.6	47.8	8.9	3.1	9.3	2.4	3.5	3.5	2.6	4.3	4.2	9.2	2.9	10.1	6.2	2.0	2.6	9.8	6.2	5.0	5.4	4.8	1.5	3.1	2.5	2.8	2.5	4.7	14.3	3.4	4.8	5.3	5.3	4.4	7.5	3.2	6.4	4.3	2.5	4.5	3.3	0.9	2.0	2.7	2.1	3.8	4.3	3.3	1.0	2.7	5.3	4.1	9.4	6.0	4.0	3.1	2.6	7.3	6.3	5.2	11.0	3.2	5.8	4.5	6.1	14.1	7.5	27.8	2.4	4.7	3.0	4.2	8.0	2.1	5.7	6.2	4.0	2.9	1.7	3.3	2.3	2.9	5.0	3.1	2.8	3.2	4.2	3.3	2.6	1.7	4.3	3.0	3.0	9.2	10.1	1.8	4.2	6.2	2.0	10.6	11.1	3.7	8.9	8.8	7.6	7.7	8.5	10.6	8.9
LYPD1	"LYPDC1, MGC29643"	ENSG00000150551	"LY6/PLAUR domain containing 1"	Q8N2G4	2	132644853-132671579	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;fallopian tube: 74.6"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 17.1;HUVEC TERT2: 14.5;SK-MEL-30: 14.9;U-251 MG: 31.1;WM-115: 62.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 57.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 10.9"	"Lineage enriched"	"Detected in single"	36	"granulocytes: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"						"unprognostic (9.25e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.40e-3)"	"unprognostic (5.60e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	1.5	2.5	16.4	1.7	27.8	1.2	1.4	3.8	16.8	1.3	2.5	4.6	0.0	1.4	2.5	1.8	1.4	74.6	3.6	1.8	18.9	19.0	3.2	1.6	1.4	3.5	16.9	5.4	8.4	3.5	2.0	12.4	1.2	11.8	1.4	1.4	5.4	21.7	1.4	1.2	1.5	1.4	1.8	7.0	1.3	1.4	1.5	3.4	1.2	1.3	1.1	2.5	1.4	0.0	0.3	0.0	10.9	0.0	0.0	0.0	0.0	0.2	4.7	5.3	0.0	0.0	0.0	0.0	1.0	0.6	2.4	0.5	0.4	0.6	0.0	9.9	1.9	5.1	0.0	0.0	1.2	0.0	1.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	14.5	0.0	0.0	0.0	0.3	0.0	0.0	5.2	2.0	0.0	0.0	0.0	7.0	0.1	0.7	1.2	0.6	0.0	14.9	0.0	0.1	0.7	0.3	7.4	3.1	31.1	0.0	0.0	0.0	6.1	0.0	62.7	1.3	0.0	10.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	27.8	3.8	11.0	18.9	19.0	16.9	5.4	11.8	3.4
MAP3K19	"FLJ23074, RCK, YSK4"	ENSG00000176601	"Mitogen-activated protein kinase kinase kinase 19"	Q56UN5	2	134964491-135047468	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 18.3;fallopian tube: 23.9"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 4.0;U-266/70: 2.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.3"	"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 20.2"	HPA011388			Uncertain	Cytosol				Cytosol	Cytosol	"HPA011388: "	"unprognostic (7.12e-3)"	"unprognostic (6.55e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.83e-4)"	0.1	0.2	1.7	0.2	6.2	0.1	0.1	0.0	0.5	1.1	0.2	7.3	0.0	0.2	1.0	6.7	0.2	23.9	0.1	0.1	2.9	3.8	0.2	0.2	5.6	0.2	0.5	1.5	7.3	0.1	0.1	1.0	0.1	18.3	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	7.6	3.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	4.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.7	6.2	0.0	0.5	2.9	3.8	0.5	1.5	18.3	3.1
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716259-143722458	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;epididymis: 27.6;fallopian tube: 29.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;HeLa: 14.0;MCF7: 13.6;T-47d: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA002704: "	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2.0	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3.0	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.7	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	7.1	0.0	1.3	0.0	5.3	0.0	0.2	0.0	1.1	1.6	0.0	14.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	13.6	0.0	0.0	2.0	1.1	0.0	2.9	0.3	0.9	1.3	3.9	3.9	0.0	2.8	0.0	12.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4
MC4R		ENSG00000166603	"Melanocortin 4 receptor"	P32245	18	60371110-60372775	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.8;fallopian tube: 10.3"	"Cell line enriched"	"Detected in single"	69	"fHDF/TERT166: 45.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016719	Uncertain									"HPA016719: AB_1853617"	"unprognostic (2.29e-1)"			"unprognostic (5.31e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.41e-1)"		"unprognostic (1.35e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.59e-1)"		0.4	1.1	4.0	0.3	9.8	0.2	0.9	0.7	6.4	0.5	0.5	0.3	0.0	0.6	0.4	1.3	0.4	10.3	0.4	0.4	3.0	7.8	0.4	0.2	0.3	0.4	1.1	7.6	0.6	0.2	0.2	0.3	0.2	3.3	0.4	0.5	0.1	2.5	0.5	0.2	0.3	0.4	0.2	0.8	0.8	0.6	0.6	5.1	0.0	0.2	0.0	1.4	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.8	0.7	6.4	3.0	7.8	1.1	7.6	3.3	5.1
MDH1B	"FLJ25341, RP11-95H11"	ENSG00000138400	"Malate dehydrogenase 1B"	Q5I0G3	2	206737763-206765547	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.7;testis: 27.6"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.1;SCLC-21H: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073761	Approved									"HPA073761: AB_2732241"	"unprognostic (1.03e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-2)"	"unprognostic (7.84e-3)"	"unprognostic (3.01e-1)"	0.9	2.3	3.1	0.7	9.0	0.6	1.9	1.5	5.7	2.0	1.1	5.0	3.6	0.5	2.5	6.6	1.1	26.7	1.5	1.9	3.4	4.2	4.2	0.6	3.6	0.8	2.4	3.5	4.5	1.1	6.3	15.1	0.5	9.5	1.3	1.1	2.8	1.7	2.2	0.9	1.0	0.6	1.5	1.6	0.6	1.1	27.6	1.8	0.1	5.2	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.7	2.3	1.7	4.9	0.3	2.3	0.7	0.0	0.8	1.0	0.7	0.2	1.6	1.0	1.1	0.2	1.1	0.1	1.4	1.0	0.1	0.1	0.5	0.4	1.5	1.1	0.8	2.5	1.4	0.4	0.1	0.3	1.4	0.1	1.4	0.7	2.9	1.5	0.6	3.1	2.8	3.1	1.8	0.1	7.1	0.3	6.7	1.4	2.1	1.1	0.6	2.1	0.0	0.1	1.2	1.2	0.3	0.6	0.7	2.9	0.4	2.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	3.1	9.0	1.5	5.7	3.4	4.2	2.4	3.5	9.5	1.8
MEIG1	"bA2K17.3, SPATA39"	ENSG00000197889	"Meiosis/spermiogenesis associated 1"	Q5JSS6	10	14959439-14988050	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 9.6;testis: 18.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.5;SK-MEL-30: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"														"unprognostic (1.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.75e-6)"	"unprognostic (6.89e-2)"	"unprognostic (1.36e-5)"	"unprognostic (2.97e-1)"	"unprognostic (3.74e-3)"	"unprognostic (8.40e-3)"	"unprognostic (3.15e-1)"	0.7	0.7	2.9	0.3	3.1	0.4	0.6	2.9	4.3	0.8	0.6	1.3	0.0	0.3	0.6	1.0	0.3	9.6	0.4	0.3	3.5	1.9	0.8	0.7	1.4	0.8	3.3	1.5	0.9	0.9	0.7	4.5	0.7	3.8	0.6	0.7	0.5	0.8	0.7	0.3	0.5	0.7	0.4	1.3	0.8	0.4	18.9	2.1	1.8	0.4	0.0	0.7	0.3	0.2	3.8	0.5	0.0	1.3	1.6	2.1	0.1	1.5	1.3	2.3	1.1	0.7	0.4	0.0	0.4	0.6	0.9	0.9	0.0	2.2	0.5	0.0	0.4	0.1	1.5	0.3	0.3	9.5	0.4	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.0	1.3	0.0	0.7	0.5	0.9	1.1	2.1	0.3	0.1	1.3	1.7	2.2	0.3	0.8	1.0	0.0	1.5	3.3	0.4	0.2	5.7	1.1	0.2	0.0	0.1	0.0	0.6	0.0	3.8	3.0	3.0	1.2	1.5	0.0	0.0	0.4	0.0	0.4	0.0	1.0	3.8	0.7	0.4	0.5	0.6	0.3	0.2	0.0	1.6	1.3	0.1	2.1	0.1	2.9	3.1	2.9	4.3	3.5	1.9	3.3	1.5	3.8	2.1
MROH9	"ARMC11, C1orf129, FLJ23550"	ENSG00000117501	"Maestro heat like repeat family member 9"	Q5TGP6	1	170935471-171064765	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 7.1;testis: 4.7"	"Cell line enhanced"	"Detected in some"		"BJ: 1.2;BJ hTERT+: 1.0;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;Daudi: 2.2;SK-MEL-30: 2.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"pons and medulla: 1.9"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.16e-1)"	"unprognostic (1.04e-1)"		"unprognostic (7.94e-3)"	"unprognostic (3.67e-2)"	"unprognostic (9.73e-2)"		"unprognostic (7.62e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.07e-5)"		"unprognostic (3.66e-8)"	"unprognostic (5.96e-2)"				0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	7.1	0.1	0.1	0.1	0.0	0.1	0.1	2.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	1.0	0.7	1.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.9	0.1
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760762-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 85.5;lung: 88.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 102.3;EFO-21: 15.8;HeLa: 31.2;hTCEpi: 22.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.0"	"Group enriched"	"Detected in many"	59	"dendritic cells: 9.0;monocytes: 2.6"	"Low region specificity"	"Detected in many"							"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	14000000	14000000	Vesicles	Vesicles	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favourable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	36.5	0.0	0.4	6.7	0.5	0.7	0.3	0.1	0.4	5.4	5.4	0.8	26.8	2.1	4.8	18.9	3.1	85.5	9.6	4.3	0.4	0.3	2.6	0.2	88.5	0.4	0.6	0.0	22.3	0.4	0.0	0.6	13.7	0.9	1.9	1.2	0.2	14.4	33.1	0.0	0.5	0.7	1.0	0.8	0.1	3.7	2.1	0.0	0.1	0.1	0.6	7.8	1.4	1.3	0.0	9.0	0.0	2.6	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.5	1.8	0.4	1.4	102.3	0.0	15.8	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	31.2	1.1	0.9	0.0	0.0	0.0	22.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.4	0.5	0.1	0.4	0.4	0.3	0.6	0.0	0.9	0.0
MYOCOS		ENSG00000283683	"Myocilin opposite strand"	A0A1B0GUC4	1	171600621-171638799	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;epididymis: 4.8;fallopian tube: 3.9"	"Cell line enriched"	"Detected in some"	6	"HEL: 24.0"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.0	0.0		0.0		0.1	0.0		0.0	8.1	0.0			0.0	1.3	4.8	0.0	3.9	0.0	0.0			1.1	0.0	0.0	0.0			0.0	0.4	0.0		0.1		0.0	0.0		0.0	0.8	0.1	0.0	0.0	0.0		0.0	0.1	1.1			0.8		0.0	0.3		0.9	0.6	1.6	0.3	0.1	1.3	0.0	0.0	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	24.0	0.4	0.4	0.1	0.0	2.7	0.0	0.1	0.0	0.0	0.0	4.2	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.9	1.8	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.2	0.3	0.2	1.0	0.9	0.4	1.1	0.1	0.9	0.5	0.4	1.6	0.1	0.0	0.6	1.3	0.0										
NEK11	FLJ23495	ENSG00000114670	"NIMA related kinase 11"	Q8NG66	3	131026850-131350465	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016908	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA016908: AB_1854364"	"unprognostic (9.15e-3)"	"prognostic favourable (7.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"prognostic favourable (5.92e-6)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	3.9	5.8	9.3	2.7	11.1	0.5	8.7	2.7	7.6	7.3	2.8	11.2	8.4	2.0	6.5	16.0	3.2	26.9	6.0	2.9	9.1	10.0	8.2	1.1	5.5	1.7	7.8	5.4	8.7	2.8	5.0	9.3	4.6	17.3	4.0	3.3	3.0	3.8	6.7	1.7	2.8	2.6	4.3	7.3	1.8	2.3	17.8	5.5	0.2	12.3	2.5	1.7	4.2	3.0	0.9	1.0	1.1	1.3	0.3	2.9	0.3	5.8	2.4	1.7	5.1	6.9	10.4	1.0	2.9	5.4	4.4	3.4	2.2	8.2	0.3	2.1	5.1	3.2	0.5	5.0	6.2	0.5	0.7	0.8	0.4	1.0	2.3	0.6	1.5	4.3	8.4	4.7	2.1	0.9	0.2	0.9	7.4	4.1	0.1	0.5	0.5	2.3	0.0	0.2	0.1	10.1	2.3	2.2	2.4	1.4	0.1	1.9	4.8	0.1	0.9	4.6	2.2	3.6	1.3	1.3	2.3	0.1	3.2	0.2	0.8	0.0	0.3	1.1	0.6	1.3	1.2	0.9	2.9	2.6	0.5	0.6	1.0	0.8	0.9	0.3	0.9	1.0	1.5	0.3	9.3	11.1	2.7	7.6	9.1	10.0	7.8	5.4	17.3	5.5
NEK5		ENSG00000197168	"NIMA related kinase 5"	Q6P3R8	13	52033611-52129078	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 11.8;fallopian tube: 12.7;testis: 15.7"	"Cell line enhanced"	"Detected in some"		"T-47d: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035565, HPA041399"	Enhanced									"HPA035565: AB_10672095, HPA041399: AB_2677453"	"unprognostic (4.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.57e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (9.44e-3)"	0.6	0.3	3.2	1.4	3.2	0.7	0.9	0.4	2.6	0.9	0.4	5.4	0.3	0.5	2.5	3.0	0.4	12.7	0.5	1.3	3.2	1.6	0.9	0.3	4.9	0.5	0.7	1.3	2.8	0.5	0.9	5.3	0.8	11.8	1.5	0.4	0.3	0.5	0.3	0.6	0.5	0.4	0.5	0.9	0.4	0.3	15.7	2.1	0.0	0.7	0.0	0.3	0.4	0.4	0.9	1.1	2.5	0.5	0.6	0.4	0.0	0.5	0.6	0.4	2.2	0.3	1.4	2.8	0.0	0.0	0.0	0.3	0.2	1.4	0.7	0.2	0.0	0.5	0.3	0.5	0.1	0.2	0.4	0.8	0.8	0.5	0.4	1.4	1.7	0.4	1.1	0.2	0.8	0.3	1.5	1.0	0.0	1.7	0.7	1.1	0.6	0.8	0.3	0.2	0.0	2.4	0.6	0.8	1.1	0.5	0.0	1.2	4.2	1.7	0.6	0.2	0.3	0.2	0.3	0.4	0.2	0.4	0.1	0.3	0.4	2.5	0.5	0.1	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.9	0.3	0.3	0.9	0.6	0.1	1.1	0.2	0.0	3.2	3.2	0.4	2.6	3.2	1.6	0.7	1.3	11.8	2.1
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;brain: 73.3;fallopian tube: 35.1"	"Cell line enhanced"	"Detected in some"		"AF22: 40.9;NTERA-2: 16.1;SCLC-21H: 29.7;U-266/70: 10.9;U-266/84: 10.8;U-698: 14.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8"	"Lineage enriched"	"Detected in many"	11	"T-cells: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	4700000	4700000	Vesicles	Vesicles	"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favourable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	2.0	10.5	22.4	6.1	24.8	4.2	1.6	15.7	73.3	14.9	2.9	3.6	0.0	15.3	1.9	0.8	1.3	35.1	1.7	0.8	40.2	20.4	1.2	1.1	3.4	11.2	6.6	27.0	1.0	1.1	0.6	18.4	0.8	7.5	18.8	1.8	9.3	1.5	1.8	0.7	5.0	8.6	2.2	2.6	3.8	2.1	2.2	2.4	0.4	4.4	0.0	9.1	2.3	2.0	0.0	0.0	0.1	0.0	3.3	36.8	8.5	0.1	0.0	40.9	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.1	4.9	0.0	0.1	9.7	0.0	0.0	0.0	10.6	0.1	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	16.1	5.3	0.0	4.9	0.0	0.0	0.0	29.7	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.1	1.5	0.0	0.7	10.9	10.8	14.7	0.1	0.1	0.2	0.0	0.0	0.0	1.6	0.0	8.5	0.0	10.3	18.1	0.0	0.0	24.5	36.8	0.1	3.3	0.0	0.0	0.1	8.5	22.4	24.8	15.7	50.4	40.2	20.4	6.6	27.0	7.5	2.4
NHLRC4		ENSG00000257108	"NHL repeat containing 4"	P0CG21	16	566996-569495	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 17.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.5;HMC-1: 13.6;RPMI-8226: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA077301			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA077301: "	"unprognostic (7.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.60e-1)"	1.3	6.9	1.6	1.4	2.3	3.4	1.4	1.4	1.8	2.4	0.9	1.7	9.5	1.4	2.5	21.1	0.7	17.3	1.5	1.8	2.4	2.4	7.0	0.3	4.8	3.8	0.5	0.9	5.1	0.2	5.9	1.4	1.5	2.0	2.2	0.3	2.1	3.1	10.9	2.3	0.3	1.7	0.5	0.8	4.8	0.8	2.8	0.7	7.8	0.4	0.4	1.2	1.3	0.7	1.1	4.4	5.0	0.5	0.7	1.5	0.7	0.0	0.0	0.6	0.1	0.1	0.3	0.1	0.0	0.8	0.2	0.2	0.1	0.2	0.8	0.6	0.1	0.1	0.0	0.1	0.0	2.3	0.2	4.5	0.0	1.0	1.0	0.3	13.6	2.8	0.0	0.1	0.3	0.3	1.4	1.6	0.0	0.0	0.4	3.3	0.3	0.0	3.5	0.0	5.7	0.3	0.2	0.0	1.3	0.0	0.0	0.5	0.6	0.7	0.7	0.0	0.1	0.0	0.0	2.1	1.9	0.9	0.0	0.1	0.3	0.0	0.5	5.0	0.4	0.2	0.7	1.1	1.3	0.6	0.6	0.7	1.5	0.8	0.0	0.7	0.2	4.4	1.4	0.7	1.6	2.3	1.4	1.8	2.4	2.4	0.5	0.9	2.0	0.7
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115172-138139443	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.1;testis: 36.2"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555"	Approved		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA035648: AB_2674719, HPA044555: AB_10960286"	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favourable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favourable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.3	5.2	12.3	0.6	18.4	0.3	3.7	3.5	13.9	7.1	1.2	3.9	4.7	0.5	4.1	18.2	1.0	28.1	6.8	2.9	12.0	10.7	15.4	0.6	3.6	0.6	9.4	9.9	4.5	3.5	12.1	8.9	0.4	13.1	4.2	1.1	4.8	3.1	3.9	0.4	0.4	0.5	2.6	4.2	0.4	2.2	36.2	4.8	0.0	9.6	0.3	0.4	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.6	0.0	0.0	0.0	0.6	0.4	0.6	0.2	0.1	1.5	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	1.8	0.0	0.7	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	25.1	0.0	5.7	2.1	0.0	0.7	3.7	0.4	1.3	0.0	0.6	0.0	0.0	0.8	0.4	0.6	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	18.4	3.5	13.9	12.0	10.7	9.4	9.9	13.1	4.8
NME9	"NM23-H9, TXL-2, TXNDC6"	ENSG00000181322	"NME/NM23 family member 9"	Q86XW9	3	138261437-138329886	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 30.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 5.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040000, HPA043881"	Enhanced									"HPA040000: AB_2676793, HPA043881: AB_2678712"	"unprognostic (2.71e-5)"	"unprognostic (1.68e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.17e-3)"	1.0	1.7	5.3	1.3	11.3	4.4	1.0	6.2	8.3	1.5	0.8	4.1	3.5	1.1	1.6	3.6	0.8	30.4	1.3	0.9	5.6	8.2	1.7	0.8	4.0	1.1	3.6	3.1	2.5	3.3	1.8	7.5	1.1	10.3	1.7	0.8	0.9	3.4	1.9	4.3	1.8	1.1	1.0	3.6	1.2	1.5	6.0	3.9	0.9	2.3	0.0	1.0	0.8	0.5	0.6	0.6	0.3	0.9	0.3	4.2	0.5	1.1	1.7	1.1	0.5	0.0	0.0	1.7	0.7	0.0	0.2	0.1	0.9	2.0	2.5	1.2	0.0	1.3	0.2	0.0	0.0	0.5	1.8	2.1	1.6	0.6	0.0	2.7	5.0	0.9	0.0	0.1	0.0	0.1	0.6	1.4	0.2	0.4	0.6	2.5	0.7	1.3	1.0	0.0	0.7	1.7	2.6	3.7	1.0	1.7	0.6	0.4	0.9	0.1	3.1	0.5	0.8	0.8	0.6	0.9	1.3	1.1	1.0	1.1	0.5	0.1	0.9	0.0	0.5	0.0	4.2	0.2	1.7	0.4	0.3	0.6	2.8	1.2	0.3	0.3	0.2	0.6	0.7	0.5	5.3	11.3	6.2	8.3	5.6	8.2	3.6	3.1	10.3	3.9
NWD1		ENSG00000188039	"NACHT and WD repeat domain containing 1"	Q149M9	19	16719976-16817963	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;fallopian tube: 14.1"	"Group enriched"	"Detected in some"	12	"MCF7: 3.3;U-937: 7.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 9.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.29e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.05e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (2.49e-1)"	"unprognostic (4.20e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.25e-1)"	0.6	0.7	6.9	0.6	8.1	0.8	1.0	0.9	5.9	1.7	0.9	11.3	0.5	0.7	1.1	6.5	0.6	14.1	0.8	0.7	10.9	4.2	1.0	0.7	1.8	0.7	3.9	7.8	0.7	4.3	0.6	1.3	0.7	27.8	10.6	0.9	10.3	2.7	3.9	0.8	0.6	0.7	0.8	2.2	0.6	1.0	1.4	4.6	0.0	1.6	0.0	0.6	0.8	0.5	0.5	0.1	1.3	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.5	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	1.3	0.5	0.0	0.1	0.0	0.1	6.9	8.1	0.9	5.9	10.9	4.2	3.9	7.8	27.8	4.6
NXF3		ENSG00000147206	"Nuclear RNA export factor 3"	Q9H4D5	X	103075810-103093125	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 18.0;gallbladder: 16.4;testis: 50.0"	"Cell line enhanced"	"Detected in some"		"HEL: 16.4;HL-60: 15.5;NB-4: 14.5;THP-1: 11.2;U-2197: 47.7;U-937: 34.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA003132, HPA046757"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003132: AB_1079514, HPA046757: AB_2679789"	"unprognostic (1.20e-3)"	"unprognostic (6.72e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.75e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.86e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-10)"	"unprognostic (1.90e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	1.3	0.5	0.1	0.0	0.3	2.4	0.2	0.1	0.2	0.9	0.3	0.0	1.0	0.2	0.2	8.2	0.6	18.0	16.4	1.1	0.2	0.1	0.7	2.1	5.7	1.3	0.3	0.0	4.4	0.7	0.0	0.1	0.2	0.1	0.3	0.6	0.4	4.2	0.3	0.1	0.1	1.9	0.2	0.3	0.4	0.2	50.0	0.0	0.0	0.2	0.9	0.2	0.2	0.3	0.0	0.0	0.5	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	16.4	0.1	0.0	0.0	15.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.0	0.3	0.0	0.0	14.5	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.0	0.2	34.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.9	0.1	0.3	0.1	0.2	0.2	0.1	0.3	0.0	0.1	0.0
OR2C1	"OLFmf3, OR2C2P"	ENSG00000168158	"Olfactory receptor family 2 subfamily C member 1"	O95371	16	3355889-3357294	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.8"	"Group enriched"	"Detected in some"	6	"Daudi: 3.8;RPMI-8226: 3.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"														"unprognostic (1.40e-1)"	"unprognostic (1.46e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.11e-3)"	"unprognostic (5.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.42e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.08e-1)"		0.2	0.3	0.7	0.0	1.0	0.0	0.5	0.9	1.0	0.3	0.1			0.1	0.7	0.0	0.0	3.8	0.1	0.1	0.9	0.7	0.5	0.3	0.0	0.8	0.7		0.6	0.2	1.3	0.1	0.2		0.5	0.3		0.1	0.7	0.1	0.3	0.2	0.3	1.3	0.6	0.1	0.7			0.3		0.8	0.3	0.1	1.3	0.1	0.0	0.0	0.4	1.9	0.4	0.1	0.0	0.3	0.0	0.0	0.4	0.1	0.6	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.6	0.1	1.3	1.9	0.8	0.0	0.4	0.0	0.0	0.0	0.4										
OR2V1	"OR2V1P, OST265"	ENSG00000185372	"Olfactory receptor family 2 subfamily V member 1"	Q8NHB1	5	181123122-181131169	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.5;liver: 5.0"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA049953	Uncertain									"HPA049953: AB_2680971"																		0.2	0.1	0.1	0.2	0.1	0.6	1.2	0.1	0.2	0.4	0.1			0.0	0.3	0.7	0.2	3.5	0.0	0.1	0.5	0.1	0.2	5.0	0.1	0.5	0.1		0.2	0.1	0.0	0.1	0.0		0.2	0.0		0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.2	0.2			1.3		0.2	0.1	0.1	1.7	0.7	1.0	0.5	0.2	0.7	0.2	1.3	0.9	2.1	1.9	0.6	0.5	0.6	0.6	0.2	0.9	0.2	1.1	1.0	0.9	0.8	0.1	1.3	0.2	0.8	0.7	0.3	0.1	0.8	0.8	0.9	0.6	0.7	1.3	0.8	0.2	0.9	1.0	0.3	0.6	1.4	1.1	1.1	1.3	0.8	1.4	0.3	0.7	0.5	0.4	0.2	2.4	1.8	1.4	0.8	0.1	0.4	0.8	0.7	1.1	0.7	1.0	0.3	1.2	1.1	0.9	1.2	0.4	0.5	0.2	0.7	0.5	1.0	0.7	0.2	0.6	1.7	0.7	0.3	0.1	1.0	0.4	0.4	0.7	0.2	0.3	0.7	0.6	0.2										
OR2V2	"OR2V3, OST713"	ENSG00000182613	"Olfactory receptor family 2 subfamily V member 2"	Q96R30	5	181147586-181159285	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 2.8;bone marrow: 2.5;fallopian tube: 2.2"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"											HPA049953	Uncertain									"HPA049953: AB_2680971"																		0.3	0.2	0.2	0.3	0.2	2.5	0.1	0.3	0.3	0.3	0.1			0.1	0.2	0.0	0.2	2.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.5	0.2		0.2	0.7	0.0	0.1	0.0		0.1	0.0		0.2	0.0	0.2	0.9	0.3	0.0	0.1	0.3	0.4	0.7			0.4		0.0	0.2	0.1	0.7	0.4	2.8	0.3	0.5	0.3	0.1	0.4	0.8	0.5	0.8	0.2	0.0	0.4	0.2	0.1	0.0	0.3	0.4	1.0	0.2	0.2	0.0	0.6	0.2	0.1	0.1	0.1	0.7	0.8	1.9	0.7	0.0	0.6	1.0	0.1	0.1	0.0	0.0	0.0	0.5	1.1	0.0	1.5	0.6	0.4	0.4	0.6	0.4	0.2	0.4	0.0	0.8	0.6	0.5	0.5	1.7	0.4	0.7	1.4	0.4	0.4	0.7	0.7	0.2	0.8	0.3	0.2	0.5	0.7	0.1	2.8	0.3	0.6	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.7	0.3	0.3	1.6	0.5	0.3	0.4	0.2	0.1										
OR6C76		ENSG00000185821	"Olfactory receptor family 6 subfamily C member 76"	A6NM76	12	55426254-55427192	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.2;fallopian tube: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0			0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR7G3	OST085	ENSG00000170920	"Olfactory receptor family 7 subfamily G member 3"	Q8NG95	19	9126012-9126950	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"fallopian tube: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0			0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 35.8;testis: 49.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favourable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favourable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	3.9	5.3	6.2	1.5	14.0	1.2	6.0	3.6	12.7	6.2	3.6	6.5	7.5	1.8	6.3	14.1	3.2	35.8	5.5	4.7	6.5	8.9	11.9	1.8	6.7	1.3	4.9	5.3	5.9	6.2	15.7	15.7	8.9	7.8	6.4	2.5	6.7	5.3	6.8	2.4	3.4	1.3	5.0	3.2	0.9	3.5	49.9	3.2	1.3	11.1	3.5	2.4	3.2	2.6	0.8	3.8	0.3	1.7	0.3	3.1	0.8	5.1	4.9	6.1	7.1	7.3	7.2	1.1	3.1	7.7	7.8	5.4	0.1	4.6	1.1	5.9	5.7	4.1	0.2	5.9	5.1	0.9	4.7	0.0	3.3	0.5	9.1	0.6	0.9	8.1	9.7	11.0	4.8	5.3	0.1	1.3	6.1	3.7	2.7	1.9	6.2	2.1	2.9	2.5	0.9	12.8	1.8	16.5	7.3	5.9	2.8	4.1	6.0	0.8	4.6	5.7	2.1	10.2	5.3	2.3	2.3	0.5	10.9	0.1	3.8	0.0	0.7	0.0	0.9	1.7	0.0	0.4	0.9	0.7	1.8	0.8	2.2	3.1	0.3	0.3	0.2	3.8	2.2	0.8	6.2	14.0	3.6	12.7	6.5	8.9	4.9	5.3	7.8	3.2
PACRG	"FLJ32724, Glup, HAK005771, PARK2CRG"	ENSG00000112530	"Parkin coregulated"	Q96M98	6	162727132-163315492	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 30.3;pituitary gland: 55.9;testis: 44.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066293	Enhanced									"HPA066293: AB_2685652"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	"prognostic favourable (2.55e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.93e-3)"	0.7	2.3	8.6	1.0	15.5	4.7	1.8	2.3	10.6	2.3	1.1	6.5	4.4	1.2	4.7	8.6	2.7	30.3	4.3	10.7	10.3	12.1	6.8	4.1	5.5	1.4	4.7	9.4	3.8	3.4	2.0	55.9	0.4	17.7	3.2	2.3	2.0	2.5	3.4	1.8	4.3	0.7	1.9	3.7	1.5	1.7	44.6	5.9	0.0	3.7	0.0	0.9	4.5	0.9	1.7	1.1	6.0	2.0	0.1	3.3	0.5	0.7	2.5	1.1	1.6	0.0	1.0	1.8	0.6	2.3	0.0	0.5	5.0	0.5	4.6	0.6	0.0	2.6	1.2	0.0	2.6	0.0	1.7	0.0	2.5	0.0	0.0	0.6	0.8	2.1	0.0	0.8	0.0	0.0	0.7	0.9	0.5	0.1	0.3	1.7	0.0	4.3	0.8	0.0	0.0	5.5	5.3	10.5	4.7	0.0	0.0	0.0	0.0	1.5	1.8	1.0	0.5	0.0	0.4	2.1	0.7	1.7	0.5	1.2	2.0	4.3	2.0	1.4	1.9	0.6	1.4	0.9	2.6	1.2	0.3	1.7	3.3	1.6	6.0	0.1	0.2	1.1	1.1	0.5	8.6	15.5	2.3	10.6	10.3	12.1	4.7	9.4	17.7	5.9
PIFO	"C1orf88, FLJ23853, pitchfork"	ENSG00000173947	"Primary cilia formation"	Q8TCI5	1	111346288-111353013	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.9;fallopian tube: 96.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 5.1;RPTEC TERT1: 7.0;RT4: 8.2;T-47d: 5.8;U-87 MG: 5.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 55.9"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3"	"Group enriched"	"Detected in many"	25	"B-cells: 1.6;T-cells: 3.3"	"Low region specificity"	"Detected in many"																		"unprognostic (3.18e-3)"	"unprognostic (3.23e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.03e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.43e-4)"	"unprognostic (8.78e-7)"	"unprognostic (6.43e-3)"	"unprognostic (7.28e-2)"	"unprognostic (9.07e-3)"	"prognostic favourable (2.48e-4)"	"unprognostic (3.32e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (6.03e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.83e-2)"	1.1	2.0	6.6	1.2	10.1	0.8	3.8	0.7	3.9	4.4	3.0	15.9	3.5	1.1	4.9	15.5	2.8	96.8	2.7	6.4	8.6	8.6	5.4	0.8	10.8	0.9	5.0	6.5	9.2	4.2	5.1	13.8	4.3	55.9	7.5	1.4	4.2	2.2	4.3	0.9	1.6	1.1	3.4	4.2	1.0	2.6	26.5	5.4	0.4	8.8	0.1	1.1	5.4	0.6	1.6	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.1	0.7	0.9	0.9	1.0	1.6	0.0	1.9	0.4	0.0	1.5	1.6	0.0	0.4	0.0	0.0	1.4	0.3	0.0	2.1	0.3	0.0	0.2	1.3	0.8	0.0	0.0	1.0	5.1	0.0	0.0	0.0	0.3	0.2	2.9	0.1	0.8	0.1	3.0	0.0	0.0	0.0	0.0	7.0	8.2	3.5	0.4	0.0	0.2	0.2	5.8	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.4	0.5	5.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	3.3	1.6	0.9	1.0	0.0	0.9	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	6.6	10.1	0.7	3.9	8.6	8.6	5.0	6.5	55.9	5.4
PIH1D3	"CXorf41, MGC35261, NYSAR97"	ENSG00000080572	"PIH1 domain containing 3"	Q9NQM4	X	107206632-107244243	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.0;fallopian tube: 16.2;lung: 7.0;testis: 13.9"	"Cell line enhanced"	"Detected in single"		"WM-115: 1.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.0"	"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in single"							"Region enhanced"	"Detected in single"		"midbrain: 4.6"	HPA072496	Enhanced									"HPA072496: AB_2732202"	"unprognostic (8.66e-2)"	"unprognostic (2.75e-3)"		"unprognostic (7.73e-4)"	"unprognostic (3.37e-1)"			"unprognostic (8.61e-2)"		"unprognostic (4.27e-1)"			"unprognostic (3.37e-2)"			"unprognostic (1.77e-2)"		0.0	0.1	0.9	0.0	4.0	0.2	0.0	0.0	0.1	1.3	0.0	1.9	1.0	0.1	0.5	4.5	0.1	16.2	0.1	0.1	1.6	1.5	0.2	0.0	7.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	13.9	1.3	0.1	0.4	0.0	0.1	0.0	0.0	0.5	0.3	2.1	0.3	0.6	0.2	0.2	0.3	0.9	0.1	0.0	0.4	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.0	0.0	0.5	0.5	0.6	0.3	0.3	0.2	0.9	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.3	1.7	2.1	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.5	0.1	0.2	1.2	0.6	0.2	0.3	0.1	0.2	0.9	4.0	0.0	0.0	1.6	1.5	0.0	0.0	8.0	1.3
PLEKHG7	FLJ46688	ENSG00000187510	"Pleckstrin homology and RhoGEF domain containing G7"	Q6ZR37	12	92721462-92772455	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 5.6;fallopian tube: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HBF TERT88: 1.3;RPMI-8226: 5.0;RT4: 1.1;SK-BR-3: 4.1"	"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	31	"memory B-cell: 4.5;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	45	"B-cells: 4.5"									HPA060632	Uncertain									"HPA060632: AB_2684333"	"unprognostic (4.47e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.91e-5)"	"unprognostic (1.38e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.75e-1)"		"unprognostic (3.27e-5)"	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.6			0.1	0.4	5.6	0.1	7.9	0.3	0.0	0.0	0.0	0.7	0.5	2.2	2.0	0.0		0.0	1.4	0.0	0.0	0.0		0.8	0.4		0.1	0.6	0.0	0.0	2.6	0.0	0.0	1.6	2.7	0.1			0.0		2.9	2.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	1.8	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	5.0	0.1	1.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;ASC diff: 10.6;ASC TERT1: 13.2;hTCEpi: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.5	1.4	5.5	1.1	8.6	0.7	3.6	5.0	4.8	4.6	1.7	7.2	7.4	1.9	3.8	12.7	2.0	36.5	1.7	2.6	6.0	5.4	4.9	1.2	8.9	1.1	3.4	3.2	6.3	4.3	6.6	7.6	1.6	18.3	1.8	1.6	2.6	2.8	5.0	3.9	1.7	1.1	5.4	3.2	1.3	2.3	20.4	5.3	0.0	17.2	1.4	1.1	2.9	2.0	5.1	1.7	2.0	1.3	1.7	1.3	1.1	1.8	1.1	1.2	6.6	10.6	13.2	1.2	0.0	2.4	0.6	0.2	0.1	1.8	0.0	0.5	0.6	1.2	1.0	0.0	0.4	0.5	0.9	0.5	0.1	0.0	5.3	0.6	0.3	2.7	6.3	0.2	4.0	0.8	0.9	0.4	0.4	0.6	0.1	0.6	0.2	1.3	0.8	0.0	0.6	5.1	0.1	1.5	2.5	0.2	0.3	4.4	0.5	1.0	0.4	0.1	0.2	1.1	0.2	0.3	0.1	0.1	2.2	0.1	0.4	2.0	1.2	1.2	0.9	1.3	0.9	5.1	1.2	1.1	1.7	3.2	1.1	1.0	1.6	1.7	1.1	1.7	1.3	1.1	5.5	8.6	5.0	4.8	6.0	5.4	3.4	3.2	18.3	5.3
PPP1R42	"dtr, LRRC67, TLLR"	ENSG00000178125	"Protein phosphatase 1 regulatory subunit 42"	Q7Z4L9	8	66964099-67056604	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 11.2;fallopian tube: 10.2;testis: 20.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.2;RPTEC TERT1: 1.7;SCLC-21H: 1.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA024313, HPA027983, HPA028628"	Uncertain									"HPA024313: AB_1853053, HPA027983: AB_10599300, HPA028628: AB_2250064"	"unprognostic (8.03e-3)"	"unprognostic (5.45e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.92e-1)"		"unprognostic (5.42e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.61e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.33e-1)"	0.3	0.5	2.3	0.3	5.7	0.3	0.3	0.3	2.3	0.9	0.3	3.5	0.0	0.3	0.6	8.0	0.3	10.2	0.4	0.4	3.1	1.4	1.1	0.3	4.1	0.3	0.6	0.8	2.6	0.5	1.0	6.7	0.3	11.2	0.3	0.3	0.8	0.3	1.5	0.3	0.3	0.3	0.4	2.0	0.3	0.3	20.2	1.8	0.0	1.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	5.7	0.3	2.3	3.1	1.4	0.6	0.8	11.2	1.8
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004304	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 17.9;fallopian tube: 48.7;testis: 23.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.7;REH: 6.8;RPMI-8226: 2.8;TIME: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA051264			Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	0.9	0.5	3.3	0.8	7.6	0.6	0.9	0.1	2.1	4.0	0.5	8.3	0.4	0.6	1.0	17.9	0.6	48.7	1.0	0.7	5.6	5.5	0.6	0.6	7.3	0.7	1.6	0.8	8.1	0.5	0.9	5.8	0.7	15.2	0.6	0.4	0.2	0.9	0.9	0.6	0.5	0.5	0.6	1.1	2.5	0.5	23.5	1.0	0.0	2.5	0.0	0.7	1.0	0.0	1.0	0.7	3.1	1.8	1.0	3.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.2	0.0	0.0	0.4	0.0	6.7	0.0	0.7	0.0	0.0	0.1	0.4	0.2	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.0	0.0	2.3	0.0	0.2	0.2	6.8	0.1	2.8	0.5	0.0	0.4	2.0	0.0	0.3	0.4	1.0	0.0	5.5	0.2	2.3	0.7	0.2	0.7	0.1	0.5	0.9	0.3	0.0	3.1	0.9	0.0	2.0	1.8	0.4	0.7	1.7	1.0	0.7	1.0	3.0	1.7	0.8	1.0	1.7	0.1	1.1	1.6	3.3	7.6	0.1	2.1	5.6	5.5	1.6	0.8	15.2	1.0
PRRT1B	IFITMD8	ENSG00000283526	"Proline rich transmembrane protein 1B"		9	131545514-131558620	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in many"		"fallopian tube: 9.0;lung: 16.0;pancreas: 7.6"	"Group enriched"	"Detected in some"	10	"A549: 15.6;BEWO: 10.4;MCF7: 4.1;T-47d: 7.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																															0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.5	4.7	0.0	0.0	0.3	0.6	1.0	0.0	9.0	3.9	0.0	0.0		1.3	6.1	16.0	0.0	0.0	0.0	1.7	7.6	1.7	0.0	0.1	0.1	3.4	2.0	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.6	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0										
RAB36		ENSG00000100228	"RAB36, member RAS oncogene family"	O95755	22	23145326-23164350	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 38.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 17.5;U-266/84: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 12.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059631			Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA059631: "	"unprognostic (2.74e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.02e-3)"	"unprognostic (5.56e-3)"	"prognostic favourable (4.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-1)"	2.4	5.9	7.6	2.0	11.9	1.3	3.5	2.7	14.1	6.5	2.8	6.8	9.3	1.4	5.4	12.7	3.0	38.2	6.6	1.9	7.7	8.4	8.2	0.8	6.1	1.7	4.5	9.3	8.1	4.3	1.9	16.6	7.0	5.8	5.1	1.8	4.8	4.6	11.2	1.2	1.9	1.5	4.9	2.6	1.9	2.7	12.8	3.1	0.0	20.7	1.2	1.9	3.6	2.1	1.0	0.3	12.7	0.6	1.7	0.7	0.3	5.5	6.5	5.0	7.6	1.2	2.5	2.0	3.1	6.4	7.0	2.6	0.4	0.0	0.0	3.5	4.1	7.0	0.2	3.7	2.3	0.0	3.0	0.0	0.2	0.6	3.0	0.0	0.9	3.1	1.4	6.5	1.3	1.0	0.3	5.7	0.3	4.4	0.0	0.1	0.6	1.7	0.0	0.0	17.5	9.0	1.0	12.4	5.4	0.2	2.7	1.6	0.0	0.6	0.5	0.9	2.1	2.4	4.5	12.4	17.2	0.0	6.4	0.0	4.1	0.3	0.6	0.0	0.7	0.3	0.4	1.0	0.1	0.2	0.3	0.3	0.5	0.4	12.7	1.7	0.3	0.0	0.1	0.3	7.6	11.9	2.7	14.1	7.7	8.4	4.5	9.3	5.8	3.1
RABL2A		ENSG00000144134	"RAB, member of RAS oncogene family like 2A"	Q9UBK7	2	113627229-113643396	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.3"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome				Centrosome	Centrosome	"HPA042642: , HPA042700: AB_2678120, HPA044007: "	"unprognostic (7.76e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.77e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.78e-3)"	"unprognostic (4.29e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.19e-5)"	2.2	1.7	6.0	5.9	9.5	1.7	3.3	6.3	20.9	4.3	3.4	4.2	0.4	2.4	4.7	9.0	2.7	29.3	2.8	3.3	7.0	6.0	3.5	3.4	12.9	1.8	4.0	7.5	7.4	2.6	1.2	6.3	1.6	6.4	3.8	2.0	3.8	5.2	12.2	2.2	2.1	2.2	3.6	4.8	2.7	2.1	4.8	4.3	2.0	5.5	2.0	3.1	2.1	2.7	8.8	9.8	2.5	7.6	12.2	10.4	5.5	2.5	4.3	5.9	4.7	4.9	7.2	4.5	2.4	2.0	3.4	2.5	3.7	1.6	3.6	10.3	0.8	2.7	3.0	0.3	2.3	5.0	5.7	1.8	0.1	0.5	4.0	0.7	1.3	2.5	5.1	0.7	1.5	2.5	1.7	0.9	2.1	2.1	12.0	0.9	3.3	1.5	2.2	2.3	1.6	2.4	0.6	2.4	8.3	2.3	2.5	2.1	0.5	3.4	0.6	0.4	0.8	0.9	1.6	3.6	3.7	0.8	7.0	2.7	1.2	0.0	4.8	2.5	7.1	7.6	7.7	8.8	10.4	7.2	7.5	8.0	8.6	6.8	0.5	12.2	7.2	9.8	5.0	5.5	6.0	9.5	6.3	20.9	7.0	6.0	4.0	7.5	6.4	4.3
RIBC2	"C22orf11, DKFZp566F0546, FLJ25720"	ENSG00000128408	"RIB43A domain with coiled-coils 2"		22	45413691-45432496	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 10.9;fallopian tube: 10.9;testis: 35.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.8;MCF7: 9.0;SiHa: 13.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"midbrain: 8.5"	HPA003210	Approved									"HPA003210: AB_1078347"	"unprognostic (2.55e-1)"	"prognostic favourable (7.08e-8)"	"unprognostic (3.58e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.51e-3)"	"unprognostic (7.21e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (9.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.13e-1)"	0.0	0.1	0.7	0.6	6.5	1.9	0.2	0.0	3.2	1.0	0.5	3.1	0.0	0.3	0.6	2.2	0.6	10.9	0.9	0.0	2.4		0.0	0.0	1.0	0.4	0.0	1.0	1.5	0.1	2.2	8.7	0.4	10.9	0.7	0.2	0.3	0.0	0.1	0.0	0.9	0.5	0.1	0.0	0.1	0.5	35.3	1.9	1.8	0.5	0.0	0.9	0.2	0.0	0.6	2.0	0.2	0.7	0.0	1.4	0.2	5.8	4.1	0.6	0.0	0.0	0.0	0.6	7.7	0.7	1.5	2.2	4.2	7.8	0.0	1.9	0.7	6.9	0.0	0.0	1.2	0.0	0.2	0.0	5.8	0.2	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.5	9.0	3.9	2.0	0.9	2.3	4.4	0.0	0.0	2.2	0.8	4.0	0.0	13.2	2.7	0.0	4.9	2.8	0.4	0.0	0.0	4.7	0.0	2.3	2.3	0.0	0.0	1.2	3.6	0.0	0.7	0.2	0.0	0.0	0.0	0.6	0.3	1.3	2.0	0.1	0.0	0.5	0.0	0.0	0.0	1.0	1.4	0.2										
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 43.4;pituitary gland: 29.2"	"Group enriched"	"Detected in some"	9	"CACO-2: 6.4;SCLC-21H: 3.5;SH-SY5Y: 6.9;SK-BR-3: 11.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favourable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.5	2.7	4.0	0.5	9.3	0.5	1.1	0.5	5.6	1.6	1.1	0.8	1.2	0.6	2.1	6.1	0.7	43.4	0.9	0.5	4.6	5.1	0.6	0.5	3.1	0.5	2.5	5.2	2.6	1.2	1.1	29.2	0.5	3.6	1.0	1.3	1.2	0.5	1.9	0.5	0.6	0.8	1.1	0.5	0.5	2.0	14.7	2.1	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	3.5	6.9	0.0	11.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.3	0.5	5.6	4.6	5.1	2.5	5.2	3.6	2.1
RSPH1	"CILD24, FLJ32753, RSP44, RSPH10A, TSGA2"	ENSG00000160188	"Radial spoke head 1 homolog"	Q8WYR4	21	42472486-42496354	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.4;fallopian tube: 85.5"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;MCF7: 10.8;RPTEC TERT1: 16.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 6.7"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016816, HPA017382"	Enhanced		Supported	Centrosome				Centrosome	Centrosome	"HPA016816: AB_1858393, HPA017382: AB_1858392"	"unprognostic (1.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.22e-3)"	"unprognostic (1.99e-1)"	0.6	2.5	11.5	0.9	16.4	0.7	1.7	1.2	4.7	4.5	2.6	15.9	3.1	4.5	3.6	22.5	1.0	85.5	3.8	0.6	11.6	15.0	3.8	0.8	17.4	0.7	4.8	4.5	12.9	2.2	4.8	21.4	0.6	38.4	2.2	2.5	1.0	0.9	2.4	0.9	2.4	4.1	1.1	4.6	0.6	3.4	21.9	7.7	0.2	4.8	0.0	0.7	1.5	0.2	0.6	6.7	0.5	0.3	0.0	0.3	0.3	1.6	1.2	0.1	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	3.5	0.1	0.6	0.0	2.0	0.0	0.5	0.0	0.2	0.1	5.4	0.5	0.0	0.0	0.1	0.2	0.3	1.0	0.0	0.1	0.0	0.0	0.3	0.0	10.8	0.1	0.2	0.3	0.5	0.0	0.4	0.0	16.2	1.3	2.5	1.0	2.6	3.9	0.3	4.4	0.4	0.2	0.0	0.1	0.1	0.0	0.5	2.5	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.3	0.2	0.1	0.4	0.3	0.3	0.3	0.6	0.3	0.2	0.2	0.0	0.1	6.7	0.2	0.3	11.5	16.4	1.2	4.7	11.6	15.0	4.8	4.5	38.4	7.7
RSPH14	RTDR1	ENSG00000100218	"Radial spoke head 14 homolog"	Q9UHP6	22	23059415-23145021	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;testis: 24.8"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 7.0;SCLC-21H: 4.6;U-266/70: 8.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 10.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA018420, HPA050425"	Approved		Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA018420: AB_1856496, HPA050425: "	"unprognostic (8.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.28e-2)"	"prognostic favourable (4.04e-4)"	"unprognostic (5.18e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.73e-2)"	0.8	3.0	4.8	0.5	6.8	0.4	0.5	1.2	8.8	1.4	0.7	2.6	0.9	0.4	1.3	4.9	0.6	15.3	1.8	0.3	4.7	4.7	9.3	0.3	1.8	0.5	2.9	3.3	5.5	0.6	0.9	3.1	0.4	6.4	1.1	0.5	1.0	1.0	2.4	0.9	1.6	0.4	0.6	1.6	0.4	0.8	24.8	1.6	0.0	2.7	0.0	0.5	0.6	0.3	0.1	0.0	10.8	2.0	0.2	0.3	0.6	0.4	4.0	3.6	3.4	0.0	1.6	0.2	0.0	0.8	0.7	0.6	0.7	1.2	0.8	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.4	0.2	1.5	0.2	0.2	1.8	0.0	0.4	0.6	0.0	0.0	0.1	1.7	0.0	0.5	0.8	0.6	0.0	0.1	0.2	0.1	3.7	7.0	0.0	4.6	2.2	0.1	0.1	0.2	0.7	0.8	0.0	3.1	0.8	0.2	0.0	8.1	3.1	2.3	2.6	0.4	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	10.8	0.2	2.0	0.0	0.1	0.6	4.8	6.8	1.2	8.8	4.7	4.7	2.9	3.3	6.4	1.6
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head 4 homolog A"	Q5TD94	6	116616479-116632985	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 7.4;U-266/84: 5.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.4;pons and medulla: 19.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.5	0.7	1.8	0.5	9.4	0.9	0.7	1.2	0.9	2.2	0.4	10.2	0.4	0.5	1.9	13.3	0.4	35.9	0.8	0.5	3.0	3.3	0.7	0.4	11.1	0.5	0.5	1.1	13.7	0.6	2.8	16.7	0.3	19.8	0.6	0.4	0.2	0.4	0.5	1.0	0.6	0.4	0.6	0.7	1.0	0.8	6.6	1.8	0.0	1.0	0.0	0.5	0.4	0.1	0.8	0.1	1.3	0.2	0.2	1.0	0.0	0.1	0.2	1.4	3.2	0.1	0.1	0.3	0.4	0.8	0.6	0.8	0.7	1.1	1.0	0.3	0.1	0.2	0.3	0.6	0.6	0.8	1.1	0.4	0.5	1.2	0.0	0.8	1.1	0.4	0.2	1.0	0.2	0.0	0.2	0.1	0.6	0.2	0.6	0.1	0.5	0.1	0.8	1.6	7.4	3.1	0.4	2.8	1.2	0.2	0.2	0.4	0.5	0.6	0.5	0.4	0.7	0.5	0.5	0.5	5.4	0.4	0.1	0.4	0.5	1.3	0.2	0.8	1.0	0.1	0.1	0.4	0.3	0.0	0.0	0.8	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	1.8	9.4	1.2	0.7	3.0	3.3	0.5	1.1	19.8	1.8
RSPH9	"C6orf206, CILD12, FLJ30845, MRPS18AL1"	ENSG00000172426	"Radial spoke head 9 homolog"	Q9H1X1	6	43645046-43672599	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.9;testis: 48.4"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031703	Enhanced									"HPA031703: AB_10602126"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	"unprognostic (7.28e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.73e-2)"	0.6	1.1	3.6	0.7	2.9	1.3	0.6	1.3	3.8	1.4	0.6	2.7	2.4	0.8	2.6	4.1	0.7	15.9	1.0	1.0	2.0	3.0	0.8	0.5	8.7	0.7	0.5	1.4	3.3	0.7	1.2	3.8	1.1	7.0	1.5	0.5	1.8	1.1	0.9	0.6	0.8	0.6	1.1	0.6	0.8	1.3	48.4	0.4	0.0	0.7	0.4	0.5	0.8	0.9	4.9	2.4	3.7	2.3	2.4	2.8	3.1	0.8	0.4	1.6	1.5	0.3	4.6	1.5	1.9	0.5	0.0	0.0	2.9	0.4	0.3	0.6	0.9	0.9	0.2	0.2	0.0	0.6	1.5	1.1	0.8	1.0	3.6	1.5	0.8	1.4	0.0	1.5	0.2	0.2	1.6	1.6	0.0	2.0	0.9	2.0	1.0	1.4	0.9	1.3	1.3	0.0	1.6	2.1	2.2	0.0	1.3	1.4	0.8	1.7	0.5	1.1	1.0	1.0	0.7	1.9	2.8	1.6	5.7	1.1	1.9	2.0	2.3	1.5	2.8	1.2	2.3	3.1	2.1	1.8	2.4	4.9	2.3	2.1	3.7	2.4	0.8	1.4	2.0	3.1	3.6	2.9	1.3	3.8	2.0	3.0	0.5	1.4	7.0	0.4
SAXO2	"DKFZp666G057, FAM154B"	ENSG00000188659	"Stabilizer of axonemal microtubules 2"	Q658L1	15	82262810-82284930	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 46.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 12.0;K-562: 11.0;SCLC-21H: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040487, HPA040833"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA040487: AB_10796457, HPA040833: AB_10796561"	"unprognostic (3.03e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.13e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.87e-2)"	0.9	1.3	4.1	1.3	5.4	0.7	2.8	4.4	5.3	2.7	1.2	3.5	5.0	0.9	2.1	14.8	0.7	46.8	1.9	1.4	5.5	2.8	2.3	1.1	9.1	1.1	3.1	2.8	9.2	2.6	4.7	11.5	0.7	5.6	2.4	1.8	1.6	2.3	3.0	1.2	1.9	1.6	0.9	2.3	1.3	2.3	18.0	3.7	1.0	3.1	0.1	1.6	1.0	1.2	6.7	1.3	5.3	0.2	3.2	2.7	0.5	1.6	2.1	1.3	4.8	1.1	2.2	0.6	0.5	0.4	0.9	1.8	0.2	2.6	1.6	1.2	0.0	12.0	2.1	1.8	2.1	1.1	7.8	0.5	3.7	0.0	0.1	0.4	0.5	1.5	2.6	1.7	1.4	1.9	11.0	0.9	1.2	1.1	0.6	0.0	3.2	0.9	1.5	0.6	1.0	0.9	1.1	9.2	1.4	1.3	0.0	1.7	4.6	0.4	0.2	2.3	1.4	4.9	0.9	2.5	2.7	1.0	2.2	0.6	1.5	0.0	0.1	5.3	1.1	0.0	1.4	2.5	0.4	2.7	0.1	6.7	1.8	0.8	0.1	3.2	0.2	1.3	0.1	0.5	4.1	5.4	4.4	5.3	5.5	2.8	3.1	2.8	5.6	3.7
SCARA3	"APC7, CSR, CSR1, MSLR1, MSRL1"	ENSG00000168077	"Scavenger receptor class A member 3"	Q6AZY7	8	27633868-27676776	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 52.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 49.6;HeLa: 54.6;HUVEC TERT2: 37.8;U-2 OS: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029861, HPA047386"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Golgi apparatus"	"Endoplasmic reticulum, Golgi apparatus"	"HPA029861: AB_2673225, HPA047386: AB_2680024"	"unprognostic (2.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (6.03e-3)"	7.5	4.6	16.4	9.0	27.3	0.4	10.6	10.3	26.8	19.9	11.2	7.7	14.2	3.4	33.8	9.4	14.5	52.2	18.4	4.8	16.2	13.0	3.8	2.7	7.8	7.4	16.4	10.3	13.1	2.8	2.2	3.6	11.8	21.2	12.4	5.4	8.6	13.7	42.6	1.1	6.0	5.1	40.5	21.8	2.0	5.9	3.9	12.1	3.2	19.2	4.7	13.2	11.3	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.1	2.5	0.0	13.5	49.6	11.3	6.5	10.2	7.0	5.2	5.9	4.2	0.0	15.3	13.0	12.1	0.0	12.0	3.3	0.0	1.4	4.7	54.6	0.2	1.4	0.0	0.0	20.8	0.7	10.8	0.5	37.8	0.0	0.0	3.9	2.9	0.0	0.0	3.4	6.2	0.0	0.0	0.0	2.2	7.2	0.0	1.6	1.5	8.6	0.0	8.4	0.1	13.4	5.8	35.0	21.4	3.4	0.0	0.0	0.0	9.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	27.3	10.3	22.5	16.2	13.0	16.4	10.3	21.2	12.1
SCGB1D1	"LIPA, LPHA, MGC71958"	ENSG00000168515	"Secretoglobin family 1D member 1"	O95968	11	62190216-62193539	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 5.4;fallopian tube: 3.2;lymphoid tissue: 2.0"	"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 11.6"	"Group enriched"	"Detected in some"	40	"endometrial cancer: 23.3;ovarian cancer: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"									"unprognostic (6.95e-3)"						"unprognostic (9.01e-2)"								0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	5.4	0.1	0.1	0.1	0.0	1.1	0.1	1.4	3.2	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	2.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1
SDR42E2		ENSG00000183921	"Short chain dehydrogenase/reductase family 42E, member 2"	A6NKP2	16	22165583-22191754	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.0;fallopian tube: 5.0;testis: 3.3"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 3.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.03e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.72e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.32e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.61e-2)"	0.1	0.1	1.0	0.2	2.1	0.1	0.0	0.0	1.1	0.5	0.0			0.6	0.1	0.1	0.0	5.0	0.2	0.0	1.7	2.4	0.2	0.0	0.4	0.3	0.0		0.3	0.5	0.1	2.2	0.2		0.2	0.1		0.2	0.0	1.5	0.6	0.2	0.0	0.3	0.5	0.1	3.3			0.1		0.0	0.1	0.0	0.8	0.3	6.0	0.8	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.3	0.3	0.4	0.5	0.3	0.4	0.1	0.8	0.3	0.4	6.0	0.3	0.1	0.3	0.3	0.2										
SERTM1	C13orf36	ENSG00000180440	"Serine rich and transmembrane domain containing 1"	A2A2V5	13	36673912-36697839	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3"	"Group enriched"	"Detected in some"	5	"HAP1: 2.6;HEK 293: 3.1;NTERA-2: 7.9;SH-SY5Y: 4.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.7"	"Group enriched"	"Detected in many"	7	"amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054814, HPA070485"	Uncertain		Enhanced	Vesicles				Vesicles	Vesicles	"HPA054814: AB_2682611, HPA070485: AB_2686272"	"unprognostic (8.71e-2)"	"unprognostic (2.11e-1)"		"unprognostic (5.58e-3)"	"unprognostic (4.66e-3)"			"unprognostic (4.05e-3)"		"unprognostic (5.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.00e-8)"	"unprognostic (2.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.44e-2)"		5.0	1.8	13.9	0.5	10.1	0.5	1.2	0.3	30.2	16.4	0.7	1.3	1.8	0.6	30.9	13.5	0.5	25.3	0.5	0.6	26.5	2.0	0.6	0.5	5.6	0.5	1.5	11.6	14.5	0.8	1.0	11.2	0.5	2.4	0.9	0.5	8.2	0.5	1.2	0.5	0.6	0.6	17.4	0.9	0.5	0.9	1.5	0.0	0.0	9.3	0.0	0.5	1.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	10.1	0.3	21.6	26.5	2.0	1.5	11.6	2.4	0.0
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777243-45851736	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.2;fallopian tube: 11.8"	"Cell line enriched"	"Detected in single"	8	"EFO-21: 4.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060576	Uncertain									"HPA060576: AB_2684325"	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.6	1.3	5.1	0.9	8.3	0.9	0.6	5.6	10.2	4.1	0.6	0.0	0.1	0.8	1.7	2.0	0.6	11.8	0.7	0.6	4.0	2.8	1.7	0.6	0.8	0.8	3.4	6.6	0.7	0.6	0.5	0.4	0.5	8.9	0.6	0.7	2.8	1.7	3.6	0.6	0.8	0.8	0.8	1.3	0.8	0.7	0.8	0.7	0.4	0.6	0.0	0.9	0.7	0.4	0.1	0.1	0.5	0.1	0.2	1.5	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	1.5	0.7	0.5	0.2	0.0	0.1	0.0	0.0	5.1	8.3	5.6	10.2	4.0	2.8	3.4	6.6	8.9	0.7
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 24.8;intestine: 94.3;liver: 25.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.0;HDLM-2: 6.9;Hep G2: 11.4;Karpas-707: 9.5;RPMI-8226: 9.2;U-266/70: 14.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA047612	Enhanced									"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.3	0.0	0.3	0.5	0.5	0.8	0.3	0.3	0.3	2.3	22.1	0.3	0.8	11.6	0.3	1.6	0.3	24.8	1.8	0.3	0.3	0.3	18.0	25.4	0.6	0.4	0.3	0.3	0.4	0.9	0.0	0.3	0.3	0.4	2.7	0.3	0.3	1.0	0.6	0.3	1.0	94.3	0.3	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.2	4.4	0.7	0.1	0.0	0.3	0.0	0.3	1.8	0.3	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	8.0	1.1	4.9	2.6	0.0	0.2	0.0	0.0	0.1	6.9	0.1	0.1	0.6	11.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.2	4.7	0.9	0.1	0.1	5.7	0.2	9.2	0.4	0.3	0.2	0.3	0.2	1.7	0.0	4.4	0.1	0.3	0.3	0.2	0.1	0.0	14.6	1.7	6.4	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	1.2	0.2	0.0	0.7	0.0	0.1	4.4	0.3	0.0	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.3
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4"	"Cell line enhanced"	"Detected in some"		"AF22: 11.2;HeLa: 5.5;U-138 MG: 3.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013843	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA013843: AB_1857233"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.3	3.3	0.1	6.8	0.1	0.2	3.1	9.2	0.4	0.2			0.0	0.1	1.0	0.2	6.7	0.1	0.1	4.8	4.2	0.0	0.0	0.2	0.1	2.6		0.6	0.8	0.0	0.0	0.0		1.8	0.3		7.4	3.1	0.2	0.2	0.0	0.0	1.0	0.1	0.5	0.2			2.0		0.3	0.0	0.4	0.7	1.4	1.6	0.3	1.4	0.4	0.1	0.0	1.2	11.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	2.0	1.3	5.5	0.0	0.8	0.0	0.0	2.5	0.2	0.0	1.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	2.8	1.4	1.0	0.3	0.2	0.4	0.0	1.7	0.3	0.0	0.3	0.0	0.8	2.6	0.0	3.9	0.0	0.0	0.6	1.7	0.0	0.0	3.5	0.1	1.1	1.1	0.3	0.4	0.4	0.2	0.4	0.4	0.4	0.3	0.1	0.7	0.4	0.3	1.6	1.4	0.3	1.4	0.2	0.1										
SMIM6	C17orf110	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647977	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;CACO-2: 4.3;CAPAN-2: 4.1;EFO-21: 10.3;HEL: 7.5;Hep G2: 4.0;RPTEC TERT1: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 22.0"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 22.0"									HPA065721	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favourable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favourable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favourable (1.64e-4)"	0.2	0.1	2.4	0.6	4.1	0.6	0.1	0.6	6.1	1.8	5.3	12.3	3.2	7.9	0.9	2.2	0.2	19.1	15.8	0.1	4.0	2.1	13.5	5.2	1.8	0.3	5.3	4.1	0.4	7.3	1.7	0.1	0.4	5.4	0.3	5.5	0.1	0.2	2.9	0.1	0.2	9.4	0.0	9.1	0.2	26.5	20.6	3.1	0.0	0.1	0.2	0.2	1.1	0.8	0.0	22.0	0.0	0.0	0.4	0.0	0.2	0.8	13.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.3	4.1	0.0	10.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	7.5	0.3	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.8	2.2	0.2	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	22.0	0.0	0.2	2.4	4.1	0.6	6.1	4.0	2.1	5.3	4.1	5.4	3.1
SOX3	PHP	ENSG00000134595	"SRY-box 3"	P41225	X	140502985-140505116	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 18.2;testis: 12.4"	"Group enriched"	"Detected in some"	10	"AF22: 7.6;HEK 293: 8.2;NTERA-2: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA054720, HPA075003"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA054720: AB_2682584, HPA075003: AB_2686727"					"unprognostic (6.04e-2)"					"unprognostic (3.75e-1)"			"unprognostic (8.62e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.27e-3)"		0.3	0.5	2.6	0.3	2.7	0.3	0.3	0.6	2.6	1.5	0.3	5.0	0.0	0.3	0.6	0.3	0.3	18.2	0.3	0.3	2.2	5.0	0.3	0.3	0.3	0.3	2.0	1.8	4.7	0.3	0.4	3.2	0.3	3.6	0.3	0.3	0.5	0.3	0.3	0.4	0.3	0.3	0.3	2.3	0.3	0.3	12.4	0.6	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	0.6	2.6	2.2	5.0	2.0	1.8	3.6	0.6
SP9	ZNF990	ENSG00000217236	"Sp9 transcription factor"	P0CG40	2	174334946-174338492	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.4;fallopian tube: 5.1;skin 1: 4.5"	"Cell line enhanced"	"Detected in some"		"A549: 8.8;fHDF/TERT166: 6.7;HEK 293: 2.7;THP-1: 14.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 6.0;olfactory region: 14.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 8.3;olfactory region: 44.8"	HPA062616	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA062616: AB_2684808"	"unprognostic (2.04e-2)"	"unprognostic (6.94e-3)"		"unprognostic (1.44e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.55e-3)"		"unprognostic (8.54e-2)"	"unprognostic (3.12e-1)"						"unprognostic (1.01e-1)"			0.7	0.3	4.6	0.3	12.4	0.3	1.1	0.0	6.1	0.6	0.3	0.4	0.0	0.3	0.4	0.3	0.3	5.1	0.3	0.3	2.3	2.2	0.3	0.3	0.3	0.4	1.1	4.3	0.3	0.3	0.3	0.0	1.1	1.0	0.3	0.3	0.0	0.4	0.3	0.6	4.5	0.3	0.3	0.5	0.3	0.3	2.0	1.4	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	8.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	6.7	0.1	0.2	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	12.4	0.0	6.1	2.3	2.2	1.1	4.3	1.0	1.4
SPA17	"CT22, SP17"	ENSG00000064199	"Sperm autoantigenic protein 17"	Q15506	11	124673798-124697518	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.2;testis: 82.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037568	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA037568: AB_10672905"	"unprognostic (1.41e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.39e-3)"	"prognostic favourable (1.03e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.78e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.71e-1)"	1.3	2.2	5.6	1.3	6.0	2.3	3.5	1.0	5.8	3.5	3.5	4.3	2.8	1.9	2.7	13.7	2.1	28.2	2.8	2.0	5.6	6.8	5.9	1.1	4.5	1.3	3.9	4.3	3.2	1.8	4.4	8.1	1.4	20.1	2.2	3.9	0.8	1.6	2.7	0.7	1.3	1.6	1.9	3.6	1.0	2.2	82.1	2.7	2.6	7.6	1.6	1.7	1.8	1.3	0.5	3.7	4.2	6.0	0.4	1.3	1.8	11.4	8.5	19.6	8.1	6.3	9.4	10.2	8.5	12.8	8.6	7.4	2.7	24.1	5.2	5.7	12.0	8.1	8.1	14.3	13.6	5.5	5.8	8.1	1.6	5.2	4.5	1.8	3.6	3.8	7.6	15.4	7.9	8.6	11.3	4.7	19.2	9.9	1.2	0.3	9.0	8.1	6.6	3.0	0.0	20.5	5.3	13.1	8.7	18.7	6.3	5.2	39.2	8.5	8.3	10.0	9.1	4.8	10.7	2.1	1.6	3.3	8.7	1.7	10.5	4.2	4.5	0.8	0.7	3.5	0.6	0.4	1.3	0.8	3.7	0.5	1.1	0.8	0.2	0.4	6.0	1.7	1.2	1.8	5.6	6.0	1.0	5.8	5.6	6.8	3.9	4.3	20.1	2.7
SPAG6	"CT141, pf16, Repro-SA-1"	ENSG00000077327	"Sperm associated antigen 6"	O75602	10	22345445-22454224	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.1;fallopian tube: 29.5;testis: 70.6"	"Cell line enriched"	"Detected in some"	28	"U-937: 47.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 31.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.9"	"Low lineage specificity"	"Detected in many"							"Region enhanced"	"Detected in many"		"midbrain: 17.9"	HPA038440	Enhanced									"HPA038440: AB_10671742"	"unprognostic (5.02e-2)"	"unprognostic (9.52e-2)"		"unprognostic (8.94e-6)"	"unprognostic (2.21e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.78e-4)"	0.3	0.3	2.8	0.3	5.2	0.5	1.4	0.0	2.0	1.1	0.3	8.6	0.0	0.3	0.4	8.7	0.3	29.5	0.3	0.3	5.0	5.1	0.5	0.4	5.3	0.3	0.7	0.6	3.1	0.5	0.3	12.4	0.3	31.1	0.8	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.3	1.1	0.3	0.3	70.6	1.6	0.0	0.3	0.0	0.3	0.3	0.1	0.0	1.2	2.9	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	47.7	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.5	0.0	2.8	5.2	0.0	2.0	5.0	5.1	0.7	0.6	31.1	1.6
SPEF1	"C20orf28, CLAMP, DKFZP434I114, SPEF1A"	ENSG00000101222	"Sperm flagellar 1"	Q9Y4P9	20	3777504-3781448	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.7;fallopian tube: 19.6;testis: 12.5"	"Cell line enhanced"	"Detected in some"		"A549: 5.8;hTEC/SVTERT24-B: 3.0;MCF7: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050786	Enhanced									"HPA050786: AB_2681238"	"unprognostic (2.41e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.08e-3)"	"unprognostic (8.12e-3)"	"unprognostic (5.95e-2)"	"unprognostic (8.41e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.60e-2)"	"prognostic unfavourable (9.87e-4)"	"unprognostic (7.49e-2)"	0.4	0.7	4.0	0.4	16.7	0.5	0.6	0.0	3.9	1.0	0.4	3.2	0.0	0.4	0.7	6.0	0.4	19.6	0.5	0.4	6.9	3.0	1.8	0.4	4.3	0.4	1.7	1.7	1.8	0.8	1.0	1.4	0.4	11.5	0.4	0.4	1.3	0.5	0.6	0.4	0.4	0.4	0.4	0.4	0.4	0.5	12.5	1.7	0.0	2.6	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	2.4	5.8	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.5	0.5	0.2	0.6	0.2	0.5	0.2	0.7	0.3	0.0	0.0	1.1	0.0	0.1	0.0	0.3	0.7	3.0	0.0	0.0	0.1	0.1	0.0	4.3	1.2	0.6	0.5	0.5	0.0	0.4	0.4	1.6	0.0	1.1	0.9	0.2	1.2	1.6	1.5	0.0	0.0	0.9	0.4	1.3	0.3	0.4	0.1	0.4	2.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.5	0.2	4.0	16.7	0.0	3.9	6.9	3.0	1.7	1.7	11.5	1.7
STMND1	FLJ23152	ENSG00000230873	"Stathmin domain containing 1"	H3BQB6	6	17102258-17131372	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.8;pancreas: 9.1"	"Group enriched"	"Detected in some"	5	"HEK 293: 4.0;SCLC-21H: 9.6;T-47d: 11.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 4.1;endometrial cancer: 1.5"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA067970	Enhanced		Approved	"Actin filaments"				"Actin filaments"	"Actin filaments"	"HPA067970: AB_2685934"	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (6.88e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.22e-2)"		"unprognostic (3.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.72e-2)"	"unprognostic (5.29e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"		0.1	0.0	0.4	0.1	0.8	0.0	3.7	0.6	0.6	1.6	1.0	2.8	1.4	0.1	0.6	4.7	0.1	21.8	6.0	0.1	0.7	0.9	0.1	0.1	7.7	0.1	0.1	0.1	3.5	9.1	0.0	0.7	0.1	2.5	0.1	1.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	7.4	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.9	1.6	2.8	1.1	0.8	0.8	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.6	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.2	0.8	0.0	4.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	9.6	0.0	0.0	0.1	0.0	11.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.7	0.3	0.8	0.6	0.4	0.7	0.3	0.2	0.9	0.8	0.7	2.8	0.8	0.8	1.6	0.2	0.4	0.4	0.8	0.6	0.6	0.7	0.9	0.1	0.1	2.5	0.1
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38991066	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2"	"Cell line enriched"	"Detected in single"	39	"AF22: 18.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"olfactory region: 29.0"	"Low region specificity"	"Detected in all"			"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favourable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.1	0.1	2.9	0.1	3.8	0.1	0.2	0.0	0.2	1.7	0.2	6.6	0.0	0.2	1.1	8.1	0.1	31.7	0.1	0.1	4.4	4.1	0.1	0.1	9.2	0.1	0.0	0.0	7.6	0.1	0.1	0.0	0.3	9.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.6	2.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.8	0.0	0.2	4.4	4.1	0.0	0.0	9.7	2.1
STOX1	"C10orf24, FLJ25162"	ENSG00000165730	"Storkhead box 1"	Q6ZVD7	10	68827541-68895432	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;fallopian tube: 19.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.9;HAP1: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;T-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037844, HPA037845"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA037844: AB_2675700, HPA037845: AB_10671369"	"prognostic favourable (3.37e-5)"	"unprognostic (5.53e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"prognostic favourable (2.08e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.33e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.46e-2)"	8.7	6.4	17.8	1.7	13.4	0.6	4.8	1.8	13.4	2.0	2.6	6.8	1.3	2.0	2.8	11.9	2.5	19.1	1.7	0.9	16.1	9.3	4.5	0.9	2.2	1.8	11.5	10.2	1.9	1.6	6.1	8.8	1.5	5.6	2.3	2.8	5.0	2.6	2.1	1.9	1.4	2.8	2.5	2.4	0.9	2.2	3.8	7.3	3.3	8.7	0.0	1.7	1.6	0.9	0.7	3.5	0.0	0.0	0.2	3.0	0.2	2.2	2.4	5.4	10.9	2.3	0.0	3.2	0.2	0.1	1.6	1.7	2.3	3.3	2.1	3.1	0.0	0.6	10.1	0.0	0.8	2.5	4.2	0.2	0.5	3.1	0.3	2.7	3.9	0.2	0.2	0.3	0.0	0.1	0.5	0.3	0.2	2.2	4.6	3.4	1.8	1.5	3.4	0.1	0.0	3.2	5.7	1.7	4.9	3.9	1.0	0.7	2.4	2.2	0.0	0.0	0.2	0.0	1.5	1.0	1.9	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.4	0.8	0.6	0.0	0.7	3.0	1.4	0.0	0.2	0.0	3.5	0.3	0.2	17.8	13.4	1.8	12.5	16.1	9.3	11.5	10.2	5.6	7.3
SULT6B1		ENSG00000138068	"Sulfotransferase family 6B member 1"	Q6IMI4	2	37167820-37196598	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.4;fallopian tube: 2.0;testis: 7.1"	"Cell line enriched"	"Detected in some"	6	"WM-115: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (1.86e-1)"										"unprognostic (8.98e-2)"			0.1	0.1	0.1	0.1	0.3	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	7.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1
SYT10		ENSG00000110975	"Synaptotagmin 10"	Q6XYQ8	12	33374238-33439819	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;fallopian tube: 8.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.7;K-562: 2.2;MCF7: 7.5;NTERA-2: 1.9;RPTEC TERT1: 1.9;RT4: 3.0;SCLC-21H: 3.9"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA055426	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA055426: AB_2682812"	"unprognostic (3.60e-1)"	"unprognostic (4.93e-2)"		"unprognostic (9.34e-4)"				"unprognostic (5.53e-2)"		"unprognostic (3.67e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.97e-6)"	"unprognostic (4.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.91e-1)"	0.3	1.5	0.6	0.7	10.1	0.1	0.3	0.2	4.1	2.9	3.6	0.9	3.0	1.0	0.3	0.8	0.3	8.1	0.4	0.5	0.8	3.1	3.3	1.4	0.2	0.1	0.6	3.4	0.4	0.2	0.1	5.8	0.2	14.6	1.6	1.6	0.1	1.8	3.2	0.2	0.2	1.3	0.6	2.7	0.2	1.6	0.6	0.3	0.0	0.2	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	7.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.9	3.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.1	0.2	4.1	0.8	3.1	0.6	3.4	14.6	0.3
TCP11X2		ENSG00000215029	"T-complex 11 family, X-linked 2"	Q5H9J9	X	102456862-102471842	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.5;pituitary gland: 3.3;testis: 3.6"	"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048311	Supported									"HPA048311: AB_2680351"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0			0.0	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0		0.0	0.0	0.2	3.3	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TCTEX1D1	FLJ40873	ENSG00000152760	"Tctex1 domain containing 1"	Q8N7M0	1	66752459-66778787	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;fallopian tube: 18.2;liver: 13.5"	"Group enriched"	"Detected in some"	6	"HEL: 13.8;HUVEC TERT2: 13.9;THP-1: 15.5"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028420	Uncertain									"HPA028420: AB_10603995"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.72e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.53e-6)"	"unprognostic (9.28e-4)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.65e-2)"	1.8	1.1	5.3	1.2	7.2	7.4	1.1	2.1	3.7	1.5	1.0	9.5	0.0	0.8	0.8	7.5	0.8	18.2	1.1	1.9	8.2	10.4	0.7	13.5	4.0	0.4	3.3	2.4	3.4	0.8	0.7	0.9	11.5	28.4	0.8	1.1	0.7	0.5	1.7	1.9	1.3	1.1	1.3	2.6	0.4	0.8	0.5	2.2	0.0	0.6	0.2	0.6	1.5	0.8	0.0	0.1	0.9	0.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	2.5	0.0	0.3	0.7	0.3	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	13.9	0.0	0.0	2.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.6	5.3	7.2	2.1	3.7	8.2	10.4	3.3	2.4	28.4	2.2
TCTEX1D2	MGC33212	ENSG00000213123	"Tctex1 domain containing 2"	Q8WW35	3	196291219-196318299	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 37.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 16.6;dendritic cells: 10.9;T-cells: 18.3"									HPA049555			Approved	Cytosol				Cytosol	Cytosol	"HPA049555: AB_2680816"	"unprognostic (1.16e-1)"	"prognostic favourable (7.83e-4)"	"unprognostic (5.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.61e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (6.23e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	4.3	7.4	20.5	5.1	21.6	5.3	7.0	15.0	18.3	5.2	5.3	7.0	7.2	4.7	8.4	10.4	10.7	37.4	6.3	6.3	15.4	18.6	11.8	2.3	9.1	9.1	12.1	15.8	8.7	6.6	6.8	18.8	4.1	10.6	6.4	4.9	6.8	7.6	6.2	3.1	9.2	3.0	5.3	8.7	4.1	5.2	24.2	8.1	6.8	11.2	5.1	6.5	4.9	5.9	16.6	10.9	1.4	2.3	2.9	18.3	5.6	13.4	10.1	15.5	10.0	4.1	8.0	2.1	5.6	3.2	5.9	6.6	3.4	16.4	8.7	10.1	3.9	14.2	6.3	5.0	5.5	7.6	5.6	3.4	9.9	1.4	4.4	2.2	0.3	3.9	13.3	4.9	6.1	3.5	4.8	4.3	11.3	33.1	11.4	11.1	11.0	19.2	14.4	3.1	3.5	12.6	5.5	19.5	16.5	12.5	6.3	11.0	38.4	6.4	7.8	5.7	2.5	2.3	6.4	7.4	14.1	18.6	17.2	4.2	9.8	0.0	2.3	1.2	9.2	0.8	5.6	16.6	11.6	7.3	6.0	9.5	7.4	7.3	1.4	2.9	0.6	10.9	18.3	5.6	20.5	21.6	15.0	18.3	15.4	18.6	12.1	15.8	10.6	8.1
TEKT1		ENSG00000167858	"Tektin 1"	Q969V4	17	6789133-6831761	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 40.1;testis: 25.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.6;Karpas-707: 2.8;NB-4: 2.8;REH: 2.9;SK-MEL-30: 1.7;U-87 MG: 1.9"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 4.6;glioma: 2.1;lung cancer: 0.9;ovarian cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044444, HPA062285"	Approved									"HPA044444: AB_10961038, HPA062285: AB_2684737"	"unprognostic (7.28e-3)"	"unprognostic (7.24e-3)"		"prognostic favourable (6.08e-4)"	"unprognostic (2.88e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.91e-1)"		"unprognostic (4.22e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.63e-6)"	"unprognostic (6.28e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.13e-1)"	0.2	0.2	2.3	0.2	9.9	0.6	0.2	0.0	0.8	2.1	0.2	10.2	0.0	0.1	1.1	13.0	0.9	40.1	0.9	0.6	3.8	3.7	0.2	0.2	8.2	0.4	0.4	0.3	10.7	0.1	0.1	3.1	0.2	13.7	0.2	0.1	0.0	0.4	0.2	0.1	1.7	0.1	0.2	0.7	0.3	0.2	25.7	2.0	0.0	0.4	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.8	0.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.7	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	9.9	0.0	0.8	3.8	3.7	0.4	0.3	13.7	2.0
TEKT4	MGC27019	ENSG00000163060	"Tektin 4"	Q8WW24	2	94871433-94876829	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 7.6;testis: 21.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.0;fHDF/TERT166: 1.8;HEK 293: 1.0;HEL: 1.3;HMC-1: 1.0;MCF7: 1.5"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 2.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA048600, HPA053929, HPA069872"	Approved		Uncertain	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: "	"unprognostic (1.49e-2)"	"unprognostic (4.00e-1)"		"prognostic favourable (1.29e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.15e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-3)"	"unprognostic (5.45e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.56e-3)"	0.1	0.1	0.7	0.2	1.5	0.1	0.1	0.2	0.2	0.6	0.1	1.4	0.7	0.1	0.5	5.5	0.1	7.6	0.1	0.1	0.9	0.9	0.1	0.1	3.7	0.1	0.1	0.2	1.7	0.2	0.1	0.0	0.1	2.9	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	21.1	0.3	0.0	1.0	0.0	0.1	0.1	0.0	1.1	1.8	0.7	0.6	0.1	0.8	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.3	1.0	1.3	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.7	0.6	0.4	0.3	1.1	0.6	0.7	0.8	0.6	0.8	0.5	0.0	0.1	0.6	1.8	0.6	0.3	0.7	1.5	0.2	0.2	0.9	0.9	0.1	0.2	2.9	0.3
TMEM190	MDAC1	ENSG00000160472	"Transmembrane protein 190"	Q8WZ59	19	55376836-55378244	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 63.6;ovary: 17.7;testis: 21.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 13.8;SCLC-21H: 6.9"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 11.5;lung cancer: 2.6;ovarian cancer: 2.6"	"Region enhanced"	"Detected in some"		"hypothalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 0.9"	"Region enriched"	"Detected in some"	6	"cerebellum: 5.6"												"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-3)"	"unprognostic (3.97e-2)"		"unprognostic (1.42e-1)"	"unprognostic (5.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.38e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.93e-1)"	0.1	0.7	0.1	0.1	0.3	0.1	0.1	0.2	0.5	5.7	0.1	0.5	0.1	0.1	1.4	1.1	0.1	63.6	0.1	0.1	0.6	2.7	0.1	0.1	11.8	0.1	0.1	0.1	17.7	0.1	0.0	3.0	0.3	1.0	0.1	0.0	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.5	21.5	0.3	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.4	2.5	0.0	0.5	0.0	0.0	0.2	0.7	0.3	0.6	0.1	1.7	1.5	2.5	0.2	0.6	4.5	0.0	0.0	0.0	4.2	0.2	0.0	2.6	13.8	0.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	3.4	0.0	2.0	0.3	0.0	0.4	0.8	0.2	1.6	1.4	0.0	1.3	6.9	1.3	1.4	1.8	0.6	0.8	0.0	0.0	0.2	1.1	0.2	0.6	0.5	3.2	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.5	0.6	2.7	0.1	0.1	1.0	0.3
TMEM212	FLJ23172	ENSG00000186329	"Transmembrane protein 212"	A6NML5	3	171843349-171938715	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.2;lung: 10.0;ovary: 12.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045736			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"				"Nucleoli fibrillar center, Endoplasmic reticulum"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA045736: AB_2679436"	"unprognostic (3.39e-2)"			"unprognostic (1.78e-2)"	"unprognostic (3.05e-1)"			"unprognostic (5.54e-2)"		"unprognostic (3.06e-1)"				"unprognostic (2.87e-1)"				0.4	0.4	0.5	0.6	0.8	2.2	0.4	0.4	0.5	1.6	0.8	0.9	0.4	0.2	1.3	2.5	0.8	19.2	0.4	0.4	0.6	0.7	0.4	3.3	10.0	0.6	0.4	0.4	12.8	0.4	0.0	0.4	0.4	0.7	0.4	0.8	0.4	0.4	2.1	1.1	1.5	0.5	0.4	0.4	0.4	0.4	1.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	4.1	3.2	6.3	2.1	3.8	2.7	0.5	4.0	2.5	2.8	3.0	0.8	0.4	5.4	2.9	0.9	1.1	1.2	2.0	3.2	5.3	3.6	1.4	2.8	1.7	1.3	2.5	7.0	2.7	6.3	6.4	2.6	0.5	3.6	5.3	1.1	1.5	1.4	1.1	1.3	4.4	8.5	0.9	2.6	3.2	4.0	4.8	2.6	2.7	4.4	4.4	1.1	3.1	3.3	3.2	4.0	3.0	2.2	3.6	3.3	6.5	4.5	4.9	7.1	3.1	5.0	4.0	3.5	2.3	3.3	2.3	6.3	2.1	1.8	2.7	1.8	2.1	1.9	2.0	1.8	1.1	4.1	2.3	2.5	5.0	3.8	2.0	3.2	1.3	0.5	0.5	0.8	0.4	0.4	0.6	0.7	0.4	0.4	0.7	0.4
TMEM231	"ALYE870, FLJ22167, JBTS20, MKS11, PRO1886"	ENSG00000205084	"Transmembrane protein 231"	Q9H6L2	16	75536744-75556286	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 58.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042081	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA042081: AB_10795391"	"unprognostic (4.29e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-1)"	3.7	5.3	7.9	2.8	14.7	2.5	4.1	5.0	12.4	7.1	4.1	16.6	3.6	4.0	6.4	10.1	3.1	58.4	4.8	7.9	9.1	9.9	4.7	2.5	7.3	2.7	6.5	9.9	14.3	4.7	6.6	7.7	3.6	14.3	5.4	3.5	6.6	3.1	5.6	1.9	3.3	4.2	7.7	6.2	2.7	3.2	8.5	6.6	0.2	8.0	1.0	2.2	3.5	3.0	5.0	3.2	6.2	0.9	1.0	3.5	1.3	3.9	2.4	6.3	10.5	6.1	15.0	3.4	4.3	5.5	5.4	6.5	1.5	6.3	4.3	6.0	6.2	9.5	0.7	5.0	3.3	0.8	2.6	0.2	3.2	1.4	5.4	2.4	1.9	3.3	6.2	5.4	13.3	3.7	4.2	0.2	1.6	10.0	1.5	4.6	3.7	2.2	0.8	0.9	9.6	6.9	1.4	5.3	3.5	8.7	2.1	3.9	2.0	2.7	5.5	4.2	3.6	2.7	2.3	8.2	7.1	1.3	10.5	1.2	4.1	3.0	0.9	0.6	1.7	0.9	3.5	5.0	1.8	2.9	2.5	2.4	1.6	2.4	6.2	1.0	0.5	3.2	0.5	1.3	7.9	14.7	5.0	12.4	9.1	9.9	6.5	9.9	14.3	6.6
TMEM232	FLJ43080	ENSG00000186952	"Transmembrane protein 232"	C9JQI7	5	110289233-110738956	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.8;pituitary gland: 19.8;testis: 23.7"	"Cell line enhanced"	"Detected in some"		"U-266/70: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049386	Uncertain									"HPA049386: AB_2680739"	"unprognostic (1.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.49e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-4)"	"unprognostic (8.96e-2)"	1.2	2.3	4.6	0.7	5.9	0.5	2.0	3.0	6.8	2.1	1.0	3.7	4.9	1.2	1.7	4.8	1.2	21.8	2.8	1.4	4.7	4.5	6.1	1.4	2.9	0.9	2.9	4.8	3.4	1.3	3.6	19.8	1.1	9.2	1.6	0.9	3.1	1.3	1.6	0.7	1.0	0.9	1.0	3.1	0.8	1.7	23.7	4.4	0.5	6.1	0.0	0.8	1.3	0.9	1.1	0.0	0.8	0.1	0.3	0.6	0.1	0.9	0.4	2.7	0.9	2.4	4.0	0.5	0.0	0.0	0.5	0.5	0.4	0.4	1.2	0.8	0.1	0.9	0.5	2.0	0.6	2.5	0.4	0.4	0.0	0.0	2.0	0.7	0.5	1.1	0.3	0.6	1.0	0.4	0.7	0.8	1.6	0.3	1.4	0.8	0.3	0.0	0.5	0.3	0.5	2.8	0.0	2.6	2.7	0.3	0.0	2.3	1.0	0.3	0.0	2.6	0.3	0.2	0.1	6.6	2.2	1.0	2.1	0.7	0.4	0.0	0.1	0.8	0.0	0.0	0.5	1.1	0.0	0.1	0.0	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.1	4.6	5.9	3.0	6.8	4.7	4.5	2.9	4.8	9.2	4.4
TMPRSS3	"DFNB10, DFNB8"	ENSG00000160183	"Transmembrane serine protease 3"	P57727	21	42371837-42396846	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.7"	"Group enriched"	"Detected in some"	5	"HEL: 18.3;U-266/84: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 6.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.3"	"Region enriched"	"Detected in single"	7	"cerebellum: 0.9"	"Not detected"	"Not detected"														"unprognostic (8.47e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (3.64e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (8.24e-4)"	"unprognostic (2.66e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.33e-1)"	1.8	0.7	8.6	0.3	7.7	0.3	9.4	0.3	7.1	6.8	0.4	0.0	0.0	1.7	0.9	0.4	0.4	24.7	8.6	0.2	1.8	1.6	3.5	3.5	3.7	0.6	3.7	2.0	2.8	7.4	0.2	5.8	5.7	3.3	0.8	0.4	2.4	12.3	0.6	0.3	0.6	1.3	0.2	0.2	0.6	15.9	0.2	0.8	0.0	9.8	0.2	0.6	1.9	0.0	0.0	0.1	0.7	0.8	0.0	6.3	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.0	0.0	18.3	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.4	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	0.0	0.0	9.5	0.4	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.2	73.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	6.3	0.0	3.5	3.6	0.1	0.0	0.7	1.8	0.7	0.0	0.8	0.0	1.6	1.0	8.6	7.7	0.3	7.1	1.8	1.6	3.7	2.0	3.3	0.8
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29061373	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.8;NB-4: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 3.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA037561, HPA037562"	Uncertain									"HPA037561: AB_10670384, HPA037562: AB_2675545"	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.3	2.3	3.0	1.7	8.4	2.6	0.4	3.4	1.7	0.6	0.6	7.1	0.0	0.8	1.1	14.4	0.7	15.7	0.5	2.6	3.3	3.9	0.3	0.5	14.2	1.1	2.1	2.0	4.5	0.8	0.1	6.1	0.6	15.3	0.5	0.4	0.1	0.5	0.1	1.7	0.6	0.7	0.8	2.5	2.2	1.5	3.2	6.1	0.0	0.3	0.3	1.3	0.4	0.3	0.3	0.3	0.6	0.3	0.6	3.7	1.0	0.2	0.2	0.3	0.2	0.3	0.0	0.7	0.1	2.3	0.7	2.2	0.4	0.3	0.3	0.3	0.0	0.9	0.4	0.0	0.7	0.4	1.4	0.2	2.0	0.5	0.9	2.0	3.8	0.2	0.3	0.0	0.0	0.3	0.3	1.0	0.8	0.2	0.8	3.6	2.7	0.7	0.1	0.7	1.5	1.1	0.3	2.6	1.8	0.1	0.1	0.1	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.5	0.5	0.2	1.7	1.3	0.1	0.5	0.3	0.3	3.7	0.1	2.0	0.2	0.6	2.9	0.1	0.3	0.4	1.0	0.6	0.6	0.2	0.3	1.5	1.0	3.0	8.4	3.4	1.2	3.3	3.9	2.1	2.0	15.3	6.1
TPPP3	"CGI-38, p20, p25gamma"	ENSG00000159713	"Tubulin polymerization promoting protein family member 3"	Q9BW30	16	67389809-67393535	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 211.3"	"Cell line enhanced"	"Detected in some"		"A549: 29.6;RH-30: 15.8;SCLC-21H: 24.4;SH-SY5Y: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 26.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047629, HPA061691"	Enhanced		Approved	"Nucleoli fibrillar center"		29000	29000	"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA047629: AB_2680108, HPA061691: "	"unprognostic (1.63e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavourable (8.84e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.86e-3)"	9.6	7.6	30.5	2.9	20.7	1.0	21.9	3.7	25.0	12.8	11.9	70.3	2.0	6.4	7.2	15.1	24.8	211.3	6.0	11.3	36.4	41.9	6.1	1.9	36.3	1.7	26.4	22.1	14.1	6.5	2.2	5.8	70.6	24.5	3.4	4.3	2.2	5.2	4.2	14.4	28.1	9.8	10.0	40.6	3.8	11.3	2.6	24.4	0.1	3.5	37.6	6.1	7.4	5.5	0.0	14.1	5.2	26.2	0.0	0.1	3.6	0.2	29.6	0.3	0.2	0.2	4.9	0.1	0.8	0.2	0.2	0.4	1.9	6.0	0.0	0.4	0.4	5.6	4.6	0.0	0.0	0.0	1.7	0.0	0.8	0.8	0.0	0.0	0.0	1.2	0.1	1.8	0.0	0.3	0.0	0.0	2.7	0.1	0.0	0.1	1.0	0.0	0.0	15.8	0.1	0.0	0.0	24.4	10.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	10.9	5.2	0.0	15.4	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	2.6	0.0	26.2	0.1	0.0	3.6	30.5	20.7	3.7	23.8	36.4	41.9	26.4	22.1	24.5	24.4
TSNAXIP1	TXI1	ENSG00000102904	"Translin associated factor X interacting protein 1"	Q2TAA8	16	67806765-67832148	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.2;testis: 40.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.9;SiHa: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA053516			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA053516: AB_2682175"	"unprognostic (9.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"prognostic favourable (2.22e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.59e-3)"	0.9	1.9	4.8	1.1	9.2	0.6	0.9	2.0	3.9	1.3	0.9	3.3	1.9	0.5	1.8	3.6	0.7	14.2	1.2	0.7	3.8	3.3	1.6	0.8	2.1	0.7	1.2	3.7	2.5	2.2	2.9	6.9	0.7	6.3	1.0	0.7	1.0	1.0	2.0	0.5	0.8	0.6	1.2	0.9	0.8	1.2	40.6	2.5	0.0	1.1	0.0	0.7	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.4	1.1	0.4	2.5	6.9	3.5	0.9	0.9	0.0	1.6	0.5	2.4	0.7	0.8	1.0	1.0	0.2	1.3	1.0	1.1	1.5	0.3	0.9	0.0	0.8	0.1	1.1	1.6	0.2	0.8	0.9	3.5	0.5	0.0	0.5	0.3	0.0	0.0	0.3	0.6	0.7	0.4	1.7	0.7	0.1	3.5	0.6	2.0	2.1	4.4	0.1	0.4	1.8	0.1	0.8	0.4	0.1	0.3	0.2	1.2	2.1	0.2	0.3	0.2	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.8	9.2	2.0	3.9	3.8	3.3	1.2	3.7	6.3	2.5
TTC34		ENSG00000215912	"Tetratricopeptide repeat domain 34"	A8MYJ7	1	2635976-2801717	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.5;testis: 4.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;Karpas-707: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA066832	Uncertain									"HPA066832: AB_2685731"	"unprognostic (1.45e-4)"	"unprognostic (5.00e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.69e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.68e-4)"	0.1	0.2	0.6	0.3	1.2	0.0	0.4	0.2	0.3	0.4	0.0			0.0	0.5	0.6	0.0	3.5	0.0	0.0	0.9	0.7	0.0	0.0	0.4	0.1	0.1		0.6	0.0	0.2	0.3	0.0		0.3	0.0		0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.5	0.3	4.6			1.5		0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.6	0.2	0.7	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.7	0.2	0.0	0.0	0.8	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.3	0.2	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.7	0.1	0.3	0.4	0.1	0.2	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.3	0.0	0.1	0.0	0.2	0.7	0.7	0.1	0.0	0.7	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0										
TTLL6	FLJ35808	ENSG00000170703	"Tubulin tyrosine ligase like 6"	Q8N841	17	48762235-48817214	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.8;intestine: 5.0;testis: 17.6"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 9.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA052397	Enhanced		Approved	Vesicles,Microtubules				Microtubules	Microtubules	"HPA052397: AB_2681812"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.21e-5)"	"unprognostic (1.10e-2)"	"unprognostic (6.01e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.09e-3)"	0.1	0.0	0.5	3.3	0.5	0.0	0.1	0.1	1.1	0.2	3.6	0.1	1.3	1.6	0.8	0.1	0.1	4.8	1.4	0.1	0.8	0.4	1.8	0.1	1.1	0.1	0.2	1.1	0.8	0.6	0.0	0.3	0.1	0.9	0.1	5.0	0.3	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.1	17.6	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	1.1	0.8	0.4	0.2	1.1	0.9	0.1
TTLL9	"C20orf125, dJ310O13.1"	ENSG00000131044	"Tubulin tyrosine ligase like 9"	Q3SXZ7	20	31870702-31944963	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;REH: 2.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041772, HPA055676"	Uncertain		Uncertain	Nucleoplasm,Microtubules				"Nucleoplasm, Microtubules"	"Nucleoplasm, Microtubules"	"HPA041772: AB_10959904, HPA055676: AB_2682881"	"unprognostic (8.77e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.05e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.23e-2)"	0.4	0.6	3.4	0.5	8.9	0.4	1.3	1.0	2.8	0.6	0.5	10.9	1.8	0.6	1.1	8.9	0.6	9.2	0.8	0.5	4.8	3.7	0.8	0.5	1.7	0.7	5.2	0.6	1.8	0.4	2.8	2.8	0.7	16.0	0.6	0.5	0.0	0.5	1.8	0.4	0.6	0.4	0.6	4.5	0.5	0.6	11.0	4.0	0.0	2.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.6	0.3	0.0	0.1	0.5	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	8.9	1.0	2.7	4.8	3.7	5.2	0.6	16.0	4.0
UBXN10	"FLJ25429, UBXD3"	ENSG00000162543	"UBX domain protein 10"	Q96LJ8	1	20186085-20196048	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 44.3;testis: 30.4"	"Group enriched"	"Detected in some"	5	"HEL: 3.7;HMC-1: 9.7;K-562: 10.8;SCLC-21H: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028555, HPA028564"	Uncertain									"HPA028555: AB_10600417, HPA028564: AB_10601897"	"unprognostic (3.00e-3)"	"unprognostic (3.30e-2)"	"unprognostic (4.31e-2)"	"prognostic favourable (2.02e-4)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.60e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	0.9	1.7	2.4	0.8	4.3	1.8	3.1	2.6	8.5	6.8	10.3	6.8	5.3	1.1	6.0	8.4	4.0	44.3	2.1	3.3	3.5	4.2	2.9	6.0	7.6	0.6	2.8	2.7	7.1	1.7	2.8	8.8	1.2	9.0	2.6	4.7	1.7	1.3	2.9	0.5	0.9	2.5	3.4	2.1	0.4	3.8	30.4	1.9	0.0	11.3	0.1	0.8	3.0	0.7	0.8	1.5	0.8	0.9	6.6	4.9	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	1.4	9.7	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.4	0.4	1.1	0.0	0.0	0.0	0.0	0.8	0.5	7.6	0.0	0.0	0.2	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.8	0.1	4.9	0.8	1.4	1.7	1.5	0.2	1.1	1.6	0.8	6.6	0.0	0.0	0.6	0.8	2.4	4.3	2.6	8.5	3.5	4.2	2.8	2.7	9.0	1.9
USP17L11		ENSG00000233136	"Ubiquitin specific peptidase 17-like family member 11"	C9JVI0	4	9215405-9217356	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.0;fallopian tube: 1.2;thyroid gland: 1.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;NTERA-2: 1.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"									HPA045642	Uncertain									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.0	0.0			0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			1.3		0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0										
VWA3A	"FLJ40941, FLJ46765"	ENSG00000175267	"Von Willebrand factor A domain containing 3A"	A6NCI4	16	22092538-22156966	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.8;fallopian tube: 27.0"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 1.5;U-266/70: 1.2;U-266/84: 2.4;WM-115: 1.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041696, HPA042044"	Uncertain				"Secreted - unknown location"					"HPA041696: AB_10964202, HPA042044: AB_10968997"	"unprognostic (2.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.75e-4)"	"prognostic favourable (8.15e-4)"	"unprognostic (2.70e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.79e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.06e-4)"	1.0	1.1	3.6	0.7	8.3	1.1	0.9	0.3	12.2	8.1	0.8	13.2	0.0	0.8	2.3	9.6	0.8	27.0	0.7	0.9	4.8	5.8	0.9	0.7	5.5	0.8	0.7	6.7	3.0	1.0	0.9	10.0	0.8	26.8	0.9	0.8	0.0	0.8	0.8	0.8	2.3	1.1	0.7	3.8	1.0	0.9	5.0	3.6	0.0	0.9	0.0	0.9	0.9	0.1	0.2	0.1	0.0	0.5	0.0	0.4	0.0	0.1	1.0	0.6	0.7	0.2	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	2.4	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	3.6	8.3	0.3	12.2	4.8	5.8	0.7	6.7	26.8	3.6
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;HeLa: 3.3;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favourable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.4	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.1	0.5	0.7	0.3	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.3	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.0	0.2	3.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	2.0	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.4	1.2	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 21.6;fallopian tube: 20.7"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;NTERA-2: 3.7;THP-1: 16.7;U-937: 8.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2"	"Group enriched"	"Detected in many"	24	"dendritic cells: 5.2;monocytes: 5.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA036225: AB_10696652, HPA036226: AB_2675007"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.5	0.7	6.5	1.1	6.8	3.6	0.6	12.6	5.0	1.2	0.9	8.5	0.0	3.9	1.2	4.4	2.1	20.7	0.7	4.7	12.3	5.4	1.0	0.4	4.0	0.9	7.6	2.8	3.2	0.9	0.4	1.7	0.4	21.6	0.7	0.6	0.0	0.7	0.4	0.4	0.5	8.0	0.7	17.6	1.1	0.8	1.5	14.2	0.0	0.5	0.0	1.0	0.8	0.6	0.2	5.2	0.0	5.6	0.0	0.0	0.7	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.8	0.0	0.0	5.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	6.5	6.8	12.6	3.7	12.3	5.4	7.6	2.8	21.6	14.2
WDR54	FLJ12953	ENSG00000005448	"WD repeat domain 54"	Q9H977	2	74421678-74425755	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 56.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043257, HPA053558"	Enhanced		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA043257: AB_10795981, HPA053558: AB_2682189"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.85e-2)"	4.8	6.3	9.4	5.4	17.0	5.0	4.8	8.4	15.4	7.0	3.9	6.0	10.5	3.0	7.0	7.8	3.1	56.8	7.2	3.4	9.9	11.6	7.9	1.4	8.1	8.6	4.8	13.0	8.4	5.4	21.3	16.0	5.4	7.8	5.0	3.7	10.5	3.9	9.0	1.5	3.5	3.9	6.8	3.5	7.7	5.7	27.6	3.7	20.6	5.8	2.5	8.9	6.2	4.0	12.6	23.1	2.3	5.3	13.2	18.7	10.0	15.9	29.6	14.5	12.6	5.3	9.9	4.5	8.1	16.8	21.5	19.9	2.5	12.6	14.2	8.5	9.1	13.7	10.2	36.5	18.8	10.7	6.3	6.9	16.3	1.6	5.4	10.9	5.7	4.4	10.4	21.7	11.3	11.1	2.8	16.8	11.8	24.7	17.2	11.5	11.1	11.2	14.8	16.4	29.7	18.8	8.0	25.3	19.7	6.4	5.8	9.4	9.4	5.2	5.5	11.0	19.4	11.8	18.1	18.4	9.2	3.6	32.5	6.7	8.0	2.3	4.2	0.3	16.2	5.3	16.3	12.6	18.7	17.4	14.1	11.1	13.2	12.8	0.3	13.2	4.5	23.1	17.5	10.0	9.4	17.0	8.4	15.4	9.9	11.6	4.8	13.0	7.8	3.7
WDR66	"CaM-IP4, MGC33630"	ENSG00000158023	"WD repeat domain 66"	Q8TBY9	12	121917862-122003927	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 21.4;hTCEpi: 20.2;hTERT-HME1: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039902, HPA040005"	Supported		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039902: AB_10795236, HPA040005: AB_10795160"	"unprognostic (4.92e-3)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-3)"	"prognostic favourable (3.11e-4)"	"unprognostic (5.58e-3)"	"unprognostic (6.89e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	1.3	1.2	6.3	1.0	13.2	0.4	1.7	0.4	4.0	4.4	0.5	4.5	1.5	0.4	2.5	11.3	0.5	24.6	2.0	1.5	6.4	3.7	3.2	1.8	6.4	0.9	0.7	3.2	3.9	2.1	4.7	28.4	1.3	18.0	0.8	0.4	1.3	1.3	2.2	0.5	1.8	0.5	1.0	0.9	2.0	0.8	35.0	2.4	0.0	6.7	0.0	1.2	0.8	1.7	0.2	4.9	0.4	0.0	0.1	0.3	0.0	1.8	0.2	0.3	0.1	0.3	0.3	0.3	0.2	1.7	0.8	2.0	0.2	0.9	0.1	2.4	0.1	0.6	0.2	21.4	3.0	0.1	0.3	0.1	0.4	0.2	2.6	0.0	5.9	1.2	20.2	1.6	13.7	0.9	4.8	0.0	1.2	0.6	0.2	0.3	0.3	0.1	0.3	0.5	0.0	3.7	0.3	1.7	0.1	0.2	0.0	0.1	0.5	0.1	0.7	1.7	2.6	0.3	0.3	0.3	0.1	2.5	2.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.4	0.1	0.0	4.9	0.3	0.0	6.3	13.2	0.4	4.0	6.4	3.7	0.7	3.2	18.0	2.4
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449376	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 68.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favourable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	11.2	16.5	10.0	17.3	16.2	5.9	9.7	8.5	18.1	9.8	10.9	14.3	5.7	9.5	13.9	15.7	19.0	68.6	15.7	16.6	9.9	10.8	13.6	19.2	9.9	16.8	12.1	9.6	14.6	14.0	15.1	11.7	12.1	15.8	12.6	16.6	10.3	16.4	13.4	27.2	8.9	11.1	13.0	7.9	16.5	14.5	12.9	9.3	19.3	9.9	23.2	22.7	19.1	11.0	24.9	25.7	6.2	17.7	26.7	16.1	11.9	20.4	18.0	17.2	14.1	10.4	6.1	23.9	15.5	8.3	23.8	15.7	26.4	7.7	35.0	15.2	13.2	14.9	31.0	29.8	28.8	13.9	24.3	20.8	21.0	37.9	11.7	21.3	35.6	7.4	21.3	23.3	15.0	15.8	27.8	9.3	23.0	25.9	27.3	11.2	33.8	30.2	27.4	27.1	13.4	21.1	36.4	14.2	10.3	13.6	17.2	12.3	13.8	14.7	11.5	13.2	26.6	25.6	32.9	7.7	9.6	31.5	16.7	24.0	38.7	6.2	11.6	2.9	13.9	17.7	15.5	24.9	15.1	15.5	25.7	21.6	16.1	15.0	1.7	26.7	15.5	16.1	12.5	11.9	10.0	16.2	8.5	18.1	9.9	10.8	12.1	9.6	15.8	9.3
WDR78	"DIC4, FLJ23129"	ENSG00000152763	"WD repeat domain 78"	Q5VTH9	1	66812885-66924887	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.7;testis: 29.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.8;RPTEC TERT1: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 7.6"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (4.26e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.08e-2)"	"prognostic favourable (9.60e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.79e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.69e-1)"	1.6	2.0	3.1	2.7	7.5	0.3	3.0	0.9	3.9	4.2	5.1	4.0	4.0	0.9	3.1	16.0	0.9	25.7	2.5	1.7	4.2	4.1	6.8	1.3	5.6	1.0	2.0	4.0	7.6	2.0	6.3	7.0	2.1	16.8	2.4	4.0	2.4	2.1	5.8	0.9	1.3	1.2	1.5	2.4	1.2	1.2	29.8	3.3	1.6	6.2	1.1	0.9	1.7	1.5	1.6	0.0	0.2	0.0	7.6	1.0	0.2	3.3	1.4	1.9	2.5	5.8	8.8	0.7	1.6	2.6	2.0	2.0	0.3	2.9	1.7	0.3	1.5	0.3	1.4	0.3	3.0	0.2	0.4	0.5	0.7	0.3	2.0	0.1	0.1	4.1	4.2	7.2	1.5	0.7	0.5	0.1	3.2	1.2	0.7	0.5	2.4	0.7	0.8	0.0	0.0	13.7	0.0	2.3	1.1	1.5	0.6	1.2	0.6	1.2	0.3	0.8	0.0	5.6	0.8	0.5	0.0	3.8	1.6	0.4	2.0	0.0	0.0	0.0	0.3	0.0	0.3	0.7	0.6	0.3	0.0	1.6	1.0	0.4	0.2	7.6	0.0	0.0	0.1	0.2	3.1	7.5	0.9	3.9	4.2	4.1	2.0	4.0	16.8	3.3
WDR93		ENSG00000140527	"WD repeat domain 93"	Q6P2C0	15	89690797-89743638	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 12.0;testis: 28.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA046196, HPA048112"	Uncertain		Uncertain	"Actin filaments"				"Actin filaments"	"Actin filaments"	"HPA046196: AB_2679582, HPA048112: AB_2680267"	"unprognostic (2.56e-3)"	"unprognostic (3.21e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.44e-2)"	0.5	0.3	1.2	0.7	2.3	0.8	1.1	1.1	1.4	1.2	0.2	3.7	0.0	0.0	0.6	8.0	0.1	12.0	0.3	1.6	1.6	1.6	2.5	0.2	1.3	0.3	0.3	0.4	1.7	0.8	0.4	3.0	0.2	6.2	0.9	0.2	2.5	1.1	1.9	0.3	0.4	0.2	0.0	0.5	0.3	0.2	28.6	1.2	0.1	3.3	0.0	0.2	0.2	0.1	0.5	1.1	2.2	0.3	1.3	0.6	0.2	1.1	1.0	0.1	0.5	1.3	1.0	1.5	1.0	0.5	1.2	0.7	0.4	2.7	0.6	1.0	0.7	0.7	0.0	0.8	1.9	1.2	0.8	0.8	1.3	0.6	1.7	1.1	0.2	1.6	1.9	0.4	0.1	0.3	0.1	0.9	0.9	1.0	1.0	0.5	1.4	0.5	0.4	0.4	0.4	2.6	0.6	3.3	0.8	2.7	0.8	3.6	0.5	1.8	0.0	1.0	0.8	1.6	0.6	0.5	0.9	0.8	1.2	0.4	0.6	1.2	0.3	0.4	0.5	0.3	0.2	0.2	0.3	0.2	0.3	0.5	0.3	0.6	2.2	1.3	0.2	1.1	0.2	0.2	1.2	2.3	1.1	1.4	1.6	1.6	0.3	0.4	6.2	1.2
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"Wilms tumor 1"	P19544	11	32387775-32435630	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 69.0;fallopian tube: 34.5;ovary: 53.4"	"Cell line enhanced"	"Detected in some"		"HEL: 13.2;HMC-1: 17.0;K-562: 11.9;NB-4: 31.9;THP-1: 15.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 0.5"	"Low region specificity"	"Detected in single"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: "	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	10.3	0.0	0.2	1.8	0.6	0.0	0.2	0.2	0.5	20.3	1.5	0.2	3.7	0.0	69.0	9.3	0.4	34.5	0.8	2.1	0.9	0.0	5.3	0.2	0.8	0.5	0.2	0.2	53.4	0.2	0.0	0.2	6.9	0.3	0.9	0.0	0.2	0.2	4.2	0.2	0.0	0.4	23.7	0.2	14.6	0.0	24.5	0.2	0.2	0.3	0.2	0.2	1.3	4.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.0	6.1	0.0	0.0	0.0	4.6	13.2	0.0	1.1	3.7	8.8	17.0	0.0	0.0	2.7	0.0	0.0	11.9	0.1	2.7	0.0	7.7	31.9	0.7	3.7	1.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	15.3	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.2	0.5	0.9	0.0	0.2	0.2	0.3	0.2
ZBBX	FLJ23049	ENSG00000169064	"Zinc finger B-box domain containing"	A8MT70	3	167240287-167381346	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;epididymis: 14.2;fallopian tube: 23.4;testis: 33.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.9;CAPAN-2: 2.2;NTERA-2: 1.5;PC-3: 1.2;SCLC-21H: 1.9;U-138 MG: 1.4;U-87 MG: 2.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA036327, HPA036328"	Enhanced									"HPA036327: AB_10672240, HPA036328: AB_2675063"	"unprognostic (2.68e-3)"	"unprognostic (4.49e-2)"		"unprognostic (6.94e-2)"	"unprognostic (3.99e-1)"			"unprognostic (4.08e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"		0.3	0.6	2.5	0.3	12.9	0.3	0.3	0.0	3.3	1.3	0.4	4.5	0.0	0.3	1.1	14.2	0.3	23.4	0.3	0.3	4.7	3.9	0.5	0.3	7.2	0.4	0.4	2.6	6.9	0.3	0.8	5.3	0.4	22.0	0.4	0.3	0.0	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.3	0.4	33.3	3.4	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.5	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.4	0.7	0.0	0.1	0.8	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	12.9	0.0	3.3	4.7	3.9	0.4	2.6	22.0	3.4
ZNF474	"4933409D10Rik, FLJ32921"	ENSG00000164185	"Zinc finger protein 474"	Q6S9Z5	5	122129513-122153571	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 11.4;fallopian tube: 21.4;testis: 22.9"	"Cell line enhanced"	"Detected in some"		"BJ: 3.4;CAPAN-2: 3.3;TIME: 4.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"																		"unprognostic (9.98e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.90e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-4)"	0.3	0.1	1.4	0.3	1.5	0.1	0.3	0.2	0.2	1.2	0.5	6.3	0.6	0.2	1.1	4.9	0.5	21.4	0.7	0.1	1.5	1.1	0.1	0.1	7.9	0.1	0.4	0.2	7.1	0.1	0.2	0.7	0.6	11.4	0.3	0.2	0.0	0.1	0.2	0.0	0.3	0.3	0.3	0.4	0.1	0.2	22.9	0.9	0.0	1.3	0.0	0.2	0.4	0.2	0.2	0.9	0.0	0.0	0.0	0.6	0.0	0.1	1.3	0.5	0.2	0.8	0.4	0.1	3.4	0.8	0.4	0.1	0.1	3.3	0.0	0.2	2.2	0.6	0.2	0.0	1.3	0.3	0.3	1.2	0.7	0.0	0.7	1.1	0.1	0.4	1.4	0.9	0.5	0.1	0.0	0.1	0.1	2.0	0.8	0.4	0.0	0.0	0.9	0.1	0.9	0.5	0.1	0.8	0.2	1.0	0.1	0.4	0.5	0.5	4.0	1.2	0.8	2.2	0.8	0.3	0.6	0.4	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.9	0.0	0.0	1.4	1.5	0.2	0.2	1.5	1.1	0.4	0.2	11.4	0.9
